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Foreword 
 
 
 
 
 
 
 
 
 
 
 
Pollution, most particularly air pollution, is receiving a great deal of attention in the 
United Kingdom at the moment. However, tackling pollution (in all its forms) has not 
been foremost in the minds of health policy makers in recent years. It has been the 
role of public health professionals of all disciplines, and the wider public health 
workforce, to guard the public from the health impacts of pollution. 
 
I chose to address pollution in this, my ninth, annual report because I believe it is 
time for policy makers to take seriously the threat to health posed by pollution, and 
therefore to understand that addressing pollution is disease prevention. Everyone 
understands that acute exposure to a toxic substance will cause ill-health. Lesser 
known, and understood, is the relationship between longer-term, lower level 
exposure to pollutants. We already know there is a link in some instances: think of 
the opportunities to improve health that may be at our fingertips if we can better 
integrate socio-demographic, health and environmental data – using this to better 
understand these threats. 
 
And who will benefit from this? Clearly we will all benefit but those dedicated to 
reducing health and environmental inequalities may take particular interest in 
Chapter 6 of this report, ‘Pollution and inequality’. 
 
I would like to see all forms of pollution at the forefront of professional and public 
attention. I hope this report helps to inform the conversation. 
 
Page 3 of 341 
 
This report could not have been produced without the generous input of the editors, 
Chapter Leads, Chapter Authors and contributors. The Chief Medical Officer, 
Professor Dame Sally Davies expresses her thanks to all those who contributed to 
this report. 
 
Editor-in-Chief 
Andrew Dalton, Public Health Specialty Registrar, West Midlands Deanery 
 
Project Manager and Editor 
Orla Murphy, Department of Health and Social Care 
 
 
An accessible PDF download of this report will be made available via www.gov.uk 
on the day of report publication.
Page 4 of 341 
 
Contents 
 
Chapter 1 Chief Medical Officer’s summary 
 
Prof Dame Sally C. Davies, Chief Medical Officer, Department of Health and Social 
Care 
 
 
Chapter 2  Pollution from the health and care System 
 
Prof David Pencheon, Honorary Professor, Health and Sustainable Development, 
Medical School, University of Exeter Medical School 
Dr Andrew R. H. Dalton, Public Health Specialty Registrar, West Midlands Deanery 
  
 
Chapter 3 21st century chemicals 
 
Prof Timothy W. Gant, Helen E. Smith, Dr Emma L. Marczylo, Dr Miriam N. Jacobs, 
Dr Timothy H. Marczylo, Dr Ovnair Sepai, Mr Andrew Tristem of Centre for 
Radiation, Chemical and Environmental Hazards, Public Health England 
 
 
Chapter 4 New horizons 
 
Prof Alistair Boxall, Professor in Environmental Science, University of York 
Dr Andrew R. H. Dalton, Public Health Specialty Registrar, West Midlands Deanery 
 
 
Chapter 5 Economics of pollution interventions 
 
Dr Laure de Preux, Assistant Professor in Economics, Imperial College Business 
School   
Prof Franco Sassi, Professor of International Health Policy and Economics, Imperial 
College Business School  
  
 
Chapter 6 Pollution and inequality 
 
Prof Gordon Walker, Lancaster Environment Centre, Lancaster University  
Dr Gordon Mitchell, School of Geography, University of Leeds  
Prof Jamie Pearce, School of GeoSciences, University of Edinburgh 
 
Page 5 of 341 
 
Chapter 7 Environmental health - response to pollution 
 
Dr Naima Bradley, Head of Environmental Hazards and Emergencies Department, 
Public Health England 
Dr Patrick Saunders, Visiting Professor of Public Health, University of Staffordshire 
Dr Benjamin Fenech, Principal Noise and Health Scientist, Public Health England 
Ms Vicki Rhodes, Senior Specialist (Special Topics), Environment Agency 
 
 
Chapter 8 Pollution - data, surveillance and health impacts 
 
Prof Paul Elliott, Dr Frédéric B. Piel, Dr Daniela Fecht and Dr  Anna L. Hansell of UK 
Small Area Health Statistics Unit (SAHSU), MRC-PHE Centre for Environment and 
Health, Department of Epidemiology and Biostatistics, School of Public Health, 
Imperial College London 
 
 
Chapter 9 Measurement and communication of health risks from pollution 
 
Prof Kevin McConway, Emeritus Professor of Applied Statistics, Open University 
Prof Helene Joffe, Professor of Psychology, University College London 
Prof Marian Scott, Professor of Environmental Statistics, University of Glasgow 
Sir David Spiegelhalter, Winton Professor of the Public Understanding of Risk, 
University of Cambridge 
Dr Heather Walton, Senior Lecturer in Environmental Health, King’s College London 
 
 
 
 
 
 
 
Page 6 of 341 
 
Chapter 1 
 
 
 
Chief Medical 
Officer’s summary 
  
  
 
 
 
 
 
 
Chapter author 
Sally C. Davies1 
 
1 Chief Medical Officer, Department of Health and Social Care  
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Introduction 
As Chief Medical Officer for England I have a statutory duty to produce an annual 
report on the state of the public’s health. These reports – like me – are independent 
of Government, and call on stakeholders across the policy spectrum to make 
changes that will improve our health. They draw on the expertise of the Chapter 
Leads – preeminent academics and practitioners in their fields – who come together 
to give their views and inform my independent recommendations. I am grateful to 
them all for their help. 
 
This year I have chosen to focus my report on the impact of pollution on human 
health.  
 
Pollution affects everyone, every day. Our children are affected by noise pollution 
from roads near their schools; our houses are washed with light pollution every night; 
we are exposed to chemicals in the almost invisible dust in our houses. There are no 
aspects of our life that do not have the potential to be impacted by pollution. Most 
pollutants are by-products of actions and processes of society. The social and/or 
economic benefit of these processes may at times outweigh the generally low risk 
they pose to human health. There are some pollutants, however, which have either 
been shown to have a significant negative impact on human health or have limited 
evidence associated with them that implies this is possible.  
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Use of ‘Risk’ and ‘Hazard’ in this report 
‘Hazard’ refers to the inherent properties of a substance that make it capable of 
causing harm to a person or the environment. 
‘Risk’ is the possibility of a harm arising from a particular exposure to a substance, 
under specific conditions.i  
 
On researching this report I expected to find many concrete actions official bodies 
could take to reduce the impact of pollution on the public’s health. I have been 
surprised by how little we know about many of the common pollutants that surround 
us each day. There are some areas where we do know enough to act, and here we 
should do so with urgency. The chapters that follow contain numerous suggestions 
from experts for policy makers and officials. I make my recommendations in this 
chapter. 
 
Overall, I have been struck by the lack of evidence we have in this field. This is not 
for want of trying on behalf of academics and practitioners. At the moment we do not 
have the systems in place to effectively monitor, understand, and act on data about 
the health impacts of pollution. The clarion call from this report is therefore to create 
these systems so that we can determine effective actions. As I will set out, this will 
require a conceptual shift: we must start to address pollution as disease prevention. 
And we must consider the impact on human health of all of the different singular 
pollutants alone AND in combination with others, over short AND over long-term 
periods. 
 
First – some context. I became Chief Medical Officer in 2011, and pollution has 
featured in most of my reports. For example, in my first surveillance report, published 
in 2012, I highlighted the World Health Organization’s inclusion of urban air pollution 
among the top ten risk factors for mortality in the UK. This should come as no 
surprise to the public health profession as we have our roots in environmental health. 
The early public health professionals in the nineteenth century set out to uncover the 
environmental causes of diseases and find solutions to improve our ancestors’ 
health.  
 
This era saw great change to the way our society and built-environment was 
structured, in order to improve health. The sweeping sanitary reforms and public 
works of the mid-nineteenth century are the basis of modern sanitation and drinking 
water systems, for example. This progress continued into the mid-twentieth century, 
with significant pieces of legislation such as the 1956 Clean Air Act which finally 
                                                          
i
  Definition adapted from https://www.chemicalsafetyfacts.org/  
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banished the infamous smog of UK cities. These achievements remain some of the 
biggest successes that we have had in improving the public’s health. 
 
That is the past. Now the question for all of us working to improve the public’s health 
–must be: is our modern approach to pollution working?  
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Purpose and remit of this report 
 
Purpose 
I intend my report to bring political, policy and health system attention to pollution as 
a threat to the public’s health, both at acute exposure but also at lower-level, longer-
term exposure. I want to emphasise the role pollution plays in non-communicable 
diseases (NCDs) and recommend means to better understand and tackle this threat; 
we can structure our research and public sector organisations to look at the whole 
spectrum of pollution holistically.  
 
Remit 
My reports cannot cover every aspect of a topic, to do so they would be 
unmanageably large. I have therefore placed a number of parameters around the 
report remit in order to make the scope of this report manageable and to ensure the 
recommendations I make are achievable.  
 
This report focuses on the direct impact of pollution on human health. This reflects 
my role as Chief Medical Officer. I do take a ‘one health approach’, which recognises 
that human illness, and the flora and fauna that surround us, can be closely linked. 
Whilst this report covers some pollutants of concern to environmental policy 
colleagues, other pollutants that concern them are not addressed. 
 
Pollution is at once intensely personal, rooted in the experience we all have of our 
own lived environments, but also global in scale, with pollutants moving across 
international borders. This is why pollution is becoming established as a priority for 
the international community. The United Nations’ Sustainable Development Goals – 
the SDGs, (also known as the Global Goals), contain specific targets for member 
states to substantially reduce the number of deaths and illnesses from hazardous 
chemicals as well as air, water, and soil pollution and contamination by 2030. My 
report is cognisant of this interconnected world, but focused on the people and 
pollutants in England. 
 
Climate change is a very serious issue and whilst I recognise there are links between 
climate change and pollution, this report does not examine these issues. I stress, 
however, that I am of the view that greenhouse gasses are pollutants and likely pose 
long-term health threats.  
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Changing how we think about pollution 
 
Pollution 
Any undesirable modifications of our human environment including air, water, soil, 
and food by substances that are toxic or may have adverse effects on health - or that 
are offensive even if not necessarily harmful to health.ii 
 
Since the mid-twentieth century, pollution has slipped down the agenda as a public 
health issue. This was driven, in part, by the eradication of many of the contaminants 
with the most visible health impacts, with the remaining ones harder to elucidate. We 
also now face competing threats to our health, such as the obesity epidemic and 
declining physical activity levels. These threats are real and must be addressed. 
However, this has all resulted in a position where the impacts on human health of 
most pollutants are not fully understood, particularly where they act in concert. 
Instead of being seen as a health issue, pollution is often seen primarily as an 
environmental problem. This needs to change. As a society we need to regain a 
focus on pollution as a threat to human health. 
 
By-and-large, pollution is currently thought of as an acute health threat: something 
which elicits a negative health response following a ‘dose’ of exposure. We think of 
pollutants as rapid poisons, rather than long-term risk factors for a variety of 
diseases. However this is not the case; evidence shows that many pollutants are risk 
factors for a range of NCDs such as cardiovascular disease, cancer, asthma, and 
chronic obstructive pulmonary disease.iii We need to investigate the longer-term 
impacts of lower-level pollution exposure; this exposure is likely to have a 
significantly deleterious impact at a population level due to the extent of the 
exposure. Pollution should be recognised for what it is: a significant cause of NCDs. 
Addressing pollution is therefore disease prevention. 
 
Recommendation 1 
I recommend that Public Health England convenes a Programme Board to co-
ordinate government action to reduce the contribution of pollution to non-
communicable diseases. This Board should include representation from Environment 
Agency and should be supported by the Government Expert Scientific Advisory 
Committees. 
                                                          
ii
  Adapted from ‘A Dictionary of Epidemiology’, edited by Miquel Porta, Oxford University Press, 2014. 
iii
  I also note the growing evidence that pollution, notably air pollution, increases risk of  
infectious disease – although currently the magnitude of this impact is smaller than that of 
NCDs 
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We must consider the health impacts of all pollutants, addressing them 
proportionately to our best understanding of the risk. A step beyond focusing on the 
full suite of pollutants that we are exposed to, is considering how we are exposed to 
them. Pollution mixtures are the norm – be it chemical mixtures or cross-media 
mixtures.  
 
The UK Government's publication, ‘A Green Future: Our 25 Year Plan to Improve the 
Environment’ sets a vision - from 'the environment's perspective'. 
 
Recommendation 2 
I recommend that the UK Government fulfils its promise to publish a chemicals 
strategy, and that this strategy takes full account of the human health impacts of 
chemicals, including chemical mixtures. 
 
As well as contributing to and causing NCDs, pollution contributes to inequalities. 
Health inequality remains one of the great social injustices in England today. There 
is both growing evidence and consensus that deprived groups in England are 
exposed more to pollution (notably air pollution), whilst certain groups – those with 
existing underlying medical conditions, the young and old, and others – likely face a 
greater health impact from pollution exposure. We must account for pollution within 
the health inequalities agenda and address and plan to prevent/ reduce pollution in 
the context of equality and fairness. 
 
Vulnerable groups, such as young children, the elderly, those with underlying 
medical conditions and others, are at a disproportionately high risk from poor air 
quality. These groups can suffer large health burdens, and children, for example, can 
have lifelong poor health outcomes attributable in part to pollution exposure. I 
commend work to protect these groups, such as the work underway in London to 
improve air quality around schools currently exposed to the highest levels of air 
pollution in the city. 
 
Recommendation 3 
I recommend the Greater London Authority commission, and Public Health England 
support, the evaluation of the health and health economic impact of action taken in 
response to Mayor of London commissioned audits designed to improve air quality 
near schools in London. 
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Acting where we can 
There are pollutants where the evidence of their health impact is reasonably strong, 
often (but not always) where it has been easiest to measure. Where the evidence is 
strong that there are negative health consequences and evidence of effective 
interventions to address it, this action should be continued and accelerated. In other 
areas, where there is evidence of health impacts but not of the effectiveness of 
interventions to reduce this, then we must act to develop the latter. 
 
Recommendation 4 
Local government holds authority over local planning and infrastructure, and has 
expertise such as environmental health and public health colleagues. It can take 
powerful action to address and avoid negative health impacts from pollution.  
Local government and public health professionals in particular must seize this 
opportunity to improve the health of their local population by implementing concrete, 
evidence based actions to address pollution. 
 
 
Recommendation 5 
I recommend that in order to prevent ill health, local authorities need to broaden 
current environment strategies (e.g. those which may or may not cover NOx or 
noise); these strategies should be cognisant of all forms of pollution, and consider  
risk at both consistent low-level exposure and intermittent high level exposure. 
 
 
Recommendation 6 
I recommend that Public Health England supports local authorities' response to the 
health impacts of all pollutants by making available: 
a) up to date evidence on the health impacts of pollution and 
b)  toolkits to assist with Local Authority actions to avoid or ameliorate pollution. 
 
Recommendation 7 
I recommend that the potential impact of all relevant forms of pollution upon human 
health should be considered at all stages of local authority planning, considering risk 
at both consistent low-level exposure as well as intermittent high level exposure. 
 
  
Page 14 of 341 
 
Outdoor air pollution has recently attracted a great deal of attention from media, 
scientists and policy professionals. Although there are great uncertainties over the 
exact extent, the evidence indicates a significant negative impact on human health 
(see Annex 1). This is, therefore, an example of where we must act, and where we 
know much of what will work. We need to roll out and embed into routine use actions 
that we know will improve health; evaluate and explore new ways to act (Box 1) – not 
missing out on the opportunities for natural experiments as action is taken; and fill 
evidence gaps. 
 
I welcome the government's national standards for air pollution. Currently these 
standards are being breached. The Government's NOx plan is a good overall 
document but as it is aimed at local authority level, it may 
a) be implemented inconsistently, 
b) contribute to inequality, and 
c) contribute to complexity of local regulation for drivers. 
 
Recommendation 8 
I recommend that future UK government national standards for air pollutants, 
developed within the next five years, should be increasingly stringent and driven by 
an ambition to protect human health. 
 
 
Recommendation 9 
I recommend that Department for Transport should agree with local authorities 
standardised mechanisms and protocols for surveillance and road charging (if 
introduced), such that  
a) health data and local authority data may be better integrated; and 
b) vehicle drivers experience a simple system with consistency across England. 
 
We must further expand this focus to indoor air. Work to gather evidence of health 
impacts, raise awareness of any harm and highlight actions to address this is 
needed, just as the Royal College of Paediatrics and Child Health /Royal College of 
Physician Working Group on indoor air quality and child health proposed.  
 
Recommendation 10 
I recommend that Department for Environment, Food and Rural Affairs investigate 
the availability and quality of (low cost) indoor air pollution monitors, publishing their 
results, in order to support the public's use of home air quality monitoring 
equipment.  
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Box 1  Solar-Assisted Large-Scale Cleaning System (SALSCS) for Urban  
PM2.5 Mitigation 
Professor David Y. H. Pui, University of Minnesota 
A Solar-Assisted Large-Scale Cleaning System (SALSCS) is an emerging method 
used for air quality abatement – or to clean polluted air. In these towers, solar 
heating warms the polluted ambient air, drawn in at the base, which rises. A filter 
bank, placed around the tower entrance, removes PM2.5 pollutants so that clean air 
exits from the top of the tower (figure 1). By placing the SALSCS near a large city, it 
pulls polluted air in and returns clean air to the city, reducing the PM2.5 
concentration. 
 
Figure A Schematic diagram of the Solar-Assisted Large-Scale Cleaning 
  System  
 
 
 
 
 
 
 
 
 
 
 
The first pilot scale SALSCS in Xi’an, funded by the Shaanxi government, aimed to 
demonstrate the concept (figure 2). As well as PM2.5 filters, catalyst-coated glass 
panels were added to reduce gaseous pollutants (for example, NOx). Short-term 
measurements showed PM2.5 concentrations in the district where the SALSCS was 
located approximately 12% below the surrounding districts. This matched the 
projected impact of the SALSCS – based on the airflow through the system. Long-
term measurements are now being conducted. This pilot tower is smaller than those 
proposed in modelling studies – for example its height of 60 m, compared with 
proposed 500m towers. Models suggest 8 full scale SALSCS units could reduce 
PM2.5 in the Beijing urban area by 15% in 30 hours.   
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Figure B A night-view of the 1st generation SALSCS built in Xi’an, Shaanxi 
Province (completed July 2016) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Further improvements to the SALSCS are being developed. A second generation 
SALSCS at Yancheng Science Park, Jiangsu Province uses water-spray droplets to 
coalesce and remove PM2.5 particles (figure 3). This gives dual capability, removing 
PM2.5 as well as atmospheric CO2 using NaOH solution. Its performance is now 
under evaluation. A 3rd generation SALSCS (called ACAN) has been designed and 
is under development. The air flow through the ACAN is reversed (figure 4). A set of 
fans draws dirty air from the tower inlet and pushes it through the filters (or water-
spray) located in the base. The clean air will bath the living quarters of the residents 
nearby, benefiting the immediate vicinity. The ACAN is intended for more targeted 
use: by placing it in the centre of a set of tall apartment buildings, it will promote air 
recirculation. Computational fluid dynamics calculations show that more than 50% of 
the PM2.5 concentration can be removed within a few hours of operation. 
Page 17 of 341 
 
 
Figure C The 2nd generation SALSCS built in Yancheng Science Park, Jiangsu 
Province (completed September 2017) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure D Schematic diagram of the 3rd generation cleaning system ACAN 
showing the reverse flow configuration 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 18 of 341 
 
The SALSCS technology represents an effective and low-cost way to mitigate both 
PM2.5 and CO2, for the health and well-being of mankind. 
 
There is sufficient evidence to say that a number of industries and sectors could be 
asked to take responsibility for the pollution they produce and its consequences for 
human health. In my report I have focused on the sector which I know best – the 
health service – and make recommendations relevant to both local hospitals and 
wider policy makers.  
 
Recommendation 11 
I recommend that industry leaders should work to: 
a)  be more transparent about the polluting effect of their activities, 
b)  strive to reduce this effect, using innovative interventions, and  
c)  bring success and best practice to attention within their industry. 
 
My reasons for focusing here are twofold. Firstly, if we are to get industries to act on 
the health impacts of the pollution they produce, much of which will be as a result of 
products and processes which we value, then it seems reasonable that health 
professionals and policy makers should lead the way and demonstrate all the great 
progress some have made. Secondly, it is the case that the health service in this 
country is a significant polluter simply due to its size. There is positive action being 
taken, some led by NHS Sustainable Development Unit and some led locally by trail-
blazing trusts. Some of this is presented as case studies here (box 2), particularly in 
Chapter 2 of this report ‘Pollution from the Health and Care System’. The health 
service causes a lot of pollution – it makes sense to strive to reduce this. 
 
To address the health impacts of pollutants the public sector, including the health 
and social care system, should implement actions that we already know work (see 
examples in this report). In leading the way, our NHS needs to demonstrate action 
and progress through transparency.   
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Recommendation 12 
I recommend that  
a) NHS Trusts report progress against their Sustainable Development Management 
Plans in their annual reports, supported by publication of all relevant underlying 
data; 
b) Public Health England should aggregate and analyse progress annually for a 
national public report to NHS Improvement; and 
c) NHS Improvement should review Trusts' performance and recommend remedial 
action to Trusts, as appropriate. 
 
 
Recommendation 13 
I recommend that  
a) Clinical Commissioning Groups should analyse local air quality monitoring data 
for breaches of air pollution standards, and publish these alongside the local 
hospital data for impacts on admissions for respiratory and cardiovascular 
disease and  
b) Public Health England should aggregate and analyse progress annually for a 
national public report to NHS England.  
 
 
I commend the efforts of Ambulance Trusts to phase out diesel vehicles and reduce 
idling. South Central Ambulance Service NHS Foundation Trust is experimenting 
with photovoltaic cells to keep electrical equipment in ambulances powered, whilst 
avoiding idling. Innovation and exploration like this should be championed locally and 
nationally.  
 
 
Recommendation 14 
I recommend that  
a) Ambulance Trusts should publish annually on their progress towards phasing 
out diesel ambulances, including explaining how their routine procurement 
decisions pay heed to National Institute for Health and Care Excellence 
guidance on low vehicle emissionsiv (nitrogen oxides and particles) and 
b) Public Health England should aggregate and analyse progress annually for a 
national public report to NHS England. 
 
 
 
 
 
                                                          
iv
  http://indepth.nice.org.uk/no-idle-zones-can-help-protect-vulnerable-people-from-air-pollution- 
says-nice/index.html 
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Recommendation 15 
I recommend Health Education England convene and lead a working group, to 
include the Royal Colleges and Faculties of Health, to ensure that the health 
impacts of pollution are included in curricula for all clinicians in training. The group 
should also ensure the health impacts of pollution are included in continuous 
professional development programmes for existing staff. 
 
 
Box 2  Nottinghamshire Healthcare NHS Foundation Trust 
Lynn Richards, Energy and Environmental Manager and Sustainability 
Advisor, NHFT 
 
Nottinghamshire Healthcare NHS Foundation Trust is committed to reducing the 
environmental impact associated with its service delivery and seeks to provide 
healthcare which is truly sustainable. Each year performance in key areas such as 
waste, energy, procurement and travel is monitored and progress is reported in the 
Trust’s Annual Report. 
 
Our environmental objectives and targets are contained within the Trust’s 
Sustainable Development Management Plan (SDMP). In response to organisational 
change, making significant progress against the existing plan, and updated guidance 
from the NHS Sustainable Development Unit, incorporating the United Nations 
Sustainable Development Goals, the SDMP is currently being reviewed to make sure 
it accurately reflects the ambitions of the Trust. 
 
Within the Estates and Facilities Directorate, the Trust holds accreditation to 
ISO14001:2004 the internationally recognised environmental standard. This ensures 
that we set environmental objectives, meet compliance obligations, and make a 
commitment to the protection of the environment, and to the prevention of pollution.  
 
The Trust has a network of staff Green Champions, and with their support we 
actively undertake projects and engage with local and national campaigns, such as 
National Clean Air Day and Fairtrade Fortnight. These help to promote behaviour 
change both within and outside of the work environment, maximising the positive 
effects.  
 
The Trust has won awards for its environmental projects, for example for the Ray 
Crampton Energy Centre at Rampton Hospital. Not only has this helped to reduce 
the Trust’s carbon footprint and costs but it has also improved resilience and local air 
quality, as the site no longer needs to burn coal. 
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Box 3 City of York Council – a holistic approach to reducing pollution  
Mike Southcombe, Public Protection Manager, City of York Council 
 
City of York Council takes a holistic approach to reducing pollution from all sources; 
examples of this are its’ One Planet York initiative and being the first council to adopt 
a holistic Low Emission Strategy (LES) with policies to reduce both carbon and other 
pollution. 
 
Planning applications are reviewed for contaminated land, air quality, noise and 
other pollution to mitigate the impact of new developments on people’s health and 
environment. Our contaminated land and low emission planning policies have been 
adopted by others to help developers to reduce pollution. York regulates pollution 
from industry and has written guidance to control noise from licensed premises and 
events, with an out of hours service to deal with complaints. 
 
York is at the forefront of developing policies to achieve the health-based air quality 
objectives, hence being awarded Ultra Low Emission City status. An extensive Pay 
As You Go electric vehicle charging network, funded by grants and a green charity, 
meant York was an early adopter of electric vehicles. A taxi incentive scheme 
coupled with an emission based taxi licensing policy has resulted in 15% of York’s 
taxis being low emission (petrol hybrids). York’s citywide monitoring network (and 
several feasibility studies) enables an evidence based approach to air quality 
strategy and planning and led to the use of electric buses and the concept of a bus 
based Clean Air Zone (CAZ) in the city centre; the CAZ is currently out for 
consultation. Anti-idling policies were approved recently and follow on from public 
awareness-raising of the health impacts of air pollution, working with local 
universities, business and the public, including participation in National Clean Air 
Day.  
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Gathering data where we cannot act with 
certainty 
Unfortunately we do not currently understand enough about many pollutants to be 
certain whether they impact negatively on human health, especially at low to 
moderate levels with long-term exposure. We understand less still about what action 
we could take to ameliorate any harmful effects on health. 
 
Some of these pollutants have been in our environment for centuries but have never 
had data collected about their health impacts. Additionally, new techniques can 
reveal previously unknown negative health impacts. I argue that we have not thought 
enough about the impact of multiple pollutants at low exposure across a long period 
or in relation to long-term health impacts (namely NCDs). Some pollutants are only 
just emerging; for example newly synthesised chemicals, new technologies such as 
nanoparticles and the potential harms from chemicals in products.v Chapter 4 of this 
report, ‘New horizons’, addresses some of the newer substances we need to 
consider as potential pollutants. 
 
Recommendation 16 
I recommend Public Health England investigate the creation and funding of a 
mechanism to synthesise evidence concerning the health impacts of all pollutants, 
and publish evidence-based statements on the health impacts of these pollutants in 
England.  
 
Throughout this report, data, information and evidence are apparent as vital 
resources to address the health impacts of pollution, and priority areas for 
improvement. Data has emerged as a central theme in my previous annual reports – 
obviously in genomics but also in the metrics that we use to monitor issues such as 
mental health. The data and information revolution is happening across biomedicine 
and has the potential to improve the health of the public. Pollution and human health 
is no different: we have a real opportunity to capitalise on the use of data to better 
understand these health impacts. 
 
Facilitated by new, especially mobile, technologies, there has been a recent growth 
in citizen science. This has a role in data collection and knowledge generation 
around the impacts of pollution on human health. Quality and standards of data 
collection must, however, be maintained to give reliable and useful data. 
  
                                                          
v
  Defined as chemicals contained in everyday consumer products 
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Recommendation 17 
I recommend that UK Research and Innovation consider a health-related pollution 
topic for one of its first, national Citizen Science endeavours.  
 
There are two distinct, albeit inter-related, types of data of the health impacts of 
pollution (Figure 1.1) that can be improved through integration of different pieces of 
data; 
a)  Static research data – helps us to gain knowledge about health harms from 
pollution and;  
b)  Surveillance data – allows the monitoring of known threats and for signals of 
new threats.  
Achieving this data integration will not be easy, but they would greatly help our 
understanding of, and ability to tackle, the health impacts of pollution. 
 
 
Figure 1.1 The relationship between research and surveillance dataset 
covering the health impact of pollution 
 
 
 
Source  Andrew R H Dalton 
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It is easy, of course, to agree that we should have high-quality data used in a joined-
up way – but what does this actually mean? Firstly, we need to integrate existing 
data and ensure wherever possible this is available open source. We need to use 
health data with a wider range of health outcome. In other words, not just focusing 
on mortality, but using data that capture the full health consequence of pollution on 
morbidity, mental health impacts, and impacts on quality of life. We need to collect 
new types of data, such as biomarkers and those relating to genetic susceptibilities. 
We need to develop bespoke statistical and research methods to mine these data. 
And we need to have access to surveillance data in real time, allowing us to act to 
improve health, identify vulnerable groups, and give insight into emerging issues.  
 
It is clear: the evidence base around the health harms caused by many individual 
pollutants is not strong. Many of the professionals I spoke to when researching this 
report, however, raised real concerns about pollutants; and we must remember that 
the absence of evidence is not evidence of absence. To me this highlights the need 
for better systems of monitoring and surveillance across a range of different 
pollutants.  
 
These data systems will build resilience to the new, currently unknown pollution 
threats, and impacts on human health. They will help to fill knowledge gaps 
highlighted in my report, such as the impacts of light pollution on human health. I 
note there is increasing public and policy concern about the impact of 
computer/smartphone screen use, and ‘blue light’, upon human health. Research is 
on-going and this is an important area of investigation, particularly given children’s 
use of social media via smartphones, increasing their exposure to potential risk. 
 
Recommendation 18 
I recommend that Public Health England works to bring together all of the routinely 
produced data on the health impacts of pollution and the surveillance of pollution 
(including data held by local authorities, the Environment Agency and others), to 
ensure availability for the public, public sector and researchers. 
 
Recommendation 19 
I recommend Public Health England develop and embed a formal, structured 
programme of surveillance on the health impacts of pollution and regularly publish 
findings. 
 
Recommendation 20 
I recommend Public Health England explore the creation of an English health bio-
monitoring data set, which includes human exposure to pollutant and health 
outcomes, and report publicly on their findings.  
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Changing the ways we work and do research 
 
Trans-disciplinary working and research 
Across the response to the health impacts of pollution and in all areas where action 
can be taken, I encourage consideration of the framework I suggest for pollution 
above. Action to reduce pollution is action to prevent ill health. Whilst it is always 
good for policy makers to think and then work in a joined-up way and 
multidisciplinary way, pollution is so complex that here it is an imperative 
(exemplified by the multi-faceted, successful response to lead pollution – see Box 4). 
 
As well as changing how we think about pollution, and the data we gather, we also 
need to think about the way in which health professionals and researchers work. 
Aligned to the data issues explored above, we need more linked-up, trans-
disciplinary research. Until now researchers into the health impact of pollution found 
they do not fit into funding structures. Too often these structures follow an old 
framework, with pollution being considered as an environmental hazard rather than 
as a broader health issue. As an example, if pollution is a driver of NCDs (as 
demonstrated for air pollution) then researchers in this field should be able to easily 
apply for biomedical research funding. 
 
Research is often funded and organised in terms of the methodology or research 
tradition. This will not be enough to understand the health impacts of pollutants: this 
is going to need evidence from different disciplines, including epidemiology and 
toxicology. Researchers need to be supported to work in trans-disciplinary ways, 
examining the health impacts of pollutants. Once the systems are in place, the 
researchers and research disciplines must work together in order to fill these 
evidence gaps. Different disciplines working on the same pollution problem, then 
synthesising these different type of information, will be the best way to answer the 
question of what the health impacts are. I believe that the new UK Research and 
Innovation (UKRI) will support a more trans-disciplinary research landscape: this 
must benefit work to understand the human health impacts of pollution. Shifts in 
funding, attitudes, and structures are required at the university level too if we are to 
fully understand the health impacts of pollution. 
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Recommendation 21 
I recommend that UKRI convene a working group on the integration of health and 
pollution data. The Group should 
a) include Health Data Research UK, other relevant bodies, and government Chief 
Scientific Advisers; 
b) review existing data coverage; review methodologies for linkage of data sets; and 
explore new opportunities for joined up data; and  
c) ensure data reviewed includes, as a minimum, data concerning the health impacts 
of pollution, socio-demographic data and pollution data. 
 
 
Recommendation 22 
I recommend research funding and structures should be put in place which 
encourage research on the long-term impacts of low-levels of pollutant exposure on 
human health. These research structures should facilitate focused multi-disciplinary 
research into health and pollution. 
 
Communication 
Through all of this, there needs to be better communication with the public about the 
extent to which we understand health risks, what these risks are (including risk 
factors for NCDs), and what can be done. There are many skilled people working 
hard on this agenda already. Further, communication around pollution and health 
does not need to reinvent the wheel; we can draw on many other fields to 
understand what works. Relative risks can be challenging for some people to 
understand, and many of us remain under-equipped to make fully informed decisions 
about pollution with regards to their and their families’ health. Public health 
professionals play a key role in describing risk levels to local pollutions in layman’s 
terms, whether to allay fears or warn of unsuspected harms.  
 
The recognition of the wide range of sources of lead exposure coupled with the 
implementation of strong mitigation measures were the key to the resolution of this 
major public health issue. 
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Box 4  Lead pollution – a pollution success story 
 
Prof Roy Harrison, University of Birmingham 
 
Lead was long recognised as a substantial hazard for workers in the lead industry - 
with limits enforced. In the 1960s epidemiological studies revealed that exposure to 
lead at environmental concentrations, far below those experienced in industry, were 
leading to impaired IQ development in children.  
 
Lead is a multi-media pollutant with significant pathways for exposure through: 
 
• The atmosphere. By far the greatest respiratory exposure for the majority of 
the population arose from emissions from road traffic. 
 
• Drinking water. Although most sources of drinking water were low in lead, 
lead could be picked up in the distribution system, especially from household 
lead pipes. 
 
• Soil and dust. Urban and roadside soils were heavily contaminated with lead, 
largely due to emissions from road traffic. Indoor dusts could also be heavily 
contaminated by outdoor dusts and from leaded paintwork. Old paints 
frequently contained a very high lead content, leading in some cases to 
clinical symptoms of poisoning in exposed children. 
 
• Food. Foodstuffs contained lead from a range of sources, most notably 
atmospheric deposits to food crops and the use of leaded solders in cans.  
 
Faced with many exposures, the response had to be multifaceted. In 1985, the 
maximum lead content of petrol was reduced and the subsequent introduction of 
unleaded petrol led to a huge decline in airborne lead concentrations. Drinking water 
from sources most liable to dissolve lead was treated prior to distribution to suppress 
lead solubility, which together with widespread replacement of leaded pipework, led 
to a substantial reduction in drinking water lead concentrations. Limits were 
introduced on the lead content of paints. The use of lead in food cans was phased 
out, and this together with a reduced input of lead into unprocessed foodstuffs led to 
a dramatic fall in dietary exposures. 
 
Lead levels in soils and dusts have responded slowly to these actions.  As a result, 
population blood leads have fallen dramatically, as have cases of clinical poisoning. 
Blood lead levels in UK children fell from 140-360 µg L-1 in 1964 to around 37 µg L-1 
in 1991-2 and have fallen further since. The recognition of the wide range of sources 
of lead exposure coupled with the implementation of strong mitigation measures 
were the key to the resolution of this major public health issue. 
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Summation and chapter summaries 
Below I summarise the contents of each chapter of my report. 
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Summary of Section 1 ‘21st century threats’ 
 
Chapter 2  Pollution from the health and care system 
Chapter 3  21st century chemicals 
Chapter 4  New horizons 
 
Instead of listing the traditional media where pollution is found, air, water, land etc. 
and their associated health impacts, this section presents a number of the threats 
from pollution that we currently face and potential solutions. We explore the polluting 
impact of healthcare as an example and how the NHS can be part of our answer to 
reduce pollution. We are faced with changing chemical threats and we explore some 
of the newer – and potential future – threats from pollution. 
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Chapter 2  Pollution from the health and care system 
 
As presented throughout Chapter 2, our healthcare system, the NHS, is a source of 
pollution. Our duty of care to our patients has, to date, not extended to how we run 
our NHS in terms of the health impact of its pollution footprint. This concept of 
environmentally sustainable health systems has recently gained greater international 
focus.vi,vii WHO guidance echoes key themes presented in Chapter 2: minimising 
waste, using efficient procurement, prioritising prevention, and others. These are all 
required to switch the health system from having a negative to a neutral or positive 
environmental impact.  
 
Five percent of all road traffic at any one time is estimated to be on NHS business, 
be it patients going to and from care or the NHS’s fleet of vehicles. This will be 
reduced if the right care is provided in the right place – using models of care with 
least amount of travel. Taking care to the patient will be part of this, so there is a role 
for us fulfilling the potential that technology has. 
 
There is limited direct evidence of the health impacts of other forms of waste in the 
NHS, although the continued use of landfill and incineration must have some. There 
are ways to stop this – which will also improve NHS finances. It will not be sufficient 
to recycle; we need to reduce waste produced: reduce unnecessary healthcare, and 
ensure more efficient procurement. 
 
Healthcare should be responsible for the pollution footprint of it’s supply chain. Gaps 
in knowledge and environmental monitoring remain. Reducing pharmaceutical 
pollution – notably through waste and overprescribing reduction – has co-benefits 
(for finances, patients and others). Healthcare, and more significantly agriculture and 
aquaculture, contribute to the overall quantity of pharmaceuticals in the environment. 
Environmental antimicrobial pollution is a cause of antibacterial resistant bacteria, 
although the exact degree remains unknown 
 
  
                                                          
vi
  WHO 2017 Environmentally sustainable health systems: a strategic document 
vii
  WHO Europe 2017, Sixth Ministerial Conference on Environment and Health 
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Chapter 3  21st century chemicals 
 
Chemical mixtures are the norm in the environment, and these mixtures are growing 
increasingly complex. Constituent chemicals within these mixtures are mostly at a 
low concentration, with any one chemical unlikely to harm health on its own, but with 
less known about the health impact of the mixture.  
 
Large datasets, new epidemiological techniques, geospatial methods, ‘omics’, 
genetic approaches, and others will help us to better understand the threat posed. 
We cannot rely solely on observational sciences, be it to study mixtures or individual 
chemicals. Experimental studies will be critical, notably toxicological studies. These 
must focus on the substances of concern to human health, providing evidence to be 
collated with observational data to give the most accurate picture of health impacts. 
They also need a real world focus, focusing on levels of exposure faced by humans.  
 
In addition to new chemical threats, another change will be reassessing ‘legacy’ 
chemicals using 21st Century techniques. Metals are an example, one of the oldest 
legacy exposures, but whose risk can be revisited. This could include using genetic 
data to better understand and highlight individual susceptibility. 
 
Some chemicals have been the subject of persistent discussion in terms of their 
health impact. These include dioxins, endocrine-disrupting chemicals, Bisphenol A, 
phthalates and others. Some of these have well defined hazard profiles, but 
exposures are believed insufficient to cause risk. Others have associations with 
diseases, but this has not been proven to be causal. These chemicals require 
vigilance. The chapter author suggests specific research examining causal links 
between concentrations of chemical and health outcomes, rather than associations. 
 
A particularly understudied area is the impact of chemicals on the genome and 
epigenome – the consequences of which could have intergenerational impacts. 
There is currently little evidence around this.  
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Chapter 4  New horizons 
 
This chapter explores pollutants that are newer, or are less well established in terms 
of the evidence of health impact. It discusses some of the newer techniques to study 
and respond to the health impact of pollution. 
 
Noise stands second to poor air quality in terms of the burden of ill health caused by 
a single pollutant, and is increasingly high on the international agenda. Over 80 
percent of people report being exposed to noise pollution in their homes. Links to ill 
health include, proximally, sleep disturbance and stress, with more distal 
associations with hypertension, cardiovascular disease and children’s learning 
development. Research may identify causal relations with the latter measureable 
health outcomes. Addressing noise level retrospectively can be costly – it is better to 
consider noise pollution in planning decisions. 
 
Other proposed threats are either far less well established or appear to have more 
limited impact. Light has some known effects on the body – but whether this extends 
to light pollution having health impacts is not known. Nanomaterials are a new and 
exciting technology, with many applications. These will pollute and will penetrate the 
human body due to their size. These need to be examined as emerging chemicals. 
With very limited information on any adverse health impacts, we must maintain a 
targeted watching brief – one that is interdisciplinary, with particular focus on 
exposure assessment. This summary of nanoparticles could well be repeated for 
micro plastics – with no current evidence of adverse human health impacts, there is 
a need for coordinated multi-disciplinary assessment.  
 
New techniques and technologies, many of which are likely to be revolutionary 
across biomedicine, will play an important role in our understanding of the health 
impacts of pollutants. Advances in epigenetics, the understanding in the way genetic 
information is used, promises to increase our understanding of how pollution causes 
ill health. Meanwhile, genome sequencing tumours may allow us to pinpoint their 
environmental – pollution – cause. Not all advances are new technologies. Older 
traditions, such as epidemiology are also innovating to further our understanding of 
the health impacts of pollution. 
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Summary of Section 02, ‘Socioeconomic world’ 
 
Chapter 5  Economics of pollution interventions  
Chapter 6  Pollution and inequality 
 
The next section of my report addresses how pollution, a facet of the physical 
environment has interrelationships with social and economic thinking about health. 
This ranges from how pollution is a factor that adds to health inequalities, to how we 
examine the impact of interventions to reduce exposure to pollution through a health 
economic lens. 
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Chapter 5  Economics of pollution interventions  
 
Economics and economies play a pivotal role in all of health. Chapter 5 presents 
evidence of the health economic evaluations of interventions to address pollution in 
England (or that are of relevance to England). In addition to this, there are many 
other questions that arise from considering together human health, pollution and 
economics. These include assessing the cost of the health impacts of pollution; the 
relationship between economic growth, pollution production and associated ill health, 
as well as the insight economics gives around changing polluting behaviours, and 
others.  
 
Our best estimates of the overall cost of the health impact of pollution are likely to be 
underestimates. There are a number of reasons behind this, presented in the 
chapter. For one, we have far less evidence about the impact pollution has on 
morbidity and quality of life – compared with mortality – which are major drivers of 
cost. More work is required to get a fuller and more accurate measure of cost of ill 
health from pollution; this will help to stimulate an appropriate policy response.  
 
This chapter is informed by a systematic review of the health economic evaluations 
of interventions to reduce pollution. Although some actions have been shown to be 
beneficial from a health economic perspective, the review highlighted the gaps in 
evidence. This evidence base needs to be expanded, with results presented in a way 
that makes it easy for decision makers at a local and national level to implement the 
evidence based options.  
 
Evidence is presented that many decisions made in England, across all geographies, 
have an impact on health through pollution but do not take into account the health 
economic impact. A major reason for this is that the evidence of health economic 
impact or modelling of potential impact is not included in the decision making 
process. For example, an economic assessment of a transport decision might 
account for the cost of the infrastructure, the financial gain to business and industry, 
but not the health economic impacts.  
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Chapter 6  Pollution and inequality 
 
This chapter collates the evidence around pollution and health inequalities, and 
considers the implications. 
 
If we use the simple ‘source-pathway-receptor’ model that describes how a pollutant 
can get from ‘the environment’ to cause health harms, there are plausible 
inequalities across the whole pathway. In terms of evidence in England, much is 
focused on air quality and the differential exposure by socio-economic position. 
Here, there is growing consensus of a U-shaped exposure to raised mean 
concentrations (lowest exposure in rural areas which tend to be in the middle of the 
socioeconomic gradient); and of a linear relationship between exposure to short term 
exceedances of air quality targets and deprivation (more exceedances in the most 
deprived). There is much more limited evidence of other types of inequality, such as 
by ethnicity, gender or others, and of inequalities in exposure to other pollutants. 
  
The chapter discusses ‘triple jeopardy’: a concept that states that: 
 
“disadvantaged groups face: first, increased risks from social and 
behavioural determinants of health; second, higher risks from high 
ambient pollution exposure; and, third, an effect modification that 
makes exposure to ambient pollutants exert disproportionately large 
health effects on them compared with advantaged groups”.viii  
 
This implies an interaction between the pollution and socioeconomic position – 
through an underlying susceptibility, therefore more severe health outcomes for a 
given ‘portion’ of pollution exposure. This is intuitive, but the evidence is not yet clear 
(although there are some suggestions), and is certainly not showing a consistent, 
large impact on clinically meaningful outcomes at present. 
 
The evidence base of health inequalities associated with pollution in England is also 
restricted by a number of limitations. A major weakness is the use of area level data 
rather than individual-level (while area-level data remains helpful and hypothesis 
generating) Combining data, including pollution exposures, health outcomes and rich 
socio-demographic data will allow better understanding of this relationship. This 
matters because addressing health inequalities is a priority in England. There is one 
question of particular importance: do our wider efforts to address the health impacts 
of pollution have positive, neutral or negative impacts on health inequalities? 
  
                                                          
viii
  Jerrett et al. 2001. Environment and Planning A, 33(955-973) 
Page 36 of 341 
 
Summary of Section 3, ‘Our human response’ 
 
Chapter 7  Environmental and health service pollution 
Chapter 8  Environmental pollution - data, surveillance and health impacts 
Chapter 9  Measurement and communication of health risks from pollution 
 
The last section of my report covers three areas where we have addressed, and 
need to do more to address, the health impacts of pollution. The three areas might 
not appear to be direct responses to pollution but are important and share a number 
of facets: these areas are a) not specific to any one pollutant, b) collaborative, and c) 
strive to ‘join up’ our response. These are not a series of interventions and solutions, 
examples of which are given through the whole report. Nor are these exhaustive, 
answering all threats to all pollution. Good work in these and other areas will make 
lasting and fundamental changes to our health in England.  
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Chapter 7  Environmental and health service pollution 
 
Chapter 7 explores how those working across environmental health are faced with 
the health consequences of pollution on a daily basis. Specialists in environmental 
health, and all allied practitioners working to curb pollution, are a vital resource to 
improve the public’s health and prevent chronic disease. 
 
The environmental health workload can often be at the acute end of the response to 
the health impacts of major pollutants. As well as working to control the immediate 
acute health impact of pollution, the chapter describes how environmental health 
professionals engage in proactive and preventive work. They can use their 
considerable expertise in the planning processes, for housing, transport and more, to 
create an environment where it is easy for the public not to pollute nor be affected by 
pollution. Practically, the skills and responsibilities to do this locally now lie in one 
place – local authorities. 
 
Polluters often do the minimum to reduce their health impact, often just meeting legal 
requirements. The chapter explores the need to forge an environment where 
individuals, institutions and public bodies find it easy not to pollute – where making 
the no/low pollution choice is the norm, and where pollution levels are reduced as far 
as possible to improve health. It describes how this will require the provision of 
information to aid decisions, real leadership and structural changes to make the 
‘right’ choice easier. 
 
Many pollutants are continually produced as we live our daily lives. Other pollution 
events are sporadic and short lived. Fire reduction represents a great success, 
although there is more work to do. Fires produce acute, high concentrations of poor 
air quality. Reductions in fires associated with the waste disposal sector (where risk 
has increased with recycling) represent an excellent example of the multi-agency, 
multi-sector working that is needed to prevent pollution and prevent ill health.  
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Chapter 8  Environmental pollution - data, surveillance and health impacts 
 
This chapter discusses the difficulty of studying and monitoring the health impact of 
pollution. 
 
There is a proliferation of data, across pollution exposures and health outcomes, 
‘Joined-up data’ increases size and richness of datasets, and can add a longitudinal 
component – all of which increases the ‘power’ of these data to answer question 
about the health impacts of pollution. Achieving this needs close collaboration and 
partnership between many institutions, the health sector, national and local 
government, academic and others. Data not only need integrating but also needs to 
be published, whilst ensuring that appropriate governance procedures remain. 
Access, particularly to routine monitoring data, must be fast enough to respond to 
emerging health threats from pollutants.  
 
The UK is well placed to remain a world leader in understanding pollution; 
methodological advances could allow us to capitalise on existing datasets to improve 
our knowledge. 
 
Biomonitoring has great potential to transform how we gather knowledge on the 
health impacts of pollutants. Using biomarkers means we can overcome difficulties in 
relating environmental pollutant concentrations to the exposure faced by individuals: 
they can give us an exact, person specific measure. When combined with health 
outcomes we can improve estimates of risk from pollutants and strengthen causal 
inferences to ill health. Internationally, biomonitoring data sets have provided 
valuable insights, and the chapter describes how an annual biomonitoring dataset 
would help us examine current and future pollutant threats, protecting the public’s 
health and monitor our actions. 
 
In England we have an excellent and comprehensive set of surveillance systems for 
most infectious diseases. NCDs, however, do not yet receive the same attention in 
terms of surveillance. Environmental public health tracking, a set of techniques to 
carry out surveillance of the NCDs caused by pollutants, could fill this gap. 
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Chapter 9 Measurement and communication of health risks from pollution  
 
This chapter expands on the difficulties in measuring the health risks from pollution, 
and the challenge of communicating risk levels. 
 
It is important to remember the context in which pollution sits when considering its 
health impact. Most pollution arises out of an activity that someone chooses to do: 
therefore there is always some inertia to maintain the status quo. Practically, this 
means we must be confident (not necessarily precise) about the health impact of a 
pollutant. We must then communicate this in an impactful way in order to elicit 
changes (a necessary – not sufficient requirement).  
 
One question, across pollutants, is understudied; what is the balance in harm 
between short term exposure to high level and long term exposure to lower levels of 
pollutants? This has an obvious implication for measuring the total burden of 
pollutants, but also has implications for the policy response. The fastest way to 
address one type of exposure may not address the other. This chapter discusses the 
advantages collaboration across disciplines provides when trying to establish 
causation, and trying to synthesise results. 
 
There is an existing body of evidence – often not from the world of pollution itself – to 
draw on upon when communicating risk. Valuable insights can be provided. For 
example, risk perception theory shows us the value of the emotive communication, 
and behaviour change theory highlights the importance of self-efficacyix in making 
changes. 
 
The chapter describes other facets of successful risk presentation and 
communication. It explores openly stating both confidence in, and precision of, best 
risk estimates as a way to overcome the uncertainty we have around risks of 
pollutants, without compromising action. This openness and using emotive 
messages are two lessons for pollution risk communication. 
                                                          
ix
  Bandura described ‘self-efficacy’ as a personal judgement of "how well one can execute courses of  
action required to deal with prospective situations.” Bandura, A. (1982). American Psychologist, 37(2), 
122-147 
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Introduction 
 
Healthcare can do much to improve health. The financial cost of healthcare should 
be seen mostly as an investment; the environmental cost should mostly be seen as 
avoidable.   
 
Not only can healthcare systems be disproportionately polluting, but they have 
special responsibilities and opportunities to be exemplary in not causing avoidable 
harm. There are many reasons why the health service pollutes: 
the size of the sector – small relative increases in efficiency or decreases in waste 
have high absolute consequences; 
the toxicity of many products used – many diagnostic reagents and the interventions 
(for example pharmaceuticals) are novel agents and therefore can have unexpected 
and polluting consequences on the environment unless rigorously and systematically 
tested. 
 
Every healthcare practitioner has a duty to do no harm: “primum non nocere”. The 
same principle should be applied to healthcare systems such as the NHS.  The 
financial cost of waste and human cost of pollution caused by the NHS means we 
need to factor this into how we design and deliver models of prevention and care.  It 
is counter-productive to provide healthcare in ways that pollute the conditions that 
create and protect health. 
 
For instance, the NHS is now responsible for almost one in 20 of all vehicles on the 
road.1  Reducing the fossil fuel transport within the NHS creates multiple health 
benefits: reducing air pollution (PM/NOx); promoting physical activity; and the 
reduction of climate change inducing greenhouse gases – all of which have 
additional beneficial health effects, both immediate and long term. A 3% increase in 
uptake of active travel by NHS staff in England, for example, would mean healthier 
staff, saving over £265m in avoided health treatment costs and improving health by 
114,000 QALYs.2 
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Healthcare’s role in pollution: part of the answer  
 
The NHS (both practically and symbolically) has a special role in not only curing 
disease but also in prevention. This translates into a responsibility to measure and 
address the preventable pollution for which the NHS is responsible: from toxic waste, 
to air pollution to greenhouse gas emissions. Examples of how the NHS contributes 
to pollution include;  
 
• business mileage and the movement of ambulances in 2016 by NHS providers 
alone equates to around 680m miles per year, creating 517 tonnes of NOx and 
27.3 tonnes of PM 2.5, this equals a health impact cost of over £15m per 
annum.;3  
• annually NHS providers spend over £540m on energy which equates to the 
release of 3.7 million tonnes of CO2. There are still NHS providers burning coal 
and oil at health sites; both are very carbon and pollutant intensive fuels, with 176 
gigawatt hours of energy from these in 2016. 
 
The NHS in England spends approximately £16bn per year on prescribing drugs, 
much of which is disposed of in uncertain ways, either before or after being 
administered.  Not only does this result in great financial, but it is unclear exactly 
what the long term polluting effects of pharmaceutical might be on the environment. 
 
Some level of pollution is inevitable in most health care activity. Much harm, waste 
and pollution can therefore be eliminated by reducing avoidable and unneeded 
health care by addressing over-diagnosis and over-prescription (supporting efforts 
to, for example, reduce over use of antibiotics). This is in addition to traditional waste 
reduction such as throwing away excess packaging, unused open packets etc. 
Waste extends to over diagnosis and over treatment.4 An estimated 20% of clinical 
practice has no benefit to the patient – whilst there is significant overuse of tests and 
interventions.5 Addressing waste produces higher value healthcare, providing more 
care for a given ecological footprint. Efforts to reduce waste – and pollution – also 
extend to having a much more strategic and ambitious approach to prevention: as 
the Prince of Wales said in 1891, “If preventable, then why not prevented”.6 
Preventing ill health has the added co-benefit of reducing the need for future 
treatment – with its associated environmental impacts. 
 
As responsible stewards, doctors can provide a more effective use of 
constrained economic and environmental resources.7 
 
Crucially, this response should be done in a way that frames pollution as a direct 
health risk. It is much better to frame the pollution (for example diesel exhaust) as an 
immediate health risk, not simply as a distant environmental risk – a cause of non-
communicable diseases just as smoking, obesity etc. are. 
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There is increasing evidence to suggest that, with sufficient will, the polluting 
ecological footprint of the health service in England could be substantially reduced – 
and in ways that would both strengthen the principles and goals of the NHS, and 
alongside deliver numerous other immediate and long term gains for health and 
wellbeing.8 
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Pollution and finances: “a convenient truth” 
 
The link between financial sustainability and environmental sustainability is a highly 
convenient truth, and an opportunity the system should seize. Much pollution caused 
by the health system is due to wasteful practices that generate harm to the 
environment (and in turn to the public and patients), waste money (and other finite 
resources), and jeopardise safety.  Understanding the scale of the problem and the 
opportunity for improvement brings significant, multiple benefits for the health of both 
current and future generations, as well as preserving those resources now. 
 
An example at the most critical part of the system – hospital admissions – shows that 
some enlightened hospitals systems assess every unplanned admission to quantify 
the degree of preventability, and thus the unnecessary activity, cost, harm, waste 
and pollution caused. This can be repeated across all other aspects of the health 
system. A population or public health approach to care9 (as practiced by systems 
such as Kaiser Permanente in the USA) can significantly reduce unnecessary and 
wasteful care, thus reducing harm and pollution.10 
 
Given the multiple benefits of actions to reduce waste in the health system – 
reducing pollution, as well as reducing costs and harms, there have to be significant 
barriers to their implementation. The NHS is largely “funded for activity”, not for 
outcomes. There are unintended perverse incentives in the system: hospitals are 
rewarded for more activity and thus have very little incentive to invest in preventative 
programmes that improve health and avoid unnecessary care with the associated 
waste and pollution.  Systems with a clear environmental and waste reduction policy 
include Kaiser Permanente in the United States. Here financial outcomes and the 
health outcomes are aligned – encouraging prevention and promoting care, where 
appropriate, in the community, reserving hospitals for what only they can do. 
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Pollution in the health and care system 
 
Three specific examples are considered here as they fulfil the important criteria of 
being widely understood and measurable, and areas where action is possible and 
effective. 
 
Travel and air quality 
 
The health system in this country, like in nearly all countries, is large (employing over 
1.2 million people in England – the fifth largest employer in the world), reaches every 
town and community in the land, and involves the movement of many goods, 
services and people. The movement of staff, patients, visitors, and the coordination 
of logistical support for the health service means that approximately 3.5-5% of all 
road traffic at any one time in England is estimated to be on some sort of NHS 
business.11 
 
Much of this is avoidable if we are to bring the right care to the right people at the 
right time. We need to understand that there is a price to pay for this scale of 
transport and travel, not just in terms of time or money but in terms of air pollution 
(NOx, PM10 and PM2.5) and greenhouse gas generation. Because no-one pays 
today for the true, full social cost of fossil fuel use and pollution (much of the cost is 
deferred to the future) and because large hospitals are fixed and immovable assets, 
we focus much of our specialised care there. These contain a critical mass of 
expertise and equipment but mean that our models of prevention and care are 
largely centralised. 
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Table 2.1 Air quality and the NHS fleet, 2016 
 
Sources of air pollution in 
England from travel Miles (million) 
CO2e 
emissions (t) PM2.5 (Kg) 
Nitrous Oxide 
(NOx) (Kg) 
Total health 
and non-
health impacts 
(£) 
NHS providers and Ambulance 
Trusts 
(Business mileage, ambulance 
fleet, patient and visitor travel and 
staff commuting) 
7,231 1,067,713  237  5,232 £646,427,991 
Primary care and commissioners 
(Business mileage, patient and 
visitor travel and staff commuting) 
1,976 426,008 61 1,319 £142,461,818 
Total 9,208 1,493,721 299 6,551  £788,889,810 
 
 
Source created using information from Health Outcomes of Travel Tool; a modelling tool for the harm; air pollution, noise, GHGs 
and accidents from all travel in the NHS including all business mileage and ambulance fleet, available at 
https://www.sduhealth.org.uk/ 
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Box 1        Personalised Care for Lung Fibrosis Patients: Reducing  
                  unnecessary travel 
 
Idiopathic Pulmonary Fibrosis (IPF) is a condition that causes progressive scarring of 
the lungs resulting in shortness of breath, leading to the need for extra oxygen. 
Treatment is given to relieve symptoms and to try to slow progression. University 
Hospitals North Midlands (UHNM) University Hospital is a specialised centre for the 
management of patients with IPF 
 
The issue?  
It is only in the past few years that drugs have become available to treat IPF. These 
can only be prescribed by specialised centres. These drugs have side effects for 
which patients require close monitoring and regular clinic visits and assessments. As 
a specialist centre for IPF, UHNM sees patients referred from a large area across the 
Midlands and Wales. For some patients this means a lot of traveling. 
Patients with IPF can also require prompt support, especially as the disease 
progresses. This is usually provided in close collaboration with the patients’ carers, 
local community and hospital-based respiratory services. Thus communication 
between all parties has to be effective. 
 
Action taken 
To address the issues of frequent clinic attendances in person and prompt 
intervention to support patients, the team in Stoke have developed a bespoke ‘app’ – 
accessible by phone, tablet or computer - on a secure hospital website. This allows 
patients to track and report their symptoms from home instead of attending the 
hospital in person.  
 
The patient-generated reports are reviewed by the clinical team daily, who can then 
guide the patient/carer. The app includes the patient’s history and co-morbidities. 
Functionality is especially useful to enable patients to recognise symptoms and drug 
side effects. It also supports patient/carer participation in the management of their 
disease with real–time communication between them and the clinical team avoiding 
the need to make unnecessary visits to the hospital clinic.  
 
The impact?  
There are currently over 250 IPF patients at the trust. Although the app was only 
recently launched over 50 patients are using it. This can mean a reduction in 
appointments of up to 50% meaning a saving in carbon costs as well as better 
outcomes for patients.  The trust is hoping the project will enable a reduction to two 
visits a year for the mild to moderate disease and four visits for severe.  
 
continues next page 
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Lessons learned  
• Internal testing was required to ensure patient safety and the suitability of the 
application  
• A simple user guide was produced; 
• Security of the system, data entry and confidentiality were addressed by entry 
protection on the Trust website;  
• The application can be used on a variety of devices for example smart phone, 
tablet, laptop or desk computer according to patient preference; 
 
Scaling up 
Replication of this application is possible across other specialist centres in the NHS 
and for other conditions. The trust has received funding to develop a similar self-
management system for Chronic Obstructive Pulmonary Disease patients. The 
clinical team are also currently in talks with commercial parties to roll-out the 
applications across the wider NHS economy. 
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Despite the extraordinary growth of person-held ICT, the miniaturisation of near 
patient testing, and the potential savings from such developments, there is little 
evidence that care is being taken to the patient. Consequently, our ability to invest in 
modern ICT systems, prevention, care in the community, powering public, patients, 
and primary care is all hindered by the centralisation of healthcare facilities. This 
results in such a high proportion of road traffic being on NHS business which 
contributes to air pollution, wasted time, higher risks of road injury and community 
severance†††, all of which adversely affect health. Figure 2.1 describes how 
investment in sustainable transport can affect improved health. 
 
The health service has an important opportunity to be a part of the solution to the 
pollution challenges we face, not part of the problem. Moreover, health services and 
health professionals have an important responsibility to visibly show that they take 
their contribution to air quality (and other issues such as climate change seriously). 
Some hospital Trusts, Bart’s NHS Trust in East London, and Great Ormond Street 
Hospital, for example, have specific programmes to reduce the damaging effect their 
activities have on air quality through reducing their energy use, stopping ambulance 
idling, other fuel efficient driver training and increasing zero carbon forms of transport 
in patients. 
 
  
                                                          
†††
     ‘Community severance’ (also known as ‘the barrier effect’) is a term to  
describe transport system interference with people’s mobility and ability to access 
goods and services e.g.  heavy road traffic impeding local people’s ability to navigate 
their neighbourhood by foot. 
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Figure 2.1 Virtuous cycle of investing in sustainable health and sustainable 
transport 
 
 
 
Source 2009 NHS Carbon Reduction Strategy12 
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Author’s suggestions for improvements 
 
• All hospitals could have travel plans as part of their Sustainable Development 
Management Plans (SDMPs) including: 
o Plentiful active and low carbon travel opportunities to and from health 
facilities (walking, cycling, public transport etc.); 
 
• Energy strategies in the NHS could consider non-combustible renewable heat 
and co-generation (for example fuel cell combined heat and power), the use of 
renewable source electricity (either by generation on site or through energy 
contracts) and District/Community Heating Schemes: 
o This should include restricting use of energy resilience equipment. It 
should be used for energy resilience, where  necessary, but not for short 
term financial gain through incentivised combustion of heavy polluting 
fuels to support the national grid. 
 
• The NHS could adopt innovative models of prevention and care that allow 
patients and staff to travel much less whilst receiving high quality care (telecare, 
long term condition monitoring, virtual clinics, specialists in primary care settings); 
 
• All action to reduce pollution in the NHS could be elevated from “expectations” to 
“must dos”. This requires complete buy-in and adoption from the regulatory 
agencies such as Care Quality Commission, NHS England, NHS Improvement, 
Department of Health and Social Care and National Institute for Health and Care 
Excellence. 
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Box 2  Reducing our emissions for sustainable healthcare is Care  
            Without Carbon 
 
Hayley Carmichael and Will Clark, Sussex Community NHS 
Foundation Trust 
 
Sussex Community NHS Foundation Trust spans 1,000 square miles, employing 
almost 5,000 people. Delivering care in homes and across over 70 sites will always 
involve travel. However, we believe that minimising that travel is essential for the 
delivery of sustainable healthcare. For us, sustainable healthcare is about more than 
saving money, it is about reducing our impact on the environment, improving 
wellbeing for our staff, and ultimately our patients. To achieve this we created our 
Care Without Carbon (CWC) strategy. 
 
Tackling local air pollution, through the reduction of our vehicle emissions is one way 
that CWC is making a difference.  The aim is to reduce travel to its lowest possible 
level, while also encouraging take up of low/ zero emission, low carbon and active 
travel alternatives.  
 
Firstly, we set up a travel bureau to support our staff in making fewer, cleaner, 
journeys. The travel bureau offers local public transport guidance, season ticket 
loans, a cycle to work scheme and route planning for drivers. Secondly, in tandem 
with the travel bureau we introduced a low emission pool car and lease scheme for 
staff, and even electric bikes. 
 
A practical and effective solution 
When Gina Cooper took on a new role at the Trust as a Patient Advice and Liaison 
Service (PALS) support worker, it required her to travel many more miles for work 
than before. Without a vehicle, the long public transport journeys would have been 
an excessive time burden and impractical. 
 
“I don’t own my own car, but the new role demanded one. With pool cars, I 
didn’t have to buy a car. Instead I’m now travelling up to 120 miles a week, 
often to several locations a day from the base. The pool cars are hybrid, so 
very efficient to run, and at least twice a week I car-share with colleagues to 
different locations – a requirement of using the scheme is that we share travel 
wherever possible, I’ve saved over 700 car miles through car sharing so far.” 
 
continues next page 
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An approach that works 
 
We have increased our low emission pool fleet (vehicles available for staff use from 
key sites) from 13 to 21 vehicles - available at six sites. This has: cut our grey fleet 
mileage (staff using their own cars for Trust work) by 826,000 miles, helped us to  
reduce local air pollution, our carbon footprint, and given a healthy return on 
investment on each vehicle.  
 
Since 2010 we have reduced our overall travel carbon footprint by 24% - on track to 
meet our 2020 target of 34%. Although the quantity has not been modelled, this will 
also reduce other air pollutants. As part of this, we have cut the engine emissions 
from our owned and leased fleet by 26.4% down to 111.1 gCO2/km. 
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Pharmaceuticals and medical supplies: waste and 
post use toxicity 
 
Pharmaceutical products cost the NHS in England more than £15 billion a year. This 
accounts for almost one-fifth of the total NHS carbon footprint.13 With the current 
ways in which drugs are prescribed, huge quantities are never used or never have 
any positive therapeutic benefit.14 Further, these can then enter the environment and 
pollute. Critically, there is currently no evidence of harm to humans from non-
therapeutic exposure to pharmaceuticals in humans (of which pollution is one 
constituent part). Indeed for one method of exposure, ingestion of drinking water, in 
2012 the WHO concluded that: 
 
“Trace quantities of pharmaceuticals in drinking-water are very unlikely to 
pose risks to human health because of the substantial margin of safety 
between the concentrations detected and the concentrations likely to evoke a 
pharmacological effect.”15 
 
There is room for vigilance, and some unanswered questions – and this is only an 
assessment of harm from a human health perspective. There is evidence of some 
harm from pharmaceutical pollution not associated with direct human exposure – 
notably from antimicrobials in the environment (more below). 
 
Active pharmaceuticals and their metabolites do enter into living systems and the 
environment,16 through a number of routes (Figure 2.2). Two of these – from human 
excretion of therapeutic drugs, estimated to be the major source of pharmaceuticals 
in the environment;17 and from drugs not taken and inappropriately disposed of – lie 
‘within’ health care. The former is inevitable, but can be reduced by appropriate use 
of medication (stopping overtreatment), whilst the latter can be stopped through 
correct disposal and providing correct quantities of medications. In terms of disposal, 
England by law (European Directive 2004/27/EC) must have appropriate schemes to 
manage unused pharmaceuticals. In England, household pharmaceutical waste 
disposal is provided by pharmacies.  Medicines are still disposed of in uncontrolled 
ways,18 although the implications for active pharmaceuticals in the environment 
depends on the route of disposal (for example if incinerated – they will not enter the 
environment). Other routes into the environment, such as the manufacture of 
pharmaceuticals, are in the supply chain for healthcare: others still, such as farming 
livestock, crop production, aquaculture, and others lie outside of healthcare – and outside of 
the scope of this report. 
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The nature of pharmaceutical pollution will not be static through time, nor does it 
occur in the absence of other threats. Demographic changes are likely to increase 
the prevalence of long term conditions such as Type 2 diabetes: with more people 
relying on maintenance drugs, the pollution burden will steadily increase.19 
Pharmaceuticals are also parts of chemical mixtures; therefore any health effects 
need to be examined in the presence of other chemicals and stressors.  
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Figure 2.2 Occurrence, sources, and fate of pharmaceuticals in the environment  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source  adapted from Li,W. ‘Occurrence, sources, and fate of pharmaceuticals in aquatic environment and soil’ 
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Box 3  Health effects of pharmaceutical pollution in England 
Paul Kay and Lee Brown, University of Leeds 
  
It is now well established that pharmaceuticals used in both human and veterinary 
scenarios enter the environment and are routinely present in English rivers. Average 
concentrations across rivers are in the order of 100 ng L-1, although can reach 
several µg L-1.i Globally, higher concentrations in the mg L-1 range have been found.i 
i
 Historically, compared to many environmental pollutants, pharmaceuticals have 
been monitored to a limited extent – although this is changing. More work is needed 
to robustly determine their occurrence in sewage and the water cycle, and critically, 
their fate and effects in the environment.  
  
Even the most advanced treatment processes fail to remove all drug residues from 
waste and drinking water, whilst many compounds are rarely detected in potable 
waters. Others, such as carbamazepine, are frequently detected. All, however, at 
concentrations well below (orders of magnitudes) levels of therapeutic effectiveness. 
iii
  
  
As for rivers and groundwaters, our understanding of pharmaceutical concentrations 
in drinking waters is limited to a relatively small number of research studies. It should 
be remembered that these substances, in contrast to many environmental pollutants, 
are designed to be given to humans and may not represent the same level of risk to 
health. Indeed, current understanding indicates that impacts in humans due to 
exposure to drug residues in drinking water are very unlikely, with concentrations 
typically being three orders of magnitude lower than the minimum therapeutic dose 
(MTD).iv 
  
Although the potential for health harm is low there are a number of outstanding 
questions before this can be fully quantified.v It is unclear if daily exposure to sub-
therapeutic doses of pharmaceuticals in drinking water, over a period of decades, 
will have health impacts. .  Much remains to be learnt about how different chemicals 
interact and whether mixtures of chemicals, including pharmaceuticals, can exert 
effects not associated with single compounds. The effects of metabolites compared 
to their parent compounds are also less certain and risk assessment approaches 
need to continue to be developed to consider all of these factors. Pharmaceuticals 
are designed not to bio accumulate – therefore bioaccumulation is one route where 
health impacts are unlikely. 
  
References 
i Kay, P., et al. 2017. Environmental Pollution, 220, pp.1447-1455  
ii Hughes, S. Ret al., 2012. Environmental Science & Technology, 47(2), pp.661-677  
iii Furlong, E.T., et al., 2017. Science of the Total Environment, 579, pp.1629-1642 
iv WHO, 2011. Pharmaceuticals in Drinking Water. World Health Organization, Geneva, 
Switzerland. 
iv Caban, M., et al 2016. Current Analytical Chemistry, 12(3), pp.249-257   
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Box 4  SIRUM: Saving Medicine – Saving Lives 
Kiah J Williams, SIRUM 
 
Industry experts estimate that 2-3% of the $270 billion of prescription drug sold each 
year in the United States go unused.20 The most recent, 2010, estimates place the 
cost of unused medicine in England at £300 million.21 What happens to the billions of 
dollars of medicine that do not reach patients who need it? Currently, incineration, 
landfills and waterways remain the most common destination for unused medicine, 
with the majority incinerated. Each fate is uniquely detrimental to our environment 
and potentially to health - medical waste incinerators are estimated to be the third 
largest producer of dioxins in United States22, whilst waterways have traces of 
pharmaceuticals. 
 
SIRUM is a nonprofit company that uses an online platform to facilitate the 
redistribution of unused medicine - much like recycling - converting medicine 
destruction into donation. It collects unopened, unexpired medicine from health 
facilities, manufacturers, wholesalers, and pharmacies and uses an online platform 
to connect surplus medicine with safety-net clinics and pharmacies. The program 
reduces the amount of time and cost associated with disposal of unused medication, 
and increases access to prescription drugs for low-income patients who utilize 
safety-net clinics and pharmacies for their health care. The network of hundreds of 
medicine donors has redistributed over $11 million worth of medicine at National 
Average Drug Acquisition Cost (NADAC) value, enough to fill 300,000 prescriptions.  
 
SIRUM combats important social issues, but by preventing medicines from entering 
the waste stream and reducing the amount needed to be produced, it reduces 
pollution.  According to the Natural Resource Defense Council (NRDC), the 
production of one pound of pharmaceutical active ingredient can generate between 
200 to 30,000 pounds of waste.23 
 
By ensuring all medications are safely redistributed and used for their intended 
purpose - to make people well and keep them healthy – SIRUM believes that millions 
of people will get the medicine they need while dramatically reducing the 
environmental impact of production and needless destruction of these valuable 
resources. 
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Hospitals are a significant concentrated site for pharmaceutical products, although 
still likely to only a make a small contribution to the overall amount of 
pharmaceuticals in the environment.24 The primary approach has to be to reduce 
overtreatment, reduce unused medication and ensure correct disposal. There are far 
too few incentives to reduce wasted, out of date supplies that need to be disposed 
of. Although recycling unused drugs is hard, there are now some schemes 
internationally that recycle unused medicines: particularly in the United States (see 
Box 5). Such schemes can address the cost of waste, improve access to drugs for 
those most in need – and, in what is likely a small part, reduce pollution. They must 
also work within the legal requirements of supply – such as including a secure chain 
of custody.  
 
Beyond waste reduction, although there are mechanisms to promote the removal 
and degradation of pharmaceuticals products from for example hospitals or 
wastewater treatment plants, it is not clear what the cost benefit is in relation to the 
possible health hazards.25 Further, internationally there are different approaches to 
address hospital effluence. One is to treat hospital waste separately – including 
onsite treatment; whilst the other is ensuring waste is channelled only into central 
waste water treatment – then ensuring the treatment process is highly effective. For 
onsite treatment, in order to prevent the spread of antibacterial resistance genes 
(below), it will be particularly important to focus on the bacterial component of the 
waste, as resistance genes can mobilise and spread within and between bacterial 
species. Wastewater treatment systems represent a significant and chronic source of 
antibiotic resistant bacteria and genes released into the environment. They also 
reflect the drug-use habits of the population in the antibiotics that persist in the 
effluent as it is discharged into receiving rivers. As such, significant innovation is 
required in wastewater treatment systems to mitigate these threats to the 
environment and human health. The challenge to the research community will be in 
providing the evidence base needed to justify appropriate wastewater engineering 
targets, while also considering the effects of chemical mixtures and the importance 
of co-selection (i.e., metals and biocides).26 
 
Healthcare is responsible for its supply chain – the production of the pharmaceuticals 
that treat patients. There are still gaps in our knowledge of environmental 
pharmaceutical contamination from manufacturing sites. There is evidence of high 
concentrations of pharmaceutical pollution linked to manufacturing sites in Europe, 
as well as examples in China, India and elsewhere in Asia.27 Where the data exist, 
internationally there is evidence of sites with environmental concentrations 
thousands of times higher than seen from UK effluence, indeed similar to therapeutic 
concentrations.28  
 
Currently, the strongest evidence of human health impacts in England from pollution 
at these manufacturing sites, given the potential global spread antibiotic resistance 
genes, relates to antibacterial drug resistance (see Box 6). High concentrations in 
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the environment impact on antibacterial resistance.29 These would notably be 
industrial sources and sites, but also farming, aquaculture and others. In terms of 
antimicrobial resistance, focus on these high concentration sites should not exclude 
other sources. Sources such as excretion, which have a large total load but spread 
through the environment, contribute – with a much greater total number of bacteria 
exposed.30 
 
The Davos declaration of 2016, an industry agreement to combat antimicrobial 
resistance, explicitly states a commitment to “reduce environmental pollution from 
antibiotics”, in order to reduce antimicrobial resistance.31 Both industry, in working to 
meet this declaration, and the NHS, through its procurement, have a role in reducing 
manufacturing pharmaceutical, including antimicrobial, pollution. Further information 
for users and transparency in the supply chain will be critical to allow consumers to 
make choices that reduce pharmaceutical pollution.  
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Box 5  Industry efforts to control PIE 
Jason Snape, AstraZeneca Global Environment 
Steve Brooks, Pfizer Inc 
 
One of the consequences of delivering essential medicines to patients is that active 
pharmaceutical ingredients (APIs) can find their way into the environment. By far the 
greatest environmental load of pharmaceuticals is a result of patient use (excretion 
after therapeutic use or improper disposal).  On a global scale, pharmaceutical 
manufacturing operations contribute a small part of the total environmental burden of 
pharmaceuticals. However, it is recognised that manufacturing discharges have the 
potential to result in ’hot spots’ unless these are adequately assessed and controlled 
by manufacturers.i 
 
Detection of trace levels (typically ng/l) of APIs in drinking waters has raised some 
concerns; however, the UK Drinking Water Inspectorate (DWI) and the World Health 
Organization (WHO) have both concluded that concentrations of pharmaceuticals 
found in drinking water are significantly lower than therapeutic doses and are unlikely 
to elicit a pharmacological effect (in the case of the WHOii) or pose an appreciable 
risk to human health (in the case of DWIiii). Additional published studies have also 
concluded that pharmaceutical exposure via drinking water is unlikely to pose a risk 
to humans.iv,v,vi Research concerning relationships between environmental 
concentrations of antimicrobials (for example from agriculture, animal husbandry, 
manufacturing effluent, human use and excretion) and the development of 
antimicrobial resistance (AMR) continues to evolve and more work in this area is 
required.  
 
The pharmaceutical industry recognises there are concerns about pharmaceuticals 
in the environment and is proactively engaged in efforts to better understand, and 
where appropriate, take steps to further reduce risk for example through its 
EcoPharmacoStewardship (EPS) initiative.  Many pharmaceutical companies are 
members of the Industry AMR Alliancevii and in September 2016, 13 leading 
pharmaceutical companies signed the AMR Roadmap to further commit to curb the 
development of antibiotic resistance.viii 
 
The AMR Roadmap includes commitments to reduce the environmental impact from 
the production of antibiotics and to develop and apply a common framework for 
managing antibiotic discharge across the supply chain by 2020. The AMR Roadmap 
companies are also committed to working with independent technical experts to 
establish science-driven, risk-based targets for discharge concentrations for 
antibiotics, by 2020. The AMR Industry Alliance issued its first progress report in 
January 2018 (https://www.amrindustryalliance.org/progress-report/).ix  
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Additionally, the Pharmaceutical Supply Chain Initiative (PSCI; 
https://pscinitiative.org/home) actively educates industry suppliers on environmental 
management and the need to manage the specific environmental risks associated 
with APIs in manufacturing effluents. 
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Box 6    Environmental pollution is a driver of antibacterial drug resistance 
William H Gaze, European Centre for Environment and Human Health, 
University of Exeter  
Andrew C Singer, NERC Centre for Ecology and Hydrology 
 
Environmental pollution containing antibacterial resistant (ABR) bacteria, drug 
residues and other bioactive compounds is associated with the evolution and spread 
of ABR. Resistance evolves through mutation or by genetic exchange, mobilising 
clusters of ‘linked’ ABR genes between bacteria. Linkage of genes conferring 
resistance to antibacterials and co-selecting compounds such as biocides and 
metals means that ABR may evolve in the presence of a range of environmental 
pollutants, increasing ABR in the environment and the risk of transmission to 
humans. Conversely, environmental bacteria harbour diverse ABR genes that 
evolved to give protection to natural antibacterials produced by micro-organisms, 
and environmental pollution is likely to play a role in amplification and transfer of 
these genes to clinical pathogens. 
 
Antibacterial drugs are excreted by humans and animals in an active form which 
enter the environment through waste water or application of sewage sludge and 
manure to farmland.  Globally, more than half of antibacterial drugs are used in farm 
animal production. Therefore, most antibacterial drugs enter the environment as 
pollutants where they are usually present at considerably lower concentrations than 
are used to treat infections. However, the concentration of antibiotics in UK sewage 
effluent may be sufficient to select for some ABR genes.i The production of many 
antibacterial drugs occurs in India and China. Despite regulation to control pollution, 
concentrations of drugs downstream of manufacturing facilities can exceed UK river 
concentrations by 1,000-fold. This has been shown to exert a strong selection 
pressure for emergence of novel resistance mechanisms.ii  
 
Concurrent with the risk of waste water and agricultural pollution driving selection for 
ABR is the risk posed by ABR bacteria. A considerable proportion of bacteria 
released into the environment are native to the gut of humans or animals treated with 
antibiotics. A study in the River Thames demonstrated that levels of ABR are 
predictable and associated with waste water and agricultural pollution.iii The cocktail 
of resistant bacteria, antibacterial drugs, biocides and metals presents a significant 
risk of ABR spread and transmission to humans. It is known that novel ABR genes in 
Gram-negative pathogens such as those conferring resistance to 3rd generation 
cephalosporins (for example blaCTX-M), carbapenems (for example blaNDM-1) and 
colistin (eg. mcr-1) originated in environmental bacteria. A critical point to note is that 
evidence suggests the environment is the single largest source and reservoir of 
ABR.iv Recent estimates suggest over six million exposure events occur in UK 
bathing waters each year resulting in ingestion of ABR E. coli and an association 
between bathing water exposure and gut colonisation by blaCTX-M bearing E. coli has 
also been reported, although the number of resulting infections is unknown.v,vi  
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Evidence of environmental transmission of ABR to humans is increasing, but it is 
currently not possible to determine the relative contribution environmental pollution 
plays in increasing ABR infections in the clinic. Mitigation strategies are available to 
reduce both ABR bacteria and drug residues in environmental waste streamsvii, 
however more evidence of the contribution of environmental pollution to clinical 
infection by ABR pathogens is necessary to inform decision making.  
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Author’s suggestions for improvements 
 
• Medical doctors and others in healthcare need training in order to increase 
awareness of environmental issues related to treatment strategies.  
o This could include environmentally better prescription choices, producing 
the same health benefit for the patient with the smallest pollution footprint 
(not simply substitute the type of pollution) 
o Information on the environmental characteristics of treatments must be 
made readily available to support this. 
 
• The adequacy of packaging sizes to consumers’ needs and doctor’s prescriptions 
might be reconsidered and there could be a need for systematic reporting of 
internet and OTC sales. 
 
• Major improvements in waste management could be focused on the improvement 
of collection schemes for unused human and veterinary medicines, as well as 
tracking their efficiency. 
 
• More efforts are needed to improve and harmonise monitoring for 
pharmaceuticals in the environment. 
 
• Engage industry and consider environmental standards in production and 
purchases globally. This should focus on industry transparency, as well as 
monitoring active pharmaceuticals in the supply chain, reductions in discharges, 
including economic incentives for less polluting manufacture. 
 
• The research community should provide the evidence base in order to select 
appropriate wastewater engineering targets with respect to pharmaceuticals and 
underpin innovations wastewater treatment systems, including considering the 
effects of chemical mixtures and the importance of co-selection (i.e. metals and 
biocides). 
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A low harm and low waste, health and care system 
 
Healthcare organisations create huge amounts of waste; in 2016/17 over 590,000 
tonnes from NHS providers in England alone was created, which is more than the 
entire municipal waste from some European countries like Cyprus and 
Luxembourg.32,33 This waste is generated from office materials, clinical waste, food, 
drugs, and medical devices: all of which must be disposed of in careful (and costly) 
ways. The WHO estimates that 75-90% of waste from healthcare facilities is non-
hazardous – akin to waste from other sites such as office or household waste.34 The 
remaining 10-25% may be infectious or biohazardous, therefore needing specific 
disposal in order not to create harm.  
 
All medical care involves some pollution. All unnecessary care, therefore, costs: in 
harm to the patient and the purse, and is unnecessarily polluting. Important 
categories of waste in healthcare include overtreatment, failures of care 
coordination, and failures in execution of care processes: these all impact on quality 
of care and cost.35 Ensuring the incentives lie with the originator of any waste and 
pollution (akin to “polluter pays”) can be hugely beneficial for health.  
 
All reduction of waste starts with procurement. Leaner procurement mechanisms 
such as “Just in time supply chains” and collaborative arrangements whereby the 
NHS buys the “service”, not the “product” can greatly reduce waste and thus 
associated pollution: this incentivises the provider (on whom the cost falls) to reduce 
waste and pollution. Environmentally preferable purchasing (EPP), the purchase of 
the least damaging products and services, and green procurement, purchasing with 
consideration of the amount and toxicity of waste also play an important role in waste 
– and pollution – reductions.36 Healthcare plastics, particularly PVC (prevalent in 
single use medical items such as anaesthetic masks) gives off harmful chlorine gas 
when incinerated. A push to phase this out by manufactures, for healthcare providers 
to procure less harmful alternatives (green procurement) and  polluter-pays 
incentives (plastic industry funded recycling schemes for PVC), will all contribute to 
reducing this harmful pollutant.  
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Box 7  RecoMed: helping hospitals to recycle PVC and save costs 
               Jane Gardner; Head of Consulting Services, Axion 
 
NHS Provider spend more than £80 million on waste each year. Hospitals can play a 
key role in contributing to valuable savings by recycling waste materials, such as 
plastics.  PVC is a widely-used plastic used in healthcare that can be readily 
recycled into new products. It is used to make 40% of medical devices, especially 
those used frequently in anaesthesia and critical care. A large proportion of PVC is 
used in anaesthetic facemasks, post-operative oxygen masks, fluid administration 
sets and associated tubing. The average UK hospital uses more than 12,000 oxygen 
masks per year and around eight million anaesthetics are administered each year.  It 
is estimated that up to 2,250 tonnes of PVC could be recycled by collecting these 
items alone from 150 hospitals in the UK.  
 
Set up in 2014, RecoMed is a unique UK-wide scheme that collects single-use waste 
PVC items used by healthy patients who have undergone elective surgery and sends 
these for recycling. Funded by VinylPlus, the European PVC industry sustainability 
programme, the scheme provides an alternative, sustainable disposal route for 
waste medical items made from high-quality medical grade PVC. Run by project 
partners Axion, a resource recovery specialist, and the British Plastics Federation 
(BPF), RecoMed supplies recycling containers, communication materials and 
collections to participating NHS and private hospitals. 
 
RecoMed recycling bins are sited on wards next to non-infectious clinical waste bins. 
Clear instruction is given to staff on what items can be accepted. Daily collections 
are taken to a central waste hold from where the RecoMed team deliver them to 
specialist recyclers. 
 
Pioneered by anaesthetists, the award-winning scheme is now active in ten hospitals 
where it is helping clinical teams to increase recycling and reduce waste costs in 
theatres. The scheme is already showing tangible results with a total of 3,573 kgs of 
waste high-grade PVC collected - equivalent to 119,100 masks. This has been 
recycled back into new goods, such as horticultural products. 
 
RecoMed collects accurate data on the tonnage recycled to calculate carbon 
savings. Each tonne of recycled PVC will replace about one tonne of virgin PVC 
compound used in new products, thereby reducing their carbon impact. This data 
can be used by individual hospitals to demonstrate efforts to reduce their overall 
environmental impact, as well as their financial savings. Recycling is much cheaper 
for hospitals, given the cost of clinical waste disposal, which ranges from £350 to 
£600 per tonne. 
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There’s huge potential for further development. RecoMed offers the healthcare 
sector a major opportunity to increase their recycling efforts, whilst achieving helpful 
savings on high specialist waste disposal costs. It could be expanded to include 
single-use medical devices made from other polymers. 
 
Too much waste is caused by poor stock control, and ends up in landfill or being 
incinerated (which in turn generates carbon dioxide, nitrogen oxides, and particulate 
matter). It is a legal requirement for NHS trusts to consider the waste hierarchy and 
strive to move away from disposal and progress to energy recovery, recycling, reuse 
and ultimately reduction/elimination. Some trusts have been zero waste to landfill for 
a number of years, meaning all waste not required by law to be treated/incinerated 
(that is, hazardous clinical) is reused, recycled or sent for energy recovery. Dealing 
with waste in a less polluting way is important (for example replacing landfill with 
mixed dry recycling, energy to waste recovery), but absolute reduction in waste 
(starting with procurement) and circular approaches to resource management should 
be the priority. 
 
Global economics now make it cheaper to manufacture single use items within 
healthcare rather than carefully assess where multi-use items re-sterilised would be 
equally safe, cheaper, and cause less pollution through landfill and/or incineration. 
Further, there can be a clinical inertia – or comfort – in using single use due the 
perceived benefits, but this can go beyond necessity. There is sometimes good 
evidence to invoke the precautionary principle and promote, if not require, the use of 
single use items (Prion disease outbreaks where the long term risk is initially 
unknown). When good research, however, establishes the true risk, then we should 
not perpetuate a culture of single use inappropriately and universally. From a health 
and pollution perspective, the adoption of every single use item should be 
considered, not the default. The overuse of disposable equipment has a downside, 
being disproportionately polluting. This may impact on human health, for example via 
plastic (or metal) incineration and landfill. That said, it must also be acknowledged 
that there can be an economic argument for switching to and maintaining single-use. 
This argument can be increasingly persuasive in areas as in times of resource 
constraint.  
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Box 8      Greenhouse gases (GHG) in healthcare and global climate change –  
                lessons for other pollutants 
 
Burning of fossil fuels causes much of the climate change happening today, and the 
health sector in this country is an important source of pollution in the form of 
greenhouse gases. In 2015, the total carbon footprint of England’s health and care 
sector was 26.6 million tonnes of carbon dioxide equivalent (MtCO2e). This accounts 
for well over a third of public sector emissions in England. 
 
The pollution caused by greenhouse gas emissions is important to assess for three 
reasons: 
• The health effects of carbon pollution pose the biggest strategic threat to health 
we face37 
• The emissions caused by any activity or any sector is quantifiable with the use of 
nationally and globally agreed standards 
• The emissions allowable to keep within safe boundaries for human health are 
well understood through high quality science from the global scientific community 
under the auspices of the UNFCC IPPC38 and through a clear legal requirement 
in this country.39 
-  
The footprint of the NHS in the country was first calculated in 2009 in the context of 
the 2008 Climate Change Act. It aspired to cover all three GHG emission scopes (1: 
All direct GHG emissions; 2: Indirect GHG emissions from consumption of energy 
used on site but generated elsewhere, and 3: Other indirect emissions that are a 
consequence of the operations of an NHS, but are not directly owned or controlled 
by the NHS). It revealed the very large proportion (60%) that could be attributed to 
what the NHS procured. Pharmaceuticals and medical devices formed 29% of the 
total footprint.40 Consequently, the NHS set itself a level of ambition to reduce the 
entire footprint of the health care sector in line with the Climate Change Act Another 
example of a co-benefit has subsequently emerged: the reduction in energy use has 
helped not only reduce air and carbon pollution, but it has also saved the NHS £80 
million in 2016/17. 
 
Laws such as the Climate Change Act (2008) establish scrutiny processes that can 
be applied to any sector including the health sector. The Climate Change Act, for 
instance, established the Climate Change Committee that ensures the government 
sets targets. This applies to GHG pollution, although other mechanisms at a national 
level address other forms of pollution: for example COMEAP (the Committee on the 
Medical Effects of Air Pollutants) provides independent advice to government on how 
air pollution impacts on health. Subsequent research and proposed actions to limit 
the effect of such pollution on health complements COMEAP’s work.41 
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Author’s suggestions for improvements 
 
• Waste reduction, notably through efficient procurement, must be at the centre of 
all efforts to reduce pollution and harm caused by healthcare. 
 
• NHS bodies should use incentives to comply with the waste hierarchy, such as 
built into waste-management/ recycling contracts. 
 
• Healthcare waste-management operations at local, regional and national levels 
should be well organised and well planned. 
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Summary and conclusions 
 
The data and case studies presented give a compelling case for the health system to 
reduce the harm associated with health care.  Laws such as the Public Services 
(Social Value) Act (2012) mean the NHS is now under a legal obligation to consider 
the environmental harm (as well as the social and economic benefit) for which it is 
responsible.   This ranges from its huge purchasing power on energy, food, 
pharmaceuticals, etc., to specific innovations that need to be spread rapidly (such as 
solar power assisted ambulances that need not idle their diesel engines42).    
 
The most effective intervention in reducing pollution and harm is to provide 
healthcare only when and where it is needed, meaning that preventing the 
preventable should be a fundamental principle of improving health: less (healthcare) 
really can lead to more (health).  Thirdly, many of the interventions that improve 
health (reducing air pollution through more active travel, improving home insulation, 
reducing overuse of antibiotics) have multiple benefits, both for patients now but also 
for the public in years and generations to come.43  The time is right to quantify, 
assess and incentivise cleaner, and greener, health and care for current and future 
generations. 
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Key points 
• There are tens of thousands of chemicals in use across many sectors with major 
use in consumer products, petrochemicals (fuels and lubricants) and polymer 
plastics. Speciality chemicals are a broad class including crop protection 
products. All have the potential to pollute either through deliberate release or 
from inadequate waste disposal.  Some chemicals are in fact highly complex and 
variable mixtures.  
 
• Humans can therefore be exposed to a complex mixture of chemicals via various 
routes and from a variety of sources. 
 
• New technologies, particularly DNA sequencing and analytical technologies for 
nucleic acids, proteins and metabolites are providing new genetic and 
physiological understanding that may necessitate re-visiting old chemical 
pollutants and their risk assessments. 
 
• There will be a much greater need to take into account genetic and physical 
susceptibilities to specific chemicals in their risk assessment. 
 
• Mixtures and complex chemical combinations are providing new challenges for 
risk assessment. 
 
• There is a need to consider the health effects of biological materials from natural 
and manmade sources. 
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Overview 
The use of synthetic chemicals in society can be traced back to the start of the 
industrial revolution in the 1700’s. Prior to this time natural chemicals and elements, 
for example metals were used but the industrial revolution saw the first manufacture 
and use of synthetic chemicals in bulk quantities. The manufacture of sodium 
carbonate by the LeBlanc process (dating to 1791) provides our first report of 
chemically mediated environmental damage and litigation due to the discharge of 
hydrochloric acid from the process. Compared to then, the obvious, but notable 
change is the vast number of chemicals now on the market. Currently 145,297 
chemicals (including duplicates) are pre-registered under REACHxi, whilst globally, 
production of chemicals has increased from one million tonnes in 1930 to several 
hundreds of million tonnes today. 
 
Chemical manufacture has provided many benefits to society, for example increased 
food production, hygiene improvements, drugs, new materials and electronics 
manufacturing. However there have also been adverse consequences from these 
chemicals contaminating the environment causing harm to both wildlife and humans. 
Consequentially there is generally a risk/benefit ratio that needs to be calculated for 
chemical use. This is not a static ratio, calculated once and never revisited. As new 
understanding, often resulting from new technologies (often resulting from new 
technologies themselves dependent on new chemicals) increase our understanding 
of risk then this risk/benefit ratio will need to be revisited. Furthermore, new 
alternatives may provide the benefit with reduced risk, or conversely may even 
provide an equal or greater risk to the chemicals they have replaced. 
 
This chapter explores some of the chemicals for which we still have concerns in the 
21st century.xii  Many of these are not new. The prodigious advances in our scientific 
understanding, particularly since the elucidation of the structure of DNA in 1952 and 
establishment of molecular biology, together with the parallel revolution in 
instrumentation and computing, have, led to an ability to recognise a much wider 
range of hazard types associated with chemicals and susceptibilities resulting from a 
variety of physical and genetic factors. Similarly advances in analytical chemistry, 
and associated technologies, have reduced the limits of detection and means that 
we can detect chemicals in environmental samples and humans at lower and lower 
concentrations leading to a revolution in understanding of human exposure to 
chemicals. Many of these methods generate so-called ‘Big Data’ that is the focus of 
Chapter 8, ‘Pollution - data, surveillance and health impacts’. In totality these 
                                                          
xi
  https://echa.europa.eu/information-on-chemicals/pre-registered-substances 
xii
            Chemicals in the context of this chapter will be taken to include all molecules regardless of  
use, products thereof, and include natural chemicals.  
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methods and data have led to an appreciation of the potential risks associated with 
chemical use but also challenges in terms of correctly interpreting the available data. 
 
 
 
Box 1        The precautionary principle  
The precautionary principle states that “When an activity raises threats of harm to 
human health or the environment, precautionary measures should be taken even if 
some cause and effect relationships are not fully established scientifically.”*  
While laudable this can raise issues as scientific understanding of the interaction of 
chemicals with biological systems is further and more rapidly understood. In 
particular  
a)  if new understanding causes existing chemicals to be withdrawn on a 
precautionary basis are the alternatives used any better?, and  
b)  as new biochemical cause and effect relationships are understood there is a 
need particularly to understand if these relationships are causal in respect of 
disease and of sufficient concern to justify precautionary action. 
 
*   Tickner, J.A. and C. Raffensperger, The precautionary principle: A framework for sustainable 
business decision-making. Corporate Environmental Strategy, 1998. 5(4): p. 75-82. 
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Epidemiology and health outcomes 
Epidemiology has played a crucial role in the identification of human harm. For 
example, epidemiology was essential in identifying the phocomeliaxiii (a condition in 
which the limbs are underdeveloped or absent) caused by thalidomide and 
mesothelioma caused by asbestos fibres. The association of the exposures in this 
case with the adverse outcome was strong enough to allow intervention long before 
causality was proven.1,2  For both of these examples, and others such as lung 
cancer and smoking, there are some critical factors that allowed epidemiology to be 
effective. The exposure was easily determined and the adverse outcome was 
unusual so epidemiology could come to a proven association between the exposure 
and outcome that was sufficient to justify intervention. For thalidomide there was the 
additional advantage that only a year was required to assess if the intervention of 
removing the exposure was successful as phocomelia occurs during, and is 
observed, at birth, whereas other adverse outcomes, such as some cancers have 
long latency periods making it difficult to assess the effectiveness of interventions.  
 
Epidemiology in the 21st century is more complex. For many environmental 
exposures, including ‘21st century chemicals’, associations can be much more 
difficult to derive for two major reasons. The exposure can be difficult to measure, 
particularly if at low level concentrations or a chemical combination. Secondly, the 
adverse outcomes often have a high background level in the general population 
making the determination of an increase in events difficult to distinguish.  An 
example would be reported headaches and dizziness from low level or intermittent 
fume exposure. An increase in dizziness and headache is difficult to quantify against 
the high background, and difficult to associate with an exposure, making 
epidemiological association of cause and outcome challenging. These factors 
provide a critical challenge to epidemiology that can often only be resolved by larger 
studies to gain statistical power that then become increasingly expensive. 
Epidemiology, though, is benefitting from the data now available from electronic 
systems such as internet, satellite imaging and mapping and personal devices. 
Ultimately this will benefit the development of epidemiology to inform on human risk.  
 
This is an important factor in looking at how we go ahead in the 21st century and 
dictates that epidemiology alone will not be sufficient. We are going to need more 
experimental studies where confounding variables can be separated. These 
experimental studies are going to need to focus more on real world exposures rather 
than doses high enough to get an effect, and be carefully designed to ensure as far 
as possible the data are translatable back to humans. This is also going to need to 
be achieved against a background of reduced animal use and needs to take into 
account human diversity.   
                                                          
xiii
  A condition in which the limbs are underdeveloped or absent. 
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Burden of disease from pollutants 
A Lancet Commission has recently examined the burden of disease from pollutants 
in detail. Worldwide premature deaths due to pollution were estimated to be nine 
million worldwide in 2015 (16% of the total) with the majority of this burden falling on 
low to upper middle income countries. A common factor across all countries, 
however, is that the majority of the burden is due to air pollution.3 This seems 
unlikely to change during the 21st century as air is arguably the most difficult to 
control of all the exposure routes. However while tackling air pollution, it is important 
not to forget the burden of disease due to land, food and water chemical exposures. 
Such exposures, although more prevalent in lower to middle income countries, still 
contribute to the overall burden in high income countries. Furthermore the nature of 
exposure is changing. Experimental methods to recognise acute hazards are well 
developed and so is risk management/prevention of acute exposure. For the 21st 
century the emphasis is going to be on the long term low level exposure that are 
both more difficult to assess (often requiring long extrapolations from acute exposure 
effects) and more challenging to manage. 
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Chemical regulation in the 21st century 
Chemical legislation ensures a uniform approach to controlling the risks associated 
with the use of chemicals across a given product sector and geographical area. In 
the European Union the primary legislation for regulating chemicals is ‘Registration, 
Evaluation, Authorisation & restriction of Chemicals Regulation’  (REACH) (EU No 
1907/2006) and ‘Classification Labelling and Packaging Regulation’ (CLP) ((EC) No 
1272/2008), which outline a common set of rules across the EU that govern how 
chemicals are classified, labelled and packaged. Equivalents exist globally such as 
the Toxic Substances Control Act in the US, whilst equivalents exist globally. The EU 
has some additional regulations; the Plant Protection Product Regulation (EU No 
1107/2009), the Biocidal Product Regulation (EU No 528/2012), the Water 
Framework Directive (2000/60/EC) and the Cosmetics Regulation (2009/1223/EC). 
 
These pieces of regulatory legislation require agencies to oversee them, for example 
the REACH, CLP and Biocidal Products Regulations are overseen by the European 
Chemicals Agency (ECHA) and in the US the Environmental Protection Agency 
(EPA). Testing uses specific protocols, often agreed globally by the Organisation for 
Economic Cooperation and Development (OECD), but the protocols generally only 
apply to data generation, not to interpretation. Although guidance for interpretation is 
available, it can differ between agencies and countries. Data can be reviewed and 
interpreted by different, independent agencies that can lead to differing opinions, as 
has been seen recently with the evaluation of glyphosate by IARC and EFSA. 
Though the opinions of all agencies are valid, they are often different because they 
are based on different criteria; for example active substance versus formulation. 
These differences can be somewhat opaque and can lead to public confusion.  
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Box 2   REACH regulation  
 
The REACH Regulation entered into force on 1st June 2007 and is designed to 
ensure a high level of protection for human health and the environment from 
chemicals, as well as the free circulation of chemicals in the EU market enhancing 
competitiveness and innovation. Crucially REACH shifted the responsibility to 
manage chemical risks from public authorities to industry. 
 
REACH implementation requires data, which are usually derived from companies 
testing their chemicals (with additional data from academic sources). Testing uses 
specific protocols, often agreed globally by the OECD, but the protocols generally 
only apply to data generation, not to interpretation. Although guidance for 
interpretation is available, it can differ between agencies and countries. OECD tests 
can be used to determine a chemical’s hazard by comparing the available data on a 
chemical to the standardised criteria for classification and labelling outlined in the 
United Nations Globally Harmonised System of classification and labelling of 
chemicals (GHS), which is implemented in the EU via the Classification Labelling 
and Packaging Regulation (CLP). Currently the REACH regulation requires that 
substances manufactured or imported within the EU at a quantity of one tonne per 
annum or more are registered. 
   
For chemicals where it is deemed that their use poses an unacceptable risk to 
human health or the environment, risk management measures may be implemented 
and placed on a list of substances of very high concern. This may be followed by 
restriction or authorised use classifications. Before a chemical is subject to restriction 
or authorisation under the REACH regulation, the risks of the chemical, its 
alternatives and the socioeconomic impacts of that regulatory action are considered. 
 
 
 
 
 
‘  
  
Page 82 of 341 
 
‘21st century chemicals’ and new science 
Understanding the impact of chemicals on health in the 21st century requires an 
appreciation of the advances in science over the last century, especially the last 50 
years. Genomic methods and genetic biology in particular have had a substantial 
impact. It is now possible for the whole genomes of individuals to be sequenced 
quickly and at relatively low cost, giving rise to the very real possibility that each of 
us will have our personal genome as part of our medical records within the 
foreseeable future. The same technology means that many thousands of endpoints 
can be assessed for a chemical. Consequentially we can now measure chemical 
effects on biological systems before the development of recognisable physical 
outcomes. This raises the question how such effects relate to, and predict, adverse 
health outcomes.  
 
Other molecular biology advances include high throughput screening, quantitative 
structure–activity relationship models. These approaches to testing and assessment 
are all advancing our ability to conduct hazard assessment more rapidly but 
translating this knowledge to and actual assessment of risk is becoming more 
challenging. The challenge, though, of managing hundreds of thousands of 
chemicals on the market will not be achieved without high throughput methods and 
grouping approaches. 
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Figure 3.1  Association of biological changes and apical outcomes 
 
 
 
Source  Professor Timothy W. Gant, Public Health England 
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New interactions or susceptibilities can be identified and thus ‘old’ chemicals have to 
be reconsidered in terms of their potential toxicology. Chemicals can only be 
regarded as no longer relevant to health when there is no longer any exposure – that 
is when they are removed entirely from the environment. There are therefore some 
chemicals that are both legacy chemicals but are still a 21st century concern due to 
the impact of new technologies recognising new interactions and potential toxicities. 
One such example is diesel particles, which act through newly identified 
mechanisms in immune cells, contributing to asthma development and exacerbation. 
 
Allied with the development of new technologies has been the development of new 
biomarkers. These give greater insight into alterations in biochemistry and 
physiology, and therefore to changes that may occur due to chemical exposures that 
may not have been previously detected. Biomarkers are further discussed in Chapter 
8, ‘Pollution - data, surveillance and health impacts’. 
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Mixtures and chemical combinations 
Historically chemical hazard evaluation tended to be considered in terms of 
individual chemicals but exposure to individual chemicals is not strictly 
representative of the real world scenario. We are exposed throughout our lives to 
complex mixtures of chemicals from a variety of sources on a daily basis and these 
mixture exposures can change both temporally and spatially. Furthermore chemicals 
are often used in mixtures, and many chemical products are mixtures in their own 
right. The challenge: to assess health risk from chronic, lifelong exposure to complex 
chemical combinations is difficult. It requires the nature of the composition to be 
taken into account but also the interaction of those chemicals. Further interactions 
with the wider environment and lifestyle need to be taken into account. These 
complexities are often poorly understood, resulting in a default of adding up the 
hazard potential of individual chemicals – which may be an underestimate if effects 
are in fact synergistic.  
 
This issue becomes particularly acute when considering chemicals that fall into the 
class of unknown or variable composition, complex reaction products or biological 
materials (UVCB). The composition of these substances cannot be easily identified 
for various reasons, including having too many chemicals within them or showing 
variance in composition (between batches). Though it might be considered that 
these are rare, in fact the opposite is the case. Most refined oil products fall into this 
class, as do substances such as natural oils and perfumes. As of January 2017, 21% 
of substances registered under REACH were Chemical Substances of Unknown or 
Variable Composition (UVCBs).4 There is a need for better methods to assess the 
hazard of these UVCB mixtures and put them into groups. One such UVCB grouping 
project using oil products as an exemplar is Cat-App.xiv 
  
                                                          
xiv
 https://www.concawe.eu/mediaroom/cat-app-project/  
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21st century pollutants 
The next sections address some of the classes of chemicals often found in the 
environment that could continue to be a source of concern into the 21st century, even 
as in some cases their environmental concentration, or use, declines. In some cases 
compounds are subject to restrictions and authorisations but this can then drive 
replacement by alternatives that may be less adequately tested – this can lead to 
‘regrettable substitution’ where a chemical with a greater hazard is substituted for 
one with a lesser hazard. 
 
Dioxins and polychlorinated biphenyls 
Dioxins and polychlorinated biphenyls (PCB’s) are a large category of chemicals. 
Exposure was first noted in the 1940s with experimental demonstrations of toxicity in 
the 1970s. One example, 2,3,7,8-tetrachlordibenzodioxin (TCDD) is classified as a 
Group 1 carcinogen by IARC.  Studies following up past exposure, such as from the 
Seveso industrial accident or after exposure to herbicide agent orange have 
identified possible birth defects in the exposed populations at high doses,5,6 with 
studies continuing to assess long term impacts. The major observable toxicity in 
acutely exposed humans is chloracne.7 
 
Dioxins and PCBs fall within a class of chemicals listed as persistent because they 
do not degrade in the environment. They also have little solubility in water, therefore 
tend to accumulate in fat sources and concentrate up the food chain. Though 
historically more than 90% of exposure has been  through the food chain8 this has 
been falling in recent years. Their metabolism and excretion from the body is also 
slowly adding to their ability to accumulate in humans, animals and fish. Estimates 
from food samples collected in the US in 1995 showed that freshwater fish had the 
highest concentration, with fruits and legumes containing the lowest concentrations.9 
The UK Committee on Toxicity of Chemicals in Food, Consumer Products and the 
Environment (COT) has more recently reviewed exposures from food and found that 
the levels are greatest from oily fish and some meats such as deer. Importantly, 
exposure has been declining since 1980 and continues to do so.10  The current 
estimate for exposure is for 70% of the tolerable daily intake (TDI) and therefore 
though a current concern decreased use does not indicate a need for continued 
vigilance.11 
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Since the 1980’s dioxins have been known to elicit many of their toxicological effects 
via binding to a specific intracellular protein, the aryl hydrocarbon receptor (AHR).12-
15
 What had not been known until recently is that this mechanism is important in the 
activation of immune system cells and is a link to autoimmune diseases (see Figure 
3.2).16 There may therefore be a link between exposure to these chemicals in the 
environment and the substantial rise that has been observed in autoimmune 
diseases over the last decade.17 Evidence has recently been published in respect of 
a mechanistic link between diesel particles from transport and immune cell activation 
that could partially explain the increases in asthma incidence that affect 1:12 adults 
and 1:11 children in the UK.18  
 
 
Figure 3.2  Role of the AHR receptor and activation by environmental pollutants in 
autoimmune and allergic immune diseases  
 
 
 
Source Professor Timothy W. Gant 
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Polycyclicaromatic hydrocarbons (PAHs) 
Polycyclicaromatic hydrocarbons (PAHs) are a large group of carcinogenic 
chemicals formed as byproducts of combustion and widely distributed in the 
environment.  PAHs are found in both air resulting from vehicle exhaust particulate 
matter19 and in soil, typically in old industrial sites or heavily populated areas.20,21 
Additionally, PAHs result from wood and biomass burning.22-24 Emissions overall 
have been declining in the UK since 1990 particularly from commercial and 
agricultural sources, the latter probably reflecting the much decreased use of 
biomass burning.19 However, despite an overall decrease in PAH levels since 1990, 
they have been increasing again between 1995 and 2010. This is probably due to 
the increasing use of wood burning stoves.25 Nevertheless monitoring stations 
across the UK still indicate the PAHs in the atmosphere are much less than the 
1ng/m3; the European commission target value.  
 
Many, but not all, PAHs are carcinogens and classified by the IARC as class 1 
(carcinogenic to humans). Carcinogenicity of certain PAHs has been well studied in 
laboratory animals, with observed increased incidence of skin, lung, bladder, liver 
and stomach cancer. Therefore increases in the environment would be of concern 
and there are some indications of health effects associated with wood burning that 
could be due to PAHs such as inflammatory responses,26 vascular dysfunction27 and 
breast cancer.28 In addition to cancer effects recent discoveries in basic science 
have thrown new light on the relationships between asthma and air pollution 
mediated though the AHR receptor (Figure 3.2).29  
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Box 3  Indoor air pollution 
Professor Alastair Lewis, National Centre for Atmospheric Science, 
University of York 
Air pollution found inside homes and the workplace makes an important contribution 
to an individual’s overall exposure to any given pollutant. Indoor air pollution can be 
affected by outdoor concentrations, with air pollutants exchanged readily where 
buildings have poor insulation and high ventilation rates. In the UK, outdoor air 
quality has improved over the past 40 years and buildings have become more 
energy efficient, with low rates of air exchange. A consequence has been that indoor 
air pollution is increasingly decoupled from air quality outdoors; it is now affected 
predominately by emissions and activities occurring within buildings themselves.  
 
The chemical and biological classes of air pollutants found indoors are broadly 
similar to those found outside, with similar underlying biological mechanisms for 
impacting on human health. There are however differences in the relative distribution 
of pollutants and chemicals. Most of the key outdoor air pollutants are found indoors, 
including particulate matter (PM2.5 and PM10), NO2, CO, and a range of volatile 
organic compounds (VOCs). Ozone is not found in substantial concentrations 
indoors since as a reactive species it is readily destroyed on indoor surfaces. Few 
UK homes burn high sulphur-content coal and a consequence is that SO2 is also not 
found in large amounts indoors. 
  
The key sources of indoor air pollution are related to combustion-related processes 
and emissions associated with the consumption of manufactured chemical products. 
Combustion sources in the home release a broad range of pollutants (as they do 
outside) including PM, NOx, CO and VOCs. The largest indoor combustion sources 
are from central heating (as a primary heat source), cooking (including direct 
combustion and oils/fats released as aerosols) and discretionary activities including 
decorative use of open fires, solid fuel stoves and candles. 
 
Indoor air pollutants deviate most substantially from outdoors in the relative amounts 
of VOCs. Outside, VOCs are now found at typically very low concentrations, rarely 
above limit values set in air quality legislation. Indoors, VOCs can be found at 
substantially higher concentrations reflecting the wide range of products that emit 
this class of pollutant. Well-established sources of VOCs include building materials 
(wood treatment, carpets, paints, flooring and so on) and furniture; both sectors are 
subject to product regulation that aims to minimise indoor emissions. In addition a 
wide range of other consumer products also release VOCs indoors, including 
adhesives and inks (where the VOC is a solvent), pesticides and volatile fragrance 
contained in cleaning and personal care products.  
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Most VOCs are considered to be of low toxicity, however long-term impacts on 
health are uncertain. Further, there is evidence that the trend for increased building 
energy efficiency and increased public consumption can result in elevated 
concentrations indoors.  A chemical of specific health interest indoors is 
formaldehyde. Outdoors formaldehyde, typically at low concentrations, is rarely 
considered in the context of direct harm to health. Indoors formaldehyde can be ten 
to 100 times higher in concentration, a result of direct emissions and from secondary 
production where formaldehyde is formed as other VOCs oxidized in air. 
Formaldehyde has a wide range of reported health impacts including as an eye and 
lung irritant, and it carries longer-term cancer risk.  
 
There are some notable differences in how individuals can manage exposure to 
indoor air pollution that differ to outdoors. Outdoor air pollution is not the 
consequence of the actions of any single individual. Concentrations in the home are 
largely a consequence of a series of specific occupant actions coupled to the 
building air exchange rate, both factors over which individuals have a substantial 
degree of autonomy and control. In most locations (away from busy roads), outdoors 
air is likely cleaner than indoors for the majority of classes of air pollution. In such 
circumstances reducing the indoor emissions of pollutants, for example by changing 
patterns of discretionary combustion and chemical consumption, may lead to direct 
reductions in exposure, as can actions that increase ventilation through simple 
actions such as opening windows more frequently.  
 
A barrier to supporting more direct individual action is a lack of a reliable low-cost 
measure of indoor pollution to support decision-making and a limited awareness of 
how personal actions impact on indoor air quality. More broadly variability in indoor 
air quality is a major confounding factor in the interpretation of epidemiological data 
on outdoor air pollution effects, since indoor exposure cannot be easily predicted 
based on simple factors such as age, postcode, and income.  
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Microplastics 
The world economy generated about 299 million tonnes of plastic in 2013.30 
Approximately  2-5% of this is estimated to have ended up in the ocean, much in the 
form of discarded plastic packaging.31 Thus, between five and twelve million tonnes 
of plastic waste was discarded directly into the environment, much of it non-
biodegradable. Over time this will break down to form microplastics that are found in 
deep sea creatures, indicating just how pervasive these 21st century pollutants have 
become.32,33 
 
Microplastics are small plastic particles, less than 5mm in diameter, that arise in the 
environment from the degradation of discarded plastics (secondary microplastics) or 
are manufactured (primary microplastics) – including cosmeticsxv and products, such 
as those used in oil drilling and as abrasives. Other sources of these particles (and 
fibres) are vehicle tyres, road paint and clothing.33 As these particles are now 
extensively found in the environment there are concerns about their transfer into 
food chains and into the air. For this reason the major exposure routes of concern in 
respect of human exposure are ingestion from food and inhalation. Consequentially 
there are three main concerns:  
a) physical toxicity such as blockage of the gut,  
b) chemical toxicity arising from chemicals released from the particles that could 
be plastic monomers, colourings and plasticisers and;  
c) lung damage such as inflammation and secondary fibrosis.  
 
The human exposure, hazard and therefore consequences of exposure to these 
microplastics are largely unquantified. The plastics themselves will be of different 
types and so the identity and quantity of the chemicals involved could be challenging 
to assess: as is the degree to which component chemicals of the plastics will be 
released into the environment.  
 
The consequence, even the extent, of exposure in humans is unknown. Exposure to 
microplastics through food is possible, based on studies of seafood; however, it is 
unknown if this translates into meaningful exposure in the population.34 There is an 
absence of toxicological data that has meant that effective risk assessment is not 
possible. It is possible that lipid soluble phthalates and other chemicals from the 
plastics could be absorbed from microplastic ingestion, as they are lipid 
soluble.  Humans, however, are already almost universally exposed to these 
chemicals as a result of their use in plastic products. Phthalates used in plastic are 
                                                          
xv
      There are now extensive voluntary bans in place on the use of these particles in consumer  
products because of the concerns about the subsequent transfer of the particles to the 
environment.  
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currently considered to have a low hazard despite some concerns in respect of their 
potential ability to interact with hormonal systems.35 
 
Nevertheless, the burden in the environment should not be further increased.35 
Microplastics can potentially act as vectors for, and enhance the transport of, other 
organic materials.36 They can also break down to very small sizes which can be 
translocated from the gut37 and in some cases across the placenta.38 In marine 
organisms blockage of the intestinal tract can occur, although this is unlikely to occur 
in humans due to the larger size of the intestine.  There is also a theoretical 
possibility for physical toxicity from accumulation in organs such as the kidneys. 
Thus more work on the potential for human health effects is required. 
 
Recently cosmetics manufacturers have voluntarily reduced or eliminated plastic 
micro-particles as exfoliants because of concerns over their release into the 
environment. However microbeads are only a small part of the overall problem. A 
substantial amount of plastic waste still enters the environment from land and at sea 
and will contribute to the problem of microplastics in the environment for a long 
period even if further environmental contamination does not occur. 
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Endocrine-disrupting chemicals (EDCs) 
Endocrine-disrupting chemicals (EDCs) are substances that alter the functions of the 
hormonal system and consequently can cause adverse effects for human health.39 
As public concern has increased and NGOs have taken an active interest, 
intergovernmental initiatives have been introduced to better screen and regulate 
such chemicals, and thus improve environmental and public health protection.  
 
Public concern started to grow in the 1960s40  following observations of reproductive 
failure in wildlife species, especially birds.41 The term ‘endocrine disruptor (ED)’ was 
adopted to describe these chemicals.42 A widely used definition is ‘an exogenous 
substance or mixture that possesses properties that might be expected to lead to 
endocrine disruption in an intact organism, or its progeny, or (sub)populations’xvi and 
scientific criteria for the identification of EDCs have been published.43 
 
A body of literature now documents an increasing incidence of breast cancer in 
women44, decreased sperm counts and increasing incidence of testicular cancer in 
men45 and other endocrine disorders increasing in the human population. As all of 
these cancers have a hormonal component association has been made with EDCs 
as a means of explaining the increase in incidence. In humans there are examples of 
such toxicity with potent pharmaceutical agents, for example diethylstilbestrol but 
association of most environmental pollutant EDCs with human disease is not proven 
and therefore contentious. There could be other physiological and lifestyle factors 
that could account for, or contribute to, the increases in hormonal cancers observed.  
 
EDCs will remain chemicals of concern for the 21st century and while the hazard 
characteristics of some EDCs have been established, the risk to human health has 
not. The focus therefore needs to be on establishing actual risk. Given the 
complexity of the endocrine systems and health end points this is a substantial task. 
 
To address the issues some international endocrine relevant chemical screening 
programmes have been created, and in 1998 the intergovernmental OECD work 
programme on Endocrine Disruptor Testing and Assessment was initiated. The first 
ED tests to be developed have focused on the oestrogen, androgen, thyroid, and 
steroidogenesis pathways. However, the array of modes and mechanisms of action 
that require test method development are expanding to a) include other related 
endocrine pathways,46 and b) specifically to address mechanisms/modes of action, 
with respect to temporal considerations through life and for subsequent 
generations.47,48 The need for the development of further test methods therefore 
remains.   
                                                          
xvi
  WHO International Programme on Chemical Safety (2011) 
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Bisphenol A and phthalates 
Bisphenols and phthalates are important in the production of plastics of various types 
and exposure is almost universal. Some of these chemicals, in particular Bisphenol 
A, have given rise to other products with different uses. For example tetra-bromo-
Bisphenol A, which is used as a flame retardant particularly in electronics. Some 
chemicals in these classes have given rise to concern for two reasons; a)  they have 
a well-defined hazard, interacting with endocrine targets, and b) because of the 
almost universal exposure primarily often from food.  
 
Defined hazards have, however, given rise to a great deal of misunderstanding 
amongst both the public and professions. Furthermore increases in endocrine 
associated tumour types have led many to make an assumption that there is a 
causal relationship between these endocrine acting chemicals and the rises in 
specific tumours such as breast and testicular. Making these associations can lead 
to misunderstanding. For example although Bisphenol A, a chemical with a known 
and defined ability to activate the oestrogen receptor it is metabolised rapidly in 
humans to a non-active metabolite and rapidly excreted, resulting in a low internal 
exposure. This means that, though there is a well-defined hazard, potential exposure 
at the relevant internal organs is low to negligible thereby substantially mitigating 
risk. Phthalates, identified as category 2 reproductive toxicants, have been banned 
from use in general consumer products, including toys and cosmetics. 
 
This indicates a challenge that we need to face in the 21st century – to regulate 
chemical use on the basis of risk rather than hazard. There is no doubt that 
Bisphenol A and many other chemicals pose a particular hazard at certain 
concentrations. For Bisphenol A though the risk – a product of hazard, exposure and 
vulnerability – is largely discharged on the basis of relevant internal exposure. 
Though the battery of tests for assessing hazard are incomplete hazard testing is 
arguably more advanced than the understanding of risk, and for this reason 
regulation is often based on hazard. Where more understanding is required is at the 
level of exposure and mode of action pathways. With more understanding of these 
facets of the toxicological pathway then regulation could move towards the level of 
risk and also address vulnerabilities. Overall this would be a more satisfactory 
approach, driving innovation and leading to the use of more sustainable chemicals 
with decreasing hazard profiles. Such testing would lead to a) a more appropriate 
regulatory framework and b) reduced use of alternative chemicals as replacements 
for which there is often less available safety, and a lower level of risk understanding 
than for the chemical they replace. For example, Bisphenol A has often been 
replaced by the structurally similar Bisphenol S, about which less is known in respect 
of its hazard or risk.  
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Perfluorinated chemicals 
Perfluorinated chemicals (PFCs) have been manufactured for approximately the last 
50 years and are used in a wide variety of products on account of their hydrophobic, 
non-combustible properties and resistance to degradation. The latter means that in 
the environment some such as the long chain (eight carbons or more) are persistent 
and bioaccumulative, and can be transported to environments distant from their 
source.49  Some, such as the perfluorinated acids are water soluble and can undergo 
aqueous transport over long periods of time.50 One PFC (perfluorooctane sulfonic 
acid - PFOS) is listed in the Stockholm Convention on Persistent Organic Pollutants 
(2009), meaning its use is restricted whilst others are being considered. They are 
used in a wide range of industrial and household products. PFCs are found in 
varying concentrations in many aquatic environments51 and, the serum and breast 
milk of many who live in industrialised countries though levels may have peaked in 
the last decade of the 20th century.52  
 
Positive associations with health outcomes in human epidemiological studies are 
increases in serum levels of cholesterol and uric acid, possibly due to competition in 
the kidney for transporter proteins.53 The outcome of increased cholesterol might be 
anticipated to be cardiovascular disease but this has not been observed in 
epidemiological studies. In high dose animal models a variety of health outcomes are 
reported including immune responses,54 thyroid hormone effects55 and liver toxicity.56 
Thyroid hormone effects have been a particular concern for the developing foetus. 
Here, the hormone is vital for neurological development and because some PFCs 
can compete for thyroxin on the thyroid hormone transport protein this could 
potentially limit delivery to the fetus.55 Some neurotoxicant behaviour has have been 
modelled in the mouse57 though the relevance for this at human exposure levels is 
not clear. 
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Other effects are seen in the liver including peroxisome proliferation, a biological 
effect known not to be relevant for human liver disease.58 All of these effects occur at 
exposure levels several orders of magnitude above those generally observed for 
human exposure. In exposed worker studies some associations of 
perfluorinatedoctanoic acid (PFOA) with diabetes mortality have been observed.59 
Currently PFCs appear not to be anywhere near exposure levels for the majority of 
the population that could lead to health outcomes, and there is still debate regarding 
the toxicity of PFCs on human health in the general population.  However, as they 
continue to be manufactured and released into the environment, and persist for a 
long time in the environment and the human body, there is a need to maintain 
vigilance for health outcomes. Monitoring is particularly important around sites where 
these are used intensely, such as the international examples near airfields and 
military sites where large volumes of firefighting foam are used. Further, there clearly 
is a need for more mechanistic evidence that would direct the epidemiology in terms 
of health outcomes as well as adding causative weight to the findings of such 
studies.   
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Metals 
Metals of all types constitute an interesting challenge for 21st century. For some of 
the recognised more toxic metals, such as lead, controls brought in to reduce 
emissions including the removal of lead additives from vehicle fuel have led to 
dramatic reductions since the turn of the century. The same is true for mercury. 
Resulting from restrictions put in place following the recognition of the role of 
mercury in causing Minimata disease have reduced emissions from the industrial 
sector. In contrast the transport sector has been contributing to an increase in 
various types of metal exposure. Traffic associated metals from transport take the 
form of particles. These particles come, not from the combustion of fuel, but from 
brake wear which means it is applicable to all types of vehicles no matter what the 
fuel type or if they are running on roads or rails. Common amongst the increasing 
particulate metal exposures are arsenic, iron, tin, copper, nickel and vanadium. All of 
these metals can elicit toxic effects in sufficient dose. Further, in the particle sizes in 
which they are released from brakes they have the capability to penetrate deep into 
the lung where they can be absorbed into the systemic circulation. 
 
Although environmental lead concentrations have been decreasing, a legacy lead 
contamination remains particularly in brownfield land development sites. This risk is 
managed by measurement and risk assessment when these sites are developed. 
Such measures should sufficiently mange any residual risk. However there are still 
debates about whether the current limit levels are sufficiently protective. These 
debates will continue as science develops and in particular as the use of genomics 
and allied technologies lead to an improved understanding of hazard and 
vulnerability. There will remain a continuous need to revisit such legacy metals.  
 
There are many more metals that have an associated hazard potential. As these 
metals are used in new applications, such as batteries, there is a need to ensure that 
efficient collection and recycling processes are in place to prevent their release into 
the environment. Many toxicological hazards can be effectively managed through 
correct use and disposal methods that substantially reduce or eliminate 
contamination and exposure. It is when these risk management standards are not 
properly implemented or enforced that environmental contamination can occur 
leading to human exposure and risk. This just a role for governments and its 
departments; all chemical users have a role to play.  
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Flame retardants 
Flame retardants (FR) are a family of chemicals incorporated into a diverse 
selection of consumer products including clothes and other fabrics, electronic goods, 
furniture, flooring and in building materials to prevent them igniting.  There are 
various types of flame retardants but amongst those that have caused the most 
concern to date are those that fall within the class called brominated flame 
retardants. These chemicals are persistent in the environment and can stay in the 
body for several years. Many types of flame retardants within this class now have 
restricted uses or are banned from use altogether. While widespread in the 
environment,60 with bans in place levels should start to slowly fall.  
 
Exposure to brominated flame retardants is mostly through food but also from 
household dust (ingestion, inhalation and through skin). The highest dietary 
exposure in the European population tends to be from fish, whereas exposure in the 
US is mostly from meat and dairy products another important source. These 
compounds have a low acute toxicity; however, the concern in respect of human 
health is long-term interference with the thyroid hormone system because there is 
some structural similarity between the chemicals and thyroid hormones. They are 
thus classified as EDCs. In addition, because of the propensity of brominated flame 
retardants to accumulate in lipid, they can be found at levels of up to 400 times 
higher (than blood levels) in human breast milk, which could be a concern both 
because of the levels and the exposure of infants at a susceptible life stage. Though 
these chemicals are widespread in the environment there is, to date, no known 
causative linkage between exposure from the environment and adverse health 
outcomes.  
 
Despite there being no direct linkage to health outcomes, the persistence of these 
chemicals in the environment means they are being phased out. Where this is 
possible, without endangering life though rendering products inflammable, it is to be 
encouraged. The persistent, bio-accumulative nature of these chemicals means that 
when they get into the environment through inappropriate disposal of waste or other 
means they are difficult to remove. For these reasons some of the restricted or 
banned brominated versions are being replaced by other chemicals such as those 
that use chlorines. Some of these are equally persistent and bio-accumulative which 
means that it is certain we will be detecting these chemicals and versions thereof in 
the environment throughout the 21st century. Much of this chemical contamination 
could likely be avoided by rigorous enforcement of waste disposal.  
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To determine the necessity of the use of these chemicals much better data are 
required to determine benefits in terms of lives saved. These data should be 
assessed alongside hazard and risk data to determine acceptable use in terms of 
the balance of benefit and risk. Another, more laudable alternative would be to use 
materials and manufacturing techniques that provide natural flame resistance.  
 
Continuing monitoring will be essential as will further work to understand if there are 
any health consequences from long term low level exposure to these chemicals.  
Those that are bio-accumulative should be restricted, or removed from use. This 
would drive innovation into the development of alternatives that, if released into the 
environment, would not accumulate there. Examples of innovation could include 
better materials and manufacturing to provide an intrinsic flame resistance.  
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New challenges 
Risk communication 
All of the sections above highlight an area in which attention is still required - risk 
communication. Many public concerns associated with the use of chemicals stem 
from misunderstandings about benefits versus risk. All too often hazard is confused 
with risk, and regulation on a hazard basis does nothing to help this. As science 
uncovers new mechanistic understanding and, in particular, vulnerabilities, there 
needs to be a vigorous effort to translate this information into a clear understanding 
of risk. This can only be accomplished by an understanding of both exposure and 
mode of action pathways. This information, with associated uncertainties, then needs 
to be converted into communications that state the case accurately and can be 
easily understood.  
 
Risk also needs to be assessed alongside benefit. There is a role here for both 
academics and independent bodies. Ultimately, however, it is going to be 
government departments and agencies that need to make decisions and provide 
advice. It is therefore important that real risk is effectively assessed and not 
confused with perceived risk. Risk assessment should take account of data lacks 
and uncertainties and communicate effectively hazard and risk assessments and 
associated uncertainty.  
 
 
Cross and trans-generational effects 
Cross-generational effects are those that occur in the developing fetus and/or the 
subsequent generation that develops from the germ cells within the fetus as a result 
of direct exposure in the womb. Trans-generational effects are those that occur in 
generations not exposed to the original exposure and result from heritable changes 
in the gametes. Both can lead to adverse health outcomes and have recently 
developed a higher profile due to new biological understanding. The oestrogenic 
drug diethylstilbestrol is an exemplar of cross-generational effects. Used in mothers 
to prevent miscarriage and premature labour, it led to vaginal carcinomas in the 
female offspring and congenital abnormalities in males.61 Furthermore, experiments 
in animals, with a variety of chemicals, have shown high dose exposure in 
pregnancy during the development of primordial germ cells (that give rise to the 
gametes) can affect the reproductive organs of both the fetus and/or the subsequent 
generation that develops from the fetus. An example of such a chemical is the 
fungicide vinclozolin, which affects the testes, and is passed down the male but not 
the female line.62 Transgenerational effects are less common, where the health 
outcome is observed in a generation not directly exposed or derived from the 
exposed gametes.  
  
Page 101 of 341 
 
 
Studies with vinclozolin and other similar chemicals are largely at high dose (and 
thus are hazard studies), up to a million fold greater than environmental exposure. 
Nevertheless, they set a precedent for the existence of chemically induced 
epigenetic toxicity, and highlight that more research is needed to enhance 
understanding of risks to human health that could cascade across the generations. 
There is to date only limited evidence of effects in humans.61 For example, 
epigenetic changes in human sperm have been shown to be affected by 
environmental influences such as smoking behaviour62  and paternal smoking has 
been epidemiologically associated with obesity in sons.63 Together with the evidence 
from model systems (including potential mechanisms of epigenetic toxicity), the 
increasing human studies warrants further work in the area.  
 
 
Susceptibility 
Since the human genome was first sequenced in 2003, the cost of sequencing has 
dropped exponentially and the capacity increased even more. Benchtop sequencers 
that can sequence the whole genome are available and multiple genomes can be 
sequenced in a few days. This technology has been applied to many genomes from 
humans of different backgrounds and animal species. In addition many cancer types 
have been sequenced. Furthermore the sequencing of epigenetic changes has also 
been developed. In parallel, computing power and associated software has improved 
such that these sequences and their analyses are available with a few clicks from a 
computer mouse.  
 
There have been many net benefits from this work, but one is particularly important 
for risk assessment – the knowledge of human genome diversity. This diversity can 
indicate differential susceptibility. To use this knowledge effectively there is a need to 
understand the mechanism by which a chemical causes toxicity and in particular, the 
key molecular interactions. Therefore we will have new knowledge that potentially 
allows assessment of susceptibilities within a human population and can be built into 
risk management as appropriate. For optimal impact, however, such susceptibility 
assessments require data that are generated about the mechanism of action, which 
is currently not typically done for chemicals.  
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Conclusions 
‘21st century chemicals’ risk assessment will be driven by two factors, new materials, 
but perhaps more strongly new technology leading to new biological understanding. 
As more is understood about the interaction of chemicals with biological systems, the 
risk from legacy chemicals, new chemicals, and chemical mixtures (a particular 
challenge) will need to be re-assessed on an ongoing basis. Two technologies in 
particular will drive this development, analytical techniques leading to better and 
more sensitive measures of exposure and the ‘omics methods for the genome, 
proteins and metabolites that will provide a greater understanding of hazard, 
mechanisms and susceptibilities.  
 
All these methods will produce large amounts of data that will themselves raise more 
questions. Therefore the major challenge ahead will not be generating data, but 
generating the right data and making the right interpretation from all the data 
available. Care will need to be taken to ensure that the new hazards recognised are 
real and relevant to human risk. Otherwise, there will be a danger that chemicals will 
be replaced with substitutes with less desirable hazard profiles. The future is good 
for the development and use of less hazardous chemicals, and a safer, healthier 
environment. 
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New horizons, an introduction 
Previous chapters have largely focused on well-understood and well-evidenced 
impacts of pollutants on health. However, the population will be exposed to many 
other pollution pressures whose effects on our health are less well understood. For 
example, one group of chemical pollutants of concern are the so-called contaminants 
of emerging concern (CECs). These are pollutants that so far have not been studied 
extensively and which are not routinely monitored, where there is a concern from 
stakeholders (scientists, regulators, NGOs etc.) that the pollutant may be harming 
human or environmental health. CECs include pollutants such as nanomaterials, 
human pharmaceuticals (see Chapter 3 of this report, ‘21st century chemicals’), 
natural toxins, veterinary medicines and micro-plastics (see Chapter 7 of this report, 
‘Environmental health - response to pollution’).  
 
Physical pollutants such as light pollution may also be adversely affecting our health, 
whilst sound is not a new issue – although there is a more recent understanding on 
the extent of the harm from this pollutant on human health. The world is also rapidly 
changing due to climate, demographic, technological and land-use changes and 
these changes will also have implications for the exposure of people in England to 
both the known pollutants and CECs. In this chapter, we describe some of the 
concerns around the impact of these more novel pollutants on human health and 
future drivers of pollution exposure and risks. We highlight the need for future work 
and potential management interventions to reduce exposure to these substances. 
We also highlight some of the emerging techniques and methods to combat 
pollution. This includes advances in methods to ascertain knowledge about the 
health impacts of pollutants, such as the use of epigenetics, mutational signatures in 
tumours, and the use of emerging epidemiological techniques.  
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Noise pollution 
This section is authored by Stephen Stansfield, Professor of Psychiatry, Wolfson 
Institute of Preventive Medicine, Queen Mary University of London 
 
Background 
The most frequent human responses to environmental noise are annoyance and 
sleep disturbance. Annoyance, which includes mild anger and feelings of intrusion of 
privacy, is also a response to disturbance of activities by noise. The level of 
annoyance to noise is influenced by many other factors including sensitivity to noise, 
fear of the noise source, and feelings that the noise producers are taking insufficient 
care. Annoyance to environmental noise increased in the UK between 2000 and 
2012 despite little increase in exposure, suggesting that tolerance of environmental 
noise has decreased.1 Noise exposure during sleep induces arousals, delays sleep 
onset, reduces slow-wave and REM sleep and increases the length of time spent 
awake.2 Short-term effects of noise on sleep include impaired mood, increased 
daytime sleepiness, and impaired cognitive performance. Generally noise exposure 
in health studies is measured as the average sound pressure over a specific period 
using decibels as the unit (dBA is the unit of A-weighted sound pressure level in 
decibels) weighted according to differences in human hearing sensitivity at different 
frequencies. 
 
The extent of noise pollution 
In 2012, 83% of a survey sample in the UK reported they heard road traffic noise, 
72% aircraft noise and 48% noise from building, construction and road works at 
home in the last 12 months.2 Forty eight per cent reported that their home life was 
‘spoiled to some extent’ by environmental noise.  Road traffic noise is the most 
prevalent form of environmental noise exposure.  125 million people across Europe 
are exposed to noise levels above 55dBLden, a level at which human health effects 
are thought to become evident.3 Although cars and planes have become quieter than 
in the past there are now many more of them.  
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The health effects of noise pollution 
In general, acute responses to noise, defined as unwanted sound, include startle 
responses and physiological arousal. In the longer term, repeated exposure and 
arousal may lead to more serious health effects which may be part of the body’s 
response to chronic stress. In recent years studies have shown that environmental 
noise exposure has been associated with a range of health outcomes (Basner et al, 
2014). The mechanism of noise effects on health is thought to be via the stress 
hypothesis where prolonged noise exposure increases physiological arousal and the 
secretion of stress hormones such as adrenaline, noradrenaline and cortisol. This 
causes raised blood pressure and heart rate, raised blood sugar and blood lipids and 
may lead to arterial endothelial dysfunction.4     
 
There is convincing evidence that road traffic noise is linked to increased risk of 
hypertension (meta-analysis of 24 studies between 1970 and 2010, OR=1.034 
95%CI 1.01,1.06 per  5 dB increase in 16hr average road traffic noise level).5  There 
is also a small but consistent risk of coronary heart disease related to road traffic 
noise (OR=1.08 95%CI 1.04,1.13 per 10dB Ldn increase in road traffic noise).6 In 
ecological studies aircraft noise has been associated with increased cardiovascular 
disease risk and hospital admissions.7 Aircraft and road traffic noise exposure have 
also been associated with increased risk of stroke8.9, diabetes mellitus10 and even 
mortality.11,12 Some variation in the magnitude of these associations may be related 
to noise exposure misclassification and noise levels at residences are only an 
approximation of noise exposure across the day. One suggestion has been that 
effects of noise might be explained by concurrent air pollution exposure but Tétrault 
(2013)13 found that the point estimates of the association between road traffic noise 
and cardiovascular disease changed less than 10% after adjustment for air pollution. 
 
Environmental noise exposure is also related to range of other effects. In children 
aircraft noise exposure has been linked to delays in children’s reading on standard 
scales in cross-national studies.14,15,16 Prenatal exposure to modelled road traffic 
noise has been related to low birth weight in a large Canadian study, adjusting for 
the effects of air pollution.17 However, two contemporary reviews have found no 
consistent association between environmental noise and prematurity and low birth 
weight but the studies examined were very heterogeneous.18,19  
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Noise pollution and the burden of ill health 
In order to assess the magnitude of the effects of environmental noise exposure on 
health the WHO published the burden of disease from environmental noise in 
Europe, based on noise exposure, the distribution of exposure and existing 
exposure-response relationships. 61,000 DALYs were attributed to ischaemic heart 
disease based on hypertension and IHD outcomes, 45,000 DALYs to cognitive 
impairment in children and young people, aged 7-19 years, 903,000 DALYs to sleep 
disturbance, 22,000 DALYs to tinnitus, and 654,000 DALYs for annoyance.20 
 
In terms of the health effects of environmental pollution in Europe, environmental 
noise comes second in burden of disease to air pollution and arguably is responsible 
for more disturbance of quality of life. Environmental noise is also responsible for 
more life years lost than other significant environmental pollutants such as lead, 
ozone and dioxins.21 
 
What can be done to reduce noise exposure and consequent health effects? 
Interventions to reduce population noise exposure can be considered at several 
steps along the pathway from the noise source to the receiver.22 Reduction of noise 
at source is an ideal but often expensive solution such as designing quieter cars and 
aircraft and the provision of sound absorbing tarmac to reduce tyre noise or grinding 
rail tracks to reduce noise. More easily achievable source reductions include airport 
night curfews, changes in numbers of flights from airports and changes in traffic 
flows on motorways. Interventions between the source and the receiver, such as 
sound insulation of windows or noise barriers along roads and railways have been 
shown to be effective in reducing levels of noise exposure.23 New/closed 
infrastructure interventions include closure of flight paths, introduction of bypasses 
and urban planning control such as the avoidance of new buildings, especially 
sensitive buildings such as schools, close to noise sources. Other physical 
interventions include the availability of a quiet side to dwellings exposed to road 
traffic noise which has been shown to reduce annoyance and the availability of green 
space for psychological restoration.24 Education/communication interventions help to 
educate people to change behaviour to reduce noise exposure or to explain the 
reasons for noise changes which may help to reduce community annoyance levels.   
 
 
 
 
 
 
  
Page 112 of 341 
 
At the level of public policy the European Noise Directive requires EU states to map 
noise levels in urban agglomerations and develop action plans to reduce noise levels 
in the highest exposed areas.3 This has focused attention on noise as an issue, with 
increasing effort to standardise data collection across countries, but there is still 
incomplete data from many areas. In England, the Noise Policy Statement for 
England***** sets out the long-term vision of government noise policy to promote good 
health and a good quality of life through management of noise. Its aims are to avoid 
significant adverse impacts on health and quality of life, mitigate and minimise 
adverse effects and where possible contribute to the improvement of health and 
quality of life.   
                                                          
*****
  https://www.gov.uk/government/publications/noise-policy-statement-for-england 
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Light pollution  
This section is authored by John O’Hagan, Public Health England 
 
Humans evolved with the sun as the main source of light. Therefore, daily activities 
took place when it was light: when the sun went down, we sought shelter and slept. 
Fire provided a form of artificial light, which was developed into lamps by burning oils 
and then candles. Despite this, one hundred years ago when houses had artificial 
light in the form of gas lamps, most people’s day was still driven by the availability of 
daylight. The incandescent light bulb and the installation of electrical supplies into 
factories and homes changed this, extending the day with sufficient levels of light to 
carry on complex tasks.  
 
Since then lighting has changed. The focus on energy efficiency meant that the 
incandescent light bulb was phased out, moving to fluorescent lighting and then to 
LEDs. Fluorescent lamps provided one health concern. Linear fluorescent lamps 
were known to leak small amounts of ultraviolet radiation, managed using plastic 
diffusers to filter it or by the distance the lamps were from people. Following 
concerns from dermatologists, scientists at what is now Public Health England 
carried out an extensive study of the emissions from compact fluorescent lamps. 
This showed that some emitted levels of ultraviolet radiation could exceed the 
exposure limits for workers, especially when used close to the skin. A small 
proportion of the population appeared to be particularly sensitive to these emissions. 
However, there were significant benefits to some people who needed a light source, 
for example, those needing a source close to the page of a book so that they could 
read. 
 
Ideally, light should be controlled so that it only illuminates the areas where it is 
required – and only for the times when it is required. Light pollution is not new – the 
orange glow from sodium lighting above towns and cities has been a problem for 
decades. LEDs, coupled with well-designed optical systems, provide an opportunity 
to control light distribution, specifically to ensure that light goes onto the surface to 
be illuminated and not, for example, into the sky. There are also concerns that 24-
hour light may have an adverse effect on flora and fauna. 
Moving to a 24-hour society presents some challenges for our bodies. We evolved to 
experience a reddening sky as we move into the evening. Our melatonin levels 
should start to increase to prepare ourselves for sleep and to facilitate the body’s 
repair mechanisms. When we get up in the morning, the sunlight should suppress 
our melatonin levels, whilst serotonin production is increased to prepare us for 
activities of the day. 
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In the early 2000s a type of sensor was discovered in the eye, in addition to the long 
known about rods and cones, which was also sensitive to light. Intrinsically 
photosensitive retinal ganglion cells (iPRGCs) were identified as the main sensors 
for entraining our circadian rhythms. Humans have a natural body clock that has an 
approximate 24-hour cycle. However, light is the main trigger to ensure that we stay 
entrained. The initial research on iPRGCs, suggested that melatonin suppressed 
was most effective at a wavelength of about 480 nm (blue light). However, this 
wavelength is close to the peak wavelength known to cause adverse photochemical 
changes in the retina, which at high levels can result in eye injury. More recent 
studies have suggested that the rods and cones also contribute to the body’s 
response to light and circadian processes. Therefore, it is likely that bright light, of 
almost any wavelength, could have an impact. Disruption of the circadian system 
can have a major impact on sleep quality and daytime alertness, which in turn 
impacts wellbeing and safety. It is a bit like having permanent jet lag. 
 
As artificial lighting technology developed, installers recognised the importance of 
ensuring the observer was shielded from high luminance (bright) sources of light 
because of glare, which in extreme cases can be very stressful. An obvious example 
of a shield is the lampshade used in the home. Some LED installations, however, 
have LED chips visible, which can form a source of glare. An extreme example is 
daylight-running lights on cars. These are clearly visible to other road users and 
pedestrians. At night, if they do not dim, they can be very dazzling and more so for 
young children (who have higher transmission of light through to the retina) and older 
people (who will suffer from scattering of the light, particularly in the lens of the eye). 
This means that older drivers, in particular, will be dazzled by oncoming vehicles with 
the risk that they may not see hazards until too late. The problem is exacerbated by 
fog. 
 
Local authorities have been replacing mercury and sodium street lights with LEDs. If 
this is done purely on the basis of energy efficiency and cost, it is possible to end up 
with installations that may not be fit for purpose. Some streetlight luminaires have 
LED sources that can be seen physically projecting below the luminaire, becoming a 
glare source or light pollution. The light spectrum may be enriched in the blue, which 
may be beneficial for keeping drivers alert, but many people will find the light 
uncomfortable. High levels of blue light are known to cause damage to the retina in 
the eye. This only tends to be a problem for blue LEDs and not for white-light LED 
sources containing a blue LED and a yellow phosphor. It is possible to have LED 
street lighting that directs the light only to the areas that need to be illuminated, 
minimising the light that goes in the sky. They can also be provided in a range of 
colour temperatures, where warmer colours are likely to be more appropriate for 
populated areas. 
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Aside from the wavelength and brightness, there may be another impact of LED 
lighting. Some of the LED sources assessed by Public Health England and others 
vary in illuminance at a frequency of 100 hertz. At the extreme, the LEDs switch on 
and off 100 times per second. This is of concern for a number of reasons. Some 
people seem to be very sensitive to this light modulation, resulting in headaches, 
migraine and less specific feelings of malaise. However, most people will experience 
phantom arrays (as happens when you move your eyes quickly when behind a car 
with its brake lights on, particularly in the dark) and there is the risk of a stroboscopic 
effect. This effect may manifest itself as moving objects appearing to jump, rather 
than move smoothly. More seriously, rotating machinery, which could include the 
blades on a food mixer, may appear to be stationary if the rotation rate matches the 
modulation rate or is a multiple of it. 
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Nanomaterials 
This section is authored by Alistair Boxall, University of York 
 
Nanomaterials (NMs) are generally regarded as materials that have one or more 
dimensions of less than 100 nanometres in size. At this size range, the materials 
have very different properties from their equivalent ‘bulk’ material and consequently 
NMs are now being used in a wide range of products including cosmetics, paints and 
coatings, medicines and medical devices, water treatment technologies and 
agrochemicals.25 Release of NMs into the natural environment is inevitable. Emission 
pathways include: entry to air from vehicle exhausts; entry to surface waters from 
down-the-drain chemicals that are released to the sewerage system or from runoff 
from highways and buildings; entry to soils through direct application of 
agrochemicals and the applications of sewage sludge to land as a fertiliser.26 NMs 
may also occur naturally in the environment or be formed from the breakdown of 
larger man-made particles such as plastics and polymers.27  
 
The analysis of NMs in environmental matrices is challenging – due to their size - so 
much of the work done to quantify concentrations of these materials in the 
environment has involved the use of models. Predictions from these modelling 
exercises suggest that highest concentrations of NMs in surface waters will be in the 
tens of microgrammes per litre range in surface waters, tens of mg kg-1 range in soils 
and 100s of ng m-3 in the air compartment.28 
 
Consumers will be exposed to residues of NMs in the environment through breathing 
contaminated air, the consumption of contaminated soil or drinking water, or through 
skin contact with contaminated soil or water. NMs can also be accumulated by 
plants, fish and shellfish29,30 so exposure from consumption of contaminated food 
items may also occur. While it is inevitable that human exposure to residues of NMs 
in the environment is occurring, there is less direct evidence of this. The only 
experimental evidence of such exposures comes from studies that used magnetic 
analyses and electron microscopy to demonstrate the presence of magnetite 
nanoparticles in the human brain.31 They proposed that the most likely source of 
these particles was from airborne particulate matter pollution.  
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Modelling studies have attempted to quantify the importance of environmental 
exposure to a particular NM compared to exposure in occupational and product-use 
settings. For example, Tiede et al. (2015)32 explored the potential exposure of 
consumers from drinking water. They concluded that for the majority of types of 
nanoparticles that were studied, human exposure via drinking water was less 
important than exposure via other routes. The exceptions were some NPs from 
clothing materials, paints and coatings and cleaning products containing Ag, Al, 
TiO2, Fe2O3 engineered NPs and carbon-based materials.  A similar study by 
Nowack et al., (2013)33 concluded that environmental exposure to materials used in 
agricultural production, drinking water treatment, groundwater remediation and in 
medical textiles is more significant than occupational exposure or exposure during 
use of a product by consumers. 
 
Evidence for potential effects of NMs on human health generally comes from in vitro 
studies and in vivo studies using model test organisms. For example, silver 
nanoparticles have been shown to reduce lung function, produce inflammatory 
lesions in the lungs of rats and also to accumulate in the brain.34 At the cellular level, 
the particles reduce mitochondrial function and increase membrane leakage and 
alter levels of glutathione.34 Whether or not environmental exposures can result in 
these types of effects is however, uncertain. 
 
It is inevitable that the English population will be exposed to NMs via the natural 
environment. The degree of exposure will vary depending on the particle and product 
type and, in a few instances, environmental exposure will be more important for 
health than other exposure scenarios (i.e. in occupational settings or during product 
use). NMs do have the potential to cause toxicological effects but whether exposure 
concentrations are high enough to reach toxic levels is still unclear. As the 
nanotechnology sector is rapidly growing, and exposure levels will continue to 
increase in time, there is a real need to begin to better align environmental exposure 
studies with toxicological studies in order to better characterise the risk of these 
materials. 
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Box 1  Health concerns over Carbon Nanotubes  
Dr Craig A. Poland and Dr Rodger Duffin, MRC Centre for 
Inflammation Research, University of Edinburgh 
 
Carbon nanotubes (CNTs) are classified as a ‘nano-object’ as they have two 
dimensions within the nano-range (1-100nm) but can have a length many millimetres 
long. Due to exceptional structural and electrical properties, interest has increased in 
the commercial use of CNTs within various industries - mostly relating to use within 
electronics and composites. However, concerns have been raised as to the possible 
health effects arising from exposure to CNTs owing to their similarity to certain 
pathogenic fibres, most notably asbestos.  
 
These concerns have led to a significant body of work addressing the respiratory 
toxicity of CNTs utilising different models. Typical lung responses noted in numerous 
studies include inflammation, formation of granulomas (typical of a foreign body 
reaction), fibrosis and lung cancer.i A significant concern has been whether or not 
CNTs could reach the pleural cavity and cause mesothelioma, a hallmark cancer of 
asbestos exposure with a long latency period (>30yrs). Several studies have shown 
that lung exposure can lead to deposition of CNTs in the sub-pleural region, 
transition from the lung into the pleural cavity and length-dependent accumulation. 
The retention of CNTs in the pleural cavity has been shown to cause inflammation, 
fibrosis and mesothelioma.ii  
 
It is important to note that not all CNTs display the same level of pathogenicity and 
results are conflicting. This, in part, is because CNTs are produced in a vast array of 
different shapes and sizes which impacts on toxicity meaning there is a spectrum of 
toxicity associated with CNT exposure. Broadly, those very short and/or highly curled 
CNTs, forming a compact structure (<4µm), show a much lower toxicity than those 
which are longer (>10µm) with a straighter, fiber-like morphology. The association 
between shape/ length has also been shown for other nanofibres with materials such 
as titanium dioxide showing greater toxicity with increased length.iii In addition, 
concern has been raised over platelet-shaped nanoparticles such as graphene-
based nanomaterials leading HSE in recent guidanceiv to consider nanoplatelets 
alongside CNTs. 
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Irrespective of hazard status, the risk of human health effects is very much 
dependent on exposure. Exposure is most likely to occur in the occupational 
environment during the production of CNTs as well as the incorporation of CNTs into 
products further down the manufacture chain (for example addition to a composite 
resin). Another area of possible exposure is during recycling of CNT containing 
products. A limited number of studies have shown CNTs (and other nano-carbons) 
can be produced from anthropogenic sources such as diesel exhaustv, leading to 
possible exposure of the public from the general environment. However, CNTs 
produced from anthropogenic sources are not the same as those shown to cause 
respiratory toxicity in animal models (for example they are shorter, more compact – 
generally types thought to be less harmful). The possible impact of anthropogenic 
CNTs on health is yet to be fully elucidated. Another source of exposure is through 
interaction with CNT containing products yet exposure to free CNTs is unlikely due to 
being sealed within products (such as electronic circuitry or embedded within a 
composite resin). 
 
Numerous exposure limits have been proposed for CNTs based on either mass or 
fibre number metrics yet there are currently no statutory limits for CNTs or other 
engineered nano-fibres. Evaluation of CNTs by the International Agency for 
Research on Cancer led to the classification of a specific multi-walled CNT 
(MWCNT-7) as a Class 2b carcinogen with all other forms of CNT as Class 3 
(Unclassifiable).vi 
 
References 
i
 Poulsen et al. (2016) Nanotoxicology;10(9):1263-75, Porter et al. (2010) Toxicology;269(2-
3):136-47, Kasai et al. (2016) Part Fibre Toxicol; 13(1):53. 
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Biological pollutants 
This section is authored by Bjarne W. Strobel, University of Copenhagen  
 
Natural toxins, agents of biological origin, are chemicals – therefore much of their 
characteristics as pollutants are the same as synthetic chemicals. Natural toxins are 
perhaps more familiar as contaminants of food. Examples range from the most 
acutely toxic, notably toxins that cause Paralytic Shellfish Poisoning to pyrrolizidine 
alkaloids in honey. Like all chemicals they also have the potential to disperse into the 
environment and pollute. Probably the most prominent environmental example is 
cyanotoxins, which are produced by cyanobacteria in harmful algae blooms (HABs) 
in surface water. Natural toxins are also added to man-made products, such as paint 
– therefore can pollute down the same pathways as the synthetic chemicals in these 
products. 
HABs, an increase in concentration of algal species that produce toxins, occur in 
coastal and inland waterways, and are increasing in frequency and 
magnitude.35They are often the result of invasive species, or species that take 
advantage of changed natural environments (temperature changes, nutrient 
enrichment, droughts etc.) The HABs produce species-specific toxins, such as 
cyanotoxins. Human exposure can come from ingestion of contaminated fish, 
shellfish, and drinking water; inhalation; or dermal contact. Health impacts vary 
widely, based on the specific toxin.36 Another example of a potential biological 
pollutant in England is the chemical ptaquiloside, produced by bracken. This is a 
potential human genotoxic carcinogen – but there are a number of uncertainties 
around the risk and notably around the level of exposure to the public.37 
There are currently still many questions about the nature of health impacts of natural 
toxins, with the field perhaps many years behind our imperfect knowledge of 
synthetic chemicals. Compared with synthetic chemicals, sources of contamination 
are much less understood and tend to be located more “remotely” from current 
monitoring samplers. Toxicity is also more frequently genotoxic, with the potential 
human health effects currently hard to quantify. Meanwhile, given the 
formation/release in and into the environment is constant but with degradation 
(although varying in rate depending on ambient conditions), it is hard to quantify the 
amounts in the environment using our traditional schemes. That said, exposures are 
likely very low – although perhaps heterogeneous. Wider advances in monitoring 
chemicals, such as the NORMAN database (http://www.norman-network.net/) – 
which will allow us to screen chemicals with potential effects on human health) – will 
help our response to these natural toxins, as well as to synthetic chemicals.  
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Box 2  Bioaerosols 
Timothy W Gant and Emma Marczylo, Public Health England 
 
Increasing populations and demands for food at lower cost are having an effect on 
the way farming and food production are carried out. In particular there has been a 
shift towards consolidated high density farming operations called intensive farms. 
These units generate biological and chemical emissions, both from the unit and the 
waste generated.  At the opposite end of the product life there is disposal. With the 
decreased desire for landfill, more organic matter is being composted in large 
facilities. Both of these can release bacterial and fungal spores, with fungal spores 
being more predominate from composting operations. These could have an effect on 
health, particularly for the development of immune diseases such as asthma. 
  
For intensive farming sites there is evidence of health effects on workers but only 
limited evidence for health effects in the general population. For composting, there is 
some evidence of a health effect for those living close to sites. The same applies for 
the development of asthma in children living near to intensive farming sites.* 
Conversely there could be health benefits. The so-called ‘hygiene hypothesis’ states 
that early life exposure to the type of biological agents that could be associated with 
intensive farming sites and composting sites could stop the immune system being 
unduly reactive later in life that could lead to immune disease. There is little evidence 
for this possible benefit from composting sites and only very limited evidence from 
intensive farming sites. 
  
Further work must investigate the possible links between intensive farming and 
composting sites, and effects on health (beneficial or adverse). This will involve the 
development of better assays to detect the microbial species associated with these 
facilities. Many of the traditional methods for detecting biological species are limited 
and not discriminatory. Modern molecular methods must better characterise the 
biological exposure from these facilities and link these data epidemiologically to 
health outcomes on small geographical scales. 
  
*    Int J of Hygiene & Environmental Health https://doi.org/10.1016/j.ijheh.2017.10.019  
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Impacts of future change on the health risks of 
pollutants 
This section is authored by Alistair Boxall, University of York 
 
Introduction 
England is changing: over the next century alterations are predicted in climate, land-
use, demographics, physico-chemical properties of the environment (for example 
acidification), water availability and the degree of urbanisation. Global climate 
change (GCC), for example, is predicted to result in different weather characteristics 
in England. The English population is projected to continue growing, reaching over 
63 million by 2039.38 The population is also getting older, births are continuing to 
outnumber deaths and immigration continues to outnumber emigration.38 
 
All of these changes are likely to affect the risks from chemicals and other pollutants 
in the natural environment to human health by altering:  
a)  the types and quantities of chemicals that are released to, or formed in, the 
environment;  
b) transport, accumulation and fate of chemicals in the environment;  
c) sensitivity of humans to a particular contaminant;  
d) human behaviour (for example Figure 4.1) 
 
Below we discuss some of these potential changes in exposure and risks, focusing 
mainly on GCC-drivers which is where most work has been done.  
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Figure 4.1 Potential global climate change (GCC) related and other drivers 
that will affect the risks of pollutants to human health in the UK in 
the future  
 
 
 
Source Adapted from Boxall et al. 
 
Future changes in climate will impact chemical usage patterns and the amounts 
used, as well as how chemicals are formed in the natural environment and even alter 
exposure to existing chemicals. For example: 
• For pesticides, biocides and pharmaceuticals, use will likely increase due to 
changing disease and pest pressures (in addition to increases due to 
demographic changes).39,40  
• As the generation of many natural toxins (for example algal, fungal and phyto-
toxins) is partly governed by temperature and moisture, GCC will affect the rates 
of formation of these substances in the environment as well as their geographical 
distribution.  
• For legacy contaminants, such as mercury, that have been released into the 
environment in the past and reside in soil and sediments, GCC may alter the 
environment in such a way that the contaminant can be released more rapidly.41  
 
As well as the direct impacts of GCC on pollutants (more below), our response will 
also have impacts on other pollutants. For some chemical contaminants there may 
be a reduction in emissions to the environment. As many fossil-fuel combustion 
processes that generate greenhouse gases also emit other harmful air pollutants, 
decreases in fossil fuel use, resulting from greenhouse gas mitigation policies, will 
reduce ground-level air pollution by particulate matter and ozone in urban areas.41 
Conversely, shifts to some types of biofuels may increase levels of air pollution in 
rural areas. 
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GCC and pollutant pathways 
Transport pathways for chemicals will be affected by changes in climate conditions 
which will affect human exposure.42 Aerial transport of chemicals, for example, is 
dependent on the surface temperature, air temperature and wind speed, all of which 
are predicted to change as a result of climate change. Increases in temperature 
resulting from GCC will result in increased volatilisation: this will increase long-range 
transport of persistent organic chemicals, such as PCBs and dioxins, and local 
bystander exposure to chemicals such as pesticides.41 Increases in the occurrence 
of extreme weather events, such as floods and droughts will alter the mobility of 
contaminants, providing pathways by which chemicals can move from contaminated 
areas such as contaminated land sites and sediments to uncontaminated areas. 
On the land, alterations in soil characteristics such as reductions in soil organic 
carbon content, increases in dustiness and changes in soil hydrology will alter how 
contaminants are sequestered in soil systems and transported around rural 
catchments.39 The dilution potential of contaminants in rivers and streams in the UK 
will also change.43 In agricultural areas, changes in irrigation practices and more 
reliance on re-use of wastewater, in response to GCC, could also move 
contaminants from waterbodies and sewer systems onto land.  
 
GCC and pollutant fate 
As well as affecting environmental transport processes, GCC will also alter the fate 
of chemicals. Increases in temperature and changes in moisture content are likely to 
alter the persistence of chemicals.43 Biodegradation is generally faster at higher 
temperatures and moisture contents, so faster degradation of organic chemicals 
would be expected in hotter and wetter regions. Rates of photolysis are also 
expected to increase in some regions due to reduced cloud cover meaning that 
photosensitive chemicals will be exposed to higher intensities of UV light. All of these 
different changes in fate and transport can have both positive and negative 
implications for contamination of air, surface waters, soils, food and drinking water 
supplies and air and hence human exposure. The relative changes in exposure will 
likely vary depending on region and the physico-chemical properties of the chemical 
itself.  
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Human vulnerability 
Human vulnerability to pollutant exposure will be altered.44 Heat makes humans 
more vulnerable to adverse effects of air pollutants, such as ozone and PM10, so 
anticipated temperature increases under GCC could increase sensitivity to aerial 
contaminants. Chemical exposure may also make humans more vulnerable to GCC-
driven changes, for example impairment of the human immune system resulting from 
chemical exposure could increase vulnerability to vector-borne diseases which are 
predicted to increase under GCC. Human behaviour will also be affected by GCC 
and this will have implications for exposure.  
 
Impacts of future change on the health risks of Pollutants - Summary 
Overall, human exposure and sensitivity to pollutants will be altered in the future. In 
some instances, these alterations will have a positive impact on exposure and health 
while in others health impacts may be exacerbated. We therefore urgently need to 
establish how exposures of pollutants of potential concern could change under 
different future scenarios and to use the results of such analyses to identify potential 
interventions to reduce the health impacts. 
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Box 3  Pollution and the weather 
Dr Matthew Hort, Head of Atmosphere, Met Office 
 
The gases and particulates that make up ‘air pollution’ originate from sources as 
diverse as transport, industry, agriculture and the natural environment. These 
sources are also spread out geographically across our cities, countries and the 
world. Pollution though does not stay located at its source, as once in the 
atmosphere it is blown, mixed, diluted, removed and reacts with, amongst other 
things, the wind, humidity, clouds, rain and other chemical compounds.  
 
The weather we experience knows no borders and the winds, systems, and storms 
evolve, grow and diminish perpetually in a continuum spanning from the local street 
to the world. Therefore, chemicals and particulates once in the atmosphere can 
potentially also be transported over distances ranging from a few millimetres to 
1000s in km. The transport by the atmosphere also brings together and enables 
interactions and reactions of and between the gases and particulates. While this is a 
universal phenomenon it can perhaps be appreciated more easily when we think 
about specific events: The eruption of the Icelandic volcano in 2014 that resulted in 
volcanic gases, including Sulphur Dioxide which then created sulphate particles, 
spreading across Northern Europe; the presence of fine sand from the Sahara on 
our cars that has been blown all the way from North Africa before being removed 
from the atmosphere by rain; the intermittent smell of a domestic wood fire on the 
street or in our gardens; and of course, the clear increase in traffic ‘fumes’ as we 
approach major roads and junctions. 
 
This means that the causes of air pollution at a specific location can be: 
predominantly located far away; be an even mix of near and far sources or be 
predominantly due to local emitters. Even in our cities, while the pollution can be 
dominated by local traffic emissions it still contains, often significant, elements from 
sources across the rest of the country, shipping in the surrounding waters, the wider 
continent and also the rest of the northern hemisphere. As such, while it is often 
correct to focus on local sources for local effects, it is however wrong to do this to the 
exclusion of considering the contribution and impact from the wider geographical 
area. The meteorology and dispersion after all follow the rules of physics and 
chemistry rather than administrative or societal boundaries. 
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Epigenetic changes and the environment 
This section was authored by Paolo Vineis, Imperial College London 
 
Environmental changes of the past have had consequences on the genetic 
characteristics of certain populations, such as selecting gene variants. For example, 
the migrations from the Fertile Crescent of the Middle East to Northern Europe 
(between 5,000 and 10,000 years ago) led to selection among the new settlers of the 
northern countries of the traits for tolerance to lactose and the diffusion of fair skin. 
Both mutations emerged in all likelihood to make up for the deficiency of Vitamin D, 
due to reduced exposure to the sun in northern countries. These adaptations 
appeared through selection of favourable genetic mutations in the migrant 
populations.  
 
It is unlikely, however, that slow changes in the genetic make-up of populations, that 
is, in the DNA sequence, dominated the response to rapid changes linked to 
globalisation (for example in diet). It was likely due to faster epigenetic changes, 
which are only now beginning to be understood in detail. These are functional 
changes, in how the DNA is expressed – or more simply used – which are reversible 
and transmissible from one cell to its daughters. They are not structural changes, 
such as in the sequence of the DNA bases. 
 
To give an example of how the environment impacts on one type of epigenetic 
change; methylation is a change, the binding of a molecule, to the DNA that affects 
how it is used in a cell. Work is examining the impact of air pollution on the 
methylome, a record of all of these methylation changes. Long-term exposure to air 
pollution has been associated with several adverse health effects including 
cardiovascular, respiratory diseases and cancers. However, underlying molecular 
alterations remain unclear. This work investigates the effects of long-term exposure 
to air pollutants on DNA methylation at functional regions (elements of the genome 
known to code for proteins) and at a certain recurring DNA sequence (CpG sites) 
that is methylated differently at the same site in different human tissue, with this 
methylation associated with disease. Findings suggest that global hypomethylation 
(the absence of this methyl molecule binding) is associated with air pollution. 
Further, methylation in both the genes and these CpG sites are mostly affected by 
exposure to NO2 and NOx. Previously, hypomethylation has been associated with 
genetic instability, greater probability of mutations and increased risk of disease. 
The investigation of epigenetic changes is believed to be one of the most promising 
fields of research on the mechanisms that explain the impacts of environmental 
changes – including from pollution - on health. 
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Box  4  Mutational signatures – a record of environmental exposure? 
David Phillips, King’s College London 
 
Whole genome sequencing of human tumours has revealed distinct patterns of 
mutation that hint at the causative origins of cancer. Some of these signatures can 
be attributed to environmental causative agents, while others suggest defects in 
cellular processes that maintain the integrity of the genome. A large proportion of the 
signatures are, as yet, uncharacterised. 
 
Mutational signatures can be generated experimentally by exposing cells to 
mutagens. In cancers for which tobacco smoking confers an elevated risk, smoking 
is associated with increased mutation burdens of multiple different mutational 
signatures, which contribute to different extents in different tissues. One of these 
signatures, mainly found in tissues directly exposed to tobacco smoke, is attributable 
to misreplication of DNA damage caused by tobacco carcinogens as it closely 
matches the signature induced in cells by exposure to benzo[a]pyrene, a tobacco 
carcinogen. Others likely reflect indirect activation of DNA editing and of an 
endogenous clock-like mutational process. 
 
Some other cancers also have mutational signatures indicative of an environmental 
exposure: aflatoxin in liver cancer, aristolochic acid in urothelial cancer, ultraviolet 
radiation in melanoma. Air pollution contains a complex mixture of mutagenic 
carcinogens. Whole genome sequencing of tumours attributed to air pollution may 
yet reveal a characteristic mutation signature or signatures linking their causation to 
the environmental carcinogens present in urban air. 
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Advances in epidemiology 
This section was authored by Dr Giovanni Leonardi (Public Health England); Tony 
Fletcher (LSHTM) 
 
Addressing pollution needs a new epidemiology that integrates measurements from 
across pollution-relevant domains, to human domains. When planning ahead for 
which chemicals would be safe for society to use, regulatory toxicology has a clear 
role to play, however once people are unfortunately exposed, epidemiology can have 
a crucial role. Indication of the value of integrating measurements from several 
pollution domains using epidemiology has come from several recent results. These 
include the recognition and quantification of effects of  several environmental 
exposures on (1) growth and physical development; (2) behavioural and cognitive 
development; (3) asthma and allergies; (4) sexual and reproductive development.  
 
Both toxicology and epidemiology can provide some integration, but have often failed 
to include information to provide quantitative estimation of parameters sufficiently 
relevant to a societal level capacity to intervene.  The first failure is to ignore 
population level distribution of benefits and hazards attributable to a chemical 
compound, mixture, or other environmental factor, the second is to address these 
aspects by exceedingly weak methods, inadequate to reach conclusions about either 
causal relationships or relevant interventions. In anticipating future challenges that 
do not allow time for a prolonged and laborious examination of overlapping and 
conflicting factors over decades, epidemiology has the potential to provide valuable 
and quantitative indication of the value of an intervention. 
 
Epidemiology is not a tool or method for public health; it is a science essential to 
public health.45 Non-communicable disease (NCD) that has been caused by pollution 
exposure, and for which preventive interventions exist, would not be acted upon in 
the absence of epidemiologically-based assessment of population risks and benefits. 
This applies to pollutants too. This may be counterintuitive when epidemiology has 
often been vilified in the media for proposing implausible and conflicting 
interpretations of non-communicable disease. This supposed limitation of 
epidemiology may be attributed to the general weakness of a science process that 
does not recognise the benefits of population thinking when addressing population-
level issues, more than to intrinsic deficiencies of either epidemiology or the media. 
Lack of recognition of the essential value of population thinking may be more an 
issue of general culture and education than technical competence in any given 
discipline of science. In any case, epidemiologists have produced findings of unique 
value to understanding and prevention of non-communicable disease, when clear 
high exposure groups could be defined, as in the example of smoking and asbestos.   
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Even when pollutant exposure has been lower and more widespread, such as in the 
case of air pollution, epidemiology has managed to document health impacts. So, it 
is expected that epidemiologists will be capable of producing other findings of 
comparable value on other themes such as the challenges summarised throughout 
this report, if adequately trained and supported. In the future, a  population-level 
assessment of health risk will be helpful whether we consider near-term  knowledge 
needs (five years) such as neurological and other emerging health effects of air 
pollution and transport, health impacts of airport (and other transport hub) noise, 
health impacts of waste management  approaches such as incinerators and landfill 
sites, or longer term needs (up to 20 years) where additional foreseeable 
developments include investigation of potential health impacts of new energy 
sources (for example shale gas extraction, small modular nuclear reactors), of light 
from a variety of sources, around current and legacy industrial sites, intensive 
farming practices, or simply in response to potential needs to revisit issues such as 
childhood cancer around nuclear sites, power lines, Camelford††††† etc. 
 
Typically, success in epidemiology in these themes has required careful assessment 
of environmental exposure pathways and burden of socio-economic and other 
confounding, and efforts to conduct individual level longitudinal studies as well as 
ecological and cross-sectional studies before coming to a conclusion on any topic. 
Examples include results on endocrine effects of persistent pollutant PFOA and 
other fluoridated compounds, neurological effects of DDT and other chlorinated 
compounds, and the increasing recognition of the inter-generational effects of 
pollutants and other environmental stressors by analysis of birth cohort as well as 
adult cohort studies.  
 
To characterise effective, evidence-based potential interventions to reduce NCD 
health burden attributable to pollution, epidemiology will be needed as well. This was 
demonstrated by the experience of Environmental Public Health Tracking (EPHT) 
programmes in the US and elsewhere, where evaluation of health benefits of 
complex interventions could be documented by consortia that included agencies 
responsible for interventions as well as epidemiologists (see box on EPHT in USA – 
chapter 9). Integration in EPHT of information on a new generation of biomarkers of 
exposure and disease risk, significantly enriched by mechanistic information, seems 
feasible.46 
 
 
 
                                                          
†††††
  In July 1988, 20 tonnes of aluminium sulphate entered the water supply of 20,000 residents of 
the Camelford area of Cornwall following accidental contamination.  This is considered 
the  largest accidental water contamination in UK history. 
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In conclusion, integration of epidemiology with toxicology is likely needed to design 
valid studies of potential harm of new and emerging pollutants, and integration of 
epidemiology with sciences adopted by those resourcing interventions is likely 
needed to design valid studies evaluating benefits of interventions to prevent NCD. 
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Box 5  A breath of fresh air: Novel approaches to behaviour change 
Carolin Reiner, Michael Hallsworth, Toby Park, Elisabeth Costa of the 
Behavioural Insights Team 
 
Every day we make decisions that directly affect the air quality around us - be it our 
commute, our choice of car, or the way we heat and light our homes. Cumulatively, 
these decisions have large environmental implications. In other words: improving air 
quality requires changes in behaviour, and therefore a more sophisticated account of 
human behaviour will allow us to make better policy. Behavioural insights can help 
provide this more sophisticated account.  
 
Consequently, behavioural insights can either suggest new policy options and new 
kinds of interventions, or improve existing policy options. In terms of new kinds of 
policy interventions, a recent study where Virgin Atlantic pilots were encouraged to 
fly in a more fuel-efficient way, demonstrates how behavioural insights can 
successfully reduce emissions.i All 355 pilots in the trial were aware their emissions 
were being monitored, and this fact alone was enough to increase their fuel 
efficiency. Some pilots also received behaviourally informed “interventions”, such as 
personal emission targets and feedback on their respective performance, leading to 
even greater reductions in emissions. Overall, the experiment saved 6,828 metric 
tons of fuel, which amounts to 21,507 tons of carbon dioxide not emitted.ii  
 
There is great potential for similar interventions to reduce road vehicle emissions in 
the UK. For example, there is a growing trend among business fleet owners to use 
in-vehicle telematics to monitor driving style, with insurance companies also starting 
to use the technology to assess driving safety and risk. While the awareness of 
being observed is often enough to change behaviour, the use of telematics also 
opens up possibilities for interventions such as in-vehicle prompts about driving 
behaviour, tailored fuel consumption reports, the salient highlighting of cost savings, 
and making social comparisons with more efficient drivers. The latter idea is 
analogous to successful work by Opower, whose home energy bills have been 
shown to reduce energy consumption by comparing households’ energy 
consumption to their more efficient neighbours.iii Similarly, this social comparison 
could be applied to reduce air pollution. 
 
continues next page 
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Behavioural insights can also be used to improve existing policy options, like 
incentives structures used to increase the uptake of a public service or a 
recommended product, such as low or zero emission vehicles. Scrappage schemes, 
punitive taxes on more polluting vehicles, or changes to fuel duty are such possible 
incentives under consideration, and are examples where behavioural insights can be 
used to structure incentives for maximum impact. For example, we tend to be loss 
averse (being more motivated by a loss than by an equivalent gain); we often 
overweight small probabilities (meaning lotteries and prize draws can be more 
powerful than flat incentives); and we tend to discount the future (meaning 
upfront rewards are more motivating than delayed ones, and delayed costs are 
less off-putting than immediate ones). Specifically, for instance, we could make 
scrappage schemes more salient by introducing a prize draw for everyone who 
signs up and thereby encourage the uptake of low or zero emission vehicles. 
New ‘behavioural’ policy interventions like setting targets to steer driving 
behaviour are easy to implement and more affordable than traditional policy 
levers like regulations (for example the diesel ban), and can also improve the 
effectiveness of existing policies like a scrappage scheme. Their cost-effective 
nature renders behavioural insights interventions easily scalable and can 
therefore substantially shift behaviours to clean up the air we breathe. 
 
References 
i Gosnellet et al. (2016). Working Paper (22316). National Bureau of Economic Research  
ii Lambert et al. (2016). 
https://www.virginatlantic.com/content/dam/vaa/documents/footer/sustainability/VAA_Captain
s_Study_Summary_FINAL_170616.pdf  
iii Olig & Sierzhula (2016) Evaluation Report. Navigant Consulting. 
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Suggestions for policy makers 
This section was authored by Alistair Boxall and Andrew R H Dalton.  
 
While the links between many environmental pollutants and human health are well 
established, our overall understanding of the overall impacts of environmental 
pollution on human health is actually quite limited. This is because: 
• we only monitor a handful of the 1000’s of chemical, physical and biological 
polluta nts that an individual will be exposed to over their life time;  
• even for pollutants where we have knowledge on exposure, we have a very 
limited understanding of the effects – particularly for pollutants where 
exposure is low but occurs throughout an individual’s life time; and  
• we have limited understanding of the combined effects of multiple exposures 
to a number of pollutants. 
 
 These knowledge gaps could be addressed by: 
• The development and application of prioritisation methodologies to identify the 
‘unknown’ pollutants of greatest concern to the UK population and which 
therefore require further testing and monitoring. This will likely need much 
better sharing of knowledge and data across different sectors. 
• The extension of current monitoring systems (for example for water and air 
quality) to consider a much wider range of pollutants and to generate 
exposure data at much more detailed spatial and temporal resolutions 
allowing us to better establish what different populations are exposed to 
throughout their day-to-day lives. The introduction of environmental specimen 
banks would allow us to look back in time as new pollution issues become 
apparent; 
• New models for predicting exposure of individuals to different pollutants in 
different regions of the country and across a range of timescales; 
• The application of new biomonitoring approaches (for example ‘omics’ – see 
box) and technologies (for example sensor networks and crowdsourcing of 
data) to develop information on how the health of individuals varies across 
space and time. 
By combining information for these new systems for monitoring and modelling the 
exposure and effects of pollutants on the human population with approaches for 
analysis of ‘big data’ we should begin to be able to generate a much better 
understanding of the impacts of the plethora of the environmental pollutants that 
we are exposed to on our health meaning that interventions can be focused on 
those pollution threats that really matter. 
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Summary of key points  
 
Interventions to reduce pollution have the potential to increase social welfare 
through improvements in health, social and economic outcomes. This 
potential has been shown in a range of economic analyses focusing on 
specific interventions. In this chapter we present evidence from studies 
focusing on the health impacts of environmental interventions that have been 
evaluated with an economic perspective. Overall, this body of evidence is 
strongly suggestive of beneficial welfare impacts from most interventions. 
However, there remains significant scope for expanding and strengthening the 
current evidence base in order to provide clearer guidance to policy makers in 
policy design and investment decisions. Salient points made in this chapter 
include: 
 
• England has successfully managed to “decouple” trends of economic 
growth and polluting emissions, achieving reductions in emissions of a 
large range of pollutants with an expanding economy. However, the 
detrimental health impacts of current levels of pollution are still large, as 
are the potential benefits of taking more incisive actions against pollution. 
 
• Economic analysis approaches typically applied in the appraisal of 
environmental interventions are at odds with those prevailing in the health 
care domain. A gold-standard economic evaluation approach in the area of 
environmental health interventions should take a societal perspective and 
aim at assessing overall impacts on social welfare. Available evidence 
neglecting these key components underestimates the net benefit of 
pollution reduction measures.  
 
• Research’s priorities should now be the evaluation of the societal benefits 
of pollution measures in order to justify economically beneficial 
interventions that reduce individuals’ pollution exposure or remove the 
source of emissions.   
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Introduction and background 
 
Understanding the consequences of pollution requires a multi-disciplinary 
approach, and the perspectives of multiple stakeholders must be accounted 
for in designing effective solutions. Economics can play a crucial role in 
understanding individual behaviours – how individuals respond to different 
types of incentives - and in assessing the economic impacts of interventions 
to curb pollution. Pollution is often viewed in economics as a negative 
externality of an activity, particularly for health and the environment, yet the 
economic output generated by the underlying activity contributes to increasing 
welfare. Economic analysis applies to this problem through two principles: (a) 
efficiency, i.e. the marginal (incremental) social benefits of an activity must 
always exceed the marginal social costs involved (e.g. from pollution); and, 
(b) equity, i.e. if different subjects enjoy the benefits of the activity and bear 
the costs involved, some form of redistribution is required. 
  
Pollution has been perceived by some as a necessary evil on the way to 
prosperity and economic development. The economic hypothesis linking 
growth and pollution has been portrayed as an inverted U-shape, referred to 
as the “environmental Kuznets curve”, reflecting the observation that some 
emissions tend to increase in parallel with economic growth up to a certain 
level of income, until they peak and start decreasing as income grows further. 
This concept applies in different ways to different countries and types of 
emissions.1-3 The key principle is the existence of a turning point, at which the 
“decoupling” of emissions and economic growth happens, with emissions 
starting to increase at a slower pace than economic growth (relative 
decoupling) and eventually decreasing with further economic growth (absolute 
decoupling).  
 
A DEFRA assessment showed that absolute decoupling of emissions of a 
wide range of pollutants has been achieved in the United Kingdom since 
1990, including CO2, which is typically less amenable to decoupling.4 While 
population and consumption increases are typically the strongest drivers 
increasing emissions, changes in production technology and in the mix of 
products consumed are typical drivers acting in the opposite direction. 
However, the Lancet Commission on Pollution and Health has warned against 
simplistic interpretations of the Kuznets curve, which may lead to 
complacency about pollution on the assumption that economic development 
will eventually fix the problem.5 Achieving the decoupling of economic growth 
and emissions requires effective environmental policies, including appropriate 
forms of regulation and incentives for the use of non-polluting technology and 
energy sources. Pollution is a hindrance to further economic growth6 and 
reducing levels of pollution has beneficial impacts on the economy. In the 
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case of air pollution, each dollar invested in control measures has been 
estimated to yield economic benefits of about $30 US.5 
 
Evidence of the balance between the costs and the benefits of interventions is 
essential to the design and implementation of effective and efficient policies. 
This  helps policy makers to understand not only the full extent of the 
consequences of those policies but also the critical uncertainties around 
policy impacts and future pollution scenarios.7 Given the established and 
important health impacts of pollution, a sound economic evaluation of an 
intervention to reduce exposure to or emissions of pollution should include an 
assessment of the value of the health benefits of the reduced exposure and of 
the possible impacts on the demand for health and social care. Ideally, a 
proper economic evaluation should also account for the indirect effects of 
pollution, namely the productivity loss and the cost to the ecosystem.  
 
The aims of this chapter are: (1) to review the most robust evidence from 
economic evaluations of interventions to reduce pollution, or exposure to 
pollution, which have duly accounted for the health consequences of such 
actions; and, (2) to highlight interventions that have been associated with 
favourable health and economic impacts. In the rest of the chapter, we 
present the findings of a literature reviewxix designed to identify 
comprehensive economic evaluations of policy interventions aimed at 
reducing pollution in the UK, or in countries at a comparable level of economic 
development. We also provide an overview of the main types of policy 
interventions that have been implemented and evaluated to reduce pollution 
and its impacts on mortality and morbidity.  
  
                                                          
xix
  See Appendix 2 of this report (literature review) for more details. 
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Different types of economic evaluation  
 
Economic analyses of environmental interventions cut across two fields 
(health and environment), which typically adopt different evaluation 
approaches. In health economics, the focus is traditionally on how effectively 
health care resources can be used to improve the health of individuals and 
populations, typically through cost-effectiveness analysis. In environmental 
economics, a welfarist cost-benefit analysis approach prevails, aimed at 
assessing whether interventions have an overall positive impact on social 
welfare.  
 
A gold-standard economic evaluation approach in the area of environmental 
health interventions would typically take a societal perspective, in order to 
account for the broad range of consequences that may accrue to different 
subjects, in different time frames, and with different levels of uncertainty; and 
would aim at assessing overall impacts on social welfare resulting from the 
intervention. However, many economic evaluations of environmental policy 
interventions account for only some of the wide-ranging impacts (health, 
economic, social, environmental) of such interventions. As a result, the net 
benefits of interventions calculated in different studies are often not directly 
comparable to each other. 
 
The impact of an intervention is either assessed directly by comparing the 
observed pre- and post-experiment outcomes (cf. Box 1 for an example), or 
derived or simulated using an impact pathway approach (IPA8). IPA 
combines different sources of information and model estimates. In a typical 
IPA study, one quantifies the change in emissions associated with the 
intervention, applies a dispersion model, relies on concentration-response 
functions to derive the health impacts, and translates the effects into a 
monetary value. Depending on the objective of the analysis, this approach 
may also cover non-health impacts such as changes in lifestyle, or 
environmental consequences.  
 
Health impact assessment (HIA) methods, i.e. IPA focusing on health 
impacts, have been used to document the wide and complex impacts of 
pollution on health and mortality (e.g. 9-12), but individual studies often assess 
only selected dimensions of those impacts. Assessments also provide 
estimates with large margins of uncertainty, due to the complexity of the 
relationship between environmental exposures and health.13,14 Outcomes in 
HIA can be expressed in different metrics and guidance is lacking on how to 
select the most appropriate metric in a specific context.11 
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Monetisation of the health impact  
 
In order for the health impacts to be taken into account into an economic 
evaluation, they have to be expressed in a unit comparable to the costs of the 
intervention. The objective of this session is to review the main methods 
available to monetise health impacts. Table 5.1 summarises the main 
conversion methods. Monetary values offer significant advantages over in-
kind outcome measures. They can summarise multi-dimensional outcomes 
(including non-health outcomes) into a single metric, which is the same metric 
used to assess costs in the economic evaluation. 
 
Table 5.1 Summary of main monetisation methods  
 
Health 
economic 
technique 
Description Pros and cons 
Unit costs This approach values each 
unit of health outcomes, for 
example healthcare 
resources affected, the 
number of new morbidity or 
mortality cases. 
It costs individually each 
aspect, yet not all the unit 
costs are always available 
(e.g. the cost of treating all 
the diseases affected by 
pollution such as the cost 
of depression) 
Willingness-to-
pay (WTP) 
Maximum monetary value 
that individuals are prepared 
to pay for something such 
as the removal of pollution 
exposure, or noise from 
traffic.  This measure is 
typically extracted from 
surveys.   
It provides a holistic figure 
that cover the direct and 
indirect costs as perceived 
by the payer.  
However, it is context 
specific and lacks clarity on 
what is and is not 
accounted for. It also 
depends on the individuals’ 
ability to pay and it may not 
be representative of the 
overall population.  
Value of a 
Statistical Life 
(VSL) 
It is the total WTP of a 
population to save one 
statistical life, or in other 
words, the risk of death.  
 
 
  
  
Page 145 of 341 
 
From an economic perspective, health outcomes can be valued along multiple 
dimensions. These include the health care costs involved, the productivity 
losses incurred, and also intangible costs such as the pain and suffering 
associated with a disease. A simple health valuation can be the costing of 
each health units affected by interventions. For example, if pollution is 
affecting the number of asthma cases, this health impact can be translated 
into the healthcare cost of treating these additional cases. Yet, this approach 
is limited when it comes to the costs of intangible direct and indirect health 
impacts such as mortality and loss in productivity. The literature values 
premature morbidity to about 30,000£ to 60,000£ a year. 
 
The willingness-to-pay (WTP) addresses some of these limitations and is 
often used to have a price of non-market goods such as pollution. The WTP is 
the maximum price that an individual is willing to pay, typically here to avoid 
the consequences of pollution exposure. Although this measure is abstract 
and varies by participant (e.g. as a function of income, or the nature of health 
risks), it has the benefit of capturing some of the less tangible costs and 
indirect impacts, such as the value placed on a cleaner home.15 The main 
empirical approaches for the elicitation of such values are contingent 
valuation, revealed preferences, and human-capital valuation. The contingent 
valuation method requires the participants to state their willingness to pay 
contingent on the hypothetical provision or removal of a good or service. It is 
captured through appropriately designed surveys. The revealed preferences 
method requires observational data on price responses, or preferences can 
be elicited by offering survey participants different trade-offs (e.g. wage/risk 
trade-offs in the labour market). The main limitation of these methods is that 
they do not capture unknown risks to the individuals. For example, if 
individuals do not know or understand that pollution is harmful, their WTP will 
be low. Finally, the human capital evaluations proxy the value of health 
improvements as the difference between the decreased consumption of 
health care and the increased production, typically based on earning.16 
 
Aggregate WTP can be used to derive the value of a statistical life (VSL), 
which represents the sum of what a population would pay to remove a specific 
risk. A number of reviews have been undertaken of monetary values reported 
for a statistical life or for particular health risk reductions (e.g. Viscusi, 1992). 
These have consistently shown large ranges of variation, but also some 
clearly identifiable patterns (by valuation approach, individual characteristics, 
or characteristics of health risks). The problem of identifying a monetary value 
for a statistical life can be viewed as the derivation of a demand curve for 
health, in which different levels of willingness to pay are linked to specific 
health risk reductions. The use of WTP values in international comparisons 
means that estimates of the cost associated with pollution tend to be higher in 
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high-income countries, but smaller as a proportion of income compared to 
low- and middle-income countries.17 
 
In a world with limited resources, and where choices must be made on where 
priorities should be, welfare economics offers a systematic approach based 
on a simple logic. Welfare economics is concerned with formulating and 
justifying propositions by which alternatives may be ranked.18 The starting 
point of welfare economics is individual utilities (or wellbeing), and the final 
aim is achieving a social maximum welfare derived from individual desires 
and preferences.19 Prioritising effective interventions in welfare economics is 
made easier by comparing the net benefits of interventions. The algebraic 
difference between the benefits and costs is the net value of the intervention, 
and a positive net present value implies an efficient use of resources from an 
economic perspective. However, applying this logic does not leave much 
room for judgements on the distributional implications of alternative 
allocations generally, although the use of equity weights is possible. The 
ranking of alternatives can be achieved using cost-effectiveness or cost-
benefit analysis.  
 
The health economic evaluation literature in health care settings often relies 
on Cost-Effectiveness analysis(CEA). CEA takes the perspective of an 
identified decision maker, typically a health care provider, and adopts a 
narrow view on the direct benefits and costs of health care interventions. 
Benefits are measured in natural units (e.g. survival rates, life expectancy, life 
years gained, etc.). The normative nature of CEA remains confined to the 
maximisation of a specified objective function (e.g. aggregate quality adjusted 
life expectancyxx) within a budget constraint. CEA ratios for a comprehensive 
series of (non-mutually exclusive) interventions that compete for the same 
pool of resources and then compared in a CE league table. Interventions with 
the lowest CE ratios are in principle selected as efficient uses of existing 
resources. 
 
Supporting policy makers who have to ultimately choose interventions across 
a range of options with different health outcome benefits is made easier by 
comparing the benefits and costs translated into monetary units. Cost-Benefit 
analysis (CBA) has its theoretical basis in welfare economics, whereas CE 
analysis retains a weaker link with economic theory. A simple CBA compares 
the direct cost of the intervention, and translates the health impact into a 
monetary value. This method is appropriate if most of the benefits are 
expected to be captured by health outcomes. However, if there could be large 
                                                          
xx
  The pharmaeconomy literature would refer to cost-utility analysis when the quality of  
life is taken into account.  
  
Page 147 of 341 
 
indirect impact, the true costs and benefits are likely to be much larger once 
the indirect impacts are accounted for.  
 
A few authors are referring to “extended Cost-Benefit” analysis to include 
hidden and external costs not normally account for in decision making.20 But 
due to the lack of data, this is rather a narrative than a summary figure.  
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Societal and environmental impact 
 
The regulation of economic activities that generate pollution is complex 
because of the extent of the externalities involved, including wider societal 
and environmental impacts. Societal impacts include the life-long 
consequences of in utero exposure21 and low birth weight22, the cost on 
children’s cognitive development23,24, land value, and damage to properties 
(e.g. crops), or changes to the provision of public goods (e.g. overcrowded 
public transports) just to name a few. The impact pathways are virtually 
unlimited for many pollutants. Significant progress has been made in the 
estimation of a social cost of carbon25, but there is no systematic approach for 
estimating the economic burden of other pollutants affecting primarily health, 
and some impacts may not even be quantifiable.26  
 
Policy interventions to reduce a specific source of emissions often generate 
additional impacts beyond their primary target. For example, traffic calming 
measures have the potential to generate “co-benefits” in the form of an 
increase in physical activity.27 Greenhouse gas reduction policies have the 
potential to affect emissions of other pollutants, negatively or positively, which 
could have an impact on health outcomes. Other co-benefits comprise 
reductions in energy bills when installing more environment-friendly boilers, or 
healthier food products when switching to less polluting agricultural production 
process.28 Economic evaluations of environmental interventions should take 
these benefits into account, as well as possible unintended negative 
impacts.29  
 
In economic evaluations, if certain cost cannot be estimated, their value is 
implicitly assumed to be zero. This suggests that many evaluations 
systematically underestimate the economic costs of pollution, and therefore 
the benefits of interventions.30  
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Comparing the different evaluations  
 
It is a clear that a complete CBA accounting for a complete societal impact, 
including the short- and long-term effects is not realistic due to the lack of data 
to quantify and monetise all the relevant aspects. Therefore, all existing CBAs 
have limitations: they rely on different hypothesis to depict a complete picture 
of the costs and benefits of an intervention. Even comparing CBAs focusing 
solely on health benefits is made difficult by the variety of ways health impacts 
can be monetised.31 
 
 
 
Different types of interventions 
 
Policy interventions to reduce pollution have been in place for decades32, but 
were often not the subject of an economic evaluation to assess their direct 
and indirect costs and benefits. We describe here the types of interventions 
that have been analysed in the literature from an economic perspective. Most 
of the evidence focuses on air quality intervention, but we also review other 
types of environmental interventions when available. We classified 
interventions into three categories: pollution exposure reduction, emission 
reduction, and emission removal. In practice measures rarely fall strictly into 
one category only as they may also come with some co-benefits that fall into 
different categories (see Figure 1),xxi but we review interventions focusing on 
their main objective.  
 
 
  
                                                          
xxi
  For example, a policy aiming at reducing individual exposure by providing them with  
their individual levels of exposure through an app primarily falls into exposure 
reduction as some individuals will take different routes to be less exposed. However, 
a co-benefit of this policy could be that some individuals decide not to drive to work 
any more to be less exposed to traffic emissions, and as a result, the policy will 
achieve an emission reduction.  
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Figure 5.1 Main types of policy interventions to reduce pollution 
exposure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source  Dr Laure de Preux 
 
 
Exposure reduction encompasses all types of actions that do not address 
the source of emissions, but the individuals’ exposure levels. Often, it can be 
adopted in the short-run, when more time is needed to reduce or remove the 
source of pollution, or when changes in the environment are not immediate. 
Exposure reduction is relatively easy to achieve when pollutants are confined 
into a specific location. 
  
A more concrete step toward an emission free environment is an emission 
reduction at the source. It can be achieved by reducing the activity emitting, 
or improving the quality of the emissions. The former is often achieved by a 
change in behaviour, whereas the latter implies a more efficient process in 
place. 
 
Finally, emission removal requires a complete stop of the source of 
emissions, which is not necessarily achievable in the short-run, or would be 
but at a very high cost. Given that there is no healthy level of pollution, 
emission removal should be the ultimate long-term goal.   
Exposure reduction Emission reduction 
Emission removal 
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The main sources of pollutions and their 
associated costs 
 
Pollution has been associated with increases in morbidity in some non-
communicable diseases, in particular chronic conditions, and excess 
mortality. The Committee on the Medical Effects of Air Pollutants (COMEAP) 
advises the government on all matters concerning the health effects of air 
pollutants, and have estimated the impact of long-term exposure to air 
pollution on chronic bronchitis, the mortality effects and cardiovascular 
disease related to long-term exposure to air pollution, yet they do not provide 
cost estimates of pollution on health and welfare.33,34,xxii Estimates of the 
morbidity and societal costs associated with pollution are limited, although 
they represent the largest share of the economic burden as looking after 
individuals with different morbidities is costly. 
 
The cost impact estimates for various types of pollutants vary greatly. The 
difficulty in comparing different figures from the literature comes from the fact 
that pollutants as well as sources of emissions differ between the different 
studies. Furthermore, the effect depends on the pollution reference level or 
specific change analysed. The effect of a small change in pollution levels is 
not necessarily proportional to a large change.xxiii  In addition, the health or 
societal burden estimates do not necessarily capture all the direct and indirect 
effects. The different examples chosen below illustrate the magnitude of the 
impacts distinguishing between the health associated costs and the overall 
burden for the society. The figures are not directly comparable as they cover 
different aspects, estimate the inputs in different ways, and express the 
results in different units. The Methodology for Cost-Benefit analysis for the 
Clean Air for Europe (CAFE) programme illustrates the limitations explicitly in 
this type of exercise.35-37 
 
Air quality is currently at the centre of attention. In the UK, exposure to 
particulate matter has been associated with a reduction of six months of 
average live expectancy, and a related cost of £16 billion a year.38 The Lancet 
Commission on pollution and health estimates the current cost of ambient and 
household air pollution at 117.30 billion 2015 US dollars in the UK.5 In London 
only, PM2.5 and NO2 in 2010 have an associated mortality burden of £1.4 
billion and £2.3 billion in 2014 prices, respectively. The number of hospital 
admissions in London associated with these two pollutants were 2,732 and 
419, respectively.39 Traffic has been estimated to cost to the society 0.01-
0.09€/km (0.02-0.41€/km for 1996 cars or older) in France.40 
                                                          
xxii
  COMEAP does however suggest a methodology to translate life-year into cost. 
xxiii
  In other words, the effect is not linear.  
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The Aphekom project estimates the cost of a decrease in air pollutant levels 
to the WHO air quality guidelines in terms of particulates and ozone.xxiv The 
authors use a HIA approach and monetise the mortalityxxv effect using a 
willingness-to-pay approach and the morbidityxxvi cost using the cost-of-
illness. The estimated monetary gain is €31 billion annually over 25 European 
cities estimated over 2004-2006.41 In London, if the benefits of current and 
planned policies deliver the reductions they are anticipated to, life expectancy 
would increase by six months.42 
 
Air pollution is not the only type of exposure. The Lancet Commission 
estimated the cost of lead exposure in the UK at 17.76 billion US dollars, and 
unsafe water sources to cost 13.23 billion US dollars in the UK only.5 Coal-
fired power stations are believed to cause 1,600 premature deaths per year, 
and cost £1.1 to 3.1 billion per year to the society.43 This is to give a sense of 
the magnitude of the problem.   
 
The health and societal costs of pollution are unarguably high. Yet, given that 
each estimate is context specific, there is a lack of a range of estimates using 
the same methodology that allow them to be used in economic evaluation. As 
a result, very few studies have been able to account for them in a 
comprehensive CBA allowing us to compare the net societal benefits of 
different interventions.44 We discuss three broad categories of interventions to 
reduce pollution and present in more details, when available, the net benefits 
of some specific interventions.  
  
                                                          
xxiv
  Box 2 discusses the discrepancy between the current UK limits and those  
recommended by WHO.  
xxv
  Willingness-to-pay is extracted from a value of a statistical life.  
xxvi
  The authors’ only account of respiratory and cardiac diseases.  
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How to address pollution?  
 
Pollution exposure reduction measures  
 
A first set of interventions to mitigate the health impacts of pollution involves 
reducing levels of exposure to it. Exposure reduction requires a good 
understanding and measurement of the spread of pollution in the relevant 
media (e.g. air, water, ground), as well as effective communication to the 
public. Therefore, exposure reduction often starts with an appropriate 
monitoring system, the design of which will depend on the source of pollution 
and specificity of the pollutant (e.g. water pollution from fertilisers used in 
agriculture is often assessed fortnightly or monthly only45). The sampling 
process to monitor pollutants is normally designed to optimise costs and 
benefits, as measurements can be expensive (e.g. in the case of milk dioxin 
monitoring46) and need to be justified by their benefits.   
 
Air quality monitoring is the most common. Air quality monitoring technology 
has improved significantly over the last decade; it has become cheaper, 
smaller and more reliable. Portable and affordable devices are now available 
to the public, although their precision varies greatly. Furthermore, air quality 
networks with continuous monitoring such as the London Air Quality Network 
(LAQN)xxvii are now accessible to all free-of-charge and increase people’s 
awareness of air quality in their local area. The information from these 
networks can also be combined with mobile phones’ geographical 
information47 to estimate people’s exposure to pollution without carrying 
monitoring devices. Although monitoring is a key element to evaluate the air 
quality, identify problems, and support changes with factual information, the 
Royal Borough of Kensington and Chelsea has closed or removed from the 
LAQN seven out of its nine monitoring stations in October 2017. Monitoring is 
a cornerstone in air quality improvement, and this decision goes against the 
evidence reviewed in this chapter.  
 
However, in order to be beneficial, monitoring needs to be complemented by 
additional information such as overall indicators that are meaningful to the 
user (e.g. a colour scheme that translates pollution metrics for non-expert into 
recommendations), alerts of high pollution levels, or practical suggestions to 
avoid or reduce exposure (e.g. alternative commuting routes). Alerts are 
effective in informing the public about peaks of pollution48,49 but had no clear 
impact on hospital admissions in a study based in Southampton.50 In the case 
of smog alerts in California, individuals responded to the information, although 
the effect was mostly limited to the first day of the alerts when there were 
                                                          
xxvii
  Website of the London Air Quality Network (LAQN). 
http://www.londonair.org.uk/LondonAir/Default.aspx  
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consecutive days of high pollution. As the cost of substituting activities 
between days increases over time51, alerts would not be effective in case of 
numerous and repeated peaks. Walking or cycling along a street with low 
traffic can reduce exposure to some pollutants.52 Mobile phone apps that 
propose alternative routes to individuals using active transport are becoming 
increasingly popular.xxviii However, the success of these alternatives could be 
limited by the existing infrastructure in some cities where walkable routes are 
limited.53. In the future, we should see a more dynamic and personal use of 
alerts by combining individual exposure and needs (e.g. information on when 
to take or increase respiratory drugs on the way to school.54).  
 
When the source of emissions cannot be modified, retrofitting air filters to the 
source of emissions can be an effective solution. The Washington State clean 
school bus program provided $5 million in annual funding for 2003–2008 for 
retrofitting old diesel buses, and a conservative benefit–cost ratio was 
estimated between 7:1 and 16:1, equivalent to a net present value of 
children’s health benefits between 424,000 and 989,000 dollars per adopter 
school district55 (this study is further detailed in Box 1). Stevens et al. 
considered retrofitting old cars in Mexico City with either type of diesel 
particulate filter or an oxidation catalyst, and find positive net benefits. At 
current prices (2010), retrofit with an oxidation catalyst provided greatest net 
benefits. However, the authors suggest “as capital costs decrease, retrofit 
with diesel particulate filters is expected to provide greater net benefits”.56  
Some authors have modelled building ventilation and retrofitting homes 
according to certain standards to reduce indoor exposure to outdoor PM2.5 
using enhanced filtration among others leads to positive net health benefits 
57,58
 but empirical evidence is lacking. Others have modelled the optimal 
ventilation rates to radon, while accounting for the increase in heating cost 
and have concluded that periodic ventilation in this context should be 
preferred over a continuous one, but no health impacts have been 
assessed.59 
 
Many more alternatives have been suggested to reduce existing pollution 
levels, such as planting trees and shrubs60, optimal ventilation routines to 
address various sorts of pollutants but formal economic impact assessments 
accounting for the health impacts are not available.  
 
                                                          
xxviii
  The World Health Organization has developed a Health Economic Assessment Tool  
(HEAT) to measure the benefits of walking and cycling (World Health Organization, 
“Health economic assessment tools (HEAT) for walking and for cycling - Methods and 
user guide, 2014 update,” 2014.). For example in Brighton and Hove, the tool 
estimated that 30% increase in the number of cyclists during 2007-2010 was 
associated with a mean annual benefit averaged across 10 years of £220,115, but 
these estimates to do not take into account exposure to pollution.  
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Indoor air pollution is also a health hazard, but cost-benefit analyses of 
interventions to improve health outcomes in this context are limited. A study 
from the Department for Communities and Local Government published in 
2009 finds that carbon monoxide caused the poisoning of about 80 individuals 
in a year in England and Wales, but based on a cost-benefit analysis, the 
authors found that the installation of CO detectors alongside new gas 
appliances (already incorporating secondary safety systems) comes at a very 
favourable cost-benefit ratio (except in the case of solid fuel).61 A model of 
indoor air ventilation and filtration has been developed by the EU-funded 
HEALTHVENT project. Their analysis shows a potential for a significant 
health risk reduction, but the benefits have not been compared to the 
interventions’ costs.62   
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Pollution reduction measures 
 
A reduction of pollution can be achieved at very different costs and levels of 
effectiveness depending on the policy instruments. One way to reduce 
pollution is through economic incentives that promote more environmentally 
friendly choices of products or behaviour. A first step towards a reduction in 
pollution is to inform the public of the consequences of their choices and offer 
them alternatives. For example, a reduction in traffic-related emissions can be 
achieved by encouraging commuters to choose greener transport, such as 
cycling and walking, by developing appropriate infrastructure in cities. An 
evaluation of New York City’s bicycle lanes programmexxix accounting for a 
reduced risk of injury, additional physical activity, and reduced pollution  
resulted in an incremental cost-effectiveness ratio of $1,297/QALY gained 
compared to the status quo.63 Active travel also increases pollution exposure, 
but scientists show that cycling and walking only become harmful after 1 hour 
and 15 minutes, or 10 hours and 30 minutes per day respectively in high 
background PM2.5 levels.64 Of people using different transport modes, 
pedestrians are the least exposed.65 With rising concerns about obesity 
levels, the co-benefits of a more active lifestyle are also often included in 
analyses66,67 but only limited evidence exists on the success of such 
initiatives.68 An OECD analysis of various voluntary approaches concludes 
that their effectiveness is still unclear69, but these voluntary programmes are 
difficult to assess due to the myriad of schemes that may overlap, the lack of 
adequate data on their adoption or their environmental impact, and the 
estimation of the counterfactual scenario.70  
 
Informing the public and promoting greener alternatives is often a low cost 
policy optionxxx, which does not require monitoring and sanctions in the case 
of non-compliance. On the other hand, regulation comes generally at a cost 
for governments. Traditional “command-and-control” (CaC) policies based 
on regulation typically target three aspects of pollution: the direct emission 
target, the concentration of pollutant in a specific environment, and the 
technology standard.71 Direct emission standards are defined as a certain 
level per quantity and/or unit of time, and a certain quantity is meant to never 
be exceeded by the source of pollution. Ambient pollution standards specify a 
maximum concentration level, such as the Directive of the European 
Parliament and of the Council on ambient air quality and cleaner air for 
Europe drawn up in 2008.32 Targets cannot be enforced directly and 
monitoring of the different sources is necessary to achieve the targets.  
 
                                                          
xxix
  45.5 miles of bike lanes constructed in 2015 at a cost of $8,109,511.47. 
xxx
  This is assuming that providing it does not require massive investment to change an  
existing infrastructure. 
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Setting emissions standards does not necessarily guarantee meeting ambient 
standards, and vice versa due among others to meteorological and 
hydrological phenomena.71 Human decision also plays a role in the final 
concentration of pollution. For example in the case of car emission standards, 
the overall number of vehicles on the road will affect ambient air quality.  
Low emission zones (LEZ) and new Ultra Low Emissions Zone (ULEZ) are 
examples of traffic control measures based on technology standards. Vehicles 
may only enter the relevant Zone if they do not exceed a certain emission 
threshold, but the mileage they can do within these zones is unlimited. These 
measures are considered to be the strictest traffic regulations to contain PM10 
pollution.32 LEZs have been implemented in different cities (e.g. in Munich72, 
Tokyo, Rome, Sweden73,74), and are due to be expanded in the future. An 
economic evaluation of the West Yorkshire Low Emission Zone Feasibility 
Study, where pre-EURO 4 buses and Heavy Goods Vehicles (HGVs) were 
upgraded to EURO 6 by 2016, generated an annual benefit of £2.08 million 
and a one-off benefit of £3.3 million compared with a one-off implementation 
cost of £6.3 million.75 The London LEZ (Congestion Charge Zone) was 
associated with some improvements in air pollution but modest health gains, 
but their causal link with the LEZ has been questioned due to other traffic 
interventions being implemented simultaneously.74,76 DEFRA has modelled in 
detail the societal cost and benefits of different pollution reduction measures, 
including, among others, retrofitting vehicles with pollution filters, LEZs and 
road pricing. Their findings show large net benefits from measures to reduce 
particulate matter, particularly those generating larger reductions, but not from 
measures to reduce ozone.77,78 A model-based study of the Stockholm LEZ 
shows larger  benefits79 than the London study, and a cost-benefit evaluation 
of the scheme shows a significant social surplus, with investment and start-up 
costs offset by the value of social benefits in around four years.80 
 
CaC policies have many drawbacks. First, establishing standards is difficult as 
it requires, ideally, a good understanding of the benefits and costs involved in 
order to anticipate the impacts of alternative standards. Second, regulatory 
policies do not encourage further improvement once the pollution level is 
contained within the set limit. Third, regulation does not account for 
differences in the marginal cost of abatement between individuals or firms. 
Fourth, unregulated zones are likely to see a surge in pollution, and this is 
never explicitly documented. The example provided in Box 2 further illustrates 
the difficulties involved in implementing standards. 
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Market-based policies are the main alternatives to CaC measures. The 
former are policies that “encourage behaviour through market signals rather 
than through explicit directives regarding pollution control levels or 
methods”.39, p. 19 Examples include taxes, subsides or tradable permits.  
SO2 levels have dramatically reduced over the last 30 years in the U.S., 
however it is unclear which policy can be held responsible for this decline. 
Greenstone82 evaluated impacts of the U.S. Clean Air Act (1970) over 30 
years and found that the legislation classifying counties into attainment and 
nonattainment categories appears to have had little effect on the observed 
overall reduction in SO2. The U.S. Clean Air Act Amendments enacted the 
Acid Rain Program (ARP) in 1990. Two chemicals are largely responsible for 
acidifying deposition, sulfur dioxide (SO2) and nitrogen oxides (NOx). The 
ARP established a permanent cap on SO2 emissions to be achieved with an 
emission market.xxxi Chestnut and Mills report health and environmental 
benefits over $100 billion annually for 2010, compared to $3 billion annual 
costs, respectively, accounting for both SO2 and NOx reductions.83 Similar 
systems are costly to implement84,  but their benefits may largely outweigh the 
costs involved once health and environmental benefits are fully accounted 
for.85 More generally, the U.S. Clean Air Act passed in 1970 has been 
associated with a 70% reduction in the concentration of six common air 
pollutants while GDP has increased by almost 250%.86 Its associated 
reduction in total suspended particulates led to a “one percent decline in total 
suspended particulates [that] results in a 0.5 percent decline in the infant 
mortality rate. Most of these effects are driven by a reduction in deaths 
occurring within one month of birth, suggesting that foetal exposure is a 
potential biological pathway”.87 However, in the long-run, the associated 
decrease in particulates had little effect on adult or elderly mortality.88  
 
The European Union has also implemented regulations on acidification, but 
the transboundary nature of acid rain means that different stakeholders have 
different interests in its regulation. The UK has much of its population at risk, 
and therefore has much to gain from it.89 A recent review concludes that “the 
large reduction of sulphur emissions in both Europe and the United States 
have resulted in benefits that significantly outweigh the costs” when health 
effects are accounted for.90 
 
 
 
 
 
 
 
                                                          
xxxi
  The ARP also regulated nitrogen oxides (NOx) emissions but in a different way.  
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Desulfurization of power plants in Germany was studied by Luechinger to 
identify the impact of a reduction in SO2 in a natural experiment framework. 
The study shows an annual gain of 826–1460 infant lives. The lowest health 
benefit estimate of $50 per household per year (the highest estimate is $343) 
compares favourably with compliance costs ranging between $33 to $165 per 
household per year.91 Several items of legislation have been passed over the 
last 40 years in the UK to reduce SO2, NOx, or NH3. At the same time, 
downward trends have been observed for those pollutants92, but that 
legislation has not been evaluated in a cost-benefit framework.  
 
Household indoor air quality can also be improved by pollution reduction 
measures. Replacing old boilers has been showed to have a payback period 
of four to nine years. This is a cost-effective intervention to address fuel 
poverty but also has air quality co-benefits by reducing NOx and CO2 
emissions.42 A review focusing on asthma concludes that a strategy of 
reducing exposures to both allergens and pesticides (“integrated pest 
management” - IPM) is two or three times more expensive than other 
alternatives.93 Fabian et al. find that “interventions such as IPM and repairing 
kitchen exhaust fans led to 7–12% reductions in serious asthma events with 
1–3 year payback periods”.94 Radon remediation programmes in the UK are 
effective, although the effectiveness varies with the concentration of radon in 
communities95, yet the “current strategy employed in the UK is failing to target 
those most at risk”.95 
 
Agriculture produces a large share of all polluting emissions. Ammonia 
(NH3), for example, comes largely from agricultural sources. Ammonia 
converts into acidifying compounds and also contributes to eutrophication.81 
McCubbin et al. consider livestock management to reduce ammonia 
emissions in the U.S. through diet optimisation, animal housing practices, 
animal waste storage, and land application of manure. Their analysis 
suggests that “a 10% reduction in livestock ammonia emissions can lead to 
over $4 billion annually in particulate-related health benefits”.81, p.1141   
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Schucht et al. compare the costs and health benefits of reducing PM2.5 and 
ozone concentrations in Europe at the 2050 horizon in order to limit the global 
temperature increase to 2˚C by the end of the century. Health benefits include 
reduced mortality, morbidity and the associated care, and are monetised 
using willingness-to-pay and value-of-life-year approaches. The study 
concludes that the “health co-benefits from the ambitious climate policy will at 
least cover 75%, and may in fact amount to more than 450% of the additional 
net aggregate air pollution mitigation and climate policy costs”.97 
 
Accounting for further co-benefit of these policies, such as increased physical 
activity, would make the net benefit of these interventions even larger.  
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Withdrawing pollution measures  
 
The Clean Air Act of 1956 passed in response of the Great London Smog is 
an example of a ban on certain types of smoke fuels in some specific areas 
and it successfully solved the problem of SO2. The Act imposed bans on 
various pollutants such as aerosol sprays. However, more recent policies on 
air quality have been less impactful.  
 
Many experts claim that a ban on cars in busy cities may be the only way to 
tackle pollution, although this scenario has not been evaluated from an 
economic perspective. Diesel vehicles are responsible for a large share of 
pollution and even electric cars, which do not emit NO2, generate particle 
emissions through tyre, brake disc, and road surface wear.98 As electric cars 
are on average heavier, they generate more non-exhaust particulates.99  
Furthermore, electricity generation is often not a clean process.100 A study 
comparing electric and gasoline vehicles, and accounting for type of electricity 
generation as well as the short- and long-term, local and global impactsxxxii, 
found that 90% of local environmental externalities from driving vehicles are 
simply displaced elsewhere by driving electric cars, although it may be a 
temporary solution in heavy polluted cities and arguably a way of mitigating 
health impacts.101  The authors combine a model of vehicle choice, 
econometrics and an integrated assessment model, and illustrate the 
heterogeneity in the environmental benefits. A city suffering from large 
damages from gasoline but provided with a clean energy grid can benefit from 
a move to electric cars. The authors estimate the average value of a subsidy 
across the US, based on the economic principle that “subsidy should be equal 
to the difference in lifetime damages between an electric vehicle and a 
gasoline vehicle”101, p. 3701 and conclude that, on average, the most efficient 
policy would rather be a tax on polluting vehicles. This illustrates that in high-
traffic areas electric cars may improve local air quality, but are not a 
panacea.102  
 
Lead exposure has been significantly reduced over the last years decades 
thanks to the bans on leaded fuels, paint and plumbing among others in many 
countries.93 Nevertheless, lead is still present in the environment, in particular 
in houses that were built when lead-based paint was still permitted. Gould 
estimated that “each dollar invested in lead paint hazard control results in a 
return of $17–$221, or net savings of $181–269 billion” in 2006 prices in the 
US when accounting for medical expenditures and individual’s revenue 
loss.103 
  
                                                          
xxxii
  The model includes human health, crop and timber yields, degradation of buildings  
and material, and reduced visibility and recreation. 
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Conclusions  
 
In this chapter, we have presented evidence that illustrates the magnitude of 
the net benefits of the main types of interventions available to mitigate the 
health impacts of pollution. A systematic direct comparison of interventions is 
not possible due primarily to the variety of benefits considered and the 
heterogeneity of methods adopted in the valuation of health and resource 
impacts. However, some examples exist of studies using consistent 
approaches to comparatively assess the impacts of wide ranges of 
interventions, such as an OECD study undertaken by Hunt.78 
 
Two points emerge clearly from the evidence reviewed. First, studies 
assessing a more comprehensive range of impacts of interventions to reduce 
pollution show larger societal values. Second, there is significant scope for 
expanding and improving the existing evidence base on the value of many 
interventions, in order to better support the design and implementation of 
appropriate policies.  
 
This chapter provides an overview of the impacts and value of existing 
interventions that have been evaluated, but it does not cover the potential of 
future policies to reduce pollution. The success of future policies will rely on 
a combination of public engagement and very strict policies to significantly 
reduce current and future levels of pollution. Modest interventions such taxing 
idling cars have to be put in place now, and enforced, but more permanent 
behavioural changes will be achieved with a better infrastructure. For 
example, encouraging greener transport choices will be effective with further 
infrastructure development and information campaigns, for instance to 
improve public perceptions around the safety of cycling in urban areas.104,105 
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It is legitimate to expect the overall cost of pollution, and thus the overall 
benefits of interventions, to be significantly larger than those identified in 
many existing studies. Several facts can support this claim. First, only few 
studies account for the cost associated with the impact of pollution on 
morbidity, a major driver of health care and welfare costs, and consider 
exclusively mortality. Second, most studies focus on individual pollutants and 
neglect the effects of a simultaneous exposure to multiple pollutants106, as 
well as the spill-over effects (positive or negative) of interventions to reduce 
one pollutant on other pollutants.107 Third, disentangling the effects of short- 
and long-term exposures is difficult in empirical studies. Studies tend to take 
one or the other perspective, and therefore underestimate overall effects. 
Fourth, if some people adapt their behaviour based on their awareness of 
pollution, the societal welfare costs of pollution are likely to be 
underestimated.108,109 For example, Moretti and Neidell110 estimated the cost 
of “avoidance behaviour” to be between 25% and 80% of the total cost of 
hospitalisations due to ozone in Los Angeles. Finally, technological innovation 
is rapidly improving energy efficiency and resource use, suggesting that 
analyses that do not account for innovation prospects may overstate future 
policy implementation costs.111  
 
When more regulations as well as more stringent regulations seem the 
obvious and right things to do from a public health perspective, one of the 
consequence of Brexit will be that most of the environmental legislation will 
cease to apply when the UK leaves the EEA.112 
 
A lot of attention has been given to air pollution from traffic as it is a major 
component of ambient air quality, but other sources of emissions such as the 
manufacturing sector, or electricity generation should not be forgotten. 
Furthermore, home, school and office environments are where most of the 
time is spent and more evaluation of simple measures should be supported in 
order to prioritise interventions.113  
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Authors’ suggestions for policy makers  
 
• Better monitoring of pollution, and processes in place to access, use and 
analyse the data. This is an essential aspect for assessing the current 
situation, and better evaluating interventions in the future. The cost of 
monitors has decreased significantly over time, but installation and 
maintenance remain an issue.114  Whereas the objective is the individuals’ 
exposure, technology has permitted to proxy exposure with precise 
individual’s travel trackers115, and pollution dispersion models allows us to 
have an estimate of individual’s exposure. Yet, even if air quality monitors 
are leading at the moment, air quality has many components and more 
efforts should be done to measure the various pollutants harmful to health.  
 
• The UK should adopt temporary and long-term measures, as well as 
implement local and national changes. Mitigation polices should not be 
considered in place of pollution reduction or removal. Mitigation should be 
put in place now, reduction and removal is essential to support a healthy 
population and should be implemented as early as possible. For example, 
retrofitting taxis is a beneficial intervention, but should be implement in 
conjunction to more radical and long-term changes such as Ultra-Low 
Emission Zones (ULEZ) across the cities.39 ULEZ is certainly a more 
stringent measure, but it is implemented with exemptions and unlikely to 
be sufficient to reduce traffic more permanently. Allowed vehicles in the 
zone will still be polluting and traffic can be expected to be reduced for a 
while as the highly polluting cars are replaced by less polluting cars. 
Permanent solutions will have to shift traffic to other type of transport (e.g. 
goods delivered at night by tube in central London). A more global, and 
permanent perspective should not be omitted. For example, it is not clear 
how the ULEZ will impact its neighbourhood regions, a broader 
perspective needs to adopted when implementing these changes.  
 
• Lacks of monetised health impacts that can be accounted for in economic 
evaluation by no mean justify the use of a missing value in these 
assessments. The health literature is clear on the impact of environment 
on health, and if an intervention improves the individuals’ hazard 
exposure, the health benefits and co-benefits, as well as the spill-over 
effects should be account for by some values different from zero. While 
more work needs to be done to develop a societal cost of pollution that 
could be used in policy analysis, some simple alternatives such as 
updated DALYs for conditions linked with environmental exposure would 
greatly improve the comprehensiveness of the evaluation.116   
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Box 1 Retrofitting old buses to improve children’s pollution 
exposure – A state-of-the-art economic evaluation 
 
A robust approach to assess the benefit of an intervention is to compare 
outcomes before and after the change, while taking into account any other 
factor that could bias the result. Beatty and Shimshack55 implement a state-of-
the-art evaluation of a local reduction programme that retrofits diesel school 
buses with aggressive pollution control technologies in the state of 
Washington (USA). School buses can pollute twice as much as the average 
tractor-trailer truck.117, especially in residential areas where they collect 
children, and interventions to make them cleaner can lead to significant health 
benefits. A large proportion of children use school buses to travel long 
distances and remain exposed to high levels of pollutants inside the cabin 
throughout their journeys.   
 
The study combined detailed data on bus retrofit (about 4,000 buses in 53 
school districts) with morbidity (individual inpatient discharges, including the 
patient’s zip code and diagnosis), demographic and weather data.  
 
A careful analysis of the scheme was required to exclude a possible selection 
effect, for example due to differences in underlying morbidity levels between 
the districts covered by the scheme and those not covered. The authors used 
a difference-in-differences design to account for pre-existing trends and 
unobserved heterogeneity between the districts (adopters vs. non-adopters of 
the retrofits). They also exploited the time differences in retrofit adoption 
between the districts, and control for a wide range of socio-demographic 
characteristics, such as per capita income, racial mix, and school-staff-per-
student ratio. However, their estimates had to rely on the assumption that the 
health trends of the adopters would have been the same as the non-adopters 
had they not implemented the programme.  
 
Annual health care savings per district due to reduced inpatient episodes of 
bronchitis, asthma, pleurisy and pneumonia, following the adoption of filters 
on school buses were estimated between $54,900 and $128,100. The net 
present value of the programme was between $424,000 and $989,000 per 
district, without even accounting for long-term benefits from reductions in 
chronic sequelae and non-respiratory diseases.  
 
An interesting feature of Beatty and Shimshack’s study is that the authors did 
not have to estimate the impact of the programme on local air pollution levels 
in order to assess the health benefits of the intervention. They exploited a 
natural experiment offered by the fast introduction of the programme in order 
to estimate health impacts directly, with no knowledge or assumption on 
pollution levels.   
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Box 2 Establishing pollution thresholds based on a “Less-is-
More” principle  
 
Command-and-Control policies to reduce pollution levels often impose a 
technology standard, or an emission limit. The difficulties are that, not only the 
value limit needs to be established, but also the period of time over which the 
measurement applies. Optimal measures are not straightforward to establish 
as the government never has perfect information on the effects of different 
thresholds, and even less on wider societal impacts. In the case of pollution, a 
simple principle applies: the less, the better. In other words, there is no 
healthy level of pollution.  
 
The above principle applies, for instance, to particulate matter (e.g. PM10, 
PM2.5), which represent a health hazard whether they are constant or 
observed in high concentrations over a short period of time.118 However, the 
approaches to particulate matter taken by regulators in different jurisdictions 
have been fairly heterogeneous. Not only the “US EPA National Ambient Air 
Quality Standards for PM2.5 are lower than the EU limit values” but also the 
“EU requirements for assessing compliance with the Limit Value for PM2.5 are 
not more stringent than the US EPA requirements for assessing compliance 
with the annual and 24-hour PM2.5 National Ambient Air Quality Standards”.119 
p. 6425 Compliance with particulate matter threshold values is challenging not 
only for the UK, but also for 24 other EU Member States.120 
 
Also the EU requirements have been found to be poorly aligned with current 
scientific evidence.118 In the case of particulates, they are roughly 2.5 times 
higher than the levels recommended by the WHO in 2005.121 Pollution in 
London is above WHO limits for particulate matter and NO2. Levels of NO2 
exceed also EU thresholds and are not expected to fall below the latter until at 
least 2025.121 Environmental groups won two legal challenges against the UK 
government in 2017.122 There is now enough evidence to know that less is 
more and this principle should be applied consistently in government policy.  
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Box 3  Avoidance behaviour and self-selection 
 
While there is no evidence of adaptation to pollution, there is some evidence 
of avoidance behaviour, that is people substituting their intended activities 
with different ones in order to reduce their exposure to pollution. Examples 
include the substitution of outdoor with indoor activities when air pollution 
levels are expected to be especially high, or moving more permanently to 
residential locations with lower pollution levels.  
 
Smog alerts were found to significantly reduce attendance at outdoor 
facilities.108 Bottled water purchases were found to increase by about 22% 
after public communications about tap water contamination levels exceeding 
safety thresholds.116 But responses to alerts are heterogeneous. In the United 
States, White and more educated mothers were found to respond more 
rapidly to information about toxic exposures for children, and were more likely 
to avoid those exposures.123,124,125  
 
Studies that do not account for the impact of avoidance behaviour on people’s 
health are likely to underestimate the welfare costs of pollution.  
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Summary 
 
• Pollution is unequally distributed and contributes to health inequalities.  
 
• Pollution-related health inequalities exist for various reasons. Pollution sources 
can be concentrated in particular areas, once in the environment pollution may 
accumulate and disperse unevenly, and some people can be more susceptible to 
the health effects of being exposed to pollution than others.  
 
• There are strong geographical differences in the occurrence and concentration of 
pollutants. Analysis shows that these patterns, which vary by pollutant type, are 
related to measures of socioeconomic status, with pollution sources and higher 
concentrations of ambient pollution typically found in more socially disadvantaged 
areas.  
 
• The evidence of how pollution sources and concentrations vary with other socio-
demographic variables, including ethnicity, is less substantial and consistent. 
How unequal patterns of pollution exposure relate to health inequalities is 
complex. Poor health status, adverse health behaviours, multiple environmental 
exposures and psychosocial stress are more prevalent in lower socioeconomic 
groups. These factors may mean that pollution exposure has greater impacts on 
the health of these groups, a so-called ‘triple jeopardy’ effect.  
 
• These relationships have been most substantially examined for air quality. UK 
studies provide tentative evidence of differences in susceptibility affecting health 
outcomes from air pollution exposure. International studies are more conclusive 
that these effects exist. 
 
• Options to intervene in the relationship between pollution and health inequalities 
include proactive assessment of the distributional effects of plans and policies to 
inform decision-making; targeting measures on ‘pollution-poverty hotspots’; and 
supporting community involvement in pollution monitoring and mitigation.   
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Background 
 
Addressing health inequalities is a long-standing priority of the UK government 1, 
with specific duties on the Secretary of State for Health and health care providers 
laid out under the Health and Social Care Act 2012. Not only are health inequalities, 
as the Marmot report stated, “a matter of life and death, of health and sickness, of 
well-being and misery”2, but they are also a significant detriment to realising 
employment and other life-opportunities, with consequences that ‘spill-over’ for all of 
society, including increased healthcare and welfare expenditure.3 In England, health 
and well-being indicators repeatedly reveal significant differences between 
population groups in socio-economic and other terms, such that life expectancy, 
serious illness and many other detriments to wellbeing are distributed regressively 
along social gradients.2 p.10 Across local authorities in England there are large 
inequities in life expectancy at birth. It is highest in Kensington and Chelsea for boys 
(83.3 years) and Chiltern for girls (86.7 years), compared with Blackpool for boys 
(74.7 years) and Middlesbrough for girls (79.8 years).4 The social gradient in health 
in England has also worsened significantly over the past 30 years. 
 
Health inequalities are defined by Public Health England as ‘systematic, avoidable 
and unjust differences in health and wellbeing between different groups of people’.5 
p. 41
 The impact of pollution on health, the concern of this chapter, has the potential to 
be differentiated between groups of people in systematic, avoidable and unjust ways, 
exacerbating underlying inequalities in a number of harmful non-communicable 
diseases.  
 
While there are complexities involved in making definitive assessments of the 
patterns and consequences of pollution inequalities, evidence indicates that poorer 
and disadvantaged groups in society are often systematically exposed to higher 
levels of pollution and that they may be more susceptible to the impacts of that 
pollution. Differences in pollution impacts on health can therefore be both a cause of 
health inequalities and a consequence of them, and in both respects argued to be 
both avoidable and unjust. To further compound patterns of injustice, evidence from 
‘polluter pays’ analyses show that those most at risk of health impacts from pollution 
are typically far less involved in its production6-8: least responsible, but potentially 
most at harm. The notion of environmental justice is widely used to capture these 
concerns9,10 (see Box 1). 
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Box 1  Environmental Justice 
In the US in particular, environmental justice has become the focus of a substantial 
body of activism, research and policy activity. Over the past 30 years, attention has 
been given to differences in pollution burdens between population groups defined in 
racial, socio-economic and other terms.10-12 Activists argue that various forms of 
environmental discrimination exist which need to be addressed by regulatory bodies 
such as the US Environmental Protection Agency, and government policy has since 
1994 made environmental justice part of the mission of all Federal agencies. In the 
UK there is a less established environmental justice agenda, although the research 
base is developing and both non-government organisations13-15 and different parts of 
government16-19 have made some steps towards investigating the relationship 
between environmental and health inequalities. Air pollution has been the primary 
focus, but by no means the only one.20-22 Whilst most attention is typically given to 
the distribution of exposure and impacts between different groups in current 
populations, questions of intergenerational justice can extend to consequences for 
future generations.   
 
 
In this chapter we summarise and evaluate key aspects of the existing evidence 
base. Our focus is first on inequalities in patterns of pollution distribution, 
concentrating in particular on the geographical relationships between pollution 
sources and levels and patterns of poverty or social deprivation. We then focus on 
air pollution, the subject of most of the existing work, to examine evidence of ‘effect 
modification’ – how for a given level of pollution exposure more deprived and 
vulnerable population groups can suffer stronger health effects than others. 
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Relating pollution and health inequalities 
 
Establishing the nature and detail of relationships between pollution and health 
inequalities is difficult. At each stage of the ‘source-pathway-receptor’ sequence 
there can be important differentiations to consider (Figure 6.1). Sources of pollution 
are often concentrated in particular geographic areas – due to, for example, the 
density of traffic or co-location of multiple industrial sources. Once released, the 
pathways that pollutants follow in the environment can mean that they remain or 
become concentrated in particular places, and/or at particular times. The presence of 
people, as receptors, in those places can then be differentiated in various ways, in 
terms of their demographic and social characteristics, their patterns of activity over 
time and space, and their susceptibility to harm from the pollutants they are exposed 
to.  
 
There are interactions between multiple pollutants both in a place and in peoples’ 
bodies, which can have potential accumulative and synergistic effects.23 There can 
also be synergies between social vulnerabilities, for example greater vulnerabilities 
from being both elderly and socially disadvantaged. It is therefore hard to accurately 
measure effects, and further developments in knowledge and analytical tools are 
necessary.  
 
Table 6.1 conveys the scope of UK environmental inequality research to date, 
indicating the analytical approach adopted with, on the left, a focus on socio-
environmental relationships from which impacts on health are inferred, and on the 
right, approaches which explicitly attempt to quantify associated health 
consequences. The coverage is patchy, even though the UK arguably has one of the 
better evidence bases on environmental inequality. The majority of studies fall to the 
left of the table, illustrating how environmental inequalities and health inequalities 
research have largely been pursued as separate disciplines.  
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Figure 6.1  Summary of potential for health inequality across the pollutant source-pathway-receptor model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source Professor Gordon Walker, Lancaster University 
 
 
Sources Pathways Receptors 
Located more 
intensely in 
particular 
areas and 
communities, 
rather than 
others 
Concentrate 
pollutants into 
particular 
locations and 
away from 
others  
Unequally 
susceptible to 
pollutant impacts, 
including due to 
pre-existing health 
inequalities 
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Table 6.1 Overview of UK environmental inequalities research by issue and 
approach, extending beyond pollution 
Analytical 
approach Proximity Emission 
Area level 
Concentration 
/intensity 
Concentration 
or dose 
experienced by 
individuals 
Health 
response 
 
Feature of 
analytical 
approach 
 
Environment 
metric 
Good data 
availability  
Relatively cheap  
Whole populations  
Health effects 
inferred  
 Little data  
Relatively 
expensive  
Small samples 
Health effects 
observed 
Industrial 
hazards  
(IPC sites) 
 
    
Landfill sites      
Air quality (NOx, 
fine particulates) 
 
    
Surface water 
quality  
 
    
Potable water 
quality 
 
    
Noise      
Radon      
Electro-magnetic 
radiation 
 
    
Flood hazard      
Woodland‡      
Parks /other 
green space‡ 
 
    
‘Blue space’*‡      
Multiple 
/cumulative 
  
 
 
 
 
 - Most research,  At least one study 
 
* Health-enabling spaces where water is at the centre 
 
‡ Hypothesis that deprived groups have least access to health enabler 
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Inequalities in patterns of pollution 
 
The evidence base specifically on pollution inequality has been developed through 
analysis of pre-existing spatially disaggregated environmental data against social 
variables, predominantly using various measures of poverty, deprivation and 
socioeconomic status.  
 
Air quality 
The most robust evidence relates to air quality. Concentrations of nitrogen oxides 
(NOx) and fine particulates (PM10) display a strong social gradient. For mean annual 
concentration, a U-shaped distribution (Figure 6.2a) has been repeatedly found 
across various studies, as lowest concentrations tend to be in more rural areas of 
medium deprivation.7,8,19,24   
 
Considering only locations where concentration values exceed the national air 
quality standard annual average limit values, the U shaped distribution disappears, 
and a very strong gradient is evident (Figure 6.2b). In 2001, of the 2.5 million people 
resident in areas where the annual mean NO2 limit value was exceeded, over half 
were in the poorest 20% of the population; by 2011 the exceedance population had 
fallen to 0.6 million due to overall improvements in air quality, but 85% of this 
population was in the poorest fifth25 (Figure 6.3). Studies elsewhere in Europe have 
varied in geographic extent, spatial unit, social metric, atmospheric pollutant, and 
analytical method, yet broadly confirm that the most deprived populations experience 
higher and more health-threatening environmental exposures.26,27 
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Figure 6.2a Social distribution of annual average NO2 concentration in 
England, 2001 
 
 
 
Note  
i Bars denote 5-95 percentile range, N=8,414.  
ii Each decile represents the average of electoral ward mean NO2, measured as an 
annual mean.  
 
 
Source Walker G et al.Environmental Quality and Social Deprivation. Phase II: 
National Analysis of Flood Hazard, IPC Industries and Air Quality. The 
Environment Agency (2003) 
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Figure 6.2b Population resident in areas exceeding the annual average 
legal limit value for NO2, by deprivation decile, England 
2001 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes 
i Annual mean standard is 40 ug/m3, applied as a ward average.  
ii Decile 1 is most deprived. All deciles have 4.9 million people.  
iii 2.51 million people are in an NO2 exceedance ward, 5.1% of the population of 
England. 
iv 53% of all person exceedances are in the most deprived quantile.  
 
 
Source Walker G et al.Environmental Quality and Social Deprivation. Phase II: 
National Analysis of Flood Hazard, IPC Industries and Air Quality. The 
Environment Agency (2003) 
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Figure 6.3     Great Britain population in lower super output areas (LSOAs) where NO2 exceeds the 40 µg m3 annual  
average legal limit value 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note  
Q1 is the least deprived fifth, Q5 the most deprived fifth. Concentration values are the mean of annual average concentrations for 
LSOAs where NO2 concentration >40 µg m3. NB. log-scale (25)  
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Ethnic minority populations in the UK are also exposed to higher concentrations of 
NO2 and PM10 but there is no indication whether this is a casual link with ethnicity or 
a facet of the socioeconomic status of ethnic minority groups; nor is there consensus 
on the link between ethnic susceptibility to air pollution and health.28,29 However, 
fetuses, babies and children are known to be more susceptible to poor air quality30 
and increased exposure of children in UK national small area analyses has been 
observed for NO27,29 but not fine particulates.29 Gender has been little studied with 
respect to the social distribution of pollution31, but can be expected to become more 
prominent as environmental inequality analyses begin to consider an individualistic 
perspective better able to account for temporal variability in exposure, for example 
due to differences in daily travel patterns.6 
 
Indoor air quality has been less studied, but research in the US shows a positive 
association between deprivation and poor indoor air quality (NO2, fine particulates, 
VOCs, lead, allergens).  Indoor air quality is determined by outdoor air quality, indoor 
pollutant sources and occupant activity, and physical features of housing.32 No 
comparable equity research exists for the UK, but it is reasonable to assume a 
similar association, given the strong association of deprivation with outdoor air 
pollution, and smaller, often lower quality housing. 
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Other pollutants and risks 
For other environmental pollutants and risks (Table 6.1) evidence exists of a strong 
association (for England) between deprivation and proximity to activities regulated 
under Industrial Pollution Prevention and Control (IPPC) legislation, including major 
industrial and petrochemical sites and waste incinerators.33 Site specific studies are 
equivocal in terms of associated health impacts, whilst at a national level health 
impacts are analysed within the wider context of air quality (see below), for which 
road traffic is the dominant source. Landfill sites are geographically associated with 
deprivation18,34, although study results are dependent on methodological choices35 
and not clearly associated with elevated health risk.36 In England, exposure to 
brownfield land is higher in the north and is associated with spatial inequalities in 
mortality and morbidity both within English regions, and between them, although 
differential brownfield exposure does not appear to contribute to the north-south 
health divide, probably due to differences in the distribution of types of brownfield 
land.37 
 
An analysis of ambient noise emission levels from road and rail traffic in Birmingham 
found a weak relationship with deprivation38 but no other UK noise studies exist. A 
systematic international review of noise health effects, focused on vulnerable groups, 
concluded that differentials in both physiological and psychological effects were 
largely anecdotal, with subgroup-specific exposure-effect studies needed.39 There 
are various newer forms of health threats from pollution (see Chapter 4 of this report, 
‘New horizons’) where questions of inequality are yet to be examined.   
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Multiple environmental hazards 
Environmental inequalities research has also sought to understand the social 
distribution of environmental metrics in combination. National and region-specific 
analyses show that with increasing area deprivation there is a greater likelihood of 
populations being exposed to multiple environmental hazards, in terms of both the 
intensity of a specific hazard (such as the clustering of industrial or waste facilities), 
and local exposure to a multiplicity of hazard types (such as the coincidence of 
industrial hazards, poor air quality and flood risk).19,40-42  
 
Environmental inequalities over time 
Tracing how environmental inequalities develop over time is an important step in 
understanding how they have arisen, but such studies tend to be constrained by a 
lack of small area longitudinal data. However, an analysis of air quality change in 
Britain from 2001-2011 reveals a social gradient in environmental change.25 Where 
air quality has improved (falling NO2) it does so most quickly in the least deprived 
areas, and where it has worsened (rising PM10) it does so more quickly in the most 
deprived areas. This may be a consequence of the more polluted initial conditions 
experienced by the more deprived communities (for example greater air quality 
improvement is needed to attain ‘good’ air quality than in the less polluted, more 
affluent areas). Overall improvements in air quality should have reduced the 
associated national disease burden, but the social gradient (Figure 6.3) implies 
social inequality in how this benefit is distributed.25 This suggests that interventions 
that reduce pollution overall can deliver health gains, but if intended to reduce health 
inequalities, they require more targeted interventions (discussed further below).  
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Evidence linking air pollution to health inequalities 
 
As outlined earlier, the relationship between pollution and health inequalities is not 
just that pollution exposure is distributed unevenly between population groups. The 
second mechanism that can act independently or concurrently is that of differential 
susceptibility, in which for the same level of pollution, more socially disadvantaged 
groups – and others in the population – can be more vulnerable to exposure than 
high ones. Factors such as poor health status (for example COPD, asthma and 
existing CVD), adverse health behaviours (for example smoking and diet), multiple 
environmental exposures (for example occupational) and psychosocial stress are 
more prevalent in lower socioeconomic status groups and may act in addition or 
synergy (that is, as effect modifiers) with pollution exposure.  
 
The ‘triple jeopardy’ for disadvantaged groups of first, higher exposure to air 
pollution, and second a greater burden of poor health, may then be further added to 
by a third effect arising from greater susceptibility to the impact of pollution.43 These 
processes have been most investigated in relation to air pollution, and are the focus 
of this section. Existing evidence is reviewed, being careful to exclude studies that 
do not formally test differences in susceptibility between socioeconomic groups.  
Studies in many countries have considered the role of short- and long-term pollution 
exposure in explaining socioeconomic gradients in health outcomes with a plausible 
aetiological pollution link. Health outcomes considered include all-cause and cause-
specific mortality, respiratory health (for example asthma), birth weight, and hospital 
admissions due to a respiratory condition.  
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International evidence  
Recent global and European studies reviewing the evidence that socioeconomic 
status (SES) modifies the effect of air pollution on health, broadly suggest that 
irrespective of differences in exposure, lower SES populations experience the 
greater effects of air pollution. The evidence base is particularly strong (number of 
studies and quality of study design) in the United States with a handful of studies in 
other, mostly European, countries.  
 
A systematic review of the international literature found lower SES groups were at 
higher risk of death due to short-term exposure to particulate matter (PM10 and 
PM2.5).44 Similarly a review of the literature on differential effects of ozone-health 
relations by SES noted evidence of associations between ozone exposure and 
mortality for some (for example unemployment and lower occupational status) but 
not all (for example low education and poverty) lower SES groups.45 Other studies 
review the evidence relating to particular ‘vulnerable’ groups. For example, an 
international review found lower socioeconomic status pregnant women are more 
vulnerable to air pollution with an increased risk of having a child with low birth 
weight at term.46 On the other hand, another review found limited evidence that the 
association between air pollution and children's asthma exacerbations varied 
between SES groups.47  
 
UK evidence 
Whilst, as already summarised, there is a significant body of work in the UK 
documenting socioeconomic inequalities in air pollution exposure, few studies have 
examined whether there is a synergistic relationship between SES and air pollution 
that acts to affect health. To date there have been six UK studies explicitly 
addressing this question, another using a composite environmental index as the 
exposure metric (including measures of air pollution), and a further Europe-wide 
study that includes UK data (Table 6.2).   
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Table 6.2 Socioeconomic inequalities in air pollution exposure - Europe-wide studies including UK data  
 
Authors and 
year of 
publication 
Pollutant(s) SES indicators Geographical unit Location Population Findings 
Wheeler & Ben-
Shloma (2005)48  
NO2, SO2, benzene, 
PM10 
Household 
social class 
1991 census wards England Participants aged 16–79 
in the Health Survey for 
England 1995, 1996, 
1997 
Differential effect of air 
pollution on lung 
function for males only; 
effect in social classes 
III to V double that in 
social classes I & II. 
Briggs et al 
(2008)43  
Road traffic, industry, 
electro-magnetic frequency 
radiation, disinfection by-
products in 
drinking water & radon 
Index of Multiple 
Deprivation (& 
constituent 
domains) 
3 levels of analysis: 
super output areas, 
census wards 
& districts 
England Full population Some evidence of 
greater risk of poorer 
general health for those 
living in more socially 
disadvantaged areas 
Pearce et al 
(2010)42  
Composite ‘Multiple 
Environmental Deprivation 
Index’ including of PM10, 
NO2, SO2, and CO, plus 
greenspace 
Area-level 
income 
deprivation 
10,654 Census Area 
Statistics 
Wards 
UK-wide Full population Influence of multiple 
environmental 
deprivation on health 
greater in the least 
income-deprived areas 
Jephcote & Chen 
(2012)49  
PM10 road-transport 
emissions 
Area-level 
measure of 
social 
deprivation 
(Carstairs 
Index), ethnicity 
187 Lower Level 
Super Output Areas 
Leicester Children aged 0–15 Double-burden of road 
transport emissions and 
social deprivation 
related to children's 
respiratory health. 
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Authors and 
year of 
publication 
Pollutant(s) SES indicators Geographical unit Location Population Findings 
Richardson et al 
(2013)50  
PM10 Mean household 
income 
268 sub-national 
regions (NUTS level)  
Europe-
wide 
Full population Lower income regions 
more susceptible to 
health effects. 
Restricted to circulatory 
disease mortality in 
Eastern Europe and 
male respiratory 
mortality in Western 
Europe 
Halonen et al 
(2016)51  
Traffic pollution including  
NOx, NO2, tailpipe 
emissions, PM2.5 and PM10 
Area-level 
measure of 
social 
deprivation 
(Carstairs 
Index), ethnicity 
27,686 Census 
Output Areas  
Greater 
London 
Full population Higher risk  of 
emergency hospital 
admissions for cardio-
respiratory diseases 
among those living in 
areas with the highest 
socioeconomic 
deprivation 
Brunt et al 
(2016)52  
Ambient NO2, PM10, PM2.5 
concentrations 
Area-level 
measure of 
income-
deprivation 
1909 Lower-layer 
Super Output Areas 
Wales Full population Interactions between air 
pollution and deprivation 
strengthened 
associations with all-
cause and respiratory 
disease  
Milojevic et al 
(2017)53 
Ozone and particulate 
matter (sub-divided into 
PM10, PM2.5, PM2.5-10, 
primary, nitrate and 
sulphate PM2.5) 
Area-level 
income & 
employment 
domains of the 
Index of Multiple 
Deprivation 
1,202,578 residential 
postcodes in  
England Full population PM2.5 pollution made a 
modest contribution to 
socioeconomic gradient 
attributable life years 
lost.  
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The UK work has covered a variety of different pollutants, sources (ambient, traffic, 
industrial), measures of SES (both individual and area-level indicators), populations 
(adults, children) and health outcomes. There has been no relevant UK work on 
indoor pollution.  
 
Studies of overall and cause-specific mortality, life years lost, and hospital 
admissions point to an increased health risk of pollution exposure amongst those 
living in disadvantageous social circumstances. For example, a study in London of 
annual concentrations of a range of traffic pollutants, and emergency hospital 
admissions for cardio-respiratory outcomes found some evidence of increased risk 
amongst those living in more socially disadvantaged neighbourhoods.51 Similar 
findings have been noted in Leicester for hospitalisations amongst children49, all-
cause and respiratory disease mortality in Wales52, and general health43  and life 
years lost across England53, although in all cases the evidence was mixed or 
suggested modest effects.  
 
A UK wide study of ‘multiple environmental deprivation’ (a composite index of 
various health-related features of the environment including measures of PM10, NO2, 
SO2, and CO) found that whilst more socially disadvantaged populations were 
exposed to higher levels of multiple environmental deprivation, the influence of 
multiple environmental deprivation on health was most pronounced in the least 
income-deprived areas.42 Therefore contrary to the findings of most other work in the 
UK, the physical environment did not exert a disproportionately detrimental effect on 
the health of the most socially disadvantaged groups, although given the small 
number of areas with high levels of social disadvantage and ‘high quality’ 
environments this finding should be treated with caution.   
 
Finally, a Europe-wide analysis (including the UK) of 268 subnational regions found 
that lower income regions had higher average pollution (PM10) concentrations and 
that populations of these regions were more susceptible to pollution, although any 
effect seemed to be limited to circulatory disease mortality in Eastern Europe and 
male respiratory mortality in Western Europe. 
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UK evidence: summary and limitations 
Tentative evidence exists for the UK of an interactive relationship between air 
pollution and socioeconomic status in which differential susceptibility affects health 
outcomes. However, several limitations restrict the conclusions that can be drawn:  
 
• Most obviously, the UK evidence base is small, particularly when compared to 
the United States.  
• Unlike elsewhere, all UK studies use cross-sectional study designs which limit the 
quality of the evidence. There are no studies examining how SES and air 
pollution exposure accumulate over the life course.  
• Many UK studies rely on ecological associations; key variables such as health 
and SES are captured at the ecological (rather than individual) level. There is 
also a poor understanding of scale, with previous international work emphasising 
that findings can be highly sensitive to the chosen geographical unit of analysis.  
• There is little understanding of the temporal resolution of pollution exposure and 
the implications for health inequalities. For instance, pollution can vary 
significantly by season and time of day. Most geographic studies focus on home 
locations yet people move between different environments as part of their daily 
routines.  
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Addressing pollution inequalities  
 
There are some established policy measures and sources of guidance52-54 on how to 
intervene in pollution problems and their impact on health. Different measures and 
approaches are more or less appropriate to the particular pollutants and sources 
involved, with significant differences, for example, between point pollution sources, 
and those that are more diffuse. For air quality specifically, the National Institute for 
Health and Care Excellence have recently published guidance on ‘what works’ in air 
quality management, particularly in terms of reducing health impacts.54  
 
Guidance on addressing pollution inequalities and their relationship with health 
inequalities is though less well developed. It cannot necessarily be presumed that 
generic actions to address pollution problems will automatically reduce inequalities 
and improve the situation most substantially for those most exposed.55 Whilst this 
logic may well hold in some circumstances56, there is also evidence (as reviewed 
above) that air quality management strategies in the UK have not been as pro-equity 
as might be expected and that in relative terms deprived communities have 
benefitted less from improvements in air quality than others.25 If then it is accepted 
that pollution inequalities should be specifically targeted and reduced, it follows that 
there is a need to have policies and measures to identify and act on these 
inequalities. Key examples of such measures include: 
 
Appraisal of the impacts of planning decisions, government policies and 
strategies to explicitly include implications for environmental inequalities. This 
is to ensure that decisions are taken with full awareness of their potentially unequal 
consequences.24 Established assessment methodologies applied in England often 
either require or provide scope for assessing ‘distributional effects’, but are typically 
poor at specifically identifying environmental inequalities57, and beyond a few 
examples58,59 (see Box 2) are not generally carried out very thoroughly. Given the 
nature of the current evidence base, such appraisal needs to extend beyond the 
protected social characteristics identified in the 2010 Equality Act, to include socio-
economic status.    
 
Application of impact assessment methods in land use and other decision 
processes to explicitly address the cumulative effects of multiple decision 
processes, such as the cumulative effects on a community of a series of transport 
infrastructure and industrial developments. This is important given that, as noted 
above, pollution sources often accumulate in deprived areas where people’s health 
tends to be significantly worse. It is unfair to add further burdens on those already 
taking more than their ‘fair share’ and suffering additional health consequences, and 
impact assessments should clearly identify where this is taking place.  
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Targeting of investment in local pollution management measures specifically 
on more deprived communities where health indicators are most 
problematic.52 The identification of ‘pollution-poverty’ hotspots has been suggested 
as one way of implementing targeting19, and in particular where environmental 
quality standards are breached, offer the strongest support for claims of 
environmental injustice.25 
 
Actively supporting innovative community based approaches to identifying 
and addressing local pollution problems (see Box 3) recognising that deprived 
communities will typically have fewer resources and less capacity to participate and 
have influence on decision-making than others. The Environment Agency has some 
experience of advocating for and experimenting with participatory approaches to 
working with deprived communities.16 ‘Good neighbour agreements’ have also 
provided the basis for negotiating performance standards between industries and 
communities in some localities, although with varied outcomes.60,61 
 
Ensuring that socially disadvantaged groups are properly included in bio-
medical studies. Whilst the weight of evidence from environmental justice research 
shows socially disadvantaged groups are often more exposed to environmental 
pollution, some of these groups (for example ethnic minorities, homeless) have been 
found to be under-represented in biomedical studies thus potentially biasing 
understandings of health outcomes.62 
 
 
In following and selecting from such approaches, two further considerations are 
important. First, it makes much sense to seek synergies with wider policies focused 
on addressing health inequalities.2,52,63,64 The greening of deprived areas is a good 
example, given that green spaces can be of direct and indirect benefit to physical 
and mental health65 and tree and vegetation planting can play a role both in 
improving general environmental quality and in scavenging air pollutants before they 
reach sensitive lungs. Investment in sustainable transport modes is another good 
example of where there can be strong policy synergies.  
 
Second, it is a generally accepted principle that those who are suffering from 
pollution inequalities should not be made responsible for addressing them - making 
the polluted rather than the polluters pay - and are not unfairly penalised by the 
implementation of pollution reduction policies. Policy responses focused principally 
on personal protective measures are problematic in these terms66, as can be policies 
focused on economic penalties and/or with cost implications that have 
disproportionate impact on those with low incomes.67 Progressive approaches can 
ameliorate such effects, including, for example, focusing car scrappage schemes 
more substantially on low-income households.68   
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Box 2   Heathrow expansion and Equality Impact Assessment 
 
In 2008 campaigners protesting against proposals to further expand Heathrow 
airport argued that a proper assessment and consultation on the ‘equality’ 
implications of the development had not been carried out, and lodged legal 
proceedings against the Department of Transport. Their case rested on the 
obligation on all public authorities, under the Race Relations (amendment) Act 2000, 
to ensure that their policies do not have disproportionate impacts on ethnic minority 
groups. The response was an initial ‘Equality Impact Assessment’ screening which 
concluded that a full assessment should be undertaken because of the high 
proportion of black and Asian minority ethnic (BAME) groups near to the airport. The 
full assessment, undertaken for various potential airport expansion options, 
concluded that:  
 
“Each development option could result in both positive and negative noise, air 
quality and economic impacts on equality priority groups. BAME groups, 
children, young people, older people, women / carers, disabled people and 
those with low incomes are likely to be differentially affected by the 
development proposals. Additionally, BAME groups, children, older people 
and those on low incomes could also be affected due to their disproportional 
representation in particular areas around the airport.” 
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Box 3  Mapping for Change 
  Prof Muki Haklay and Louise Francis, University College London 
 
Mapping for Change (MfC) is a social enterprise that was founded by University 
College London (UCL) and London 21 Sustainability Network in 2009. It builds on 
ongoing research at UCL, focusing on participatory mapping and participatory 
Geographic Information Systems (GIS). These focus on the use of geographic 
information technologies to work with communities to solve problems that they face. 
By using mapping and geographical technologies such as GIS to collect, analyse 
and display information about communities’ life and environment, MfC projects have 
helped increase community engagement in the local environment, led to new 
environmental monitoring by local authorities and stimulated policy debate about 
noise and air pollution.  
 
MfC specialises in community engagement, aiming to empower individuals and 
communities to make a difference to their local area through the use of mapping and 
geographical information. In particular, MfC works to provide benefit to individuals 
and communities from disadvantaged or marginalised groups, along with the 
organisations and networks that support those communities, where the goal is to 
create positive sustainable transformations in their environment. 
 
Since 2010, MfC has been involved in community-led air quality studies. In these 
projects, MfC worked with communities to use a dense network of diffusion tubes to 
measure nitrogen dioxide levels at local locations. An early study in 2011 with seven 
community groups from across London showed that along main road networks NO2 
levels were as much as 75% above EU guidelines; it also highlighted issues in 
several residential back roads, used as ‘rat-runs’. In Putney, concerns raised about 
air quality by the Putney Society, citing MfC findings, were successful in leveraging 
political support to lobby for change, leading Transport for London to introduce to the 
area new buses that comply with higher standards for emissions.  
In another study, in the Barbican, in collaboration with the City of London, a year-
long study was carried out in 2013-2014 which identified a number of pollutant 
hotspots in the area. More than 100 residents have been involved in the project, with 
many hosting a diffusion tube for a year. More than half of residents said that they 
would change their walking routes as a result of the research; 85% reported that they 
felt more aware of some of the legal and technical aspects of air quality and 90% 
reported an improved understanding of the health impacts of air quality in London. In 
addition, the City of London is considering how to regulate local traffic in order to 
reduce the exposure of the local residents to harmful pollution. 
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Author’s suggestions for policy makers  
 
There is now substantial evidence across different pollution types and sources that 
there are significant pollution inequalities in England, with measures of deprivation in 
particular shown to be associated with a higher pollution burden. For pollutants 
injurious to health, this implies a priori, an adverse effect on health inequalities. 
However, the interactive consequences of environmental inequalities for health 
inequalities are complex to firmly establish. More research and systematic attention 
to the interaction between pollution and health inequalities is undoubtedly needed, 
bringing together research domains that have remained largely separate, as recently 
recognised in a set of priorities laid out by Public Health England.5  
There is however sufficient knowledge already in place to much better integrate 
pollution reduction and health inequality programmes and interventions. In addition 
to further research;  
 
• Decision-making that has the potential to exacerbate or reduce pollution 
should be better informed about how these effects are distributed by social 
group, and the implications for inequality (proactive inequality assessment). 
 
• The targeting of interventions to reduce pollution problems in particular places 
or communities should take account of the need to, at the same time, address 
health inequalities (targeted intervention). 
 
• Communities should be closely involved in addressing pollution problems, 
particularly where health impacts are most severely experienced (participatory 
monitoring and mitigation).   
 
 
 
 
 
 
 
  
Page 202 of 341 
 
References 
 
1. Government H. Healthy lives, healthy people: our strategy for public health in 
England. Cm7985. London: HMSO; 2010. 
2. Marmot M. Fair Society: Health Lives: Strategic Review of Health Inequalities 
Post 2010. The Marmot Review; 2010. 
3. Woodward A, Kawachi I. Why reduce health inequalities? Journal of 
Epidemiology & Community Health. 2000;54(923-929). 
4. Office for National Statistics. Life Expectancy at Birth and at Age 65 by Local 
Areas in England and Wales: 2012 to 2014. Available at 
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarri
ages/lifeexpectancies/bulletins/lifeexpectancyatbirthandatage65bylocalareasin
englandandwales/2015-11-04. 2015. 
5. Public Health England. Chemical Hazards and Poisons Report: Issue 26. 
London; 2016. 
6. Rivas I, Kumar P, Hagen-Zanker A. Exposure to air pollutants during 
commuting in London: are there inequalities among different socio-economic 
groups? Environment International. 2017;101:143-57. 
7. Mitchell G, Dorling D. An environmental justice analysis of British air quality. 
Environment and Planning  A. 2003;35(5):909-29. 
8. Barnes J, Chatterton T. An environmental justice analysis of exposure to 
traffic-related pollutants in England and Wales. WIT Transactions on Ecology 
and the Environment. 2017;210(12): 431-42; Available from: 
http://eprints.uwe.ac.uk/28882. 
9. Walker GP. Environmental Justice: Concepts, Evidence and Politics. 
Abingdon: Routledge; 2012. 
10. Holifield R, Chakraborty J, Walker GP, editors. Handbook of Environmental 
Justice. Abingdon: Routledge; 2018. 
11. Schlosberg D, Craven L, Matthews C, Agyeman J. Trends and directions in 
environmental justice: from inequity to everyday life, community, and just 
sustainabilities. Annul Review of Environmental Resources. 2016;41:321-40. 
12. Reed MG, George C. Where in the world is environmental justice? Progress 
in Human Geography. 2011;35(6):835-42. 
13. Friends of the Earth. Pollution Injustice. London: Friends of the Earth 
(England and Wales); 2000. 
14. Friends of the Earth. Pollution and Poverty - Breaking the Link. London: 
Friends of the Earth (England and Wales); 2001. 
15. Walker GP, Fay H, Mitchell G. Environmental Justice Impact Assessment: an 
evaluation of requirements and tools for distributional analysis. London: 
Friends of the Earth (England and Wales); 2005. 
16. Chalmers H, Colvin J. Addressing environmental inequalities in UK policy: An 
action research perspective. Local Environment. 2005;10(4):333 - 60. 
  
Page 203 of 341 
 
17. Environment Agency. Addressing environmental inequalities. Position 
Statement. Bristol: Environment Agency; 2004. 
18. Lucas K, Walker G, Eames M, Fay H, Poustie M. Environment and Social 
Justice: Rapid Research and Evidence Review. London: Sustainable 
Development Research Network and Policy Studies Institute; 2004. 
19. Walker G, Mitchell G, Fairburn J, Smith G. Environmental Quality and Social 
Deprivation. Phase II: National Analysis of Flood Hazard, IPC Industries and 
Air Quality. R&D Project Record E2-067/1/PR1. Bristol: The Environment 
Agency; 2003. 
20. Walker G, Burningham K, Fielding J, Smith G, Thrush D, Fay H. Addressing 
environmental inequalities: flood risk. Science Report SC020061. Bristol: 
Environment Agency; 2007. 
21. Damery S, Petts J, Walker G, Smith G. Addressing Environmental 
Inequalities: Waste Management. R&D Technical Report, SC020061/SR3, 
Bristol, Environment Agency; 2008. 
22. Damery S, Walker G, Petts J, Smith G. Addressing Environmental 
Inequalities: River  Water Quality. Bristol: Environment Agency; 2008.  
Contract No.: R&D Technical Report, SC020061/SR2. 
23. Stephens C, Willis R, Walker G. Addressing environmental inequalities: 
cumulative environmental impacts. Bristol: Environment Agency; 2006.  
Contract No.: R&D Technical Report, SC020061/SR4. 
24. Pye S, King K, Sturman J. Air quality and social deprivation in the UK: an 
environmental inequalities analysis Final Report AEAT/ENV/R/2170 to Defra. 
Didcot, Oxon: AEAT; 2006. 
25. Mitchell G, Norman P, Mullin K. Who benefits from environmental policy? An 
environmental justice analysis of air quality change in Britain, 2001–2011. 
Environmental Research Letters. 2015;10(10):105009. 
26. Deguen Sv, Zmirou-Navier D. Social inequalities resulting from health risks 
related to ambient air quality - A European review. European Journal of Public 
Health. 2010;20(1):27-35. 
27. Braubach M, Fairburn J. Social inequities in environmental risks associated 
with housing and residential location—a review of evidence. The European 
Journal of Public Health. 2010;20(1):36-42. 
28. Department of Environment FaRA. UK notification to the European 
Commission to extend the compliance deadline for meeting PM10 limit values 
in ambient air to 2011: Racial Equality Impact Assessment (England). London: 
DEFRA; 2009. 
29. Fecht D, Fischer P, Fortunato L, Hoek G, de Hoogh K, Marra M, et al. 
Associations between air pollution and socioeconomic characteristics, 
ethnicity and age profile of neighbourhoods in England and the Netherlands. 
Environmental pollution. Environmental Pollution. 2015;198:201-10. 
30. Royal College of Physicians. Every breath we take: the lifelong impact of air 
pollution. Report of a working party. London: Royal College of Physicians; 
2016. 
  
Page 204 of 341 
 
31. Buckingham S, Kulcur R. Gendered geographies of environmental injustice. 
Antipode. 2009;41(4):659-83. 
32. Adamkiewicz G, Zota A, Fabian M, Chahine T, Julien R, Spengler J, et al. 
Moving environmental justice indoors: understanding structural influences on 
residential exposure patterns in low-income communities. American journal of 
public health. 2011;101(S1):238-45. 
33. Walker G, Mitchell G, Fairburn J, Smith G. Industrial pollution and social 
deprivation: Evidence and complexity in evaluating and responding to 
environmental inequality. Local Environment. 2005;10(4):361 - 77. 
34. Richardson EA, Shortt NK, Mitchell RJ. The mechanism behind environmental 
inequality in Scotland: which came first, the deprivation or the landfill? 
Environment and Planning  A. 2010;42:223-40. 
35. Higgs G, Langford M. GISscience, environmental justice and estimating 
populations at risk: the case of landfills in Wales. Applied Geography. 
2009;29:63-76. 
36. Macklin Y, Kibble A, Pollitt F. Landfill sites: impact on health from emissions. 
London: Health Protection Agency; 2011. 
37. Bambra C, Robertson S, Kasim A, Smith J, Cairns-Nagi J, Copeland A, et al. 
Healthy land? An examination of the area-level association between 
brownfield land and morbidity and mortality in England. Environment and 
Planning A. Environment and Planning A. 2014;46(2):433-54. 
38. Brainard J, Jones A, Bateman I, Lovett A. Modelling environmental equity: 
Exposure to environmental noise pollution in Birmingham UK. Urban Studies. 
2004;41(13):2581-600. 
39. van Kamp I, Davies H. Noise and health in vulnerable groups: A review. Noise 
Health. 2013;15:153-9. 
40. Fairburn J, Butler B, Smith G. Environmental justice in South Yorkshire: 
locating social deprivation and poor environments using multiple indicators. 
Local Environment. 2009;14(2):139-54. 
41. Wheeler BW. Health-related environmental indices and environmental equity 
in England and Wales. Environment and Planning  A. 2004;36:802-22. 
42. Pearce JR, Richardson EA, Richard J, Shortt NK. Environmental justice and 
health : the implications of the socio-spatial distribution of multiple 
environmental deprivation for health inequalities in the United Kingdom. 
2010(April):522-39. 
43. Briggs D, Abellan JJ, Fecht D. Environmental inequity in England: Small area 
associations between socio-economic status and environmental pollution. 
Social Science and Medicine. 2008;67(10):1612-29. 
44. Bell ML, Zanobetti A, Dominici F. Evidence on vulnerability and susceptibility 
to health risks associated with short-term exposure to particulate matter: a 
systematic review and meta-analysis. American Journal of Epidemiology. 
2013;178(6):865-76. 
  
Page 205 of 341 
 
45. Bell ML, Zanobetti A, Dominici F. Who is more affected by ozone pollution? A 
systematic review and meta-analysis. American Journal of Epidemiology. 
2014;180(1):15-28. 
46. Westergaard N, Gehring U, Slama R, Pedersen M. Ambient air pollution and 
low birth weight - are some women more vulnerable than others? 
Environment International. 2017(March):0-1. 
47. Rodriguez-Villamizar LA, Berney C, Villa-Roel C, Ospina MB, Osornio-Vargas 
A, Rowe BH. The role of socioeconomic position as an effect-modifier of the 
association between outdoor air pollution and children’s asthma 
exacerbations: an equity-focused systematic review. Reviews on 
Environmental Health. 2016;31(3):297-309. 
48. Wheeler BW, Ben Shlomo Y. Environmental equity, air quality, socioeconomic 
status, and respiratory health: a linkage analysis of routine data from the 
Health Survey for England. Journal of Epidemiology and Community Health. 
2005;59(11):948-54. 
49. Jephcote C, Chen H. Environmental injustices of children's exposure to air 
pollution from road-transport within the model British multicultural city of 
Leicester: 2000-09. Science of the Total Environment. 2012;414:140-51. 
50. Richardson E, Pearce J, Tunstall H, Mitchell R, Shortt N. Particulate air 
pollution and health inequalities: a Europe-wide ecological analysis. 
International journal of health geographics 2013;12(1):34. 
51. Halonen JI, Blangiardo M, Toledano MB, Fecht D, Gulliver J, Anderson HR, et 
al. Long-term exposure to traffic pollution and hospital admissions in London. 
Environmental Pollution. 2016;208:48-57. 
52. Brunt H, Barnes J, Jones SJ, Longhurst JWS, Scally G, Hayes E. Air 
pollution, deprivation and health: understanding relationships to add value to 
local air quality management policy and practice in Wales, UK. Journal of 
Public Health. 2016:1-13. 
53. Milojevic A, Niedzwiedz C, Pearce J, Milner J, MacKenzie I, Doherty R, et al. 
Socio-economic and urban-rural differentials in exposure to air pollution and 
associated health impacts in England Environmental Health. 2017;in press. 
54. Excellence. NIfHaC. Air pollution: outdoor air quality and health (NG70) NICE 
Guideline. London: NICE; 2017. 
55. Tonne C, Beevers S, Armstrong B, Kelly F, Wilkinson P. Air pollution and 
mortality benefits of the London Congestion Charge: spatial and 
socioeconomic inequalities. Occupational and Environmental Medicine. 
2008;65(9):620-7. 
56. Mitchell G. Forecasting environmental equity: air quality responses to road 
user charging in Leeds, UK. Journal of Environmental Management. 
2005;77(3):212-26. 
57. Walker GP. Environmental justice and the distributional deficit in policy 
appraisal in the UK. Environmental Research Letters. 2007(4):045004. 
58. Department for Transport. Adding capacity at Heathrow airport: equality 
impact assessment. London: Department for Transport; 2009. 
  
Page 206 of 341 
 
59. Pye S, Norris J, Searl A, Watkiss P, Wilkins G, Pooley M. London Low 
Emission Zone Health Impact Assessment Final report: a report for Transport 
for London. Didcot: AEA Energy and Environment; 2008. 
60. Friends of the Earth Scotland. Love thy neighbour? the potential for good 
neighbour agreements in Scotland. Edinburgh: Friends of the Earth Scotland; 
2004. 
61. Illsley BM. Good Neighbour Agreements: the first step to environmental 
justice? Local Environment. 2002;7(1):69 - 79. 
62. Morrens B, Den Hond E, Schoeters G, Coertjens D, Colles A, Nawrot T, et al. 
Human biomonitoring from an environmental justice perspective: supporting 
study participation of women of Turkish and Moroccan descent. 
Environmental Health. 2017;16(1):48. 
63. Public Health England. Achieving Good Health for All. A framework for PHE 
action on health inequalities 2015–2020. London; 2015. 
64. Brunt H, Barnes J, Longhurst J, Scally G, Hayes ET. Local Air Quality 
Management policy and practice in the UK: The case for greater public health 
integration and engagement. Environmental Science and Policy. 2016;58:52-
60. 
65. Wolch JR, Byrne J, Newell JP. Urban green space, public health, and 
environmental justice: The challenge of making cities ‘just green enough’. 
Landscape and Urban Planning. 2014;125:234-44. 
66. Zheng S, Sun C, Kahn M. Self-protection investment exacerbates air pollution 
exposure inequality in urban China (No. w21301). National Bureau of 
Economic Research; 2015 
67. Friends of the Earth. The environmental reasons for reducing inequalities. 
London: Friends of the Earth; 2015. 
68. Institute for Public Policy Research. Lethal and Illegal: Solving London's Air 
Pollution Crisis. London: IPPR; 2016. 
 
  
Page 207 of 341 
 
Chapter 07 
 
 Environmental 
health - response 
to pollution 
 
Chapter lead 
Dr Naima Bradley1  
 
Chapter authors 
Dr Naima Bradley1, Dr Patrick Saunders2, Dr Benjamin Fenech3, Vicki 
Rhodes4 
 
1 Head of Environmental Hazards and Emergencies Department, Public Health 
England 
2 Visiting Professor of Public Health, University of Staffordshire 
3 Principal Noise and Health Scientist, Public Health England 
4 Senior Specialist (Special Topics), Environment Agency 
 
  
  
Page 208 of 341 
 
Summary  
 
• Pollution has a significant negative, and largely avoidable, impact on health and 
well-being. 
 
• Exposure to, and the effects of, pollution are influenced by other environmental, 
social and biological stressors. 
 
• A good quality environment has a powerful positive effect on health and well-
being. 
 
• Environmental Public Health (EPH) addresses all aspects of health that are 
affected by the natural and built environment.  
 
• A number of government departments, agencies and organisations work together 
to prevent or mitigate the impacts of environmental hazards on health in the 
home, in schools, at work and in the wider environment and improve health and 
well-being through safe, health promoting and empowering environments.  
o EPH professionals address the direct risks to public health arising from noise, 
air, water and land pollution and pollution arising from the transport, treatment 
and disposal of waste;  
o EPH professionals tackle the wider social determinants of health and 
environmental health inequities; 
o Environmental Health Professionals provide a wide range of public health 
functions at the local level, delivered through local authorities. 
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Introduction and background  
 
At a local level, Environmental Health Professionals (EHPs) are public health 
professionals, currently largely employed by local government but also active in 
Public Health England, the NHS, academia, business and the third sector, and are a 
key component of the Environmental Public Health (EPH)1 service. EPH is defined 
as all aspects of health that are affected by the natural and built environment. This 
remit includes, amongst other things, communicable disease control, food safety, 
inspection and enforcement, planning and building standards, and pollution control. 
 
EHPs protect and improve the public’s health and well-being through both regulatory 
and advocacy functions. They work in partnership with planners, Directors of Public 
Health and Public Health England teams, influencing change to secure 
environmental improvements in their localities. EHPs also enforce occupational 
safety standards preventing work-related ill health, such as occupational exposures - 
a significant burden for society, businesses and individual workers. This requires 
long term coordinated local action to make the essential sustained improvements. 
 
Environmental hazards impact on health outcomes directly, through physiological 
exposure, and indirectly, e.g. concerns about perceived or actual exposures can be 
detrimental to mental health. As EHPs have a thorough knowledge of the local 
environmental risks and mitigation options, they are ideally placed to tackle these 
environmental inequities – and the health threats from pollution.  
 
Closer working relationships between key organisations, agencies and government 
departments are central to the delivery of Environmental Public Health. Professionals 
within these organisations, agencies or departments may not see them themselves 
as being part of the public health workforce; however, they have a key role in 
bridging evidence, policy and practice for environmental public health gain. The 2013 
return of the NHS public health function in England to locally accountable councils, 
which hold most of the levers of influence in this field, was widely welcomed as an 
opportunity to underpin interventions with both evidence and popular consent. There 
are several examples of where this integration is working well but it is important that 
this good practice is replicated across the country.2   
  
Page 210 of 341 
 
 
Box 1           Contaminated land 
 
Historically the United Kingdom was the first industrialised country in the world and 
as a consequence the UK is thought to have over 400,000 hectares of land which is 
contaminated, much of it as a legacy of the industrial Revolution1. Contaminated 
land is an issue for public health due to the nature of the chemicals contained within 
the soil (which can sometimes be carcinogenic). Examples include lead which can 
lower IQ, benzo(a)pyrene which is carcinogenic and asbestos which can cause long 
latency cancers such as mesothelioma. When undertaking a contaminated land risk 
assessment the potential contaminant, the routes of exposure such as ingestion or 
inhalation and the potential duration of that exposure are considered.     
 
Contaminated sites where there has been a real potential immediate risk of harm to 
health include those with elevated levels of contaminants such as arsenic and lead in 
formerly industrialised areas, which pose a real threat to young children. Inadvertent 
ingestion, pica tendencies and tracked-back dust into properties can result in a 
significant possibility of significant harm to young children. 
 
Perceived risks to residents of remediation include the excavation and either 
treatment on site or removal off-site of these soils, which can lead to considerable 
anxiety and concerns to local residents.   
 
The current gap in the UK for contaminated land is the lack of funding and suitably 
experienced staff within LAs to undertake their statutory duty. There is also no fixed 
methodology to ascertain acute risk from contaminants in soil that LAs can draw on. 
There are a number of organisations, which include members of the industry, trying 
to fill the gap such as the Society for Brownfield Risk Assessment (SOBRA), and 
CL:AIRE who publish guidance to support industry such as SOBRA’s Design of an 
Activity Based Sampling Protocol for the Testing of Asbestos Fibre Release Potential 
from Residential Garden Soil which was published in 2015. 
 
Source 
https://www.gov.uk/government/publications/land-remediation-bringing-brownfield-
sites-back-to-use/land-remediation-bringing-brownfield-sites-back-to-use)   
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Health and the physical environment 
 
Environmental health professionals have been protecting the public from 
environmental hazards since Victorian times (see Box 2). Their enforcement of laws 
to tackle dangerous levels of pollution in air, water, food and land, unsafe housing 
and working conditions, insect and rodent infestations, as well as improving basic 
standards of sanitation and fighting infectious diseases, has saved countless lives. 
EHPs also make an enormous contribution to making people’s everyday lives better 
by preventing or stopping public health nuisances.3 These are not just irritations but 
serious threats to individual and community health and quality of life including fly 
tipping, anti-social behaviour such as noisy late night parties, garden bonfires 
producing choking clouds of smoke, and filthy and verminous living conditions. There 
are hundreds of thousands of such complaints made every year to local councils in 
England4 and while EHPs will always try to negotiate a resolution, they will use the 
law if necessary.  
 
The success of EHPs since the 1840s can be seen everywhere in the quality of the 
air we breathe, the food we eat, the places we live, work and play in, and the huge 
reductions in levels of previously devastating diseases such as tuberculosis, cholera, 
food poisoning, and typhoid. However, we cannot be complacent. The physical 
environment continues to have a major impact on our health and some of issues we 
thought were things of the past have re-emerged or evolved. Broadly, for example, 
diseases such as tuberculosis have re-emerged, whilst specific to pollution, different 
mixtures of air pollutants have become a threat.5  
 
We have had great successes in the past and we can do so again through 
understanding both the causes of ill health and the most effective interventions. We 
have also come to recognise that good quality environments improve health and 
well-being and that there are wide differences in the experience of both poor and 
good quality environments and the consequences of those experiences e.g. deprived 
people are likely to live in polluted environments and have poorer health.6 This 
applies to most aspects of the physical environment – including pollution – and, 
again, we are increasingly aware that there are important interactions between them. 
Polluted areas, for example, also tend to have higher concentrations of take away 
food outlets and fewer opportunities for safe recreation in green spaces; factors 
plausibly associated with obesity.7 Innovative urban design and planning control can 
help address all these issues, delivering a cost effective intervention by tackling 
multiple challenges and reducing inequalities at the same time.  
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Box 2 Pollution history and public health 
Stephen Mosley, Leeds Beckett University 
 
Anxiety about the pollution of air, water, and streets in the fast-growing cities of 
nineteenth century Britain saw the rise of the public health movement. The world’s 
first industrial nation was also a pioneer in tackling the harmful side-effects of 
unplanned urban growth: sewer rivers, smoke-filled skies, and vast quantities of 
organic wastes (such as manure from horse-drawn transport). So-called ‘filth 
diseases’, most notably waterborne cholera, dysentery, and typhoid fever, became 
major killers in overcrowded cities. Noxious emissions from factory and domestic 
chimneys caused chronic respiratory diseases, especially bronchitis, which claimed 
many thousands of victims every year. Early industrial centres like Glasgow, London, 
and Manchester were ‘devourers of population’. 
 
By the 1830s, pressure was building on Britain’s authorities to clean up polluted 
urban environments that contributed to serious health problems and preventable 
deaths. Influential figures rallying public opinion behind the sanitary movement 
included Edwin Chadwick (author of The Sanitary Condition of the Labouring 
Population, 1842), William Farr (medical statistician), and Thomas Southwood Smith 
(founder of the Health of Towns Association). Although the need for pure drinking 
water, clean air, and sanitary streets was not perfectly understood (miasmatic 
theories about disease transmission held sway), their lobbying helped to secure the 
passage of the first statutory nuisance legislation. In 1846 the Nuisance Removal Act 
gave justices the power to prosecute those responsible for urban ‘nuisances’ – 
defined broadly as accumulations of refuse, foul-smelling drains or cesspools, and 
‘unwholesome’ housing – that were believed to be the source of ‘bad air’ and 
disease. And in 1848 the first Public Health Act empowered local authorities to 
manage refuse, sewage, and water systems. It also established a General Board of 
Health; an important step towards formalising the state’s role in protecting the health 
of the nation. However, the implementation of public health legislation was slow 
initially. For example, it took London’s Great Stink of 1858 and fears of a cholera 
outbreak – the faecal stench from the polluted River Thames was so disgusting that 
Parliament was suspended – before the money and political will was found to build 
an effective metropolitan sewerage system. The underground system, designed by 
Joseph Bazalgette, was then emulated countrywide.     
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Advances in waste removal and water supply saw mortality rates from ‘filth diseases’ 
decline dramatically by the turn of the twentieth century, but Britain’s cities still 
suffered from excessive levels of smoke pollution. As air pollution was closely linked 
with jobs and prosperity, anti-smoke clauses in public health legislation were weakly 
drafted and rarely enforced. The catalyst for change was London’s Great Smog 
disaster of December 1952, which brought about the premature deaths of around 
12,000 people by exacerbating existing heart and lung conditions. Contemporaries 
finally understood that dirty air could be just as dangerous as contaminated water, 
and most supported the introduction of a tough Clean Air Act (1956) and the creation 
of smokeless zones in urban areas. By the 1980s coal smoke was no longer 
considered a significant factor in explaining respiratory deaths in Britain’s cities. As 
we struggle today with less tangible pollution problems, the history of public health 
shows that positive change is possible.     
 
 
One of the key benefits of the return of the NHS public health function to local 
authorities8 has been the closer collaboration between environmental health, public 
health, planning, transport and housing professionals. It is this collaboration that we 
need to reduce the health burden from pollution. There are already many examples 
of imaginative collaborative practices such as ‘greening’ urban corridors, improving 
public transport and improving opportunities for walking and cycling. We need to 
continue finding opportunities for collaborative interventions that address multiple 
hazards and target them where they have the most impact: some local authorities 
have used industry quality control methods to review public health nuisance 
complaints and environmental threats to do just that.9 We now explore two areas of 
pollution, air and noise pollution, and the role that EHPs have in reducing this threat. 
 
Environmental health opportunities – Air quality and environmental health 
One of the more recent examples is in the area of air quality where environmental 
public health professionals in local authorities, government, academia, the NHS and 
health charities are working together to reduce the health burden attributable to air 
pollution10,11 Environmental legislation has been successful in tackling some of the 
traditional domestic and industrial sources. However, different air pollutant mixtures 
have evolved as the modern economy and our way of life is increasingly reliant on 
road vehicles. Ironically, this increase in road traffic is damaging not only to the 
global climate, health and the environment through the emission of air pollutants and 
noise, but also to the local economy due to, for example, road congestion and 
additional pressure on the NHS.   
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Box 3  Cold ironing 
Dr Matthew Loxham, BBSRC Future Leader Fellow, Faculty of 
Medicine, Ocean and Earth Science, University of Southampton;  
 
Over 90% of the world’s trade travels by ship, the most fuel-efficient mode of 
transport per tonne of goods. When berthed in port (termed “hotelling”), cruise and 
cargo ships need to keep their systems powered, and therefore usually run their 
auxiliary engines. The resultant emissions may contribute significantly to local air 
pollution, contributing around 20% to the local air pollution load by source 
apportionmenti, although other techniques have suggested greater contributions.  A 
potential remedy is to connect hotelling ships to a shoreside electricity supply, 
allowing the auxiliary engines to be turned off, referred to as “cold ironing”. As long 
as the electricity is from a relatively clean source (renewable/LNG/nuclear), this 
reduces emissions from hotelling ships to near zero. Unfortunately, shoreside power 
is not commonplace because of the inability of the local power grid to meet the 
demands of multiple hotelling ships, incompatibility between ship- and land-based 
electrical supply characteristics, initial financial outlay (e.g. €10 million for a recent 
terminal in Hamburg), and debate over who should bear the financial costs. 
 
The Air Resources Board of California has introduced At-Berth Regulations to 
reduce emissions of NOx and particulate matter from hotelling ships at six major 
ports in California. Currently, at least 70% of the passenger, container, and 
refrigerated cargo fleet’s visits to regulated ports (80% by 2020) are limited to three 
hours of auxiliary engine operation with further limits on auxiliary engine power 
generation; additional power must come from shoreside supplies. Alternatively, 
approved emissions reduction technology, such as exhaust treatment systems, can 
be used. Importantly, emphasis is placed both on fleet operators to ensure that their 
ships are equipped with the necessary technology, and on port and terminal 
operators to ensure that infrastructure is available. Air pollution control agencies and 
port operators have made money available to contribute to equipment costs.  
Conversely, non-compliance is met with stringent financial penalties of up to $10,000 
per violation per day. 
 
In the EU, funding has been made available through the Marco Polo programme, 
ahead of a 2025 deadline for mandatory installation of shoreside power. It is 
noteworthy that, while cold ironing is already in operation in several EU ports, 
including Gothenburg, Hamburg-Altona, and Rotterdam, it is not used in the UK and 
nor are there any concrete plans for its introduction. Although there are barriers to be 
overcome in its adoption, shoreside power offers obvious potential for improvements 
in port city air quality and associated pollution-related health outcomes. In the long-
term, the costs of installation and operation are likely to be significantly outweighed 
by the cost savings in terms of the financial consequences of ill health due to 
shipping emissions which, including in-port and at-sea emissions, are estimated to 
exceed €64 billion in continental Europe by 2020.ii,iii  
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Renewed efforts are under way to ensure that local actions complement the global and 
national efforts. Environmental public health professionals are called to apply their expertise 
and experience in understanding the evolving evidence on the impact of environmental 
stressors on health, considering the needs of the local populations, work collaboratively to 
identify priorities and interventions, raise awareness amongst health professionals and 
advocate for behaviour change in order to reduce car usage and promote active travel.12   
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Box 4     A better real-world vehicle emissions ratings system 
      Nick Molden, Founder and Chief Executive Officer, Emissions Analytics 
 
Emissions Analytics (www.emissionsanalytics.com) is a specialist in real-world 
emissions and fuel economy testing.  Founded in 2011, it has now tested over 1,500 
different vehicles using regulatory-approved equipment but on a standardised, 
independent protocol. Company funding and operations are independent of 
manufacturers and other interested parties.  
 
Since 2016, Emissions Analytics has published free-to-access vehicle ratings based 
on its test data.   These make up the EQUA® Index (accessed at 
www.equaindex.com). These ratings can be used by fleet and private buyers in 
vehicle purchasing, and by manufacturers to evidence the performance of their 
vehicles. Unlike official figures, the EQUA Index ratings provide the ability to base 
consumer information, incentives and access restrictions on real-world performance. 
This offers a promising route to achieve air quality goals as quickly as possible, and 
with the smallest private and public cost. For example, these data could act as a 
baseline for effective clean air zones (CAZs). 
 
Real-world NOx emissions compared to regulated levels (the European “Euro” 
Vehicle certification programme) 
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At each Euro stage (stricter restriction applied through time) the cleanest vehicles 
have been getting cleaner, as measured by the EQUA; the dirtiest vehicles have not.  
Therefore, any system of discriminating between vehicles based only on Euro stage 
will be inefficient, permitting some vehicles with high real-world emissions. To 
exemplify the divergence between Euro standards and EQUA index, the dirtiest Euro 
6 diesels are six to seven times higher emitting than the cleanest Euro 5.  More 
striking still, the dirtiest Euro 6 diesels are around three times worse than the 
cleanest Euro 3/4 vehicles (remembering a 14 year gap between Euro 3 and Euro 
6). These variations are due to the official laboratory testing processes and 
exploitation of loopholes in the Euro standards regulation. 
 
Using the EQUA Indices would allow governments and cities to target only those 
vehicles which are high emitting in practice, minimising the private and public cost. 
By using it, for example, estimates suggest that 54% of Euro 6 diesels would have to 
be restricted from urban areas to achieve an 87% reduction in nitrogen oxide 
emissions. The EQUA index has been designed in the light of lessons from other 
labelling schemes – typically based on official figures or where multiple pollutants are 
combined into a less transparent “eco” rating – to be simple, accurate and action-
guiding.  Manufacturers would compete to get the best ratings, as it would deliver 
them marketing, sales and reputation benefits, thereby harnessing the market to 
solve an environmental and health problem. 
 
 
We must encourage environmental public health innovations, often driven by local 
democracy, as the status quo is not an option. In order to encourage behaviour 
change, such as encouraging active travel to improve health and reduce 
environmental pollution, we need to do more than simply enforce the law, we need to 
make the ‘doing the right thing’ the ‘easy thing to do’ and, along the way, change 
social attitudes as we have with smoking and drink driving. These interventions are 
investments not subsidies. Indeed, poor quality environments will put towns and 
cities at an economic disadvantage in attracting businesses.13 Well-planned and 
evidenced-based public health interventions are good value for money with high 
return on Investment and Cost Benefit Ratios.14 Transport-induced poor air quality, 
ill-health and road accidents costs society £40 billion per year. Getting one more 
child to walk or cycle to school could pay back as much as £768 or £539 respectively 
in health benefits, NHS savings, productivity gains and reductions in air pollution and 
congestion. Basic improvements to damp, cold and unsafe housing are an efficient 
use of resources. Every £1 spent on improving homes saves the NHS £70 over 10 
years. 
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Environmental health opportunities – reducing noise pollution 
As well as addressing the direct impact of environmental threats on clinical health 
outcomes, Environmental Public Health professionals are faced with environmental 
opportunities and challenges that can be beneficial for, or impact on, people’s mental 
health and quality of life. One such issue is sound/noise. Sound is an essential 
element in our daily lives, allowing us to communicate and express our feelings and 
capture information about our environment.15  Noise is sound that occurs in the 
wrong place or at the wrong time that leads to a negative effect on health and well-
being.16   
 
The scale of noise as a public health issue is clear. Noise is the single largest issue 
of complaint made to local authorities in the UK. Transportation noise is the second-
largest environmental health risk factor in Western Europe17  The annual social cost 
of urban road traffic noise in England is estimated at £7-£10bn.18 There is good 
evidence that transport related noise is associated with sleep disturbance, 
cardiovascular morbidity, cognitive impairment in children and chronic annoyance.19-
21
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Figure 7.1  Reproduction of European Union Tyre label (with notes) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note Environmental health practitioners have a role in informing the public of less polluting 
behaviours – for car drivers this means not leaving engines idling, driving more efficiently 
(going easy on the gas pedal and brakes) and replacing tyres with quieter alternatives.   
 
Current EU legislation has established a framework for providing consistent information on 
three tyre parameters: fuel efficiency, wet grip and external rolling noise. The label provides 
ratings of noise both in decibels and in more general terms for those unfamiliar with the 
decibel system – black waves indicating whether the tyres are ‘quiet’, ‘moderate’ or ‘noisy’. 
Quieter tyres are generally no more expensive than standard tyres and perform similarly in 
terms of wet grip and rolling resistance.
22
 
 
 
Source  Adapted from https://commons.wikimedia.org/wiki/File:EC_tyre_label_CA.svg  
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However, transportation is not the only noise source of concern. Environmental 
Health Practitioners are well aware of the impact of nuisances from neighbours and 
wider neighbourhood noise. One in ten people report themselves “very or extremely” 
bothered, annoyed or disturbed by noise from neighbours and other people nearby.3  
Data from the Public Health Outcomes Framework23 show around 400,000 
complaints made to Local Authorities in England every year about neighbour and 
neighbourhood noise, and this represents only a small percentage (10-15%) of 
actions taken by those affected by noise.3,24 Several studies have shown that 
neighbour and neighbourhood noise can have a negative impact on physical and 
mental wellbeing in adults24-27, and one study found that exposure to neighbour 
noise at home is associated with conduct problems and hyperactivity in children.28,29 
Statistics compiled in 2014-15 by the CIEH on Local Authority noise enforcement 
activity show that EHPs resolved 82% of complaints received. 
 
The journey towards a healthier, less polluted, sound environment offers many 
challenges. Increasing urbanisation is bringing people’s dwellings closer together 
and closer to roads, railways, airports and industry. Major infrastructure projects are 
making construction noise a semi-permanent feature of the urban sound 
environment: the 24hr economy can be a barrier to people’s desire to “turn down the 
volume” at night to allow a good night’s sleep. But solving these problems is not just 
about reducing noise levels. Noise acts as a psychosocial stressor30, and the 
psychological reaction to it is influenced strongly by a number of personal, situational 
and environmental factors.30-32 A holistic sustainable development approach 
featuring good acoustic design33,34 can protect against adverse health outcomes by 
minimising exposure and maximising restorative opportunities such as respite35 and 
tranquil urban areas.36 Behavioural interventions such as coping strategies37, should 
also be considered, particularly for those most at risk.  
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Box 5    A typical day in the life of an Environmental Health Professional 
 
09.30 hrs:  
Responds to complaints about a householder routinely lighting large bonfires 
producing clouds of dense smoke preventing neighbours from using their gardens. 
Advises the householder about the legal requirement not to create a ‘nuisance’ and 
explains the local authority services available for the disposal of garden and other 
waste. EHO will monitor the situation and serve a notice if there are further incidents.  
 
10.00 hrs:  
During the visit EHP is called to a privately rented property by tenants complaining of 
mould affecting the health of their newly born baby. The property has several 
structural defects, including a leaking roof which the landlord has refused to repair. 
EHP undertakes a thorough inspection of the dwelling based on the housing health 
and safety rating system (HHSRS), an evaluation tool to help local authorities 
identify and protect against potential risks and hazards to health and safety from 
deficiencies identified in dwellings.  
 
11.30 hrs:  
EHP attending a complainant’s home that is in a filthy state with piles of rubbish and 
food waste cluttering the premises and where the adults smoke heavily while the 
children are watching television. The EHP had attended a training session on 
“making every contact count” (MECC) training the previous week and advises the 
parents on the health hazards, provides detail of the local stop smoking programme 
and liaises with social services colleagues to arrange the premises to be cleaned 
and the situation assessed for other hazards and interventions. 
 
13.30 hrs:  
Attends meeting with the Director of Public Health (DPH) and planning colleagues 
about the high levels of NO2 around a heavily trafficked retail high street. Advises 
that given the impracticality of technical interventions, the council should consider, in 
collaboration with local businesses and residents, a no idling near the school 
campaign, a walking to school plan led by the pupils and parents and potentially, the 
installation of ‘living walls’ (panels of foliage) at strategic points including around a 
primary school. EHO and DPH advise on ensuring that the interventions are properly 
evaluated. 
 
15:30 hrs:  
Site visit for a planning application for dwellings with gardens. EHO makes 
recommendations to the planning inspector on the need for a more comprehensive 
contaminated land assessment by the developer.  
 
16.30 hrs:  
Completes the required evidential and legal documentation. 
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Acute incidents and pollution 
 
Another aspect of protecting the environment is to anticipate, plan for and respond to 
acute pollution events. All human activity generates waste and this can become a 
threat to the environment and ultimately to human health. The UK generated 202.8 
million tonnes of total waste in 2014. Over half of this (59.4%) was produced by 
construction, demolition and excavation, with households responsible for a further 
13.7% (Figure 7.2).38 
 
Figure 7.2  Waste generation by source (United Kingdom, 2014) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note 
C&I = Commercial & Industrial 
CD&E = Construction, Demolition & Excavation and includes dredging 
'Other' consists of waste from mining, agriculture, forestry and fishing 
 
Source Bradley et al. using data from Health Protection Agency, Impact on Health of 
Emissions from Landfill Sites (2011) 
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The regulatory regimes to mitigate the potential public health risk posed by waste 
disposal and treatment such as deposition to landfill and incineration, are well 
documented.39,40 
 
For many years, the policy of prevention, re-use and recycling of waste products has 
driven up recycling rates (Figure 7.3).41 The preferred option is to reduce the amount 
of waste that is generated at source. If that is not possible, priority should be given to 
preparing the waste material so it can be easily re-used or turning it into another 
useful product or material (recycling). Although this has led to an improvement in the 
environment by reducing the impact of waste disposal activities such as air, water 
and land pollution due to landfill, it has also increased the number of waste storage 
sites.   
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Figure 7.3 The Waste Hierarchy  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source Department for Environment, Food and Rural Affairs (Defra). Guidance on applying the Waste Hierarchy (2011) 
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Waste facilities could harm human health by polluting the environment unless they 
are controlled. The environmental permitting regime requires operators to obtain 
permits for some facilities and ensures their ongoing supervision. Permitting aims to 
protect the environment, ensure policy and legislative standards are met and 
encourage best practice in operation of facilities.42 Of all the serious pollution 
incidents in 2015, 65% had an impact on water and 19% had an impact on air. 
Activities with permits caused 26% of incidents affecting water, and 71% of incidents 
affecting air. Non-permitted activities caused 61% of incidents affecting water, and 
29% of incidents affecting air.38 
 
There are approximately 8,500 permitted sites storing combustible wastes in 
England and each year there are around 250-300 fires at such sites. Many of these 
fires occur at sites that are close to local communities, meaning that people can be 
affected by combustion products within the smoke. In addition to causing adverse 
effects on human health, smoke can cause significant disruption to major travel 
infrastructure, neighbouring businesses, and utilises resources from emergency 
responders.     
 
The Environment Agency has a statutory duty to protect the public and the 
environment at those sites it regulates, by controlling emissions to air, land and 
water. These emissions include accidental releases from fires. (42). In 2015/16, the 
Environment Agency completed a formal consultation, and responses were received 
from Public Health England and other Emergency Responders. These comments 
were used to revise the regulatory guidance on fire prevention. This sets out clear 
objectives that site operators must achieve in order to reduce the overall likelihood 
and the impact of waste fires on the public and the environment.  
 
The environmental permitting regime requires operators to obtain permits for some 
facilities and ensures their ongoing supervision. For permitted waste sites that store 
combustible wastes, conditions in the permit now require an operator to draw up a 
fire prevention plan. All plans have to be approved by the Environment Agency and 
are required to meet the objectives in the regulatory guidance. Over the next few 
years, the requirement for all existing 8,500 permitted sites to have an approved fire 
prevention plan is being phased in. 
 
The composition of the smoke from these fires varies with the type of combustion, 
the availability of oxygen, the temperature and the materials involved. The immediate 
adverse health effects are likely to be caused by particulate matter, asphyxiants and 
irritants35, particularly in the most vulnerable groups within the local community 
including children, the elderly and pregnant women. Current precautionary public 
health advice provided during many fire incidents is for members of the public to 
reduce their exposure by sheltering indoors; keeping windows and doors closed. 
However, sheltering becomes less effective over time if outdoor concentrations 
remain high. Effectiveness is dependent on people starting sheltering as soon as a 
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fire starts and stopping as soon as it ends. Many Fire and Rescue Services routinely 
use live social media feeds to inform the public of local incidents including fires. All 
emergency responders should encourage the public to follow these social media 
feeds, and to immediately shelter if they are within a 1km radius of a waste fire. 
 
 
 
Box 6      Working together to manage risk from waste sites 
 
It is not possible to prevent all fires and there is a need to minimise the duration of a 
fire, in order to protect members of the public from being exposed to unacceptable 
levels of smoke. In July 2016, the Environment Agency revised its regulatory 
guidance on Fire Prevention. Requirements are being phased in, so that all 
permitted sites storing combustible waste are required to draw up and implement a 
plan to meet the objectives of the guidance: 
 
• to minimise the likelihood of a fire occurring; 
• to  extinguish a fire within 4 hours; and  
• to minimise the spread of fire within the site and to neighbouring sites.  
 
Waste sites that are regulated by local authorities, those that are illegal or exempt, 
do not comply with the objectives of the regulatory guidance.  
 
When fires do occur there is very close working between the site operator, the Fire 
and Rescue Service, public health professionals, the local authority and the 
Environment Agency. Such joint working means the fire can often be brought under 
control quickly and a plan developed for putting it out. Where fires can be quickly 
extinguished, the health impacts on the local community are reduced significantly. 
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Box 7       Bio-aerosols and waste 
 
Recycling waste can bring its own environmental challenges such as addressing 
concerns about the potential public health risk from bacteria and fungi arising from 
commercial composting sites.  
 
The Environment Agency worked with PHE, academic and commercial partners to 
identify what levels of exposure to bioaerosol may be harmful, what contribution 
composting sites may make to the bioaerosol exposure of people living nearby, and 
how emissions can be mitigated. With our data we have developed a regulatory 
position that protects public health while minimizing the financial and regulatory 
burden on operators. 
 
A literature survey indicated that there is evidence of health effects from exposure to 
high concentrations of bioaerosol in some occupational situations, but it is not clear 
whether measurable harm occurs at the lower concentrations typically found 
downwind of biowaste sites. A precautionary approach to regulation was therefore 
deemed necessary, under which composting sites would not contribute to ambient 
exposure. 
• There is evidence of health effects from exposure to high concentrations of 
bioaerosol in some situations. 
• It is not clear whether measurable harm occurs downwind of biowaste sites. 
• Epidemiological studies confirmed that no statistically significant health 
impacts are found in people living 250m downwind of sites. 
• Containment of composting mitigates bioaerosol emissions. 
• Biofilters are primarily designed to reduce odour emissions. Their 
effectiveness to mitigate bioaerosols is variable.  
• Stacks can be used to reduce ground level bioaerosol exposure. 
 
In addition to public health risks from bioaerosol from waste facilities, there is a 
potential risk from intensive farming facilities. Further evidence is needed to inform 
us. A key question is whether bioaerosols downwind of these facilities pose a risk to 
public health with respect to the types of species found in the bioaerosol and the 
quantities.  
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Box 8        Occupational exposures   
Health and Safety Executive 
 
Ill health that develops from exposures in the workplace continues to be a significant 
challenge. In 2016/17 an estimated 1.3 million people who worked were suffering 
from an illness they believed was caused or made worse by work and an estimated 
13,000 deaths a year (12,000 lung disease deaths) are linked to past exposures to 
hazardous substances at work1. In addition to the direct personal 
consequences, this results in a considerable economic burden. 
New cases of work-related illness resulting from working conditions today (excluding 
long-latency illnesses) led to annual costs of £9.7 billion in 2015/16.i But past 
working conditions also continue to cause high costs today. The Health and Safety 
Executive (HSE) estimates that new cases of work-related cancer, caused largely by 
past exposures to carcinogens at work, resulted in costs of around £12.3 billion in 
2010.ii  
 
HSE’s Health and Work strategyiii highlights the toll of work-related ill health and sets 
out the actions that it will take forward to address this challenge. Exposures resulting 
in work-related ill health can occur across all industry sectors irrespective of the 
sizes of the business. However, HSE cannot tackle all work-related ill health at once 
and it will focus on those health issues that have a widespread prevalence, the 
largest lost-time and economic-cost consequences and/or have life-altering or life-
limiting impacts for the individual. Using a robust science and evidence baseiv, as 
well as considering the impact of the future world of workv, HSE is prioritising its 
activity on tackling exposures that lead to: 
• occupational lung diseases; 
• musculoskeletal disorders; and  
• work-related stress and related mental health issues. 
 
HSE’s activities are aimed at driving collective action in the health and safety system 
towards managing health in the workplace (see example) and it is engaging with a 
variety of stakeholders and partners including industry, trades unions and the wider 
workforce, Local Authority co-regulators, professionals and academia to develop its 
work on the priority health areas. Actions include championing the need for 
prevention, working with strategic partners and networks (national and international), 
directing HSE and Local Authority inspection and enforcement activity to where it 
can have the most effect and raising awareness with employers to promote 
behavioural change through the ‘Go Home Healthy’ campaign.vi 
 
An example of collaborative work HSE are undertaking for one of the health 
priority areas is aimed at reducing ill health from exposure to respirable 
crystalline silica (RCS) in brick making, stone masonry, foundries, quarries and 
construction industries. Activities include:  
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• Engaging: with workers and employers to drive interventions and behavioural 
change through facilitating specific industry partnership groups to implement 
tailored actions and novel communications materials e.g. the Quarries 
Partnership Team animated YouTube video to highlight good and bad working 
practices (www.safequarry.com).   
 
• Promoting: key practical messages e.g. to consider workplace exposures when 
workers return to work after illness. Supporting partner’s initiatives e.g. British 
Occupational Hygiene Society and their ‘Breathe Freely’ campaign aimed at the 
construction industry (http://www.breathefreely.org.uk/) and Institution of 
Occupational Safety and Health on the silica phase of their ‘No Time to Lose’ 
initiative (http://www.notimetolose.org.uk/Free-resources/Silica-pack-lite-
version.aspx).  
 
• Anticipating new challenges: through foresight and the synthesis of existing 
evidence to identify novel techniques to address RCS health and safety issues, 
e.g. in mask sampling for exposure measurement. 
 
• Evidence-based activity: synthesis of the evidence base from 20 years of 
research findings, considered by the Workplace Health Expert Committee (lead 
by an independent Chair). 
 
• Longitudinal workplace research: undertaking a study of workers in stone 
working, brick-making and foundries. 
 
• Policy and operational activity: issuing supplementary RCS health surveillance 
guidance, alongside enforcement campaigns in targeted industries as part of 
wider activity. 
 
• Partnership working: establishing a leadership body, the Healthy Lung 
Partnership across existing stakeholder groups to co-ordinate activity and provide 
direction on tackling occupational lung diseases. 
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Authors’ suggestions for policy makers   
 
• Environmental pollution poses a significant burden for society, businesses and 
individuals. Long-term coordinated action is required to make sustained 
improvements. Focused engagement with stakeholders and networks of 
individuals to support behaviour change and develop the required awareness 
programmes to achieve tangible health outcomes is needed. The consolidation of 
the public health function in local government presents a great opportunity for 
focused, evidence based interventions driven by local needs. 
 
• It important to recognise the full scope of environmental public health function, 
which includes research, regulation, policy development and advocacy functions. 
These functions are carried out by wide range or government departments, 
agencies, organisations and universities. It is crucial to consider all these 
activities when developing the multi-disciplinary workforce required to carry out all 
these functions.     
 
• There is an urgent need to improve collaborative intelligence and horizon 
scanning activities for environmental public health threats to prioritise investment 
in research and prevention activities. 
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Summary  
 
• The large volume of data on pollution and health outcomes now, and becoming 
available (‘big data’), provide exceptional opportunities to carry out investigations 
into the impacts of environmental pollution on human health and for the detection 
(‘surveillance’) and prevention of non-communicable diseases in England and 
elsewhere. 
 
• The data needed to realise these opportunities include information about 
personal and population exposures to environmental pollutants, for example, 
through novel -omics techniques and use of biomarkers, linked to individual 
health records and geocoded routine health statistics. 
 
• Analyses of such data will improve our understanding of the health implications of 
exposures to a complex range of polluants over both short and long time periods. 
In addition, developments in computational processing, novel spatio-temporal 
statistical methodologies and innovative technologies such as data mining and 
artificial intelligence, will facilitate detection of unusual signals in the routine 
health and pollution data for surveillance and environmental public health 
tracking. 
 
• A multi-disciplinary approach is needed, as exemplified by studies conducted by 
the UK Small Area Health Statistics Unit (SAHSU). On-going funding is required 
both to maintain and develop infrastructure to receive, curate, hold, link and 
analyse such data, as well as for specific research projects.  
 
• Despite the large volume of data available, they are not necessarily easy to 
access and use. Robust procedures need to be in place to assure the quality and 
completeness of data, to make them available for research in timely fashion 
across different linked data sources and to ensure that ethical and information 
governance requirements are met. 
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Overview  
 
Exposure to environmental pollutants, for example from air and water, is an 
inevitable consequence of everyday living. Studies of the effects of environmental 
pollutants on health have often been limited by a lack of high quality information on 
what people are exposed to, where and when the exposure occurs and by problems 
linking pollutant data to health outcomes, especially over the long term. Interpretation 
of health effects linked to a specific pollutant may be complicated by impacts of 
lifestyle factors, socioeconomic deprivation and exposure to more than one pollutant 
at a time. Better and more integrated data will help to overcome these problems for 
researchers, providing a stronger evidence base for policies to reduce exposure to 
environmental pollution and consequently improve health. A further issue arises 
where the impacts on health of any one pollutant may be relatively small and difficult 
to detect compared with the effects of lifestyle and other causes (see Chapter 10 of 
this report, ‘Measurement and communication of health risks from pollution’). 
Detecting small risks reliably requires large studies – and large datasets. However, 
increases in disease risk that may appear small for any one individual may be 
important for public health as overall they can add up to a large disease burden 
across the population.1 
 
Vast amounts of electronically stored data are now being collected about us, the way 
we live and our environment, including information on pollutants and our lifestyles 
(Annex 3). These data can, in principle, be linked to health data to investigate risks 
to health. Sources of health data include national health datasets, such as birth and 
death records, general practice patient records, hospital admissions and other 
National Health Service (NHS) data (Annex 4), as well as information from specific 
surveys and personal monitoring devices. Through appropriate linkages of the 
pollution and health data, these ‘big data’ resources can provide remarkable 
opportunities to: 
• rapidly investigate associations between our health and the environment we live 
in;  
• identify demographic, environmental and socioeconomic risk factors for specific 
diseases and ill-health;  
• inform public health policies by improving our scientific understanding about the 
ways in which environmental factors may influence health.  
 
Analysis of these data requires the careful use of appropriate methodologies, 
allowing other important health risk factors such as age, socioeconomic status and 
ethnicity to be accounted for. Small area studies, such as neighbourhood studies, 
allow for the linkage of such data from multiple sources (Box 2). Small-area studies 
have been used to map disease risks (Figure 8.1) and pollutant concentrations 
(Figure 8.2), and to investigate potential health risks associated with various 
pollutants and exposures. Examples include waste disposal2,3, temperature 
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extremes4,5, air and noise pollution6,7, chlorination by-products in the water supply8,9, 
and electromagnetic fields from overhead power lines and mobile phone masts.10- 
National data coverage also allows the investigation of the extent by which different 
population groups, defined by geographical region or socioeconomic characteristics, 
are exposed to different levels of environmental pollutants (termed environmental 
inequality).13-16  
 
  
 
Box 1  The UK Small Area Health Statistics Unit 
 
The UK Small Area Health Statistics Unit (SAHSU, http://www.sahsu.org/) holds 
many of the routinely collected national health, environmental and socio-
demographic data in the UK.17 It was set up 30 years ago following the observation 
of an excess risk of leukaemia and lymphoma among children and young people 
living near the Sellafield nuclear plant.18 SAHSU has a national remit to develop 
methodologies, particularly for small areas (neighbourhoods) to improve detection of 
health risks from pollution, to conduct targeted research and monitoring and advise 
government on unusual clusters of disease. It has an international reputation as a 
centre of expertise in methods in spatial and environmental epidemiology. Overall, 
SAHSU collects, curates and maintains more than 600 million UK health records. 
The development of new biostatistical methodologies19,20, the use of state of the art 
geographical information systems (GIS) to integrate data and develop advanced 
environmental models21,22, offer a powerful approach to study potential health risks 
to the public.  
 
Data mining capabilities, already commonly used for commercial and marketing 
purposes in other settings (for example, by search engines, banks, supermarkets 
and on social media), are starting to be used in health research, and offer the 
prospect of analysing national sources of health data for public health surveillance. 
The government Chief Scientist’s Blackett report on wide-area surveillance23 recently 
concluded that the rapid detection of unusual health signals would have significant 
benefits for public health. The use of such methods for health surveillance in the 
public good needs careful attention to privacy and data security, as enshrined in 
Caldicott principles in the UK24-26 and the European General Data Protection 
Regulation (GDPR, http://www.eugdpr.org/). 
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Figure 8.1  Disease incidence maps of (a) lung cancer in women and 
(b) mesothelioma in men extracted from SAHSU’s 
Environment and Health Atlas for England and Wales 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source  adapted from data from the Office for National Health Statistics 
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Note 
1. The incidence risk for each small area (in this case wards) has been smoothed towards a 
combination of the national average and the averages of neighbouring wards. Smoothing is a 
statistical method used to adjust for chance fluctuations in disease risk that can occur when risks 
are calculated using rare diseases or small populations.27 They show higher risks for lung cancer 
in urban areas particularly those in the north of England and highly localised increased risks of 
mesothelioma secondary to occupational asbestos exposure.  
2. Maps are available online at www.envhealthatlas.co.uk and can be searched by 
postcode. 
 
 Figure 8.2  Maps of (a) nitrogen dioxide concentrations (NO2, µg/m3), 100m × 100m annual average concentrations 
for 2001 developed using land use regression (LUR), and (b) herbicide usage (kg) per census ward in 
2000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source Extracted from SAHSU’s Environment and Health Atlas for England and Wales and based on data from the English Department for 
Environment, Food and Rural Affairs (DEFRA) and the Pesticides Usage Survey (PUS), respectively. 
Note 
Maps show higher levels of NO2 in urban areas reflecting road traffic as a major source, and higher usage of herbicides in agriculture intensive areas.  
a b 
 A new era of big data 
 
Accurately estimating exposure to environmental pollution and relating that to health 
over the lifecourse is a major challenge. We provide below an overview of the major 
sources of data to investigate ongoing impacts of pollution on our health and present 
some of the methodological opportunities and challenges associated with processing 
and analysing such big data.28 
 
 
The exposome – the totality of exposures 
The concept of the exposome is providing a new systems-wide paradigm to help 
understand the health effects of environmental pollution. The exposome covers the 
totality of all types of exposures – from genetic/genomic sources, lifestyle and diet, 
psychosocial, medical, occupational and other sources, as well as environmental 
pollutants – over a person’s lifetime. This concept should help researchers gain new 
mechanistic insights into disease causation and progression and to develop novel 
approaches to treatment and disease prevention.29-32 It involves bringing together 
data on measured (e.g. personal monitoring device) and modelled (e.g. interpolation 
based on monitoring network) exposures and biological dose (e.g. from biomarkers), 
as well as potential health effects.  
 
Biological signatures cover a wide range of molecules, including metabolites in blood 
or urine (metabolomics), proteins (proteomics), mRNA (transcriptomics), and 
covalent complexes with DNA and proteins (adductomics) (Figure 8.3). Such rich 
biological information allows the assessment of the internal (chemical) and external 
(environmental pollutants and stressors) exposures of an individual, especially 
during critical life stages. Proof of concept studies have identified, for example, 
metabolic profiles that detect early effects of environmental and lifestyle exposure to 
33
, and susceptibility to tobacco smoke-induced cardiovascular diseases among 
women.34 
 
 Figure 8.3 The exposome concept 
 
 
 
 
 
 Big data on environmental pollution 
 
The ‘big data’ revolution is providing much improved information on pollution and 
pollutant sources. Publicly available data, based on satellite images, aerial 
photographs and ground surveys conducted at increasing resolution, tell us about 
land use changes, the precise geographical location of roads, industrial facilities and 
waste disposal sites, patterns of light pollution and pollen concentrations and other 
sources of environmental pollution. Routine meteorological and air quality monitoring 
stations generate precise localised time series for large urban areas and reliable 
modelled surfaces nationwide. Local monitoring networks, such as the London Air 
Quality Network********* which provides estimates of air pollution for 20m grids across 
the city (one of the most advanced such systems worldwide), allow users to access 
detailed hourly forecasts of local air pollution levels (Figure 8.4a). These can then be 
used to offer advanced services, for example, a route planner to identify routes that 
minimise exposure to air pollutants when walking or cycling in London.†††††††††  
 
It is not practical to make pollutant measurements on the whole population, but 
models can provide proxy estimates of pollution exposures experienced by 
individuals. Local monitoring networks support the development of detailed air 
pollution models to assign air pollution exposure to individuals, for example, at their 
residential address (Figure 8.4b). A standard method for modelling residential air 
pollution is land use regression (LUR).35 (45). LUR uses input from air pollution 
monitoring sites and geographical information on potential sources including local 
traffic, industrial sites and population patterns. This information is used to build a 
statistical model that predicts air pollution concentrations in areas where people 
live.36-40 The combination of measurements from 5,220 air monitors across 58 
countries has, for example, enabled the development of a global LUR model for 
nitrogen dioxide air pollution41  that is being used to investigate health effects and 
burden of disease. LUR methods have also been applied to assign air pollution 
levels to the UK (Figure 8.4a) and, using historic air quality monitoring data going 
back to the 1970s, to study effects of air pollution on health over 30 years.7 
 
  
                                                          
*********
  https://www.londonair.org.uk/LondonAir/Default.aspx 
†††††††††
  http://www.breathelondon.org/plan-lower-pollution-travel-route 
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The application of advanced methodologies in geographic information systems (GIS) 
and high-performance computing, enables the capturing, storing and processing of 
large quantities of spatial and temporal data. This allows the modelling and 
assessment of exposures with complex dispersion patterns such as road traffic and 
aircraft noise or electromagnetic fields42,43 Further advances are needed to account 
for activity and migration patterns of people to estimate their exposure to different 
pollutants throughout a day, year or lifetime. Combining modelled and measurement 
data, for example through the joint use of satellite-derived models44, high-precision 
exposure methods and information from personal monitoring devices45, can provide 
high quality information on pollutant exposures for a subset of individuals that can 
then be extrapolated more generally to the population.   
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Box 2  Air quality exposure application 
 
Dr Andrew Grieve, Kings College London 
 
Air quality monitoring is undertaken by local authorities across the UK. The data 
collected is highly time resolved, quality assured and comparable across cities and 
regions. Although these data are collected for compliance assessment, they are 
increasingly being used for public dissemination and information. 
 
The City Air app uses a combination of real-time air quality monitoring data from the 
London Air Quality Network (LAQN) and highly detailed dispersion modelling to 
provide users with air quality alerts and an innovative low pollution routing tool. 
 
Every hour, maps for nitrogen dioxide (NO2), PM10 and PM2.5 particulates and 
ozone (O3) are updated using the latest data from the network to create a ‘Nowcast’ 
model of air quality across the city. 
 
Each map is highly detailed, consisting of 5.5 million 20x20 metre grid squares so 
this process involves the recalculation of over 10 million grid cells each hour by 
King’s College servers. 
 
Since the pollution concentration in each grid cell is known, the app can therefore 
calculate pollution concentrations along any particular route. 
 
When provided with a start and end point, the app calculates up to three alternative 
routes between those points and calculates the pollution difference between the 
routes by summing the average of each of the pollutants in all of the grid cells that 
the route transects. 
 
Using data from the LAQN, the app provides users with a range of lower pollution 
routes between two points thereby helping them to minimise their exposure as they 
travel across the city.  
 
The application was developed by King’s College London and City of London 
Corporation and received a Defra air quality grant in 2012. 
 
 Figure 8.4  Maps of (a) the air monitoring network and (b) modelled annual average NO2 concentrations in London 
estimated by CMAQ-Urban for 2008  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note 
1. Stations monitoring levels above and below the legal limit of 40 µg/m3 are shown in red and green, respectively.  
2. Monitoring stations with insufficient data are shown in white.  
3. CMAQ-urban is a comprehensive system for modelling air quality in large urban areas, cities and towns.46
a b 
  
Furthermore, new technologies of integrated micro sensors combined with 
smartphone applications, accurate GPS tracking and Wifi connectivity are enabling 
real-time crowd-sourced monitoring of a range of environmental parameters 
surrounding users (such as temperature, carbon monoxide, particulate matter).  
If widely used across the country, such devices would provide a wide network of 
measurements with relatively low maintenance costs. Crowd-sourcing has the 
potential to validate and improve modelled exposure estimates, particularly in areas 
of low population density and to better assess differences in health risks between 
individuals, based on real-time monitoring of their pollutant exposures, daily activity 
patterns and health. However, this will require detailed assessment of the accuracy 
and representativeness of such methods before they can be widely used. 
 
Despite increasing availability of large environmental datasets, we found when 
compiling for SAHSU the Environment and Health Atlas for England and Wales 
(www.envhealthatlas.co.uk), that environmental data from different sources are 
collected in different ways with different access permissions (Annex 4), not all data 
are available nationally, while data that were available nationally were not readily 
available at small area level. SAHSU therefore had to carry out intensive work of 
data compilation and harmonisation in order to map these data at small area level 
nationally. In some cases, such as in an ongoing study of health risks around 
municipal waste incinerators3, paper records may be the only or main source of 
pollution data available especially if looking back in time at past exposures.  
 Biomarkers  
 
The term biomarker is used to describe either a biological measure of current or 
historic exposure to a pollutant, or a biological measure of disease onset.  
A measurement of a pollutant concentration in the environment does not always 
correlate well with an individual’s actual exposure. This may be affected by a wide 
range of factors including a person’s daily activities, the type and location of their 
residence, workplace, travel and migration patterns, diet, lifestyle, medication, 
breathing rate as well as their genetic make-up. Biomarkers from biological samples, 
such as blood and urine, may allow quantification of these complex lifestyle and 
exposure factors at the individual level, providing data to evaluate population-level 
exposure models. Biomakers can also provide information on spatio-temporal 
variability in exposure data and other factors that may be related both to the 
exposures and health outcomes (i.e., confounders). Use of biomarkers can therefore 
lead to improved risk estimates of health effects of pollution by providing better 
estimates of exposure, thus reducing measurement errors and other sources of bias 
and strengthening possible causal inferences.47 
 
In a number of countries, nationally representative surveys have been set up to 
collect and store health information and biological samples that can be used to 
investigate biomarkers of environmental risks and to monitor how the health of the 
national population changes over time. One of the earliest such surveys is the United 
States National Health and Nutrition Examination Survey ‡‡‡‡‡‡‡‡‡(NHANES), which 
began in the 1960s and tests thousands of individual samples for hundreds of 
chemical exposures, allowing the investigation of biomarkers of environmental 
exposure and disease, as well as population surveillance of exposures to multiple 
pollutants48 (Box 3). Biological samples from NHANES were, for example, 
instrumental in generating biomonitoring data on heavy metal concentrations such as 
lead49,50, cadmium51 and manganese.52 Some countries, such as Germany, have 
gone a step further by creating an environmental specimen bank§§§§§§§§§ to 
permanently archive ecological and toxicological evidence of current and past 
pollutant exposures allowing detailed retrospective investigations.53,54 
 
  
                                                          
‡‡‡‡‡‡‡‡‡
  https://www.cdc.gov/nchs/nhanes/about_nhanes.htm 
§§§§§§§§§
  https://www.umweltprobenbank.de/ 
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The UK government funds the annual Health Survey for England (HSE), which has 
collected data since the early 90s, on physical health, mental health and wellbeing, 
social care, lifestyle behaviours based on interviews, as well as physical measures 
(height, weight and blood pressure) from around 8,000 adults and 2,000 children per 
survey, who are representative of the general population.********** HSE data allow the 
monitoring of changes in health and lifestyles (e.g. alcohol drinking, smoking), and 
the prevalence of specific health conditions, as well as being used to plan services 
and develop and evaluate public health policies. In recent years, HSE has also 
collected saliva, blood and urine samples for assessment of, for example, 
cardiovascular risk (e.g. cholesterol) and diabetes. HSE has to date been little used 
for studies on health effects of pollution, though the collection and storage of 
biological samples and health data mean that such studies using HSE data could be 
undertaken were funding to become available.  
 
 
 
Box 3  The National Health and Nutrition Examination Survey (NHANES) 
  
NHANES (https://www.cdc.gov/nchs/nhanes/index.htm) is a programme of national 
studies in the USA, managed by the Centres for Disease Prevention and Control 
(CDC), and designed to assess the health and nutritional status of adults and 
children in the United States through interviews (including demographic, 
socioeconomic, dietary, and health-related questions), physical examinations 
(medical, dental, and physiological measurements) and biological samples (blood 
and urine). NHANES includes data on a range of medical conditions (e.g. anaemia, 
cardiovascular disease, diabetes, eye diseases, hearing loss) as well as on 
environmental exposures, physical fitness and physical functioning.  
 
The fifty years of data from NHANES provide a remarkable resource to monitor 
temporal trends in pollutant levels and disease risk factors through direct 
measurements. Some of the main achievements of NHANES are the development of 
new policies to eliminate lead from petrol in the US as well as in many other parts of 
the world; the development of growth curves and monitoring of obesity; the 
implementation of a national education programme to reduce hypertension and 
cholesterol levels. NHANES has been used, for example, to investigate the potential 
effects of urinary bisphenol A (found in plastics) on diabetes, cardiovascular disease 
and liver function55, and data from NHANES have been ‘mined’ to explore effects of 
a wide range of exposures on health.56 The value of NHANES data is further 
increased by being made accessible to users and researchers throughout the world. 
 
 
 
                                                          
**********
  (http://content.digital.nhs.uk/healthsurveyengland 
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Public Health England is leading for the UK in the European Human Biomonitoring 
Initiative (HBM4EU), a joint effort of 26 countries funded by the European 
Commission to coordinate and advance biomonitoring in Europe, which launched in 
2016. This presents an opportunity to create an ongoing national resource similar to 
NHANES, possibly linked to HSE, to monitor pollution exposures in the general 
population. These could include both well-known contaminants, such as lead and 
dioxin-like chemicals, as well as newer chemicals such as flame retardants and 
those with endocrine disrupting properties. Such an initiative would provide a rich 
source of information on people’s exposure to pollution and be an invaluable 
resource for studies of environmental hazards and health that could both inform 
public health policies and help assess the benefits of policy changes over time.   
 
In addition, biological samples are collected in large national (e.g. UK Biobank) or 
local (e.g. the Avon Longitudinal Study of Parents and Children57) studies, which 
offer opportunities to identify biomarkers of major chronic diseases, as well as for 
analyses of environmental contaminants in stored samples. Linkage of such data on 
individuals with small area data, often called “mixed design” studies, presents new 
opportunities to better understand the associations between pollutant exposures and 
health.3,11,58-61  
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Health data  
 
Good quality data on health outcomes as well as pollution exposures are crucial to 
investigate the impact of pollution on health. The volume and accessibility of health 
records in England, collected mainly for the purposes of delivering and auditing 
healthcare throughout the NHS, have dramatically increased in the last two to three 
decades. For example, on average over 100 million individual records from 
outpatient, maternity, adult critical care and accident and emergency (A&E) services 
across all NHS hospitals are added every year to the Health Episode Statistics 
(HES, http://content.digital.nhs.uk/hes) database. A remarkable feature of NHS data 
in England and throughout the UK is the near universal coverage which allows 
investigation of environment and health associations in neighbourhoods and local 
areas for any part of the country.3,12,62   
 
In addition to routinely collected health data, around 3.5% of the UK general 
population - 2.2 million people - participate in ongoing long-term health studies 
(cohort studies) following people over time to investigate risk factors among people 
who do or do not develop disease. The largest of these cohort studies is UK 
Biobank, mentioned above, which includes over 500,000 individuals with clinical 
measurements, demographic and health data and blood, urine and saliva samples 
stored for assessment of biomarkers.63  
 
There has also been an explosion of data collected by individuals through use of 
smartphone technology and personal monitoring devices, including heart rate, 
physical activity, sleep patterns, calorie consumption and other health indicators. 
Such devices collect information in real-time at short intervals, potentially over long-
periods of time, accessible to each individual user but also collectively to the device 
manufacturers (and potentially to researchers). These emerging data sources 
provide yet largely untapped information on health behaviours of many thousands of 
people at low cost.64  
 
However, just because health data are collected does not mean that they can be 
used in research on health effects of pollution or for health surveillance. For 
example, their quality, coverage or completeness may not be suitable for health 
analysis (Box 4), they may have restricted access or usage, or it may be difficult to 
link them together with pollutant data. Issues of data harmonisation and linkage also 
apply to cohort studies and biobanks. Initiatives, such as the Cohort & Longitudinal 
Studies Enhancement Resources (CLOSER, http://www.closer.ac.uk/), are working 
to harmonise longitudinally collected data from UK cohorts. The European Union 
funded BioSHaRE project (http://www.bioshare.eu/) (2010-15) helped develop 
methods to harmonise and combine data collected in large European biobanks 
including UK Biobank65 and to advance data analysis techniques.6  Lessons learned 
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from such initiatives could help in integrating and harmonising data from newly 
emerging sources. 
 
 
 
Box 4 Selected examples of challenges for research related to the use of 
routinely collected health data in England  
 
1. Birth data are collected in four different databases in England, each having 
differing strengths and weaknesses.66 Careful assessment of the quality and 
completeness of each database and their overlap is needed for use in studies of 
environment and health and for surveillance. 
  
2. Cancer registrations used to be collected in seven regional cancer registries with 
slightly different coding practices that led in the past to apparent differences in 
regional incidence and trends for some cancers. There is now a unified cancer 
registration system for England led by Public Health England: the National 
Cancer Registration and Analysis Service (NCRAS). This registry records over 
300,000 cases of cancer per year (https://www.gov.uk/guidance/national-cancer-
registration-and-analysis-service-ncras) using the same methods and can be 
used to monitor geographical and time trends. 
  
3. Until now, registries of congenital anomalies were managed at the regional level 
and did not cover the whole of England.67 The recent creation of a National 
Congenital Anomaly and Rare Disease Registration Service (NCARDRS, 
https://www.gov.uk/guidance/the-national-congenital-anomaly-and-rare-disease-
registration-service-ncardrs) for England will greatly facilitate studies of 
anomalies, an important sentinel for environmental risks.68,69  
 
4. Demonstrating responsible handling of personal data, including data privacy and 
good information governance is important, e.g. ensuring that outputs comply to 
confidentiality rules (suppression of low number in a small area) to reassure 
patients that their data is not identifiable. 
 
5. An increasing proportion of NHS patients in England are opting out of the use of 
their health records beyond their GP practice or the NHS system 
(http://content.digital.nhs.uk/article/7092/Information-on-type-2-opt-outs). 
Although the overall rate of such opt-outs is quite low, gaps in the data are highly 
clustered which can create problems when conducting studies of environmental 
hazards and risks to health, particularly at the small area level. 
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Data methods, linkage and analysis 
 
Rigorous protocols are necessary to share, link and analyse health and pollution 
data in a timely fashion.58 Combining information from different data sources can 
provide important insights into the effects of pollution on health, but complex 
administrative procedures often mean researchers have delays of months or years in 
accessing and compiling the data, requiring approvals from multiple data providers. 
The creation of Health Data Research UK (HDR UK, 
https://www.mrc.ac.uk/about/institutes-units-centres/uk-institute-for-health-and-
biomedical-informatics-research/), bringing together a consortium of world-leading 
groups in health and biomedical informatics should facilitate ready access to and use 
of large patient and research data sets, while ensuring compliance with information 
governance regulations. 
          
Efficient statistical methods and software are needed to process, analyse and 
visualise the data. Use of dedicated analytical software can considerably reduce the 
time required by a researcher or a public health professional to investigate potential 
health risks to the public. The Rapid Inquiry Facility (RIF), developed by SAHSU, 
supports disease mapping and risk analysis for environmental health studies, 
especially those in the vicinity of industrial sites or other sources of environmental 
pollution (Box 5), allowing the rapid analysis and dissemination of results.  
 
Data quality checks are essential when compiling and processing environment, 
health and socioeconomic and biomarker data to avoid gaps in the data or 
interpreting errors rather than real signals of public health significance.70 
Misclassification can occur due to inaccuracies in the location of cases and 
populations, potentially diluting true associations or introducing spurious temporal or 
spatial patterns in risk.71 Studies of small numbers of individuals or those conducted 
at small area level are more prone to errors or local variations in the quality of both 
the health (numerator) and the population (denominator) data than studies 
conducted over larger areas. Health risks are often mapped to relatively arbitrary 
administrative areas. Grouping data at different levels of spatial resolution (e.g., 
wards, census tracts, regions) or aggregating data to different areal arrangements 
will lead to variation in the results and may affect the interpretation and 
generalisability of the findings.58 
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Box 5  The Rapid Inquiry Facility - RIF 4.0 
 
The Rapid Inquiry Facility (RIF) provides a powerful tool to link and evaluate spatial 
relationships between different data sources, to explore and visualise the data 
through disease mapping and to calculate health risks in relation to sources of 
environmental pollution (26, 81). It can dramatically speed up data analysis and 
public health inquiries such as those to investigate potential disease clusters. The 
current version of the RIF (4.0) integrates advanced methods in statistics, exposure 
assessment and data visualisation. It is based on open-source software integrated 
with the statistical package R with the ability to read in local sources of environment 
and health data for data analysis.  
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Surveillance 
 
Public health surveillance mechanisms are well established for infectious disease in 
England and in most other countries worldwide to detect outbreaks and inform 
prevention measures. Similar mechanisms for surveillance of non-communicable 
diseases (NCDs) or for health risks from environmental factors (environmental public 
health tracking) in England are still in development stage (Box 6), despite NCDs 
being a larger public health issue.72,73 One of the best established environmental 
public health tracking (EPHT) systems worldwide is in the USA (Box 8), which 
provides timely, accurate and systematic pollution data to both public and public 
health decision makers.   
 
NCD surveillance in England needs further investment to help develop strategies for 
prevention and for detection and treatment of those already affected. Surveillance of 
exposure to pollutants that contribute to NCDs and reliably detecting spatio-temporal 
signals in NCDs data (e.g., ‘clusters’, peaks or unusual trends) rely both on high-
quality data74 and on use of advanced statistical methods.75 Being able to detect 
areas of potentially high risk of specific NCDs requires methods that display both 
specificity (few false positive findings) and sensitivity (high ability to detect true 
positives). Apparent local clusters of disease may, after investigation, indicate areas 
with higher-quality data registration or areas where there are many duplicate 
registrations. Results from an epidemiological study might only apply to a certain 
portion of the population based on, for example, the size of the study area, the 
nature of the environmental risks, the local socio-economic context. Differentiating 
real signals from false positive ones is therefore an important methodological 
challenge. Surveillance of chronic diseases has so far mostly focused on specific 
conditions (e.g. hepatic angiosarcoma76, mesothelioma77, leukaemia,78), rather than 
on a generic approach to detecting excesses or anomalies in the data. Emerging 
methods, such as BaySDetect19, along with machine learning and other computing 
intensive data science methods, offer potential to carry out such analyses using a 
systematic approach. Potentially, such methods could be applied to the national 
health datasets on an on-going basis, to provide early warning of any untoward 
trends in the data. 
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Box 6  Environmental Public Health Tracking in England 
Helen Crabbe, Environmental Epidemiology Group, CRCE, Public 
Health England 
 
Public Health England (PHE) has a programme of Environmental Public Health 
Tracking (EPHT) much like the US CDC (Box 8).  
 
Environmental Public Health Tracking (EPHT) has been defined by the US Centers 
for Disease Control and Prevention as: "The ongoing collection, integration, analysis, 
and interpretation of data about environmental hazards, exposure to environmental 
hazards and human health effects potentially related to exposure to environmental 
hazards. It includes dissemination of information learned from these data.”i  
EPHT can provide timely, accurate and systematic environmental data to public 
health decision makers on how to reduce the environmental health burden. By 
effectively linking environmental health data and translating it into meaningful 
information, EPHT can help protect the health of the public.  
 
PHE’s EPHT programme aims to explore and develop a methodology for addressing 
environmental hazards that delivers integrated, local and national surveillance of 
those hazards, exposure assessment and relating health effects of environmental 
exposures to those hazards. This provides evidence of the health burden 
represented by such hazards and exposures, informs responses to new exposures, 
and supports the ongoing development of environmental epidemiology, toxicology 
and exposure science.  
 
Within this remit, PHE has developed an environmental public health surveillance 
system (EPHSS)ii, which facilitates collection and collation of environmental hazard 
and health outcome data. The component parts encapsulate: 
• Hazard identification and mapping;  
• Exposure assessment and quantification;  
• Development of bio-monitoring;  
• Systematic review of health outcomes and disease surveillance;  
• Horizon scanning;  
• Development of environment and health indicators.  
 
The tracking programme builds on the experience and expertise developed through 
the design and operation of related systems currently used by PHE and other 
government agencies. The programme aims to benchmark best practices in 
environmental surveillance. It exploits elements of existing national non-infectious 
environmental and chemical incidents surveillance systems in England, Wales and 
Scotland. The developing EPHSS is currently being built to capture information on 
environmental hazards, exposures and related health outcomes. 
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PHE’s Tracking programme started in 2010 with two proof of concept projects.  
A ‘Hazard tracking’ project explored exposure to chemicals (especially arsenic) 
through drinking water from Private Water Supplies (PWS). 500 PWS were tested for 
arsenic and other chemicals and biomonitoring confirmed exposure to arsenic 
through this route. PHE worked with the British Geological Survey and the University 
of Manchester to characterise exposures and develop a geological based hazard 
model to estimate risks to health. An ‘Outcome tracking’ project involved 
characterising the burden of disease from Carbon Monoxide (CO) poisoning. The 
project aims to quantify the effects of CO exposure, on accidental deaths, hospital 
visits and admissions, GP consultations and effects in the community. PHE has been 
working with the Coroner’s Office to better understand causes of accidental deaths 
involving CO.  
 
More recently PHE’s Tracking programme has worked with over 200 stakeholders to 
develop EPHT in England over the last few years and is actively delivering on a few 
topics; e.g. developing a prioritisation tool to support local authorities Environmental 
Public Health interventions, public health impacts of fluoridation of public water 
supplies, set up and development of an International Network on Public Health and 
Environment Tracking (INPHET)iii, developing guidance for investigating non-
infectious disease clusters or environmental exposures with unknown health 
consequences, and implementing surveillance systems for Lead Exposures in 
Children.  
 
PHE is currently consulting on its National Environmental Public Health Strategy with 
stakeholders. Its’ vision is to provide a service to enhance understanding of the 
health effects of environmental exposures and provide expert advice and support to 
public health practitioners and the public in minimising the effects of the environment 
on health. The tracking programme is well placed to provide data and evidence and 
the systems to measure success. 
 
i US CDC Environmental Public Health Tracking: http://www.cdc.gov/nceh/tracking/ 
ii https://www.gov.uk/government/publications/environmental-public-health-
surveillance-system/environmental-public-health-surveillance-system-ephss 
iii INPHET: http://www.epiprev.it/INPHET/home 
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Box 7 Health and Occupation Research (THOR) surveillance network 
and environmental surveillance  
 
‘Stressors’ often first occur in the workplace, where the same environmental 
contaminants are present at concentrations or intensities which are orders of 
magnitude higher than in the general environment. As an example, we recently 
observed an increase in incidence of occupational dermatitis attributed to 
isothiazolinones (MI/MCI), particularly in healthcare and beauty workers. MI/MCI 
were present (as preservatives) in many personal care products so environmental 
exposure was highly likely. The observations from THOR data strengthened the 
evidence for the subsequent EU regulation banning the use of MI/MCI in leave-on 
cosmetics from 2016/2017. 
 
THOR could provide the platform for public health surveillance, particularly of 
chemical exposures. Reported cases are routinely screened to identify 
new/emerging hazards (e.g. novel causes or workplaces, unusual clusters etc).  
For example, we recently observed increased reports of chemical pneumonitis in 
marine engineers attributed to waterproofing spray (the same substance is used to 
waterproof shoes so environmental exposure is likely). Additionally, methodologies 
developed and improved over time within THOR, for example to determine 
incidence, trends in incidence and to evaluate change in incidence due to specific 
interventions, could be applied to non-occupational disease reporting to determine 
population estimates due to environmental exposures and to identify new chemical 
hazards. 
 
A main advantage of capturing environmental exposures through the THOR network 
is that a well-established structure is already in place, thus ensuring an efficient use 
of an existing UK resource. THOR is composed of several different reporting 
schemes (e.g. for chest physicians, dermatologists, occupational physicians, GPs) 
and across all the schemes we currently have approximately 900 reporting 
physicians, with in excess of 111,000 cases reported to date. Initial discussions with 
key THOR reporters have indicated an interest and a willingness to consider 
widening their reporting to include non-occupational exposures. Central to the 
longevity and success of THOR (the first scheme commenced data collection in 
1989) is the loyalty of the participating physicians, facilitated by an excellent rapport 
with the medical community in general and with the individual reporters themselves 
(including extensive feedback/benefits, including CPD, for participating).  
 
Source 
Carder M, Hussey L, Money A, Gittins M, McNamee R, Stock SJ, Sen D, Agius RM. 
The Health and Occupation Research Network (THOR) - an evolving surveillance 
system. SHAW 2017; 8(3):231-236 
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Box 8  Environmental Public Health Tracking in the US 
Capt. Fuyuen Yip and Ms. Holly Wilson, Centers for Disease Control 
and Prevention; Dr. Wendy McKelvey, New York City Department of 
Health and Mental Hygiene 
 
In September 2000, the Pew Environmental Health Commission issued a report 
stating that public health agencies in the United States lacked capacity to evaluate 
and conduct key investigations into the status of the health of their environment (84) 
The Commission found that information on non-infectious diseases was not routinely 
collected; environmental hazard monitoring and data collection were conducted for 
regulatory purposes, not public health; and, very little data existed with respect to 
human exposures to environmental hazards.   
 
In 2002, in response to the Pew report, Congress appropriated funds to the Centers 
for Disease Control and Prevention (CDC), under the leadership of the National 
Environmental Public Health Tracking Program, to develop an environmental public 
health tracking network (Tracking Network) that would monitor the burden from 
environmentally related disease and help fill in the data gaps. 
 
One of the environmental hazards that the Tracking Program focuses on is outdoor 
air pollution. To better understand how air pollution affects health, CDC’s Tracking 
Network displays air pollution data on ozone and particulate matter (PM2.5) from the 
U.S. Environmental Protection Agency (EPA) 
(https://ephtracking.cdc.gov/showAirLanding.action). EPA’s data come from 
approximately 4,000 monitoring stations around the country, mainly in urban areas. 
While these data are considered the "gold standard" for determining outdoor air 
pollution, they are limited in geographic and temporal scope. CDC and EPA have 
worked together to develop a statistical model to make modelled predictions 
available for environmental public health tracking purposes in areas of the country 
that do not have monitors and to fill in the time gaps when monitors may not be 
recording data. State and local health departments funded by the CDC National 
Tracking Program are working to fill data gaps. 
 
continues next page  
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An example of how this approach has been used to prevent ill-health due to pollution 
comes from New York. The New York City Department of Health and Mental 
Hygiene, a CDC-funded tracking program partnered with Queens College of the City 
University of New York to conduct the New York City Community Air Survey 
(NYCCAS). The survey monitors variation in air pollution levels across the city and 
looks at how local sources of air pollution (e.g., vehicles and building boilers) 
contribute to the variation.79 The NYCCAS showed that higher levels of PM2.5 were 
measured in areas with the highest densities of oil-burning boilers. Health impact 
analyses suggested that many hospital visits and deaths could be prevented by 
reducing PM2.5 emissions generated by burning heating oil. NYC leaders used the 
findings to support a local law, enacted in 2010, and regulations, finalized in 2011, to 
phase out use of the most polluting heating oil in NYC.80. Once the clean heating oil 
polices are fully implemented, it is estimated that lower PM2.5 levels will prevent an 
estimated 300 deaths in NYC each year.81  
 
 
 Conclusions 
 
The burden of NCDs in England is increasing, reflecting the ageing of the 
population.82 Epidemiological evidence to identify risks to health, including from 
environmental pollutants, is fundamental to help prevent future complications and 
high-costs associated with the occurrence and management of these diseases.  
This relies on the availability of high-quality data and on close partnerships between 
government, public health and academic institutions, as illustrated by the work 
conducted by SAHSU over the last thirty years. As environmental risks to health 
affect populations worldwide, there is enormous potential for UK researchers and 
public health specialists to share their world-leading expertise in this field. This would 
include building local capacity to support the collection of appropriate data to study 
the impact of environmental factors on the health of local populations, particularly in 
low- and middle-income countries. 
 
 
Box 9  What can be done?  
 
The surveillance of non-communicable disease and environmental public health 
tracking should be given the same legal and ethical protections as control of 
infectious disease, including full access to health and other data for this specific 
purpose. Further investment is needed to fully develop methods and systems. 
 
A population biomarker panel would greatly help monitoring of personal exposure to 
chemicals and other pollutants that cannot be monitored by other means – i.e. 
NHANES for the UK – using for example, Health Survey for England, UK Biobank 
and British birth cohorts. 
 
Sustained infrastructure support and funding from governmental and research 
funders such as UK Research and Innovation (UKRI) are essential to conduct 
reliable and high-quality studies into the health effects of environmental pollution for 
the benefit of the population of England and the world. An efficient way forward 
would be to use ongoing programmes and build on the initiatives where government 
is already providing funding for such infrastructure such as the Health Survey for 
England. 
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Summary 
 
• With pollution, there is always a trade-off between the benefit to humans of the 
polluting activity and the risk to health.  
 
• Measurement of health harms from pollution is often complicated, because of 
difficulties of measuring exposure, the (often long) timescales involved and the 
fact that a pollutant may have different acute and chronic effects, the impossibility 
of most kinds of experimenting on humans and hence the difficulty of assigning 
cause, human variability, many sources of uncertainty and the range of scientific 
disciplines involved. 
 
• There is an extensive research tradition on the communication of risk, going back 
many decades, mostly based in psychology and related fields. Psychological 
theories of behaviour change are important in developing effective 
communication of risk 
 
• Good communication requires a clear understanding of the audience and of what 
one wishes to communicate. Research has established the importance of feeling 
and emotion in risk communication.  
 
• The use of public engagement in developing communication on pollution risks 
has been patchy, though the importance of public engagement in most areas of 
communication in medicine and health is well established. However, there are 
good exemplars in pollution communication. 
 
• Trust in the research and its communicators are vital. A communicator must 
provide the evidence in a form that allows the audience to assess 
trustworthiness. Trust requires a relationship between the communicating parties, 
which is another important reason for considering the role of emotive and 
experiential aspects.  
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Introduction  
 
Pollution poses a range of health risks. That said, the quality of current knowledge 
about the health risks from different pollutants is very variable: the risks are not 
always well measured. There are many reasons for this. The presence of pollutants 
changes over time – new threats are less well studied, as do the extent of public 
concern and the quantity of research funding – again causing inconsistent focus on 
pollutants. Further, some health effects are fairly direct and relatively easy to 
measure, while others are more complex, relating to long-term patterns of exposure, 
involving many specific pollutants or having a significant time lag from the exposure. 
The emphasis in this chapter is on measuring health risks to humans. There are 
good reasons to monitor pollutant levels and to reduce pollution, which are not 
primarily driven by human health concerns. These measurements however, are not 
the focus of this chapter. 
 
It makes little sense to concentrate narrowly on the communication of ‘facts’ about 
health risks from pollution. In communicating to the public, the underlying aim is 
often to change individual behaviour to mitigate risk, or to increase awareness and 
engagement. The long tradition of research and understanding of communication 
about risks indicates that the communication must go well beyond simply telling the 
public the size of the risk in a comprehensible form. 
 
Issues of measurement and communication of human health effects are to some 
extent common to different pollutants and to some extent not (for examples see 
Boxes 9.1, 9.2 and 9.3). Several of the examples in the chapter relate to air pollution; 
this is not because air pollution is necessarily more important, in relation to health, 
than other pollutants, but only because it is better researched than many other types 
of pollution and because it demonstrates the issues well. 
 
Putting together an accepted causal narrative about the health effects of a pollutant, 
and communicating it effectively, is a complicated business. Box 9.4 relates the 
research and communication needs for pollution health risks to a different kind of 
example – health harms from smoking. Many health risks from tobacco are now well 
understood and effective actions have been taken to mitigate them – but to get to 
this position took many decades. Regarding pollution, health risks are more 
complicated, less clear and usually harder to research than with tobacco. Yet the 
complication is not a reason to avoid action. 
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Box 9.1 The nature of our understanding of pollution in the environment: 
Radioactive particles 
Radioactive particles have been discovered in the environment near the 
decommissioned nuclear facility at Dounreay. They are small fragments (sand size) 
of spent fuel that were released more than 20 years ago into the sea, which have 
been distributed by tides and storms, resulting in their deposition on beaches.1,2,3 
The particles could prove a hazard if encountered by a beachgoer, so the regulator 
and site operators have been required to instigate routine monitoring. The exposure 
pathways include ingestion, inhalation and skin contact. The resulting dose depends 
on several factors, including the radionuclide involved, the activity, whether the 
particle is ingested (then how soluble it is), whether it is inhaled and how long an 
individual stays in contact with it (skin dose).  
The detection of the particles is challenging, but a system using detectors attached 
to a beach buggy has been built. Each month, it is driven over the beach and when a 
signal is triggered (which depends on the spatially varying background radioactivity), 
the vehicle stops and the particle is retrieved and taken back to the laboratory where 
concentrations of radionuclides of interest are measured. To cover the entire beach 
takes the buggy many days and the chance of detecting a particle, if present, 
depends on its activity and depth. This is a difficult sampling problem since the 
pollutant is a very small particle, widely distributed and not uniform, whilst its 
detectability also depends on a dynamic population of particles on the beach (and 
tide). 
 
Communicating that risk 
For an individual beachgoer, exposure to the hazard depends on when they visit, 
and their activities. There are potentially only a small number of particles on the 
beach at any time, so the probability of encountering one is also very small. (In over 
10 years of monitoring the number of particles retrieved is a few hundred). The 
Dounreay Particles Advisory Group concluded that  
 
“only those particles [whose] activity is above a certain level pose a realistic potential 
to cause harm to members of the public, and the probability of the most frequent 
beach-users […] coming into contact with a relevant particle is one in 80 million.” 
 
Depending on the individual dose, health effects could include skin ulceration.4 In this 
case, the contaminant is not widely distributed in the environment and relatively few 
particles have been found, with a widely varying distribution of activity. There have 
been several interventions (including removal of seabed particles), but still particles 
are being found on public beaches and the risk of harm remains.5 
 
E. Marian Scott, Professor of Environmental Statistics, University of Glasgow 
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Box 9.2 The nature of our understanding of pollution in the environment: 
Soil contamination 
There are many studies that have shown that exposure to high concentrations of 
certain metals in soil can have potentially harmful effects such as cancer or 
developmental effects in young children.6,7,8,9 There is a location-dependent natural 
metal concentration background, but as a result of anthropogenic activities, 
heterogeneous elevated concentrations occur. 
The measurement of such metals requires soil samples to be collected (spot 
samples) over a region of interest. The soil sample (which may be a few tens of 
grams) is subjected to a variety of physical and chemical processes in the laboratory 
before a concentration is reported. How sure are we of this value and how it should 
be interpreted? The measured value will have been subject to quality control within 
the laboratory, but will be uncertain to within typically a small value (the 
measurement error). In addition, as a spot sample, there will also be the uncertainty 
about the representativeness of the sample for the region. 
How might the metal present in the soil have a health effect? First we need an 
exposure pathway – in the case of soil, this might be inhalation - small particles 
could become lodged in a lung, or by ingestion (eating directly or through the food 
chain – such as in plant’s leaves or tubers). Thus an individual’s exposure to the 
metal depends on their habits.10 
 
The biological effect on the individual of the metal then depends on the concentration 
(dose) to which that individual is exposed and in a population, individuals will 
experience different doses and will manifest different degrees of health effect. There 
may be more than one metal of concern, therefore a combined exposure and health 
effect. Some of the evidence may be based on observational epidemiological studies 
from occupational exposure, with others in wider populations.11 
 
Communicating that risk 
It may be that advice is offered suggesting that the vegetables are safe to consume 
since their concentrations are below a certain concentration; it may be that certain 
critical groups such as pregnant women or young children12, 13 are advised not to 
consume more than a certain quantity of the contaminated vegetables. 
 
E. Marian Scott, Professor of Environmental Statistics, University of Glasgow 
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Box 9.3  The nature of our understanding of pollution in the  
environment: Trihalomethanes (THMs) in drinking water 
 
Drinking water needs to be of high quality. We are all aware of serious health issues 
in countries where drinking water is not as well regulated and managed as in the 
UK.14 Drinking water flows in a chain from the reservoir or other source to treatment 
works to holding and then eventually is pumped to our homes. Our drinking supplies 
are tested for bacteria, lead, iron (which may come from cast iron distribution pipes) 
and other metals, nitrite, pesticides (both potentially from agricultural practices in the 
catchment providing the water source), pH, trihalomethanes (THMs) and other 
parameters.15 Water at the treatment works is disinfected using chlorine to deal with 
microbial contaminants and THMs are formed as a result of the reaction of the 
chlorine with (naturally occurring) organic material. 
 
At elevated levels, THMs have been associated with health effects such as cancer 
and adverse reproductive outcomes.16,17 Some studies showing these effects have 
been carried out in animals, while others have used observational 
epidemiologyError! Bookmark not defined.. There are concerns about long-term 
exposure to THMs18, however, the widely held view is that the “health risks from 
THMs are much less than the risks from consuming microbiologically unsafe 
water”.19 A clear line has been taken on trading off competing health risks. The EU 
and other bodies have defined maximum allowable concentrations in drinking water 
(100 µg (microgrammes) per litre) to help protect the population (and indeed 
especially vulnerable sub-populations). In defining such levels, the lifetime of the 
individual (assumed 70 years) and typical drinking volumes must be considered. 
 
Regular testing is undertaken by the water companies and the drinking water 
regulator. There have been considerable improvements in the numbers of failures of 
the standard for THMs (100µg/l) becoming rare (average of just four failures a year 
since 2010) and in 2014, there were no failures of the THM standard in England.20  
 
Communicating that risk 
In this example, the hazard being presented by the THMs is being balanced against 
the risk of drinking contaminated water. The evidence for health effects of long term 
exposure (in some cases based on animal studies) was considered not consistent21, 
and in some cases, results between different studies are inconsistent.  
 
E. Marian Scott, Professor of Environmental Statistics, University of Glasgow 
 
  
  
Page 279 of 341 
 
Box 9.4 Putting together evidence on health effects 
In investigating possible health gains from an intervention at an individual level, the 
gold standard study is the randomised clinical trial. Yet randomised trials are more 
difficult with interventions at a population level and carrying out a randomised trial to 
investigate potential adverse health effects is usually ruled out on ethical grounds. 
So how do we establish and measure the harmful effects of exposure to a substance 
such as a pollutant? 
 
It might help to consider a different kind of health risk. Nowadays everyone knows 
that smoking cigarettes vastly increases the risk of several diseases. But how do we 
know that? The underlying research did not come from a single study, or even a 
single type of research, but unavoidably involved epidemiological research in human 
populations (such as Doll and Hill’s study of British doctors22,23), studies which found 
that exposing experimental animals to substances in tobacco smoke led to the 
development of cancers and several other study types. Animal studies established 
the carcinogenic potential of cigarette smoke, but could not - on their own - show this 
in human populations. The epidemiological studies showed a (strong) correlation 
between smoking and lung cancer in humans, but on their own could not establish 
that the effect was causal. The risk is stochastic – that is, not everyone who is 
exposed will suffer harmful health effects, so that an element of chance is operating. 
To establish a clear causal narrative linking smoking to lung cancer and other 
diseases required evidence from all these sources to be put together, a process that 
took many years. And after the links were clearly established, there were further 
issues of communicating them to the public and making appropriate policy 
interventions – an ongoing process that has taken half a century so far. 
 
Establishing and measuring health risks from pollution has to involve a similar 
process of putting together different kinds of evidence from different types of study. 
Answers cannot come from one or two critical experiments. With environmental 
pollutants, exposures are typically much harder to measure than with (active) 
smoking and the magnitudes of the health risks at an individual level are usually 
considerably smaller. Yet, because very large numbers of people may be exposed, 
the overall public health impact may be very large. Thus it is crucial to combine 
results from different research traditions to measure health risks from pollution. 
Compared to investigating the health risks from a pollutant, understanding the risks 
of cigarette smoking was in most respects an easy target. It still took a great deal of 
time and effort to provide the necessary evidence and make effective policy 
interventions. Difficulties in measuring, communicating and acting on the health risks 
of pollution must not be an excuse for inaction. 
 
Kevin McConway. Emeritus Professor of Applied Statistics, Open University 
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The contexts 
 
It is important to take account of the contexts within which health risks from pollution 
are discussed and considered. Knowledge of these contexts, particularly about the 
way the risks are construed by the general public, is far from complete. 
Pollutants generally arise because of human activities that are desired. People value 
the products of industrial processes that pollute and may not be happy when 
measures to reduce pollution increase the cost of those products, or reduce their 
availability. People, on the whole, like driving their cars and many feel that they have 
rights to do so; these feelings conflict with measures to improve air quality by 
restricting car use. More broadly, we wish (indeed, need) to travel, for many reasons, 
and the gains from the travel need to be traded off against the various kinds of 
pollution that arise from transport activities. Using precautionary principles may be 
useful in a few contexts, such as where an intervention has low costs, in all senses. 
Yet all mechanised transport cannot be ceased on a precautionary principle. This 
emphasises that trade-offs are inevitable. 
 
Trade-offs arise in most economic contexts, but changing where the balance lies in a 
trade-off between a desired activity and its polluting consequences can be 
particularly difficult. This is because many important pollutants cannot be seen, 
tasted or felt. Their health impacts may be subtle and may take a long time to 
become apparent after exposure. Thus the way that the trade-off works is obscure. 
Moreover, public attitudes to these matters have not been extensively researched, 
though they are likely to be variable between individuals and between those who aim 
to influence opinion. There may well be a range of public opinions, which may 
include, at one extreme, the view that pollution is an unavoidable by-product of 
economic prosperity, and, at the other, an exaggerated precautionary principle that 
everything that pollutes and is potentially harmful in any way must cease. Both of 
these extremes have certainly appeared in political and academic discourse about 
pollution. 24,25,26 Arguably they are to a considerable extent straw men, but they need 
to be challenged where they arise. We have to work hard if we wish to arrive at an 
evidence-based narrative that will be consistent and credible across all the relevant 
audiences. 
 
All of this implies that evidence for changing behaviours needs to be solid (implying 
good measurement) and persuasive (implying good communication).  
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Measurement 
 
The difficulties with pollution 
 
Arguably, measurement of health risks to the public from pollution has not advanced 
as far as the measurement of many other kinds of health risks. This has to do with 
the nature of the work required, with several sources of difficulty: 
 
• Many pollutants are present in the environment, they occur together, therefore it 
is difficult to disentangle which pollutant is linked to which health effect. A related 
issue is that some health effects are caused by mixtures of substances rather 
than by single compounds; this adds complexity. In the environment, the 
composition of mixtures can vary substantially, making exposure levels difficult to 
measure and to correlate with health. 
 
• The health effects of a pollutant may vary with the timescale of exposure. The 
health effects from a short-term acute exposure can be very different from those 
of a long-term exposure. Peak exposure may be the key factor for some effects 
on health, while the ambient level may be more important for others. (More 
below.) 
 
• Many health effects of pollution only become apparent after a long time. This may 
be because the condition takes a long time to develop, or because it is caused by 
exposure over a long period of time. Long-term effects can be measured, but, the 
longer the term, the harder accurate measurement is and the greater the cost of 
measurement. 
 
• Exposure of individual people to pollutants, in the real world, is often very difficult 
to measure accurately. This can even be the case when the levels of pollutants in 
the environment are accurately known. As an example, individual exposure to 
lead depends on childhood experience, occupational exposure, whether the 
individual lives or lived in a house that still has lead pipes or lead paint, on diet, 
and on the geographical location where one lives. Mathematical modelling may 
help, though it is difficult without detailed lifestyle information. Modelling adds to 
complexity but does not remove all the uncertainty. 
 
• Much research in the real world uses observational epidemiology. It is difficult, 
often impossible, to be clear about causality in observational studies because of 
the effects of confounding. An apparent health effect of a water pollutant might be 
caused by exposure through a different diet. Confounders can be allowed for 
statistically, but the possibility of residual confounding always remains. 
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• People vary. In particular they vary, often considerably, in the extent to which a 
particular pollutant may affect their health. For instance, the effects of poor air 
quality are different between people with asthma and others, between different 
people with asthma and in the same person on different occasions. In some 
situations, it may be possible to model and describe how the health effects vary 
in terms of personal characteristics, but often there is insufficient data or 
understanding of the mechanisms to do this effectively. This variability is different 
from the uncertainty about the size of health effects, although this variability can 
in turn lead to further uncertainty about the nature and size of the health effects. 
 
 
As exemplified in Boxes 9.1 and 9.2, developing an understanding of health risks 
from pollution involves multiple stages, each with uncertainty and complicated by 
variability. It may be necessary to use mathematical and statistical modelling, based 
on data from several sources, to estimate the health effects of a pollutant at local 
levels. Policy makers and others therefore need to be primed to expect different (and 
generally more complicated) forms of evidence and measurements of risk than might 
be used with other threats to health. For researchers and advocates in this field, this 
also draws attention to a need to communicate about the nature of the evidence as 
well as simply communicating the evidence. 
 
For policy choices in particular, ideally one needs reasonably precise measurement 
of the effects of pollutants in a real-world context. It is too much, however, to expect 
that all health effects of pollution can be measured precisely. Policy makers need to 
understand that one can act with confidence that the action is appropriate, that is, if 
one can be sufficiently confident that the action is beneficial (taking costs 
appropriately into account), even if there remains considerable uncertainty about the 
actual size of an effect. 
 
Measurement methods 
It is possible and important to learn about physiological effects of pollutants from 
laboratory experiments on animals or tissue samples. This is generally the approach 
of toxicology to investigating health effects of pollution. However, most experimental 
work with humans on health of pollution effects is not possible: one cannot choose 
susceptible people at random to be exposed to highly polluted air or water. 
Therefore, studies in humans mostly have to be observational, using the methods of 
epidemiology. Put simply, one compares health outcomes in individuals exposed to 
differing levels of pollutants. These two approaches have been dominant in 
measuring health effects of pollution (Table 9.1). 
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Table 9.1 Comparison of toxicology and observational epidemiology in investigating health effects of pollution 
 
 
Toxicology and pollution Epidemiology and pollution 
Overview  
Focus on pollutants (chemicals), examining their actual or 
potential hazard on – in this case – humans: laboratory 
studies 
 
Studies (and seeks to control) the impact that 
pollutants have on human health across 
populations: ‘real-world’ studies 
Methods  
Studies the effects that pollutants have on tissue or animal 
models, in controlled conditions, with control groups. It 
investigates the dose-response, mode of action and species 
specificity – amongst other facets – of an agent. 
 
Examines the distribution of health states in or 
across populations, and their association with the 
distribution of exposure to pollutants. Pollution 
epidemiology largely observes existing 
exposures. 
 
Strengths • focus on single agent in a controlled setting, therefore no 
confounding 
• exposure to the agent of interest is quantified directly; 
• examines the mode of action 
• unit of study is the unit of interest – the 
human 
• ‘real world’ studies, therefore directly reflect 
the exposure faced by people 
Weaknesses  
• Extrapolation required from the animal/ tissue model to 
humans 
• Effect does not account for impact of other ‘real world’ 
stressors which can modify the impact of pollutant 
• High doses of a substance used in a toxicological study 
might never be seen in human populations 
• Real world exposure route might differ (e.g. through 
lungs), and impact on biological effect 
 
• Confounding and co-occurrence of pollutants 
can be hard to control 
• Ubiquity of pollutants can mean little variation 
in exposure across populations 
• Even if a pollutant is measured in the 
environment, the dose received by people 
can be hard to measure 
• Study samples often not the whole population 
therefore some extrapolation needed 
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Challenges 
and next 
steps 
Fully assess the toxicity and harm from complex mixtures 
and their interactions 
Methods and data to assess low level, chronic 
exposure – overcoming co-occurrence of 
pollutants and homogeneity of exposure 
 
Concerns remain that the two disciplines work in parallel, not truly and fully together. They have different 
paradigms, which might be incompatible – but an integrated and systematic use of information and evidence 
would allow stronger inference about causality. Formal frameworks have been proposed to do this risk 
assessment.27 
Example  
A 2000 study exposed 12 dogs to concentrated particulate 
matter (PM) (30 times higher than in Boston at the time), 6 of 
which had induced coronary occlusions to mimic existing 
coronary artery disease. Dogs’ response to the PM was 
assessed by ECG. 
Dogs with induced coronary artery disease and exposed to 
the PM had a shorter time to ST segment elevation and an 
increase in magnitude of it: a sign of myocardial ischaemia 
(restricted oxygen to heart muscle) when in humans.28 
 
A 1999 study compared daily counts of 
cardiovascular disease (CVD) hospital 
admissions (in over 65s) with the mean PM10 
reading from the monitoring stations in 8 US 
counties.  
Allowing for confounding variables, such as the 
daily temperature, the study found that the 
changes in PM10 were associated with CVD 
admissions (a central estimate of a 2.8% 
increase across the interquartile range of PM10 
exposure).29 
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Toxicology and observational epidemiology, although the most common, are not the 
only methods. In some cases, health effects in humans can be studied using 
experiments using human volunteers. These have most of the strengths of 
toxicological experiments (Table 9.1) – controlled conditions, accurately quantified 
exposure, (generally) accurately quantified response and specificity. However, it is 
not possible to use large numbers of subjects and the need to avoid deliberate 
serious harm to subjects means that only minor and temporary effects can be 
studied and only in those who are healthy or mildly ill. 
 
Specific areas of concern, where there is need for further research, include: 
 
• The extent to which health harms from pollutants are related to ambient 
(average) exposures or to peak (acute) exposures.30,31,32  
o This is an important knowledge gap, partly because appropriate policy 
responses can depend on the balance between these. For example, 
interventions have dramatically reduced the size and number of peaks in 
ground-level ozone, but background levels have risen.33 Longer-term 
studies and longer-term, more accurate, exposure assessment would help 
to disentangle the two effects. Locations with high peaks tend to have high 
ambient exposures, however, adding difficulty. Furthermore, this would 
require specific long-term (expensive) epidemiological cohort studies. Most 
previous long-term studies in this area have been within cohorts designed 
for other purposes, with exposure measured retrospectively. Multi-
disciplinary work, including research on biological mechanisms, would 
enhance the epidemiology results. 
 
• It is possible to set up mathematical and statistical models to investigate the 
effects of potential policy interventions, but this can be hard. One recent example 
is the modelling of potential impacts the UK Government’s July 2017 Air Quality 
Plan.34 Often, though, this modelling will involve extrapolation beyond situations 
that have been observed and there may be limits to the extent to which that 
extrapolation can be based on firm science. 
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Recent advances and next steps 
 
Despite difficulties, progress is being made. For example, in measuring individual 
exposure, there is now instrumentation to collect data at a more personal level and 
mathematical and statistical modelling based on individuals’ movements – but this 
requires considerably more development. Rapid advances in informatics and in 
particular in availability of and use of big data, are providing new opportunities to 
learn about (and indeed communicate) the health effects of pollution. 
 
Understanding and measuring the health effects of a pollution source will involve 
collaboration between different research traditions and professions (toxicology, 
epidemiology, atmospheric chemistry, environmental health, informatics and 
mathematical and statistical modelling etc.). Such collaboration does occur already. 
Some toxicological studies investigate whether an effect from an epidemiological 
study is causal. Epidemiology can look at whether effects suggested by toxicology 
operate in human populations. However, generally, funding for research into health 
risks from pollution in the UK has been split between different Government 
departments and research councils – leaving gaps unfilled. The Nurse review35 
highlighted a need for better support of multi-disciplinary and interdisciplinary 
research, and UK Research and Innovation (UKRI) is currently being set up in 
response. Focused multi-disciplinary and interdisciplinary research into health risks 
from pollution, including research into effective methods for synthesising different 
types of information and evidence from different research traditions to produce an 
overall meaningful narrative, and (importantly) extending into appropriate ways of 
communicating the risks, is an area where UKRI could make an important difference. 
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4.4 Measurement for a reason 
 
Measurement in this area, as in others, should always be done for a reason. Of 
course, the overarching reason for any measurement in public health is to improve 
the health of the public, but that can operate at many levels. Much research on 
health effects of pollution is aimed primarily at understanding those effects 
scientifically and the associated communication would largely be aimed at other 
researchers rather than directly at policy-makers or the public. Yet wider 
consideration of communication needs must sometimes inform the planning and 
execution of research. 
 
One vital and occasionally neglected aspect of the measurement of health risks from 
pollutants, is that the outcomes must be expressed in terms that can be 
communicated appropriately, to policy makers and to the wider public. There needs 
to be a comprehensible currency for measuring the harms to health. In relation to air 
pollution, COMEAP36 proposed two different measures, for different types of 
communication Boxes 9.5 and 9.6. These, however, relate only to effects on 
mortality. There has been considerable research measuring morbidity, as well as 
death, for many pollutants but less has been done to investigate how to 
communicate this. Policy makers may also require comparative information on 
different health risks. Considerable effort in mathematical modelling may be required 
to produce these comparisons.37 This leads into the subject of the next section, but 
there is a feedback loop. If the communication, for example, is to be about deaths or 
years of life lost – in order to compare (with obesity, mental illness, etc.) – 
measurement must provide those quantities.   
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Box 9.5 Communicating about mortality effects: COMEAP’s consideration 
of mortality associated with long-term exposure to air pollution 
For policy analysis, the benefits of reductions in levels of particulate pollution are 
best assessed using actuarial life-table methods to estimate years of life gained 
because of the reduced exposure of the population.13 However, mortality benefits of 
small reductions in pollution, expressed as years of life lost, might not be well suited 
to communicating the size of the effect of air pollution on public health. Estimates of 
the mortality burden associated with current levels of pollution are more useful in 
highlighting the public health importance of good air quality and in encouraging 
action to reduce pollution.38 
 
The mortality burden can be expressed in a number of different ways: attributable 
fraction; attributable deaths; years of life lost; or loss of life-expectancy from birth. All 
of these describe the overall effect across the population, rather than representing 
effects on individuals: long-term exposure to air pollution is a contributory factor to 
deaths from respiratory and cardiovascular disease and is unlikely to be the sole 
cause of individual deaths. Therefore, although ‘percentage of mortality’ or ‘number 
of deaths’ are widely used in communicating public health risks, ‘attributable deaths’ 
is not the number of individuals whose length of life has been shortened by air 
pollution. Air pollution contributes a small amount to the deaths of a large number of 
exposed individuals rather than being solely responsible for a certain proportion, or 
number, of deaths. Attributable deaths can therefore more accurately be described 
as ‘an effect on mortality equivalent to ‘X’ deaths at typical ages’ and this is the 
terminology that the Committee on the Medical Effects of Air Pollutants (COMEAP) 
has recommended.36,38 
 
Although there are some differences in the methods used to calculate mortality 
burdens attributed to different public health risk factors (e.g. air pollution, smoking, 
alcohol), the approaches adopted are similar. Nonetheless, the estimates are not 
directly comparable.39 Long-term exposure to particulate air pollution affects deaths 
from the same sorts of diseases (respiratory and cardiovascular) as smoking. 
However, air pollution is a contributory factor to mortality rather than the sole or 
primary cause of death. This is different from smoking and alcohol, which can be the 
primary underlying cause of some deaths.  
 
 
Acknowledgement:  
This information draws on the thinking of the Committee on the Medical Effects of Air 
Pollutants (COMEAP): www.comeap.org.uk  
 
Alison Gowers, Air Quality and Public Health Group, Public Health England 
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Box 9.6 Putting numbers on the impact of pollution 
We’ve seen in Box 9.4 that communicating the possible harms of air pollution is 
complex. As a specific example, consider the much-quoted claims that 29,000 
deaths each year are due to fine particulate air pollution.36 This is obtained by a 
complicated statistical model, but in fact it’s easy to get to a rough figure. 
 
COMEAP assume a relative risk of 1.06 per 10 µg/m3 increase in PM2.5, meaning 
that the average risk of dying each year is increased by 6% for every extra 10 µg of 
PM2.5 per cubic meter of air (more formally, this is known as a ‘hazard ratio’). The 
average exposure to human-made PM2.5 is around 9 µg/m3 in the UK, so on average 
mortality risk is increased by around 5%, or equivalently around 5% of all deaths are 
associated with PM2.5. There are 600,000 deaths a year in the UK, and 5% of 
600,000 is 30,000 deaths, which is remarkably close to COMEAP’s actual estimate 
of 28,861 attributable deaths. 
 
But the crucial issue, repeatedly emphasised by COMEAP, is that we cannot identify 
these 29,000 as individuals– nobody has ‘pollution’ on their death certificate as a 
cause of death. As pointed out in Box 5, it might be better to describe this as an 
effect on mortality equivalent to ‘29,000 deaths’ – Table 1 shows a variety of other 
ways of expressing the same impact. 
 
Table 1  Estimated annual impact in UK of human-made PM2.5 pollution 
(2008 level) 
  
Measure of effect Estimate Plausible interval 
‘Attributable deaths’ 28,811 5,000 to 60,000 
Burden on total survival (life-years lost) 340,000 55,000 to 680,000 
Average loss in life expectancy:  
For whole population aged 30+: 
(38,000,000) 
For all deaths (600,000) 
For deaths from cardiovascular causes 
(191,000) 
For ‘attributable deaths’ (29,000) 
 
3 days 
7 months 
2 years 
11.5 years 
 
½ to 6 days 
1 to 14 months 
4 months to 4 
years 
2 to 23 years 
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All these results are driven by this estimated relative risk of 1.06, a figure that was 
originally derived from studies of US cities41 and has been reinforced by pooled 
analysis of other studies42, but with tighter confidence intervals. 
It is important to note the uncertainty associated with these estimates. The 6% 
increase (relative risk 1.06) comes with a standard statistical confidence interval, but 
COMEAP carried out an interesting elicitation of expert judgement to widen this 
interval to create a ‘plausibility distribution’, which resulted in an assessment that the 
range of 1% to 12% represented a 75% plausibility interval and should be used for 
sensitivity analysis: a 95% interval based on expert subjective assessment ran from 
0% (i.e. no effect of particulates) to 15%. This judgement of uncertainty is reflected in  
 
Table 1. This plausibility range is remarkably wide (although might be somewhat 
narrower now in the light of more recent studies), but there is sufficient 
evidence of a substantial impact to justify mitigating actions. 
 
Additional uncertainty arises from many sources, including the 
structure of the statistical model and the degree of overlap of between 
the effects of different pollutants.  
 
 
David Spiegelhalter, Winton Professor of the Public Understanding of Risk, 
University of Cambridge  
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Communication 
 
The communication landscape 
We are not starting from scratch in communicating health risks from pollution to the 
public and to other audiences. The way publics apprehend risks has been an active 
area of research for more than half a century. Perception, as well as how targets 
think about the subject area before the risk communications, must be taken into 
account (and targeted) by those needing to communicate risks. Beyond academic 
work, areas of government have worked on managing and communicating risk41 and 
on specific aspects (Box 9.6). The Academy of Medical Science has produced a 
major report on how best to use scientific evidence in relation to the benefits and 
harms of medicines, including how to communicate them.42: much of what it says 
applies equally to the harms and benefits of interventions on pollution. In addition, 
international agencies have developed different ways of classifying and 
communicating risks (7 and 43). Specifically regarding pollution, COMEAP discusses 
how to communicate the impacts of air quality (Box 9.8). 
 
One thing that this work into risk communication has established clearly is that it is 
time-consuming and often difficult to make changes by way of communication. One 
cannot expect to change either policies or the behaviour of individual members of the 
public solely by communicating what has been measured regarding the health 
effects of pollution, however well-understood that communication may be. There are 
no magic communication bullets to bring about change. 
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Box 9.1 Communicating the risk of severe flooding 
 
One in six properties in the UK are at risk of flooding but many residents are 
unaware whether their home is at risk or, if it is, what they can do in the event of a 
flood.  
 
Recent research has shown that not only does flooding present a risk to life and 
cause damage to property but it can also have long-term health and social effects. 
Such effects include anxiety, depression and post-traumatic stress. Also, disruption 
to schooling and friendship groups due to living in temporary accommodation (often 
for a year or more) can affect the development of children. Reducing or preventing 
flooding can avoid or limit the worst of these effects by enabling a return to normal 
life quickly. 
 
Working with Sciencewise, the Environment Agency, undertook a public dialogue to 
find out what people knew about their own flood risk and how to improve 
communication. The findings showed that people want clear and simple information 
about whether their home is at risk of flooding and what they can do to prepare for a 
flood. They did not find information on the probability of flooding helpful as it was 
difficult to know what to do and how to interpret this. Also, broad scale maps showing 
flood risk across the country were seen as too high-level and not giving information 
relevant to individuals. 
 
The way people, especially Millennials, want to receive information is changing. An 
estimated 99% of this age group use social media with over 40% checking it over 10 
times a day. This group of people also tend to live in areas of higher flood risk but at 
the same time have lower awareness.  
 
These insights into the perspectives of those at risk of flooding have proved very 
valuable and really challenged thinking that more detailed information was better. 
The findings of the public dialogue have influenced work by the Environment Agency 
to redesign its flood warning services with easier ways to find out about flood risk, 
especially via social media. There are also improved links to resources for how to 
increase flood resilience and actions to take if a flood is imminent.  
 
 
Cr Doug Wilson, Director of Evidence at the Environment Agency  
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Box 9.7 Examples of approaches to expressing confidence and 
uncertainty about risks 
 
The UN’s Intergovernmental Panel on Climate Change (IPCC) has refined its 
approach to presenting information on uncertainty through its Assessment Reports. 
The most recent, the 5th Assessment Report44 (AR5), distinguishes between the 
confidence of a finding and quantified measures of uncertainty in it.45 Generally, 
authors were discouraged from providing quantified probability measures, except in 
cases where the confidence in the validity of a finding was high – with agreement 
between experts and the robustness of evidence. Levels of confidence are 
expressed in qualitative terms only, using the scale “very low,” “low,” “medium,” 
“high,” and “very high.” (This was in contrast to the 4th Assessment Report where the 
same words were explicitly linked to a quantitative scale46). 
 
Where the probability of an outcome had been quantified, at least approximately, 
authors used an agreed way of translating ranges of probabilities into words: 
Term Probability 
Virtually certain 99-100% 
Very likely 90-100% 
Likely 66-100% 
About as likely as not 33-66% 
Unlikely 0-33% 
Very unlikely 0-10% 
Exceptionally unlikely 0-1% 
 
The IPCC approach has been widely praised; one potential issue is that, however 
consistent authors may be, readers may be inconsistent in their understanding of 
verbal descriptions of probability.47 
 
continues next page 
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The World Health Organization’s International Agency for Research on Cancer 
(IARC) categorises possibly carcinogenic agents, most of which are pollutants, into 
five groups in terms of hazard, that is, the strength of evidence that they have a 
cancer-causing effect in humans.48 They explicitly do not specify the level of risk, 
partly because, in many cases, the main evidence of carcinogenicity comes from 
toxicological and similar studies, which do not generally provide measures of 
individual or population risk in humans. Therefore two different agents, both 
classified by IARC as possibly carcinogenic to humans, such as non-ionizing 
electromagnetic radiation from mobile telephones and petrol exhaust fumes, may 
present very different cancer risks and levels of public health concern.  
 
This has caused considerable confusion in media reporting of IARC classifications 
when IARC review an everyday exposure49,50, (e.g. mobile phones, eating processed 
meat), despite increasing efforts from IARC to make their system clear. This can be 
seen as a failure of communication in which, if the information that people want is not 
provided, they may make false assumptions about the information that actually is 
provided. 
 
 
Kevin McConway. Emeritus Professor of Applied Statistics, The Open University 
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Box 9.8 Taking the audience’s views into account when communicating 
about pollution – using COMEAP’s development of the Daily Air 
Quality Index as an example 
The Committee on the Medical Effects of Air Pollutants (COMEAP) published 
updated recommendations for the UK Daily Air Quality Index (DAQI) in 2011 at 
Defra’s request.51 The DAQI is used to provide information to the public about real-
time and forecast levels of outdoor air pollution. It is accompanied by health advice 
intended to allow individuals who are sensitive to the effects of air pollution to modify 
their behaviour to reduce the likelihood or severity of symptoms.  
As well as considering relevant scientific and technical issues, COMEAP was keen 
to ensure that its recommendations would meet the requirements of users of the 
index. In order to inform COMEAP’s review, dedicated public insight research was 
undertaken.52,53 This included: 
 
• small-group workshops of older people with respiratory/cardiovascular 
illnesses or children aged 9–11 years old (both with and without respiratory 
illnesses)  
• focus groups with a geographical spread and timed to ensure that a cross-
section of society (gender, age and socioeconomic status) could attend  
• an online questionnaire to gather a broad spectrum of views 
 
Public preferences for the DAQI and accompanying health advice were for: 
• information which is clear, concise and easy to understand 
• focused, jargon-free, activity (health) advice 
• separate health advice for susceptible and non-susceptible groups 
• clear identification of groups at greater risk than the general population 
• avoidance of information that might be alarming or fear-inducing 
• use of visual cues and colours 
In addition, most participants wanted to know the level of air pollution in general, but 
not information about the levels of individual pollutants. 
Although there was not a clear preference for the number of ‘bands’ or ‘points on a 
scale’ within the DAQI, a need for a scale that allowed greater gradation than 
provided by four pollution bands alone was identified. Participants disliked possible 
descriptors for pollution bands based on health risk (e.g. Low Health Risk to Very 
High Health Risk) but found descriptors based on either air pollution or air quality to 
be acceptable. 
 
continues next page 
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COMEAP found the public insight research at the outset of the review very helpful in 
steering its discussions on some aspects of the DAQI. Its initial proposals, which 
took account of the views expressed, were then tested within additional focus 
groups. Feedback from these was used to further refine COMEAP’s final 
recommendations for a revised DAQI and accompanying health advice. 
 
Acknowledgement:  
This information draws on the work and thinking of the Committee on the Medical 
Effects of Air Pollutants (COMEAP): www.comeap.org.uk  
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Communication for a purpose 
 
We cannot communicate effectively without a reasonably clear understanding of 
which audience we are communicating to and what the aims are. This determines 
the choice of what is communicated, and how it is communicated. For instance, 
communicating to policy makers is, in several respects, different from communicating 
to the public (Box 9.9). 
 
In communicating flood risk to the public (Box 9.6), for example, one may need to get 
people to take action to mitigate the effects of an imminent flood, or one may need to 
communicate levels of risk to people deciding where to live, or where to build 
houses. These different purposes require rather different approaches. Some 
pollution issues, such as communicating about peaks of air pollution to particularly 
susceptible individuals who ought to take action quickly, are similar to the situation of 
an imminent flood, but most pollution issues are less immediate and (in public 
communication) the need is to extend awareness or promote behaviour change. 
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Box 9.9 Communicating across disciplines including policy makers 
Communication needs to be focused on the intended audience, so communication 
with experts in other disciplines and with those developing policy will necessarily be 
different from that designed for the public. The metrics in which results are 
expressed may also differ from those easily understood by the public. Life-years* (or 
quality-adjusted life years) are more appropriate for analysing policies than numbers 
of deaths, as it is when people die rather than whether they die that matters. They 
can be used to communicate relative importance of different policy areas, such as 
the fact that removing widespread exposure to air pollution would lead to more life-
years gained than preventing road accidents (although the causal basis of the latter 
is clearer).  
 
Working across disciplines can lead to a powerful improvement in the ongoing 
development of the quality of the evidence supporting measures to improve health. 
For example, understanding the correlation between pollutants is key to interpreting 
epidemiology studies. With older techniques, air pollution effects stopped being 
detected54 until statisticians applied time-series analysis.55 
 
It is important for communication to be interactive. Other disciplines may identify new 
questions that need to be asked. Government committees provide one forum for 
multi-disciplinary discussions.56,57 Disciplines have different strengths – epidemiology 
studies reflect reality more closely, in all its complexity, whereas toxicology studies 
are more specific but less representative. Reflecting these perspectives and 
systematically reviewing the expanding literature, needs to be maintained and 
resourced. Focusing on one area or only updating previous documents58 is 
understandable for short-term prioritisation but would lead to loss of knowledge long-
term. 
 
In the policy context, joint working across Departments allows discussion of the 
health risks and the implications as a policy develops. This has been the practice in 
outdoor air quality policy59 as acknowledged by the National Audit Office60, but may 
be less developed in other areas e.g. indoor air quality policy.  
Investigating questions that are crucial for policy can be scientifically demanding. 
Economists designing questions for willingness to pay studies61 wish to transmit 
information that may not be easily derived from population-wide studies. Regulation 
by specific pollutant requires disentangling of effects in a way that may be difficult in 
epidemiological studies.62. Those developing environment and health policies need 
to communicate policy challenges to specialists who need access to research funds 
that can be targeted at these questions.63,64 
 
Heather Walton, Senior Lecturer in Environmental Health, King’s College London 
                                                          
*
 One year lived by one person, adding up across the population and over time. 
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Risk perception theory 
 
Several areas of psychological research are relevant to the communication of 
pollution’s health risks. Firstly the area of risk perception has provided insight into the 
three key factors that lead people to be concerned about risks65 their demographics 
(groups with less political or socio-economic power feel more concerned), the 
characteristics of the risks themselves (e.g. how controllable and dreaded they are 
perceived to be) and a range of cognitive mechanisms (e.g. optimistic bias, 
overconfidence and the availability heuristic), which are lenses with which people 
absorb the risks communicated to them. More recently there has been a shift from 
focus on these more cognitive aspects of risk apprehension to the more affective, 
emotive aspects. This may weaken direct links between measurement and 
communication. If the aim is to engage the audience and (potentially) change what 
they do, it is not enough simply to get across the size of the risk. Box 9 11 explains 
the relevance of disgust to air pollution and health-related behaviours and Box 9.12 
highlights a campaign from a different public health area that was particularly 
successful in engaging a wide public using more emotive queues. 
 
Both the more cognitive and the more affective aspects have been reviewed, 
regarding climate change, in a model - the ‘Dragons of Inaction’66. Stemming from 
the risk perception field, a burgeoning risk communication field has produced a set of 
key principles for effective risk communication.67 This includes use of images and 
human stories to convey risk, rather than numbers.  
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Box 9.10 Why risk information should not form the central aspect of a risk 
communication: Dual Processing 
Communications to change health-related awareness and behaviours traditionally 
rest on the assumption that if experts can provide the public with information in an 
absorbable format, the information will then be known and heeded. However, this 
model suffers a number of problems addressed by the Psychology of Risk over the 
past half century. Most recently, within Psychology, there has been vociferous 
rejection of the importance of health risk information’s potential to change awareness 
and, especially, behaviour. This is based on dual-process models that advocate that 
human behaviour is shaped by two systems: one more non-conscious, automatic 
and affective and another more deliberative and rational. This idea, popularised in 
Kahneman’s68 ‘Thinking fast and slow’, sees the first characterised by habit, impulse 
and emotion and the second as more consciously cognitive. Recent work in the risk 
sphere talks not just of the existence of the separate automatic/emotive and 
deliberative dimensions but of a sequence: ‘feeling before thinking’.69 The thesis that 
the first type is more primary when humans process risks is increasingly supported 
by neuroscience.70 
 
Numerical risk communications, therefore, are likely to be processed by the 
secondary, deliberative system, which is the less influential of the two systems. The 
empirical evidence for this is strong: two major reviews of health-related risk 
interventions found that information, even when given in a highly personalised form, 
had no perceptible effect on the targeted behaviour.71,72 Marteau et al.73 advocate 
that environmental cues can therefore be used to change health-related behaviours 
as such change occurs at a non-conscious level - not amenable to information. 
However, one might argue, especially with promising communication effects seen in 
interventions with visual elements,74 that another way of influencing the non-
conscious is persuasion via visuals, with their tendency to be more emotionally 
evocative than textual and verbal messages.75 
 
The take home message is that risk information should not be a central aspect of risk 
communication to the public and that messages that speak to non-conscious 
affective systems are more likely to be effective. 
 
Helene Joffe, Professor of Psychology, University College London 
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Box 9.11 How do people living in cities experience pollution? A Liveable 
Cities perspective from London and Birmingham dwellers 
Using a novel, free association technique76 that taps more latent factors than survey 
techniques do, we set out to examine aspirations for future cities in matched 
samples of people who dwell in the UK’s two largest cities: London and 
Birmingham.77 When we tapped the naturalistic, stored and arguably less conscious 
(and more primary, see Box 9.10Error! Reference source not found.) 
conceptualisations, the wish for clean air featured prominently regarding desired 
aspects of future cities. When the city dwellers elaborated on their free associations 
in interviews that followed the task, transport, both public and private, was seen to be 
a source of pollution and dirt which evoked strong feelings of disgust. Disgust was 
associated with air pollution’s sensory assault rather than with concern for its 
environmental impact or worry about its fatal consequences.  
 
This intense dislike of pollution and exaltation of clean air could be garnered in 
efforts to reduce harmful emissions. Research demonstrates that disgust can be 
used highly effectively in risk communications to change risky health behaviours. In 
relation to smoking, in particular, exposure to disgusting messages, for example on 
cigarette packets, seems to reduce smoking behaviour. The use of graphic cigarette 
packaging warning labels in Canadian smokers, lead to 20% of the sample reporting 
smoking less as a result of the labels and 63% reporting at least one cessation 
benefit .78 Similar results regarding hand hygiene in Australian experimental and 
field-based tests,79 demonstrate that even brief disgust-based communications are 
effective. It is not only the emotional tone of disgust that is at work in graphic 
cigarette packaging warning labels but a visual, rather than textual or verbal, 
approach to communication (see Box 9.12). Emotive images play an effective role in 
communicating risk to the public. 
 
Helene Joffe, Professor of Psychology, University College London 
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Behaviour change theory 
 
Theories of behaviour change are also relevant to the communication of pollution’s 
health risks. In the ascendant within this domain is the COM-B model84, which posits 
that in order for behaviours to be taken on or changed, people need to have the 
capability, opportunity and motivation. Here, aspects like people’s sense of self-
efficacy affect their capability. Interestingly the risk communication and behaviour 
change literatures operate independently yet both would be enriched by the insights 
of the other. 
 
While there has been widespread recognition of the limited role that information 
plays in changing health-related behaviours85, it remains important to know what the 
numbers say. Awareness of the objective risk is a necessary though far from 
sufficient condition for behaviour change. Knowledge of the scale of a problem is 
central for policy makers, who must allocate resources on this basis. That said, a 
range of interests make it difficult for even the most severe risks to become 
prominent policy concerns. A concept of the different information needs of policy-
makers and more general audiences is behind COMEAP’s recommendation of 
different measures of health impact for different audiences . Research-based 
insights into effective ways of conveying information on health risks do exist and 
should be used where appropriate.  
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Communicating complexity 
 
The scientific position on health risks from most pollution sources is complex and 
involves serious uncertainty. Therefore the question arises as to how far to reduce 
this complexity in communicating the risks. There has been considerable research 
and discussion into the most appropriate numerical measures to use in 
communicating health risks from air pollution. Gigerenzer’s approach86 does use 
numbers, but in ways that have been demonstrated to be more comprehensible. 
COMEAP proposed using different numerical measures for different purposes, and 
this has arguably had important impacts on how the risks are communicated. 
Communications from bodies such as COMEAP do not usually go directly to the 
public. This can introduce error. COMEAP’s recommended wording for numbers of 
attributable deaths from air pollution, “an effect equivalent to a specific number of 
deaths at typical ages”, seems not to be popular, unfortunately. Re-use and reporting 
of their conclusions largely omits their caveats. 
 
While there is substantial uncertainty concerning the true magnitude of health 
impacts of air pollution, the high chance that there are substantial effects means that 
there is sufficient justification for mitigating actions. This can be communicated 
informally or in more formal sensitivity analysis in a cost-benefit model. 
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Next steps 
 
The importance of engaging the public (and service users) in research and service 
development on health matters is clear in relation to risk communication.42 Despite 
some excellent exemplars (see Boxes 9.11, 9.12), in developing a shared 
understanding of the communication of quantitative information and use of emotion, 
such engagement is not as common as it ought to be. In the longer term, 
improvements in education on the environment, pollution and its health 
consequences, particularly at school level, can be an important step in increasing 
public awareness and engagement, though it does not remove the need to consider 
emotion and motivation in promoting behaviour change. 
 
Finally, a key aspect of effective communication of information based on scientific 
research, of whatever kind, is the trust placed in the research and in its 
communicators. It must be remembered that it is the audience that decides whether 
a communicator or information source is trustworthy, not the communicator. Trust in 
science and scientists and in Government, is not always high.42 Openness and 
transparency are ways to help audiences to judge trustworthiness. The key aim 
should be for a communicator to provide evidence in a form such that its 
trustworthiness can be assessed87,88 – in that it makes sense to the audience, and 
they can see the evidence and act on it where necessary. Trust requires a 
relationship between the parties involved – another reason why more emotive, 
experiential aspects need to enter the communication.  
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Box 9.12 A successful risk intervention in public health: The Swiss Stop 
AIDS campaign 
The Swiss Stop AIDS campaign began in 1987 and is ongoing, having broadened 
out to the host of sexually transmitted infections. The campaign has provided 
amusing, surprising, seductive visuals, as well as communications regarding the 
need for social solidarity, loving life and valuing of quality of life. This highly positively 
toned campaign has been accompanied by a vast and sustained increase in condom 
sales and condom use, with major health effects including a reduction in AIDS and 
sexually transmitted infections rates as a whole. Condom use in the Swiss public 
increased from 8% when the campaign first started in 1987 to 60% in 1992.89,90 
Persuasion was brought about by emotions such as humour, surprise and stressing 
the joy of life, as well as by calling for identification with people with AIDS rather than 
psychological (or spatial) distancing from them. Such distancing plays a major role in 
people’s dis-identification from (and therefore dismissing of) a host of risk  
 
communications.91,92 This central insight has now been adopted in a new generation 
of studies testing how to induce people to identify more with risk communications.  
One might argue that The Swiss Stop AIDS campaign’s emotive visuals appealed 
primarily to the more emotive system of processing messages, rather than to the 
deliberative, rational system. It also, unusually, inserted its messages into 
commercial advertisements, for example, by inserting its symbol, a pink condom, into 
the Volkswagen symbol and so mixed public health broadcasting with private sector 
advertising. 
 
This highly individual, closely evaluated campaign, with its strong emphasis on 
visual, emotive content demonstrates the potential for positively-valenced emotive 
communications (i.e. those communication that use a positive emotive tone, rather 
than fear or disgust, for example) to facilitate absorption of risk messages. 
 
Helene Joffe, Professor of Psychology, University College London 
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Box 9.13 CleanSpaceTM Tag: air quality monitoring for all 
 
Conventional static air quality measurement stations are expensive and have high 
maintenance costs and are therefore often sparsely located. The Royal College of 
Physicians and The Royal College of Paediatrics and Child Health in the report 
published in February 2016 recommended that new technologies should be 
developed to improve air pollution monitoring to track population-level exposure to 
pollution. 
 
In 2015 Drayson Technologies launched the CleanSpaceTM Tag, a personal air 
pollution smart sensor and is a great example of how new technologies can be used 
to improve air pollution monitoring. The CleanSpace Tag linked to a smartphone app 
gathers hyper-local air pollution information allowing users to see the air they are 
breathing both indoors and outdoors and take action, such as avoiding busy roads or 
increasing the ventilation at home. This is particularly important for people most 
vulnerable from air pollution, highlighted by the fact that nearly a fifth of 
CleanSpace’s top users have a respiratory condition. 
 
“CleanSpace monitoring has become essential in planning my schedule and 
locations. I can look at the pollution readings and avoid polluted areas, 
preventing the onset of any respiratory symptoms and potentially avoiding a 
COPD attack. Knowledge is power!”  
 (Derek, a COPD sufferer and member of the British Lung Foundation, August 
2017) 
The CleanSpace community has generated over 100 million hyper-local data 
readings to date. However, it is vital that the data gathered by affordable air pollution 
sensors is credible and tested through independent scientific validation. The 
CleanSpace Tags use machine learning to dynamically calibrate the sensors 
keeping their readings accurate over time and they have been scientifically tested by 
the National Physical Laboratory and King’s College London and shown to have a 
resolution of +/- 0.3ppm.  
 
CleanSpace is bringing affordable and scalable personal monitoring not only to the 
public, but also to scientific communities, as a digital tool to compare the more 
complex traditional methods for measuring personal exposure to air pollution and the 
links to health conditions such as asthma or COPD.  
 
James Clifton, Diana Stefan (Drayson Technologies) 
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Authors’ suggestions for policy makers 
 
• The involvement of several research disciplines and traditions in measuring the 
health effects of pollution is valuable and inevitable given the complexity of the 
field. However, there is a clear need for more funding and coordination of 
interdisciplinary work on such measurement, potentially also linking 
measurement to communication. This should also include research into effective 
methods for synthesising information and evidence from different research 
traditions. Responsibility thus far has been divided between several research 
councils (at least EPSRC, MRC, ESRC, NERC) as well as Government 
departments (Department for Environment, food and Rural Affairs, Department of 
Health and Social Care, and others). The start-up of UKRI provides an 
opportunity for better coordination and particularly for removing some of the 
barriers that have stood in the way of interdisciplinary and multi-disciplinary 
research. 
 
• Public engagement has not been as prominent or routine in research on health 
effects of pollution and on communication of the health risks and calls for action, 
as in many other areas of health research and service development. In particular, 
there is a need for more direct research that engages with the public on 
communication needs and methods. There are successful examples of such work 
that can be learned from, particularly in relation to air quality and (in another 
context) flood risk. 
 
• Ways of communicating risk have differed, in their general approach and in the 
kinds of information, between pollutants, between health risks from pollution and 
other health risks and (arguably) between health risks and other risks to public 
safety. While the diversity of this approach is a good thing, given the importance 
of context in communication and given the different audiences involved, we do 
wonder whether there is sufficient awareness across Government of the 
successes (or otherwise) of risk communication in different areas. The 2014 
Government Chief Scientific Adviser’s report41 is an excellent basis for such co-
operation, but are enough internal channels of communication in place to share 
good practice consistently? 
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Conclusion 
 
The measurement and communication of health risks from pollution is inevitably 
complex. Interactions can be complex, both between the pollutants themselves and 
between the various research disciplines that are necessary to cover the wide field. 
Good progress is being made and must continue to be made, given the level of the 
threat to the public health and the need to allow desired activities that may pollute, to 
continue in an appropriate manner. Further opportunities for collaboration and 
coordination in measurement must, however, be promoted. 
 
To communicate, we need evidence from measurement, but communication is never 
just a matter of getting the evidence across. Given a good understanding of the 
audience and the reasons for communication, it is important to realise that 
psychological insights into communication and behaviour change do not apply only 
to ways of helping the public to change behaviour, but can also inform the 
implementation of policy, particularly where there are multiple agents involved. 
Whatever the audience, effective communication requires trust and trust requires a 
real and transparent relationship between those concerned.  
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Annex 1 – Outdoor Air Pollution 
 
 
Unlike smoking, air pollution is not a lifestyle choice but an involuntary environmental 
exposure, which can affect all of the population from the womb to death. Air pollution 
results from a complex mixture of thousands of pollutants. This chemical mixture 
includes particulate matter (PM) coated with combustion-related chemicals, and 
gases such as oxides of nitrogen (NOx, including NO2) and volatile organic 
compounds (VOCs) as well as “secondary” pollutants such as ozone (O3) and 
particles derived from primary pollutants. Health effects are measured using a 
marker of pollution e.g. particles of diameter <10µm (PM10) or <2.5µm (PM2.5), 
NO2 and O3. Commonly used indicators are traffic density at the nearest road or 
residential distance from busy roads. Background pollutant levels increase markedly 
with low wind speeds resulting in air pollution episodes lasting days - weeks. On a 
daily basis, extremely high pollutant concentrations accumulate within urban 
environments adjacent to busy roads and traffic intersections. Outdoor pollutants 
also penetrate indoors extending daily exposure to 24 hours.  
 
While the risks of air pollution to adverse health in Britain were thought to have been 
solved by the Clean Air Acts of the 1950s and 1960s, in the UK, it is contributing to 
40,000 excess deaths each year, considerable morbidity and leading to a total 
annual cost to the economy of around £27 billion. The adverse health effects 
produced by ambient air pollution cannot be attributed to a single pollutant but 
pollutants act together by interrelated mechanisms causing oxidative stress, tissue 
injury, local and systemic inflammation. Fine particles can also cross the lung into 
the circulation and via the nasal mucosa where the olfactory nerves pass into the 
brain producing more widespread toxic effects. 
 
Effects of pollutants depend on health outcomes, timescale (e.g. acute versus long-
term effects), underlying individual susceptibilities and the nature and concentrations 
of co-pollutants. Examples of established associations between frequently used 
markers of ambient air pollution and various respiratory health outcomes are shown 
in the table. Markers of air pollution are often correlated with each other and the 
health effects are frequently nonspecific, therefore specific effects cannot be easily 
assigned to single pollutants. 
 
 
 
Short-term effects: The daily number of deaths, mainly from cardiovascular (CHD, 
arrhythmia and stroke) and respiratory diseases (COPD and pneumonia), tracks with 
daily fluctuations in air pollution. The daily variation in urban pollution also increases 
emergency hospital visits and admissions due to respiratory diseases such as 
asthma and COPD. Patients with asthma also suffer more on or after days with 
higher pollution levels. 
 
Long-term consequences: Long-term or lifetime exposure to ambient pollutants have 
pathological effects that contribute to a variety of chronic diseases. The overall 
effects of pollution on mortality are far larger than the fraction attributed to acute 
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exposures. In general, respiratory disease is less often the cause of death than 
cardiovascular disease, and the two are often combined as cardiopulmonary 
mortality. In the entire Medicare population of the US, there was significant evidence 
of adverse effects related to exposure to PM2.5 and ozone at concentrations below 
current national standards, with adverse effects being most pronounced among 
racial minorities and people with low income.  
 
Air pollution influences the developing foetus, increasing the risk of premature birth, 
decreasing birthweight, promoting intrauterine growth retardation, reducing lung 
function at birth. Since infant’s and children’s lungs are still growing and maturing, 
any deficit in growth will have an impact for the whole of the child’s life. Many cross-
sectional studies have reported lower lung volumes in children living in more polluted 
areas and longitudinal studies e.g. the University of Southern California (USC) 
Children’s Health Study show this extends to adult life. Living close to a busy road 
increases the risk of developing asthma in childhood, even when confounding factors 
are taken into account. The contrasting lack of association between asthma onset 
and urban background pollution, and the strong associations between proximity to 
traffic arteries and asthma suggests that those pollutants occurring at very high 
concentrations along street corridors play a role in the genesis of asthma. Many 
studies have reported associations between lung function and pollution and a few 
also suggest that air pollution may also contribute to the development of COPD.   
 
The IARC list diesel exhaust as a Group 1 carcinogen. Particles, in particular those 
from diesel engines, are loaded with carcinogens. Lung cancer incidence increases 
by 8% per 10µg/m3 increase in PM2.5 and 3.7% per 10µg/m3 increase in NOx. Air 
pollution has also been associated with a range of other disorders including Types 1 
and 2 diabetes, hypertension, premature skin aging increased blood coagulation 
(and DVT) and dementia. Causality for pollution’s effect on dementia is revealed by 
accelerated loss of cognition in those with the E*4 variant of the APOE gene, the 
largest known genetic risk factor for late-onset sporadic Alzheimer's disease .
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Table A1.1 Examples of established associations between frequently used markers of ambient air   pollution and various 
respiratory health outcomes 
 
Marker of air 
pollution 
Questionnaire-
based 
respiratory 
health data 
Objective 
respiratory 
markers 
Biomarkers of 
effect 
Health system 
use 
Acute effects 
on mortality 
Long-term 
effects: 
mortality/life 
expectancy 
Particulate 
Matter (PM) 
Respiratory 
symptoms 
Diminished lung 
function, 
impaired growth 
of lung function 
Airway 
inflammation, 
chronic lung 
disease 
Emergency 
admissions for 
respiratory 
diseases, 
asthma 
Increase in 
daily mortality 
Increased 
mortality from 
cardiopulmonar
y diseases 
Ozone (O3) Respiratory 
symptoms 
Diminished lung 
function 
Airway 
inflammation 
Emergency 
admissions for 
asthma 
Increase in 
daily mortality 
Suggestive for 
respiratory 
death 
Nitrogen Oxides 
(NOx) 
Respiratory 
symptoms 
Increased 
bronchial 
reactivity, 
impaired growth 
of lung function 
Airway 
inflammation 
alteration in 
lung immune 
defences 
Emergency 
admissions for 
respiratory 
diseases 
Increase in 
daily mortality 
Increased long-
term mortality 
from 
cardiopulmonar
y diseases 
 
 
 
 Annual Report of the Chief Medical Officer 2018    Annexes 
 
Annex 2 – Chapter 05 Literature Review 
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We searched for various combinations of terms in PubMed using MeSH terms and 
key words. The results are reported in Table A.1. We complemented the searches 
below using Google and Google Scholar.  
We considered peer-reviewed publications, reports, policy briefs, and working 
papers. We focused on the UK, but also similar countries in their level of 
development.  
We excluded the following topics:  
• Economic evaluations focusing on CO2 
• Economic evaluations of Chinese cities  
• Studies assessing the impact of pollutants on health 
• Smoking as a source of pollution 
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Table A2.1  Search results  
Search Term 
Count of 
Number of 
results 
Average of 
Number of 
results2 
( "Inhalation Exposure/economics"[MeSH] AND 
"Inhalation Exposure/prevention and 
control"[MeSH] )  1 1 
("air pollutants"[MeSH Terms] AND "policy"[MeSH 
Terms]) AND "costs and cost analysis"[MeSH 
Terms] 4 12 
("air pollutants"[MeSH Terms] AND ("health"[MeSH 
Terms] OR "health"[All Fields])) AND 
("economics"[Subheading] OR "economics"[All 
Fields] OR "economics"[MeSH Terms]) (Called 
SearchApp01_P*.pdf) 19 487 
("environmental policy"[MeSH Terms] AND 
"health"[MeSH Terms]) AND ("costs and cost 
analysis"[MeSH Terms] OR ("costs"[All Fields] 
AND "cost"[All Fields] AND "analysis"[All Fields]) 
OR "costs and cost analysis"[All Fields] OR 
"costs"[All Fields]) 2 7 
("Greenhouse Effect/economics"[MeSH] AND 
"Greenhouse Effect/prevention and 
control"[MeSH]) AND ("health"[MeSH Terms] OR 
"health"[All Fields]) 1 4 
Air Pollution, Indoor/analysis[MeSH] AND "Air 
Pollution, Indoor/economics"[MeSH] AND "Air 
Pollution, Indoor/prevention and control"[MeSH] 3 4 
Air Pollution, Radioactive/economics[MeSH] AND 
"Air Pollution, Radioactive/prevention and 
control"[MeSH] 1 13 
Cost-Benefit Analysis/economics[MeSH] AND 
"Environmental Pollution"[MeSH] 
 1 11 
Environmental Policy/economics[MeSH] 2 160 
Environmental Policy/economics[MeSH] AND 
("health impact assessment"[MeSH Terms] OR 
("health"[All Fields] AND "impact"[All Fields] AND 
"assessment"[All Fields]) OR "health impact 
assessment"[All Fields]) 1 2 
environmental policy[MeSH Terms] AND 
"health"[MeSH Terms] 2 106 
Environmental Restoration and 
Remediation/economics[MeSH] 1 213 
Food Contamination/economics[MeSH] AND "Food 
Contamination/prevention and control"[MeSH] 8 46 
Greenhouse Effect/economics[MeSH] AND 
("insurance benefits"[MeSH Terms] OR 1 4 
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Search Term 
Count of 
Number of 
results 
Average of 
Number of 
results2 
("insurance"[All Fields] AND "benefits"[All Fields]) 
OR "insurance benefits"[All Fields] OR ("health"[All 
Fields] AND "benefit"[All Fields]) OR "health 
benefit"[All Fields]) 
Maternal Exposure/economics[MeSH] AND 
"Maternal Exposure/prevention and control"[MeSH] 1 2 
Occupational Exposure/economics[MeSH] AND 
"Occupational Exposure/prevention and 
control"[MeSH] 1 38 
Radiation Exposure/economics[MeSH] AND 
"Radiation Exposure/prevention and 
control"[MeSH] 2 32 
Tobacco Smoke Pollution/economics[MeSH] AND 
"Tobacco Smoke Pollution/prevention and 
control"[MeSH] 3 42 
Water Pollution, Chemical/economics[MeSH] AND 
"Water Pollution, Chemical/prevention and 
control"[MeSH] 1 32 
(("environment"[MeSH Terms] AND "health"[MeSH 
Terms]) AND ("costs and cost analysis"[MeSH 
Terms] OR ("costs"[All Fields] AND "cost"[All 
Fields] AND "analysis"[All Fields]) OR "costs and 
cost analysis"[All Fields] OR "costs"[All Fields])) 
(Called SearchApp02_P*.pdf)  532 
((cost*[Title]) AND pollut*[Title/Abstract]) AND 
health 
(Called SearchApp03_P*.pdf)  165 
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Keywords used on Google and Google Scholar 
 
Economic cost of pollution impacts health / Air pollution cost health / Health pollution 
cost / Economic cost of air pollution on Health / Health economic cost of pollution 
assessment / Health based economic assessment air pollution / Social cost of air 
pollution / Societal cost of air pollution / Economic consequences of air pollution / 
Health impacts of air pollution / Air pollution cost / Cost and benefits of air quality on 
the health cost of pollution / Economic valuation of air pollution economic cost on 
public health / Measuring health cost induced by pollution / Public health impact of 
air pollution, economic assessments / Risk assessment of air pollution / Benefits on 
health from reducing air pollution / Health cost externalities of air pollution / Health 
impact and cost of pollution / Cost efficiency and health benefit approach to improve 
air quality / Valuing the cost of air pollution on health / Reducing air pollution 
economic benefits on health. 
 
Environmental policies evaluations / Air quality policies CBA / Tackling air pollution / 
Air pollution control strategies / Air quality improvements / Policies to address air 
pollution / Policies to abate emissions / Public health impacts of city policies to 
reduce climate change / Policies to reduce air pollution emissions / Estimation of 
pollution policies tackle climate change / Climate policies impact on health / 
Assessing the public health impacts of urban air pollution european cities / 
Relationship environmental policies and air quality / Urban air quality improvement 
policies / Applying policy and health effects of air pollution / Transport policies 
reducing air pollution / Cities environmental policies / vehicle policies and air quality / 
Health benefits of air pollution policies / cars emissions impacts on human health / 
Air pollution effect / Tackling air pollution / Improve air quality UK / Benefits health 
congestion charge London /  Cost policies reduce air pollution / Air pollution public 
health policies economic cost / Economic valuation of environmental policies in cities 
/ Air pollution and transport health impacts.  
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Figure A2.1 Using Ovidsp, selecting Embase and Medline 
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Annex 3 – Chapter 08 Table A3.1 
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Table A3.1 Examples of data which provide information about environmental pollution 
 
Theme Dataset Resoluti
on 
Geographi
cal extent 
Data Type Provider How to obtain the data & comments 
Land usage 
 
Land Cover 
Map 
25m x 
25m 
Great 
Britain 
Map Centre for 
Ecology & 
Hydrology (C
EH) 
Under license from CEH Data Licensing 
Team  https://www.ceh.ac.uk/services/land-
cover-map-2015#form    
Land usage 
 
CORINE 
Land Cover  
100m x 
100m 
EU Map European 
Environment 
Agency (EEA) 
Freely available - see 
https://www.eea.europa.eu/publications/COR
0-landcover  
Land usage 
 
Agricultural 
usage of 
land  
2km x 
2km 
England Map  Defra 
Agricultural 
Census 
Under license to UK Academic Sector from 
EDINA http://agcensus.edina.ac.uk/  
Land usage 
 
Tree cover Electoral 
Ward  
Greater 
London 
Online Map The Greater 
London 
Authority 
(Mayor of 
London) and 
the 
GeoInformatio
n Group  
Interactive map at 
https://www.london.gov.uk/what-we-
do/environment/parks-green-spaces-and-
biodiversity/parks-and-green-spaces/mayors-
street-tree 
Ordnance 
survey 
details incl.  
greenspace 
and road and 
water 
networks 
 
MasterMap 1:1250 
vector 
data 
Great 
Britain 
Map Ordnance 
Survey 
 
Under license from Ordnance Survey, some 
features only available under academic 
license 
https://www.ordnancesurvey.co.uk/business-
and-government/products/mastermap-
products.html   
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Meteorology Hourly 
meteorologic
al data   
x,y 
locations 
of MET 
stations  
Great 
Britain 
Measureme
nts 
MET Office 
(supplied by 
Centre for 
Environmenta
l Data 
Analysis) 
Under license from the MET office 
Air pollution Particulate ( 
PM10, PM2.5) 
and gaseous 
((NO2, CO, 
NOX, O3) air 
pollution 
concentratio
ns  
x,y 
locations 
of 
Automati
c Urban 
and 
Rural 
Monitorin
g 
Network 
stations 
stations 
United 
Kingdom 
Measureme
nts 
Department 
for 
Environment 
Food & Rural 
Affairs   
Freely available under the Open Government 
License- see  https://uk-air.defra.gov.uk/data/  
Air pollution NO2, CO, 
NOX, O3, 
SO2, 
Benzene, 
PM10, PM2.5 
1km x 
1km  
United 
Kingdom 
Map Department 
for 
Environment 
Food & Rural 
Affairs   
Maps available on request: 
Carol.Hrynkiewicz@defra.gsi.gov.uk 
Air pollution 
 
 
 
Historic 
Black smoke 
(BS) & 
sulphur 
dioxide 
(SO2) 
concentratio
ns 
1km x 
1km  
Great 
Britain 
Modelled CHESS – 
funded by 
Wellcome 
Trust, grant 
075883  
Modelled for 1962, 1971, 1981, 1991 (7, 17), 
further back in time than available from Defra. 
Available by contacting the Environmental 
Exposure Group; 
http://www.sahsu.org/content/environmental-
exposures-group 
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Air pollution PM, NO2, 
NOX, Roads 
nearby, 
Traffic 
intensity, 
Metals in PM 
Address
es 
EU Modelled ESCAPE and 
TRANSPHOR
M – both 
funded under 
the EU 7th 
Framework 
Programme  
Modelled for the European Study of Cohorts 
and Air Pollution Effects (ESCAPE) research 
project (18, 19) and metals for Transport 
related Air Pollution and Health impacts 
(TRANSPHORM) (20). Available by 
contacting the Environmental Exposure 
Group; 
http://www.sahsu.org/content/environmental-
exposures-group 
Air pollution NO2 
concentratio
ns 
 
200m x 
200m 
Great 
Britain 
Modelled ESCAPE – 
funded under 
the EU 7th 
Framework 
Programme  
Modelled for a research project for 1991, 
2001, 2009 at finer resolution than Defra data 
and further back in time (21).  
Available by contacting the Environmental 
Exposure Group; 
http://www.sahsu.org/content/environmental-
exposures-group 
Light 
pollution  
Light 
emissions 
200m x 
200m 
EU Modelled MANTLE - 
funded under 
the EU 5th 
Framework 
Programme 
(22)  
Available by contacting the Environmental 
Exposure Group; 
http://www.sahsu.org/content/environmental-
exposures-group  
Heavy 
metals in soil 
Lead, 
cadmium 
concentratio
ns in soil  
100m x 
100m 
England & 
Wales 
 British 
Geological 
Survey  
Under license from the British Geological 
Survey. Four surveys were conducted and 
data covers 1978-2012 depending on 
survey.Interactive map at  
http://mapapps.bgs.ac.uk/londonearth/london
earth.html  
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EMF Overhead 
power lines 
incl. power 
output (kV) 
Lines England & 
Wales 
Map 
location 
National Grid Under license from the National Grid – 
available via  
http://www2.nationalgrid.com/uk/services/land
-and-development/planning-authority/shape-
files/  
EMF Mobile 
phone masts 
Sites Great 
Britain 
x,y co-
ordinates 
Mobile Phone 
providers 
Obtained on request with permission to use 
for a research project to model power density 
at addresses near mobile phone masts  using 
input data from mobile phone providers (23)) 
Water Concentratio
ns of 
chlorination 
disinfection 
by-products 
and other 
contaminant
s 
Water 
supply 
zones 
England Modelled Measurement 
data 
conducted 
under Water 
Supply 
(Water 
Quality) 
Regulations 
Summary of tests for each water company 
available from the Drinking Water 
Inspectorate http://www.dwi.gov.uk/.   
Modelled at water supply zone to provide 
information about population exposures for a 
specific research projects (e.g. 
Nieuwenhuijsen et al. 2008 (24)) 
Waste Public 
register of 
Environment 
Agency 
Licenses for 
potential 
releases of 
pollutants  
Site 
postcode 
England Type of 
release 
permitted 
Environment 
Agency 
Searchable by postcode and by local 
authority 
https://environment.data.gov.uk/public-
register/view/index  - gives information per 
permit, not aggregate or mapped information 
Waste Landfill, 
Incinerator 
and 
Biocomposti
ng site 
locations 
Location England x,y 
coordinates 
Environment 
Agency 
Obtained on request with permission to use 
for a research project 
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Waste Daily total 
dust,  SO2, 
NOX,; 6-
monthly 
dioxin & 
metals 
emissions 
from 
municipal 
waste 
incinerators 
x,y 
coordina
tes of 
incinerat
ors 
Great 
Britain 
Measureme
nts 
Environment 
Agency 
Obtained on request with permission to use 
for a research project  
Radon Radon 
concentratio
ns 
1km x 
1km 
England & 
Wales 
Modelled Public Health 
England 
Interactive map at  
http://www.ukradon.org/information/ukmaps  
Noise Aircraft noise 
around 
major UK 
airports  
10m x 
10m 
grids 
Major UK 
airports 
Modelled Civil Aviation 
Authority 
Obtained on request with permission to use 
for a research project 
Noise Road and 
railway noise  
Address
es 
Major 
conurbation 
areas 
Modelled Defra 
(supplied by 
Extrium) 
Searchable map available from 
http://www.extrium.co.uk/noiseviewer.html  
Noise Road traffic 
noise 
Postcod
e 
centroids 
Great 
Britain 
(CNOSSOS
-EU) and 
London 
(Tranex) 
Modelled BioSHaRE - 
funded under 
the EU 7th 
Framework 
Programme 
(25) 
Models available via 
http://www.sahsu.org/content/data-download  
- can be run with appropriate input data to 
obtain estimates at specific postcodes 
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Table A3.1 Details of the main health datasets and data providers in England 
 
Data provider Dataset Coverage Time period 
Number 
of annual 
records 
Year 
Office for National 
Statistics (ONS) Vital Statistics     
 
Births All registered (England & Wales) 1850 - 698k 2015 
 
Stillbirths All registered (England & Wales) 1927 - 3k 2015 
 
Deaths All registered (England & Wales) 1838 - 530k 2015 
 
NN4B (NHS Numbers for Babies) 
    
National Institute for 
Health Research 
(NIHR)  
Clinical Practice Research 
Datalink (CPRD) 
All patients registered at general 
practices contained in CPRD 
(subset of all practices in the UK), 
who have not dissented from 
secondary use of GP patient data 
(UK) 
1987 -  14M 2015 
 
Prescribed Primary Care drugs Selected GP practices (see above) 
   
 
Administered Hospital drug Linked to NHS.Digital data (see below) 
   
 
Laboratory data Primary care data from 674 practices in the UK 1987 -   
 
Consultations Primary care data from 674 practices in the UK 1987 -   
 
GP and hospital coded 
disease data 
Linked to NHS.Digital data (see 
below) 
1997/2003 
-   
 
Cancer & Disease Registers Linked to PHE and MINAP data (see below) 
1190/2003 
-   
NHS.Digital  Hospital Episode Statistics (HES)     
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HES - Admitted Patient 
Care 
NHS hospitals and NHS 
commissioned activity (England) 1989 -  
18,2M 
FCEs, 
15.5M 
FAEs 
2013
/14 
 
HES – Outpatients NHS hospitals and NHS 
commissioned activity (England) 2003/04 -  82.1M 
2013
/14 
 
HES - Adult Critical Care NHS hospitals and NHS 
commissioned activity (England) 2008/09 -  250k 
2013
/14 
 
HES - A&E Attendance NHS hospitals and NHS 
commissioned activity (England) 2007/08 -  18.5M 
2013
/14 
 
Patient Reported Outcome 
Measures 
NHS hospitals and NHS 
commissioned activity of 4 
common elective surgeries 
2009 - 779k 2013/14 
 
Mental Health & Learning Disability 
Data Set 
NHS-funded treatment from all 
specialist practitioners (England) 2003- 1M/month  
 
Maternity and Children's Data Sets 
 
2014 - 
  
 
Diagnostic Imaging Dataset Any NHS-funded diagnostic imaging tests/activity (England) 2012 -  40M 2014 
 
Improving Access to Psychological 
Therapies England 2008 - 1M  
 
National Renal Data Set England 2009 - 
  
 
Prescribed Primary Care drugs 
All prescriptions – generics and/or 
branded products issued in 
primary care 
 48M 2016 
 
Administered Hospital drug 
Derived from IMS Health Hospital 
Pharmacy 
Audit Index database, covering 99 
per cent of NHS beds across 
England, and data from the 
Prescription Services Division of 
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the 
NHS Business Services Authority 
(BSA) 
Public Health England 
(PHE) Cancer registries 
All identified cancer cases 
(England) 
1990-
2013 10M 2013 
 
National Congenital Anomaly and 
Rare Disease Registration Service 
(NCARDRS)  
2017- 
  
British Isles Network of 
Congenital Anomaly 
Registers (BINOCAR) 
Congenital Anomaly Registers 
(now part of NCARDRS) 
Northern region (NorCAS), West 
Midlands (WMCAR), Wessex 
(WANDA), East Midlands & South 
Yorkshire (EMSYCAR), 
Oxfordshire, Berkshire & 
Buckinghamshire (CAROBB), 
South West region (SWCAR) and 
Yorkshire & Humber region 
(YHCAR) 
1985/2011 
- 2017 381k 2012 
Department of Health Termination of Pregnancy England and Wales 1968 - 190k 2016 
UK Data Service  1946 Birth Cohort Study England, Scotland, Wales and Northern Ireland 1946 -  5k  
 
1958 National Child Development 
Study England, Scotland & Wales 1958 -  17k  
 
1970 British Cohort Study England, Scotland, Wales and Northern Ireland 1970 -  17k  
 
Adult Dental Health Survey 
(ADHS)     
 
Avon Longitudinal Study of 
Parents and Children (ALSPAC) Bristol area 1991 -  14k  
 
English Longitudinal Study of 
Ageing (ELSA) 
Representative sample of the 
English population aged 50 and 
older 
2002 -  10k 2014
-15 
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Health and Lifestyle Survey 
(HALS) 
12,672 addresses were selected 
from the electoral rolls of 198 
randomly selected constituencies, 
including 7,414 visited by a nurse 
who carried out various 
physiological measurements and 
6,572 returned self-completion 
questionnaires 
1984/85 
1991/92 
9k 
6k 
1984
/85 
1991
/92 
 
MINAP: Myocardial Ischaemia National Audit Project; FCE: finished consultant episode; FAE: finished admission episode; M 
million; k thousand 
 
 
